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Abstract 
Background: 
Asthma is the most common long-term condition in children in the United Kingdom (UK). 
Asthma-related hospitalisations and mortality are disproportionally higher in the UK, compared 
with other European countries, however the reasons for this disparity remain unclear. A putative 
explanation is that that prevalence of suboptimal asthma control in children in the UK is higher 
than in continental Europe. If this is indeed correct, then the drivers of suboptimal control, such 
as poor adherence to therapy resulting from poor understanding of the role of preventer 
medication (inhaled corticosteroids (ICS)) in UK children would be of significant clinical interest. 
Therefore, in this thesis, I sought to first identify the levels of asthma control and medication 
adherence in a non-random sample of London secondary school children. Then, I used focus 
groups to further highlight the barriers to good medication adherence, and generate insights into 
potential solutions. To achieve these aims, I developed and implemented an online questionnaire 
to be delivered in schools, which included the validated Asthma Control Test (ACT).  
Methods: 
This thesis is divided into three main sections. The first and second sections include original data 
from an observational research study, which collected data about asthma control, from 24 London 
secondary schools between December 2014 and March 2016. The aim of the first section was to 
assess current levels of asthma control and medication adherence among children with asthma in 
London secondary schools. Data were collected using an online questionnaire, which included 
the validated ACT to measure asthma control, as well as additional questions about knowledge, 
healthcare use, medication use, school attendance, lifestyle and emotion and behaviour, using the 
validated Me and My School (M&MS) questionnaire. The second section of this thesis includes 
data generated from six focus groups, conducted in four London secondary schools with 56 
students. In order to generate data to inform future interventions, discussions focused on the 
barriers to medication adherence among teenagers, and how these barriers could be addressed.  
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The third section comprises a systematic review of school-based self-management interventions 
for children with asthma. The review uses a mixed-methods approach, and includes both 
quantitative and qualitative study data. A process evaluation is also included, to identify 
intervention elements that are associated with implementation success. 
Results: 
766 children with asthma from 24 schools were surveyed. Almost half of the students (45.7%; n 
= 350) had poor asthma control by ACT score. Adherence with asthma medication was low, 
regardless of asthma control (56.2% self-reported forgetting to use their ICS “preventer” inhaler; 
29% self-reported not using their SABA “reliever” inhaler when they needed it, at least some of 
the time). Health care involvement was relatively high, with at least one unplanned GP visit, due 
to asthma in the previous four weeks, reported by 28.1% of students; at least one unplanned 
hospital visit was self-reported by 15.7% of students; and at least one unplanned school nurse 
visit due to asthma was self-reported by 16% of students. At least one whole school absence was 
reported by 20.9% of students. Unplanned medical care and school absences were higher among 
children with poor asthma control, according to the ACT.  
Themes from focus groups suggested that social stigma, fear of embarrassment, forgetfulness, 
and incorrect attitudes towards medication were all contributory factors to poor medication 
adherence. Communications with healthcare professionals were also identified as key unmet 
needs of teenagers with asthma.   
The findings from the meta-analyses, included in the systematic review of school-based self-
management interventions, showed that such interventions were effective in improving several 
outcomes, largely related to healthcare use. These included hospitalisations, emergency 
department (ED) visits, and health-related quality of life. There was no evidence that school-based 
interventions improved school absences, experiences of day and night time symptoms, or the use 
of medication. The findings from the analysis of the process evaluation studies showed that a 
theoretical framework is important in the development of a successful intervention.   
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Conclusions:  
First, in a large non-random sample of secondary school children with asthma, the proportion of 
children with suboptimal control is worryingly high, and this is associated with general poor 
adherence to prescribed therapy asthma. Second, focus groups identified practical and social 
barriers to good adherence, that should be addressed in future studies. Third, previous studies 
suggest that school based interventions are effective in reducing incidences of unplanned and 
urgent healthcare use. The systematic review included studies that included relatively hard-to-
reach populations, suggesting that such interventions may be effective across diverse populations, 
including those considered hard-to-reach.   
The findings in this thesis informed the development of a school-based self-management 
intervention, to be piloted in London secondary schools, and an NIHR-funded global research 
group award on improving asthma control in African children.  
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Chapter 1. Introduction 
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1.1 Overall rationale 
Asthma is a common chronic respiratory condition that affects over 300 million children and 
adults worldwide [1]. Symptoms of asthma include episodic feelings of breathlessness, wheeze, 
and cough, tightness in the chest and difficulty engaging in daily activities, including physical 
exercise.  A major goal of therapy is to achieve good control of asthma symptoms. However, 
despite diagnosis and initial treatment, some patients remain symptomatic. In these patients, 
treatment may therefore need to be escalated (i.e. stepped up). For this reason, the definition of 
asthma severity by the Global Initiative for Asthma (GINA) combines both symptoms and current 
therapeutic status. By the GINA classification, patients with “mild” asthma are well controlled 
with reliever medication on an as needs basis, or with a low-dose inhaled corticosteroid inhaler 
(ICS). “Moderate” asthma is well controlled with inhaled low-dose ICS + long acting beta 2 
agonist (LABA), whereas “severe” asthma can be well controlled on high dose ICS + LABA). 
Severe asthma, in particular, should only be considered after the exclusion of other explanations, 
such as poor inhaler technique; poor medication adherence; incorrect diagnosis of asthma (some 
children have rare conditions such as primary ciliary dysplasia (PCD)); comorbidities; and 
ongoing exposure to asthma triggers [2]. The severity of asthma symptoms varies widely between 
individuals, and in the most severe cases, acute or chronic episodes of airway narrowing can result 
in hospitalisation or, rarely, death. 
Airway narrowing during exacerbations of asthma, where children become acutely breathless, are 
due to the contraction of smooth muscle and inflammation of the lining of the airways. According 
to GINA, the long-term goal of asthma management is to achieve good day to day asthma control 
in order to reduce the number of asthma symptoms and exacerbations experienced by all 
asthmatics [2]. Asthma, particularly if it is poorly controlled, can considerably impact on daily 
functioning and quality of life for asthma sufferers; particularly in their ability to take part in 
everyday activities, and, for children, their capacity to fully engage in school lessons or work. 
Clinicians therefore take asthma control seriously, since it is an indicator of future asthma 
exacerbations [3]; i.e. poor control of asthma increases the risk of asthma attacks, and is used as 
a guide for the need to step up or step down inhaler therapy. In this context, asthma control can 
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be considered as a way of describing the extent to which the various clinically relevant symptoms 
of asthma have been reduced, or removed completely, as a result of diagnosis and subsequent 
treatment [4]. Clearly, there are several domains that contribute to the assessment of asthma 
control, but the presence or absence of symptoms and the extent to which an individual can engage 
in everyday activities is a key component. In poorly controlled cases, it is a greater burden of 
asthma symptoms and more subjective (and objective) experience of asthma exacerbations [4]. 
The result of poor asthma control is not only of significance to the patient (child) themselves, but 
also to the National Health Service (NHS), with increased need for unplanned General 
Practitioner (GP) and hospital emergency department visits [5]. 
In the United Kingdom (UK), asthma remains a major problem in children. Approximately one 
in eleven children and young people in the UK have a diagnosis of asthma, and the prevalence of 
asthma among children and young people in the UK is higher than elsewhere in Europe. 
According to Asthma UK, three children in every school classroom are living with asthma, 
although many more will have experience the symptoms of asthma during their lifetime [6]. The 
effect of asthma on UK children at school is not well reported.  However, research by Moonie et 
al [7] in the US in 2006, reported that children with asthma, particularly those with severe or 
persistent asthma, are more likely to have time off school, compared to their peers without asthma 
[7]. Over the course of one academic year, students with asthma in the study of Moonie et al [7] 
averaged 9.5 days absent from school; an additional 1.5 days more than their peers. Further, 1537 
school absences were tracked, and the data showed that 31% of absences were directly as a result 
of asthma symptoms [7]. Whether these results are generalizable to children attending UK 
schools, remains unclear.  
Adherence to medication is defined as the extent to which an individual abides by the treatment 
plan set by their doctor for any given condition [8]. Possible factors which may predict adherence 
behaviours include obtaining new prescriptions for medication, social concerns, and attitudes and 
beliefs towards the medication. Medication adherence is considered to be associated with 
hospitalisations and mortality [9], and tends to be more often seen in patients with poorer asthma 
control, since suboptimal adherence in a child with very mild asthma may not necessarily result 
in acute worsening of symptoms. Currently, there are no specific guidelines for what constitutes 
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nonadherence in asthma treatment; however Strandbygaard et al suggest that it is applied to cases 
where less than 80% of medication is taken as prescribed [10]. Although similar in meaning, 
adherence is generally preferred to the term compliance, due to the negative connotations 
associated with compliance, in placing full responsibility with the medical provider, rather than 
giving some responsibility to the patient [11]. Throughout this thesis, I have referred to 
medication adherence as meaning cases where children are taking (or not taking) their medication 
as prescribed by their GP.  
Maintaining good management of asthma symptoms, and achieving good asthma control, can 
reduce the negative impact of asthma on quality of life, as well as ease the economic burden 
placed on healthcare services. According to GINA, good asthma control is characterised by 
minimal or no day or night-time symptoms, however healthcare professionals in the UK recognise 
that this may not always be possible in some more severe cases [12]. It is reasonable to assume 
that achieving good asthma control in children and young people at school will positively impact 
on social and educational development, through minimising the likelihood of missed learning and 
social opportunities as a result of asthma symptoms. One component of achieving good control is 
supporting self-management – a process that involves the patient taking responsibility for their 
asthma away from the clinical environment. It involves working in partnership with their doctor 
to successfully manage the symptoms of asthma at home. Self-management will be discussed 
further in chapter two.  
 
1.2 Hypothesis, Aims and Objectives 
Hypothesis  
I hypothesise, from the evidence discussed above, and subsequently in Chapter three, where I 
discuss the findings of my school-based questionnaire for children with asthma, that there is a 
high prevalence of poor asthma control, as measured by the ACT (Asthma Control Test), in 
children and young people with asthma attending secondary schools in London. I further 
hypothesise that children with poor asthma control will have (i) higher rates of school absences; 
(ii) high rates of unplanned GP and hospital visits, due to their asthma, and (iii) poorer quality of 
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life, compared to students with good asthma control. I also hypothesise that one reason for the 
high prevalence of poor control is that the majority of children with asthma have suboptimal 
knowledge of prescribed asthma medication, and suboptimal adherence to prescribed medication. 
My null hypothesis is that there is no significant difference in knowledge, adherence to prescribed 
medications, school attendance and healthcare use between the children and young people with 
asthma with good and poor control, as assessed using the ACT.   
 
Aims and Objectives 
To address these hypotheses, I sought in this thesis to address three specific questions: 
i. How well controlled is asthma among children and young people in 
London secondary schools? 
ii. How well is asthma medication adhered to among children and young 
people in London secondary schools, and what are the barriers to 
achieving good adherence? 
iii. What is the evidence that self-management interventions are effective, 
according to the current literature? 
To answer the first question, I sought to identify current levels of asthma control and adherence 
to medication among secondary school children in London, using an online assessment tool, 
including the Asthma Control Test (ACT). I also sought to record unplanned medical visits, 
school attendance, and emotional and behavioural wellbeing - comparing their frequency between 
students with asthma who had good and poor asthma control, according to the ACT. To answer 
the second question, I sought to explore putative barriers to suboptimal adherence among 
teenagers, using free-text data within the online assessment tool, and subsequent focus groups. I 
aimed for these data to inform the development of a school-based self-management intervention, 
to be implemented in secondary schools across London – an intervention aimed at improving 
asthma control in children and young people.  
To answer the third question, I sought to conduct a systematic review of school-based self-
management intervention for children with asthma. I planned to use the findings of the systematic 
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review, along with the findings from the online assessment tool and subsequent focus groups, to 
justify the development of a school-based intervention.  
 
1.3 Overall structure to address hypothesis and aims 
Chapter ONE introduces the research, including the rationale for the study. The research 
questions, and the primary and secondary aims are also described, accompanied by an overview 
of how the aims will be achieved. Chapter one also includes the research hypothesis.  
Chapter TWO delivers the general background to paediatric asthma, including a comparison of 
global statistics for asthma prevalence, morbidity and mortality. The Chapter continues with a 
review of asthma control, including how it is measured, and the success of these measurements 
in assessing asthma control, as well as the determinants of poor control. Also included is an 
evaluation of the prevalence of poor asthma control across different countries. The Chapter ends 
with an overview of asthma management among children and young people in schools.  
Chapter THREE discusses the school-based survey, including the development of the online 
assessment tool, the methods that were used to implement the tool, and the findings from the pilot 
study and the main trial.  
Chapter FOUR includes the rationale for the qualitative component of the study and an overview 
of the development of the focus groups, and concludes with the main findings from the qualitative 
work.  
Chapter FIVE consists of a mixed-methods systematic review of school-based self-management 
interventions for children with asthma. This review includes a process evaluation, to ascertain the 
configurations of interventions that contribute towards its success, as well as a meta-analysis of 
Randomised Controlled Trials (RCT).  
Chapter SIX brings together the content of this thesis and discusses the main findings, and the 
implications of these findings for both research and practice. It also discusses the challenges and 
successes of this thesis, as well as the plans for the next steps and future research, and closes with 
an overview of the final conclusions from this thesis.  
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Chapter 2. Paediatric Asthma: A Continuing Problem 
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In this chapter I will discuss the prevalence of paediatric asthma worldwide, and asthma-related 
morbidity and mortality in the UK, Europe and worldwide. Asthma control, and the determinants 
of poor asthma control, will also be discussed, including the current ways in which control is 
assessed clinically. This evidence specifically addresses some of the issues that remain to be 
addressed on paediatric asthma in the UK, for asthma sufferers and healthcare professionals. 
  
2.1 Background to Paediatric Asthma 
Asthma, derived from the Greek term meaning ‘short of breath’, has been a respiratory condition 
since the late nineteenth century, following the work of Doctor Salter, who himself was an asthma 
sufferer [13]. In the early half of the 20th century, asthma was treated using medicines, including 
β2-adrenoceptor agonists and salbutamol, initially as over the counter medications. Following an 
epidemic in the 1960s, which saw a sharp rise in the number of asthma deaths reported across the 
United Kingdom (UK) and Australia, a clearer understanding emerged of the immunology of 
asthma, and how it operated as an inflammatory disorder.  
There is currently no ‘gold-standard’ diagnostic test available for asthma; instead it is diagnosed 
by a physician through the presence and pattern of respiratory symptoms, repeated lung function 
tests, and a patients’ response to medication [14]. The close association of these clinical variables 
does not necessarily mean that the underlying pathology is similar. Indeed, the recent Lancet 
asthma commission (discussed below) concluded that the term “asthma”, with its implication that 
it is a single pathology, should be discarded, and researchers and clinicians should in future focus 
on “treatable traits” [15]. Irrespective of the underlying pathology, clinical symptoms of asthma 
are normally treated using an inhaler and a spacer. Although inhaled treatments vary according to 
individual patients, asthma medication typically include (i) inhaled corticosteroids (ICS), which 
have no immediate effect on symptoms, but suppress the inflammation that leads to 
bronchoconstriction, long-acting beta-agonists (LABA), and taken twice daily to provide medium 
term bronchodilation, and (ii) short-acting beta-agonists (SABA), which directly dilate the 
bronchi of the lower airway and rapidly relieve the symptoms of asthma. Some children with well 
controlled asthma may require a SABA inhaler, but the majority will require both a SABA and 
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ICS. The British Thoracic Society/Scottish Intercollegiate Guidelines Network (BTS/SIGN) 
guidelines have previously introduced a stepwise approach to asthma management, to help 
patients to achieve optimal control of their asthma [16]. The stepwise approach is shown in figure 
one. 
Figure 1. BTS/SIGN stepwise approach to asthma management [16] 
 2.2 Prevalence, Mortality and Economic Impact 
 2.2.1 Asthma Prevalence 
There is a discernible geographic variation in the global prevalence of asthma, and westernised 
countries report a higher prevalence of the disease, compared with the rest of the world. However, 
the global prevalence of asthma is continuing to rise as non-Western countries become 
increasingly more westernised. As a result, Masoli et al 2004 have reported that there could be an 
additional 100 million people living with asthma around the world by 2025 [1]. As seen in figure 
two (below), the prevalence of asthma in the UK and Republic of Ireland is disproportionately 
high, compared with standardised data for the rest of Europe [17]. The Global Burden of Asthma 
Report conveyed that an estimated 16.1% of people living in the UK and Ireland have received a 
clinical diagnosis of asthma, out of a total population of 63.3 million people [1]. This is compared 
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to Western Europe, where the reported asthma prevalence is much lower, estimated to be 
approximately 6% of the total population of 291 million people. It is also likely that many more 
people are living with the symptoms of asthma, without a formal diagnosis from a clinician. The 
prevalence of asthma in the UK is seemingly comparable with the figures reported across North 
America, Australia and New Zealand. According to Bousquet et al 2010, in these regions, the 
prevalence of asthma reportedly stands at 10%, 14.7% and 15.1%, respectively [18].     
 
Figure 2. Global asthma prevalence [17]  
In contrast, the prevalence of asthma in developing countries has historically been much lower 
than the Western world. However, the prevalence of asthma in less economically developed 
countries is growing, and the subsequent burden of asthma is far greater in these areas, due to a 
lack of available resources to teach patients about asthma management, a reduced infrastructure 
and restricted access to basic medications and clinical care [1]. In less economically developed 
regions, such as North Africa and Central America, approximately 3.9% of the population (7.7 
million people) and 3.8% of the population (5.2 million people) are living with asthma, 
respectively [17], however complications from asthma are much higher in these regions. A recent 
report looking at the incidence of atopic disorders across Africa noted that the spread of asthma 
was highest in urban areas, where a higher standard of living was commonplace [19], providing 
further evidence that the prevalence of asthma is greater in urbanised regions.  
Sharp increases in the global prevalence of childhood asthma are also becoming particularly 
noticeable [17]. Asthma generally presents itself much earlier in life than other respiratory 
conditions, and typically affects more children than adults. Asthma is one of the most prominent 
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non-communicable diseases among children internationally, and is the most common chronic 
condition in children in the UK. In recent years, an anticipated 308 million children worldwide, 
equivalent to 14% of the global paediatric population, will have experienced asthma symptoms at 
least once during their lifetime [20], however this figure is likely to be higher than the data 
suggests. According to the International Study of Asthma and Allergies in Childhood (ISAAC) 
questionnaire, paediatric asthma is also much higher in developed countries. Outside of Western 
Europe, Costa Rica and New Zealand recorded the highest prevalence of paediatric asthma. 
Approximately 27.3% and 26.7% of children aged 13-14 years, respectively, had experienced 
asthma symptoms in the twelve months prior to the study [21]. The lowest prevalence, recorded 
in Albania, was 3.4%. Similar trends were also seen among children aged 6-7 years. 
It is unclear why the prevalence of asthma is so much higher in urbanised countries. One 
explanation could be that advancements in medicine have made diagnostic screening for asthma 
and access to screening easier in more economically developed countries. In the absence of a 
standardised diagnostic tool for asthma, it could be that more westernised countries, such as the 
UK, have more sophisticated screening techniques that may diagnose asthma more readily, 
compared with less economically developed countries. Conversely, children in westernised 
countries with easy access to medical care may be at increased risk of an over-diagnosis of asthma 
- leading to a higher recorded prevalence. A further explanation could be variations in the 
measuring and recording of asthma cases in different countries. For example, different survey 
methods used by studies such as the International Study of Asthma and Allergies in Childhood 
(ISAAC) [22] and the World Health Survey [23] may contribute towards differences in the 
statistics from different areas. Ideally we need a standardised measure for assessing the prevalence 
of asthma worldwide to help compare trends in asthma prevalence across different countries. A 
third, and not mutually exclusive, explanation is that differences in the mix of asthma phenotypes 
may alter the way asthma is perceived in different countries. According to the Lancet asthma 
commission [15], at least two clinical asthma phenotypes exist: extrinsic asthma, due to 
environmental allergens and associated with younger age of onset, atopy and the presence of other 
allergic diseases; and intrinsic asthma, due to factors inside the body and associated with older 
age and the absence of atopy. If one phenotype resulted in more attacks and hospital admissions, 
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then the clinical burden of asthma may be perceived as higher than a country where the dominant 
phenotype leads to mild chronic symptoms, but fewer attacks.  
In the UK, 1.1million children (one in eleven) are currently thought to be living with asthma. This 
equates to an average of three children in every school classroom, according to Asthma UK, 2014 
[6]. Notwithstanding the issues related to assessing prevalence, discussed above, the prevalence 
of asthma symptoms among children in the UK is markedly higher than other western European 
countries, and are comparable with figures seen in Australia and New Zealand. According to the 
most recent phase of the ISAAC study, conducted between 2000 and 2003 by Asher et al, the 
prevalence of asthma symptoms among 13-14 year olds in the UK was 20.9%, compared with 
Belgium, which reported the lowest prevalence at 8.3%. The reasons for the disproportionally 
high prevalence in the UK, compared with other European countries, remains largely unclear. If 
it is a true increase, then one explanation is that there has been a rise in the tendency for allergic 
sensitisation – a major risk factor for the atopic asthma phenotype. Alternatively the increase, 
may be due to increased exposure to environmental factors, such as air pollution, which is much 
higher in urbanised areas [24], and is associated with both new onset asthma and exacerbations 
in established asthmatics. 
The ever-changing global prevalence of asthma does still raise questions over the accuracy of 
reporting, and whether or not asthma is over or under-diagnosed; particularly as many countries 
have seen a rapid increase in prevalence over time. In the absence of a standardised diagnostic 
tool in clinical practice, it is difficult to know whether all asthmatic diagnoses are appropriate. 
Historically, asthma has tended to be under-diagnosed, leading to patients not receiving their 
required treatment and notable increases in morbidity and mortality rates. However, more 
recently, some researchers have suggested that some patients, for example those with cough alone, 
or shortness of breath on exercise due to poor fitness, may be diagnosed with asthma [25], in an 
attempt to not miss any patients with true asthma. Potential over-diagnosis of asthma, has 
significant implications for healthcare systems, as well as for patients. It imposes an additional 
financial strain on healthcare systems, through unnecessary medical appointments, care and 
prescribing unnecessary treatment. Conversely, for many patients with symptoms of asthma, a 
failure to recognise true symptoms may lead to poorer long-term outcomes, and increased risk of 
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hospitalisation [26]. For example, in the UK, under-diagnosis results in more absences from work 
and school and increased GP and hospital visits, contributing both directly and indirectly to the 
overall economic cost of asthma [27].  
The potential for both over and underdiagnoses of asthma discussed above, led, in 2013, NICE to 
the development of “objective” criteria for asthma diagnosis [28]. To date, these criteria are not 
yet in routine use across the UK, and in the absence of a standardised diagnostic tool for asthma, 
doctors in primary care continue to diagnose bronchial asthma as always, using clinical symptoms 
and response to therapy. These issues are even more pronounced in younger children (under 6 
years of age), where wheeze is common - occurring in up to a third of children of pre-school age 
[29]. In this age group, data from the Tucson (US) longitudinal study [30], which reported that 
preschool wheeze for the majority of children was not associated with atopy – and most children 
were asymptomatic by school age was one of the first evidence that the mechanisms for wheeze 
in the majority of children in this age group is was not necessarily the same in all children and 
adults. A further layer of complexity when attempting to obtain an accurate overview on the state 
of paediatric asthma is the potential variations in clinicians’ use of the ‘asthma’ label. For 
example, Speight et al recruited a sample of 179 children aged seven years old, who had suffered 
at least one episode of wheeze in the previous twelve months. They found that 165 had visited 
their doctor for chest symptoms, however a diagnosis of asthma was given to just 21 children. 
This was despite 56 children experiencing between 4 and 12 episodes of wheeze in a year, and 31 
children experiencing more than 12 episodes of wheeze in a year [31]. Conversely, in a study 
done in Australia, of 100 children with chronic cough, almost half were given a diagnosis of 
asthma, without any diagnostic testing. Following investigation, diagnoses of asthma fell to 5% 
[32]. Similarly, in a population of 90 adults from a tertiary care centre in Canada, 62% were 
receiving treatment for asthma, despite not meeting the criteria for the condition [33]. Indeed, in 
a recent editorial, Bush and Fleming, 2016, suggested that over-diagnosing asthma in the general 
paediatric population is both prevalent and has serious consequences. First, children diagnosed 
with asthma will often be prescribed treatment including inhaled corticosteroids (ICS) with its 
(rare) risk of adrenal suppression and osteoporosis, unnecessarily [34]. Second, some healthcare 
professionals over-diagnosing asthma has the potential for the condition to be regarded as ‘trivial’, 
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leading to complacency in those with actual asthma and an increased risk of major adverse 
outcomes [35].  
In summary, paediatric asthma prevalence and burden in the UK is a complex construct - 
depending in part on how, and in which populations, data are generated. However, there is no 
doubt that more data are needed in unselected populations. It may well be that potentially 
“unbiased” recruitment sites such as schools, to obtain these data will offer new insights into the 
key questions about how controlled children are who have a diagnosis of asthma, and issues 
related to both over and underdiagnoses.  
   2.2.2 Asthma Mortality 
According to the World Health Organisation (WHO), there have been an estimated 250,000 
deaths worldwide attributable to asthma [36], and mortality is continuing to rise, despite advances 
in treatment and management of asthma in recent years. There are large geographical differences 
in mortality rates, with higher numbers of asthma-related deaths typically observed in lower and 
middle-income countries. A probable explanation for this includes the restricted access to 
healthcare facilities and medication in these areas [36]. In support of this, age-standardised data 
of asthma-related deaths among 5-34 year olds around the world, recorded between 2001 and 
2010, found that asthma mortality was highest in low-income countries, such as South Africa, 
where an estimated 31 fatalities per million were recorded. This compared unfavourably with 
high-income countries, where mortality rates for all nations in this category were less than five 
fatalities per million. Two countries which fell within the group of high-income countries, namely 
Iceland and Cyprus, recorded no deaths from asthma during the given time period [37].  
Due to improvements in asthma, especially the introduction of ICS treatment, asthma deaths have 
declined since the 1980s [17]. More recent mortality estimates are less clear [38], although 
Ebmeier et al reported a 57% decline in asthma related deaths from 46 countries, of which 78% 
were high-income and 22% were middle-income, between 1993 and 2012 [38]. However, 
between 2006 and 2012, the average numbers of deaths per 100,000 has remained stable at 0.19 
(0.16-0.21) across all participating countries. According to these data, England and Wales 
reported the highest number of deaths across Western Europe (0.19 per 100,000) in 2011. This is 
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compared with Sweden, with no deaths were reported [38]. It is unclear why deaths from asthma 
are disproportionally high in the UK, but one potential explanation is the higher prevalence of 
poorly controlled asthma, compared with elsewhere in Europe (of note, not all of the data were 
available for all of the countries from 1993, the year reported by Ebmeier et al [38]).  
Clearly differences in asthma-related morbidity and mortality between countries may, at least in 
part, reflect variations in asthma prevalence – i.e. the more prevalent a condition is, the greater 
the number of patients who will be at risk of severe outcomes leading to hospitalisations and 
death. But, for the UK this is cannot be the only explanation, since deaths from paediatric asthma 
are disproportionally high – even after adjusting for asthma prevalence. For example, Ingrid 
Wolfe et al, 2013 [39] found that death rates across Western Europe from asthma varied from 0 
to 1.76 deaths from asthma per 100,000, with the UK reporting 0.66 deaths per 100,000.   
In light of the disproportionately high rates of asthma-related deaths in the UK, asthma mortality 
has been more closely studied in the UK in recent years, through both confidential enquiries and 
case control studies. For example, a recent large scale national report by Levy et al, 2014, 
examined in detail a sample of 195 UK patients with asthma, whose cause of death was classified 
as ‘asthma’, for the period 2012 to 2013. Compatible with previously reported statistics, Levy’s 
report found that the majority of the asthma-related deaths in the UK were adults. Even so, 
children and adolescents aged twenty years and younger accounted for 14% of the deaths during 
the review period [14]. The major finding of Levy’s report were that deaths were associated with 
potential avoidable factors, including non-adherence with asthma medications, non-adherence 
with medical advice, the absence of an asthma action plan, failure to obtain medical assistance 
during the final exacerbation and overexposure to allergens and tobacco smoke, were all key 
contributors to the deaths. Additional confidential enquiries, conducted in the East of England 
between 2001 and 2006, reported that almost half of the deaths from asthma occurred in children 
who were being treated for mild to moderate forms of the disease [40]. One (of many) explanation 
for these deaths is that the true severity of the disease was not realised by managing clinicians. 
Overall, these reviews demonstrate the seriousness of addressing avoidable risk factors, such as 
non-adherence with ICS, and indicates a poor understanding among patients of asthma 
management and medication adherence. Environmental factors, including outdoor allergens and 
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overexposure to tobacco smoke should also not be overlooked since these also increase the risk 
of death from asthma [41]. Examples of the importance of the environment in asthma control is 
that, following the introduction of the smoke-free legislation in the UK in 2006, hospital 
admissions for paediatric asthma reduced by 6802 over the first three years of the ban [42]. 
Additional factors associated with asthma-related deaths include delays in obtaining medical 
assistance during an asthma attack. For example, the National Review of Asthma Deaths found 
that 45% of patients who died due to their asthma did so before seeking medical assistance for 
their symptoms [14]. On this background, there is increasing need to identify the ‘high risk’ 
patient. 
Patients who are identified as characteristically at high-risk of an asthma death typically fall into 
one of the categories below [2]: 
 A history of a near-fatal asthma attack 
 Unplanned hospitalisations or emergency department visits within the 
previous twelve months 
 Current, or recent, use of oral corticosteroids 
 No current use of inhaled corticosteroids 
 Overuse of SABA 
 Poor adherence with asthma medications 
 Food allergies 
Some items in this list (e.g. poor adherence) strongly suggest that one way of reducing risk is 
improving the capacity of children and young people to self-manage their disease. Self-
management involves the patient taking responsibility for their own condition and well-being, by 
working with their doctor to maintain good control of their symptoms, away from the clinical 
environment. Since the 1990s, self-management plans have become an essential part of treatment 
for asthma [43]. In many cases, complying with prescribed treatment plans is key to reducing the 
risk of an asthma exacerbation or fatality, and continued self-management and surveillance is 
required to ensure that mortality rates continue to fall until they reach near zero. Although 
personalised management plans have been introduced to try and achieve this, through 
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documenting treatment plans and individual triggers, the use of these plans in the UK remains 
low. The national review of asthma deaths found that just 23% of the patients who had died had 
been given an asthma action plan, and this finding has been echoed across Canada [44], America 
[45], Australia [46], and Europe [47]. Issues related to self-management are discussed in more 
detail in section 2.3.1. 
Another potentially addressable finding within the concept of self-management highlighted by 
the National Review of Asthma Deaths is that just under half of the patients who died from asthma 
did not request emergency help during the final attack [14]. It has been suggested by Levy et al 
2015 that while this may be due to an inability to request assistance during the final attack, it is 
equally possible that medical assistance was not requested due to patients being unaware of the 
severity of their symptoms [48]. This phenomenon may also imply that some patients have 
developed a higher threshold for coping with asthma symptoms, beyond that considered 
acceptable by a clinician.  
In summary, like asthma prevalence, assessing the burden and preventable factors associated with 
severe asthma outcomes, including death, is a complex process. However, a consistent theme 
emerging from individual case reviews of deaths in children and young people are nonadherence 
with medication, delays in seeking medical help, and no asthma action plan as contributory factors 
to avoidable deaths from asthma in children. The importance of self-management in addressing 
these issues is further discussed in section 2.3.1 below 
2.2.3 Economic Impact 
 The economic impact of asthma is high. It is estimated that asthma treatment and care costs the 
National Health Service (NHS) up to £1 billion per annum. These costs are accumulated directly, 
owing to hospital admissions, care and treatment, and indirectly because of a potential loss of 
earnings through missed days at work or school. In other western countries, the economic impact 
of asthma ranges between $300 and $1300 per patient per year [17]. As the global prevalence of 
asthma increases, the associated costs are also continuing to rise. For example, in 2007, the total 
cost of asthma in America was reportedly $56 billion; a 6% rise from 2002 [45]. Moreover, in 
Europe, the current total cost of asthma is an estimated €17.7 billion annually [17]. Patients with 
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severe, or poorly controlled asthma, are responsible for approximately 50% of the total costs of 
asthma, despite comprising only a small minority of asthma cases. The financial implications 
associated with asthma are considered to be among the highest of all chronic conditions, due to 
the strong pressures placed on healthcare services [5], and loss of productivity. As the prevalence 
of asthma is set to rise even further over the coming years, it is becoming increasingly important 
to improve asthma control and self-manage the condition away from the healthcare setting, to 
reduce the associated costs and ease the financial burden currently placed on healthcare systems.  
One of the largest contributors to the direct cost of asthma is the care administered in the hospital 
setting. A systematic review by Bahadori et al in 2009 noted that the patient care received in 
hospitals accounts for between 47% and 86% of the overall costs of asthma [5]. However, due to 
differences in study designs and definitions of costs, the economic evaluation that is reported here 
is limited. Moreover, the data was collected at different time points across different studies, 
therefore this may also account for some of the differences seen in the costings. Despite this, the 
review was first to systematically review the economic burden of asthma across different 
countries. Age standardised data for asthma-related hospital admissions also highlighted that, in 
2011, admission rates for adult asthmatics in the UK were among the highest in Europe, second 
only to Spain [49]. Age-standardised data from the European Respiratory Society (ERS) has also 
shown that hospitalisations for asthma are higher for children than adults. The lowest reported 
figure, seen in Portugal, was 76.56 admissions per 100,000, compared with the highest figure, 
from Italy, which reported 325.17 admissions per 100,000 children aged 15 years or younger [50]. 
Hospital admission figures for low and middle income countries are less readily available [20].  
In the UK, asthma is a leading cause of hospital admissions among children [51]. Between 2011 
and 2012, hospitalisations for asthma in the UK reached approximately 65,000; of which 25,000 
(38%) were children aged 14 years or younger [6]. It is widely believed that approximately 75% 
of hospital admissions for asthma in the UK could be prevented with appropriate management 
[6]. The high rates of unplanned presentations at hospital emergency departments, and 
hospitalisations, seen across the UK and Europe, are indicative of increasing incidences of 
suboptimal asthma control, poor disease management and increased exposure to asthma 
exacerbation triggers [52]. Loss of productivity, including time spent away from work or school 
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due to asthma or caring for someone with asthma, is one of the most commonly reported factors 
associated with the costs of asthma [53], and is thought to account for the largest proportion of 
the indirect costs of asthma [5]. According to the European Respiratory Society (ERS), in 
England, 69% of parents with children have reportedly taken time off work to care for their child, 
and 13% have said to have given up their jobs to provide full-time care for their child with asthma 
[50]. A cost comparison between paediatric and adult asthma populations found that the total 
accumulated indirect costs of asthma are higher among children. Moreover, parental days lost 
from work to care for a poorly child are greater among parents whose child has suboptimal asthma 
control [54]. 
Severe and suboptimally controlled asthma cases are responsible for 50% of all direct and indirect 
costs, despite severe asthma cases representing just 10-20% of all asthma diagnoses [17]. In Italy, 
for example, the annual cost per patient, stratified by disease severity, has ranged from €720 in 
patients with intermittent asthma, to €3328, in patients with severe persistent asthma [55]. 
However, this study compared costs across 16 hospital-based clinics, and differences in data 
collection methods across the different hospital may account for some of the differences seen in 
the data. Differences in disease classification may also explain some of the variations in costings. 
Similarly, severe asthmatics in France recorded an average of six or more days in hospital due to 
their asthma, compared with no days in hospital for less severe patients [53]. Across Western 
Europe, 43% of children have lost school days due to their asthma. Although no evidence exists 
showing the direct decrease in academic achievement due to asthma, time off from school can 
impact on social development, and is likely to indirectly affect academic attainment.  
Some research also suggests that nurse-led approaches are as effective as GP-led approaches in 
treating asthma and improving outcomes, and are more financially viable [39, 56, 57]. However, 
while Kamps et al [57] did see a 7.2% reduction in healthcare costs following a nurse-led 
approach, and no significant differences in outcomes between children following a nurse-led or 
doctor-led approach to treatment, this data came from a small sample of 74 children, and therefore 
is underpowered to detect a significant change. Currently, there are very few studies that provide 
a comprehensive cost-effective analysis of alternatives to GP-led approaches, and more research 
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in this area is required to confirm or deny the hypothesis that nurse-led approaches could be a 
suitable alternative to ease the financial burden on healthcare settings.  
 
2.3 The importance of targeting asthma control 
According to both the World Health Organisation (WHO) and the GINA grouping, people with 
asthma should expect that successful management of their condition will lead to a good quality 
of life [58]. GINA, a leading international asthma organisation, suggests that the majority of 
asthma cases can, and should, be managed away from the clinical environment [59]. GINA has 
played a key part in developing and disseminating standardised guidelines to try and improve 
asthma control, which have been implemented worldwide. The GINA guidelines define asthma 
control as the extent to which people with asthma experience asthma symptoms or exacerbations, 
and the degree to which the symptoms are improved with treatment [59]. The frequency of asthma 
symptoms are, in part, a reflection of how well controlled the condition is. The rate at which 
inhalers are used is also typically considered as an indicator of asthma control. GINA 
characterises good asthma control (also referred to as optimal asthma control) according to four 
goals [59]: 
1. Minimal or no day and night time symptoms 
2. The ability to fully participate in physical activity 
3. Normal, or near normal, pulmonary function (based on Forced Expiratory 
Volume (FEV1)) 
4. Minimal side effects from medication and decreased use of β-agonist 
medication. 
Poor asthma control (also referred to as suboptimal asthma control) is typically existent in people 
who use two or more canisters of SABA, or between 10 and 12 puffs per day on their inhaler. 
These markers are indicative of an increased risk of suffering a fatal or near-fatal asthma attack. 
Poorly controlled asthma, particularly in childhood, can elicit high rates of unplanned GP and 
hospital visits and absences from school [60].  
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Despite the availability of effective treatment for asthma in developed countries, and national and 
international guidelines depicting recommendations for good asthma management, poorly 
controlled asthma is still widespread, particularly among children and adolescents. Indeed, the 
true “burden” of asthma in any country is a combination of both prevalence (discussed above) 
and control. Unfortunately, there is also mounting evidence that the goals set out by GINA are 
not being achieved. For example, the Global Asthma Insights and Reality in Europe (AIRE) 
survey assessed variations in asthma control and asthma management among 7786 adults and 
3153 children with asthma in 29 countries. The authors found that just under 6% of children (one 
in twenty) met all the criteria defined by GINA [61]. Over half of the participants in the survey 
also reported experiencing day time symptoms, and over a third reported episodes of night-time 
awakenings. Unsurprisingly, school absences were also higher than expected in most countries. 
This survey is one of the largest to date, and is supported by findings from both America and 
Europe. Despite the large sample size, the findings are limited, as low-income participants are 
potentially under-reported, as the data was collected by telephone survey, therefore potentially 
excluding those who do not have a phone. Given that asthma is more prevalent in low income 
households, it may be that asthma control is in fact worse than the data suggests.  
A clue that a major driver of these unacceptable data may be poor adherence is provided by studies 
of other chronic conditions, for example diabetes. In Europe, for example, it has been reported 
that just 28% of patients with diabetes do not achieve good glycaemic control [62], and many 
others do not adhere to recommended dietary and exercise regimens [63], despite guidelines 
highlighting the importance of this in maintaining good health outcomes. Indeed, the high number 
of asthma deaths in the UK (discussed above) would suggest a high prevalence of poor asthma 
control throughout the UK.  
Indeed, the Asthma Insights and Reality in Europe study (AIRE), reported that the UK has a lower 
proportion of well or completely controlled asthma cases, compared with other European nations. 
According to this telephone survey, 52.3% of children in the UK were classified as having well 
or completely controlled asthma, compared with Germany, where 85.7% of children had well or 
completely controlled asthma [64]. Adherence to medication was also lower in the UK. The 
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proportion of children using ICS with severe persistent asthma was 23.8% in the UK, 
approximately 3.5 times lower than Sweden.  
In response to the increased morbidity associated with asthma, countries have used evidence-
based methodology to develop a set of national guidelines, informed by the GINA 
recommendations, aimed at improving asthma control. These guidelines, including those 
introduced by the British Thoracic Society (BTS) and Scottish Intercollegiate Guidelines Network 
(SIGN) provide recommendations based on current best practice. In accordance with the GINA 
recommendations, national asthma management guidelines in the UK typically encourage 
patients to self-manage their asthma, emphasising the importance of asthma management plans 
and self-management education, supported by a regular review from a doctor [65]. The aims of 
asthma self-management are to lower the economic costs associated with asthma and improve 
quality of life for asthma patients. These aims are achieved through achieving and maintaining a 
long-term control of symptoms, to the point of maintaining normal activity levels, and minimising 
the risk of future exacerbations [59].  
Since measuring and targeting asthma control is of utmost importance, it is vital to use valid and 
patient friendly tools. There are three tools available to assess asthma control, recognised by the 
BTS/SIGN guidelines. Each tool is typically supported by airway function tests, including 
spirometry, peak flow, airway responsiveness, exhaled nitric oxide and eosinophil differential 
count in induced sputum [16]. The first is the Royal College of Physicians (RCP) ‘three 
questions’. The National Institute for Care and Excellence (NICE) guidelines recommend that 
these should be asked during an annual asthma review. A response of ‘no’ to any of the questions 
is considered to be consistent with well controlled asthma [66]. The three questions include:  
1. Have you had difficulty sleeping because of your asthma symptoms (including 
cough)? 
2. Have you had your usual asthma symptoms during the day (cough, wheeze, 
chest tightness or breathlessness)? 
3. Has your asthma interfered with your usual activities (e.g. housework, 
homework etc)? 
40 
 
One potential problem with the RCP three questions is they act as a prompt to facilitate a further 
discussion of asthma symptoms, rather than as a diagnostic tool. Furthermore, these three 
questions are not recommended for use in children [67].  
The second tool is the ‘Asthma Control Test (ACT’). The potential advantage the ACT has over 
the RCP’s three questions is that it is (i) clinically validated [68] and (ii) there is a paediatric 
version for use in younger children. The ACT is also widely used in different countries, and may 
be considered a global standardised measure of asthma control. The ACT™ is a five-item, patient 
administered survey, which measures a four-week history of day and night-time symptoms, use 
of medication and daily functioning. Respondents are also asked to rate their own control over a 
four-week period. Each question includes a five-point Likert scale of responses, which are 
calculated to produce an overall score. The scores range from a minimum of five to a maximum 
of 25. Scores equal to 19 or less indicate suboptimal (poor) asthma control; scores of 20 and above 
indicate optimal (good) asthma control. This reflects the cut-off with the best sensitivity and 
specificity for predicting asthma control [68] and is also associated with an increased risk of 
urgent healthcare use for asthma over a subsequent six months (adjusted odds ratio (OR); 2.29 
(95% CI 1.45 to 3.62)) [69]. According to a recent ERS taskforce, an ACT score of 19 or less in 
a child should trigger more intense clinical monitoring [70]. The ACT is validated in children 
aged 12 years and older; the Childhood Asthma Control Test (CACT) is a validated alternative 
for use in children aged 4-11 years. The CACT comprises a similar format, with the addition of 
two questions. The child is encouraged to answer the first four questions themselves; 
parents/carers typically complete the remaining three questions. A limitation of the ACT is the 
use of self-reported data, and therefore subject to social desirability bias, where people completing 
the tool may wish to be perceived a certain way and therefore amend their answers accordingly, 
rather than reflecting their true opinions. There is also no differentiation between those toward 
the middle end of the scale (e.g. scores of 18) and those towards the end of the scale (e.g. scores 
of 6), despite clear differences in asthma symptoms and daily functioning.  
The third tool used to measure asthma control is the ‘mini Asthma Quality of Life Questionnaire 
(AQLQ)’, developed in response to the original 32-item AQLQ. The mini version includes 15 
questions across four domains, including symptoms, activity limitation, emotional function and 
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environmental stimuli [71]. Unlike the ACT, each question refers to the previous two weeks and 
responses are scored on a seven-point scale from one (severe impairment) to seven (no 
impairment). Similar to the ACT and the CACT, the mini AQLQ has good reliability and cross-
sectional and longitudinal validity [72]. The paediatric version (PAQLQ) has 13 questions and 
covers the same domains as the adult AQLQ, however the paediatric version is currently not 
validated.    
All three tools are self-report measures, and, apart from social desirability bias (described above), 
incorrect information may therefore be given because the patient may be unable to accurately 
recall their asthma symptoms over an extended period.  
One ‘by product’ of the use of validated tools to assess asthma control is that they offer a way of 
comparing what the patients (including children, and/or guardians) think about their own asthma 
control with what level of control should actually be achieved. Indeed, as discussed, the Levy 
survey suggests there is evidence that a high degree of discrepancy exists between perceived 
levels of asthma control and actual levels of asthma control, with many patients regularly over-
estimating how well controlled their asthma is. Additional evidence for this phenomenon is 
provide by the 2006 European National Health and Well-being Survey (NHWS) was conducted 
on 37476 adults and young people across France, Germany, Italy, Spain and the UK, of whom, 
2337 people (<18 years of age) had doctor-diagnosed asthma. When asked to rate their own 
control on the ACT, 35.3% of people believed that their asthma was poorly controlled. According 
to the ACT, however, poorly controlled asthma was apparent in half of the participants (50.4%) 
[73]. Underreporting of asthma symptoms in this way could explain some of the reasons for 
under-treatment of asthma, and indicates that some people may be either unaware of the 
characteristics of good asthma control, or their threshold for experiencing asthma symptoms is 
higher.  
To date, data on assessment of asthma control, and discordance in perceived control and actual 
control, in UK children is limited, and only one community study to date has been reported, using 
the CACT [74]. In this study, Carroll et al, 2012, administered the CACT by telephone to the 
families of 1284 asthmatic children aged 8-15 years, including 200 children from the UK. Overall, 
40% of the children had either parent-reported or self-reported poor asthma control, according to 
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the CACT guidelines. However, the tools used to assess asthma control are usually supported by 
airway function tests, and as this data was collected over the telephone, the findings are solely 
dependent on accurate self-reported data. Moreover, as this was an international survey, there 
may be cultural or geographical differences that could explain some of the findings. Finally, the 
sample included children up to 15 years old, despite the CACT only being validated in children 
up to 11 years of age. There are currently no studies in the UK which have assessed asthma control 
in schools, using the ACT. Two UK-based studies have recruited school children with asthma, 
however both studies were conducted in primary schools and neither study assessed asthma 
control [75, 76].    
2.3.1 Self-Management 
The GINA guideline recommends that, to achieve effective asthma control, the patient and doctor 
must work together, from the point of diagnosis, to encourage the patient to self-manage their 
condition, and reduce the risk of future attacks [2]. As mentioned above, self-management, now 
considered an important part of asthma management [77]. It involves the patient becoming 
independent and taking responsibility for the management of their asthma, which includes 
managing symptoms and using their medication according to their treatment plan, and making 
lifestyle changes necessary for this long-term condition [78]. Self-management programs 
emphasise and encourage the development of a relationship between the doctor and the patient. 
The primary aims of most self-management programs are to increase knowledge and improve 
control of symptoms [79], as well as reduce rates of medical care. These outcomes are facilitated 
by behaviours including improved medication adherence. Reviews of self-management in asthma 
have shown that self-management can be successful in improving health outcomes for both 
children and adults [80, 81]. There are several interlinked components to consider when 
addressing effective self-management:  
First, patients must have an understanding of the fundamental features of asthma, including 
changes in breathing, triggers, symptoms, evaluating asthma severity, and knowledge of how to 
reduce the risk of a future asthma attack [79]. An understanding of medication, and why it is 
important, is also key to promoting successful self-management. Improving knowledge alone is 
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not enough to facilitate self-management behaviours and improve asthma control. Instead, people 
with asthma must make a conscious effort to adhere to their personalised asthma action plan and 
avoid known asthma triggers, to achieve good control of their symptoms [82]. A review by 
Coffman et al 2009 of self-management programmes, usually implemented as Randomised 
Controlled Trials (RCTs), showed consistent improvements in these areas [83]. However, usual 
care was not defined in all of the studies that were included in the review, therefore it is not clear 
whether children in the control groups were exposed to any other form of education. Second, the 
number of children with moderate or severe asthma is limited in the sample, therefore it is unclear 
whether the findings would also be seen in children with more severe asthma. Finally, some of 
the studies that were included in the review included a small sample size, thus were underpowered 
to detect a change. Behavioural experts have also recommended that self-management 
interventions should be grounded in a theoretical framework of behaviour change, which was not 
included in the review by Coffman et al. The use of theory in school-based interventions will be 
discussed further in the systematic review in chapter five.  
Second, patients may not feel confident enough to manage their condition independently, 
however, as asthma sufferers become more familiar with how to self-manage their asthma, and 
as the time since their last attack increases, their confidence in their own abilities is also likely to 
rise. In support of this, Brown et al 2014 suggested that, among parents of children with asthma, 
self-efficacy (that is, confidence in one’s own ability to perform a given behaviour) is higher for 
tasks that are carried out routinely, such as taking regular medication, and is lower for tasks that 
are less frequent or more complex, such as recognising the symptoms of asthma and managing 
asthma attacks [84]. However, this study discussed self-report data only, and did not consider 
parental education and language proficiency, which may influence self-efficacy. However, 
although knowledge is associated with improved self-efficacy, there is evidence that no 
relationship exists between self-efficacy and level of education, suggesting that knowledge is 
related to personal experience, rather than educational attainment [85]. There is also some 
evidence that cognitive variables, such as attitudes, knowledge and self-efficacy, are associated 
with improved quality of life among people with asthma, and are lower among those who have 
visited the hospital emergency department in the previous three months [85]. 
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Third, adolescence is a particularly challenging age group for encouraging self-management 
behaviours, due to a desire to fit in with peers, and conform to social norms. Teenagers also 
typically strive to obtain full independence from their parents during adolescence. As children 
and young people become teenagers, parental involvement in their asthma management is often 
reduced, and the child assumes more responsibility. However, feelings of embarrassment and 
concerns about social norms can often lead to poor medication adherence in this age group. 
Unsurprisingly, Rhee et al 2009 also found that higher self-efficacy is associated with lower 
perceived barriers to asthma self-management in teenagers [86].        
Fourth, education is an important component of asthma self-management, and teaches patients 
about asthma itself, as well as about the skills and motivation needed to independently manage 
their disease. There is a wealth of evidence to date, which supports the role of self-management 
education in improving clinical outcomes, although the impact of knowledge on health outcomes 
is limited. A comprehensive ten year programme, implemented in Finland, between 1994 and 
2004, aimed to reduce the societal burden of asthma, through improved doctor-patient 
relationships and self-management techniques. The premise of the programme was to use new 
knowledge, particularly in primary care, to diagnose and treat asthma early. People with asthma 
were educated to self-manage their condition, and be proactive in preventing asthma attacks. 
Since the programme was implemented, mortality rates, number of days in hospital due to asthma, 
and disability due to asthma has fallen 70-90%, between 1994 and 2004 [87]. Despite some 
limitations to this programme, including a lack of a rigorous evaluation right from the beginning, 
the success of this programme offers a compelling argument for the effectiveness of asthma self-
management strategies, in reducing the burden of asthma.  
An important component of the Finland programme was the inclusion of a multidisciplinary team 
in managing asthma from the point of diagnosis, to ensure continuity throughout the treatment 
pathway. This included a collaboration between asthma doctors and nurses and community 
services, including pharmacists. The programme also emphasised the importance of written 
asthma action plans in self-management, and the role of asthma nurses in routine follow-up 
appointments. The GINA guidelines recommend that a written asthma action plan should be 
implemented for all patients diagnosed with asthma [77]. Written asthma action plans help 
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patients and their caregivers to recognise the early stages of an asthma attack, and familiarise 
themselves with their individual triggers and medication plans. Asthma action plans are best 
devised during the initial consultation with the doctor, to support the development of the doctor-
patient collaboration, which is key to self-management, and to help the patient fully understand 
their treatment plans and management processes involved in their asthma care. Despite evidence 
showing that action plans can improve medication adherence and other health outcomes [88], they 
are often not implemented in practice, even with recommendations in national and international 
guidelines [89, 90]. The national review of asthma deaths found that, of the 20 children who died 
in the UK due to their asthma, as few as 30% had an asthma management plan recorded [40]. A 
second study found that, in a stratified group of 785 adults and children with asthma, just 3% had 
reportedly been given an asthma action plan [90, 91].  
Despite the evidence supporting the benefits of self-management, many people do not possess the 
skills or motivation to perform health improving behaviours, and doctors often do not have the 
time to support their patients effectively in this area, particularly in primary care. In recent years, 
digital technologies, such as smartphone apps, have been developed as tools to support successful 
self-management. One example of this is a device attached to an inhaler that monitors inhaler use 
and triggers alerts on a smartphone when it is time to take medication. A recent review of 
technology in chronic conditions, by Morrison et al 2016, concluded that technology does have 
the potential to support active self-management, through passive self-monitoring, although the 
research into digital health is still new [92]. A potential limitation of digital health is that it relies 
heavily on people having access to a smartphone or device, which may exclude some people from 
lower-income populations. It may also exclude some younger children and teenagers.  
The delivery of self-management sills is not necessarily limited to clinical settings. Indeed, 
school-based self-management education programs have been of particular interest to researchers 
in recent years, and UK policy-makers also recommend that combining health and educational 
services is an important aspect of improving quality of life for children with long-term conditions. 
The integration of these services can also reduce discrepancies in outcomes such as school 
attendance, which continues to be a key contributing factor to the rising costs of healthcare [5, 
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93]. The school holds a unique advantage for delivering education interventions for two main 
reasons: 
 Children are familiar with receiving instruction in this environment. 
 The school can identify large numbers of children with asthma in a single location, 
regardless of asthma severity, ethnicity or social deprivation [83, 94, 95]. This also 
includes children who are ‘hard to reach’, including those who either do not regularly 
attend appointments with their doctor, and those who do not have a usual source of care. 
 The school location removes the potential bias of parental or clinician input. 
To date, there is some evidence detailing the effectiveness of child-centred asthma self-
management education, delivered in schools, in improving asthma knowledge, self-efficacy and 
self-management behaviours, however the evidence for outcomes such as experience of day and 
night-time symptoms is  less consistent [83]. This is further discussed in the systematic review in 
chapter five of this thesis.  
Despite the benefits of self-management strategies, a number of barriers to self-management also 
exist and need careful consideration. The main barrier to successful self-management is finding a 
model that fully engages the patient [96]. Given the complexity of managing many long-term 
conditions, it is difficult to develop a single strategy that will work for all people. This is 
particularly true for school-age children, as the gap between five and 18 is broad, and spans a 
number of developmental stages. Therefore, it is important to acknowledge that not all self-
management techniques will work for all people. To overcome this, interventions can focus on 
commonly reported gaps in knowledge, including the basic pathophysiology of asthma, or the 
role of medication in treating the condition. Gaps in knowledge are explored further in the focus 
groups, discussed in chapter four. Some people will also find the concept of self-management 
daunting, and will be overwhelmed at the prospect of taking responsibility for managing their 
asthma. This further highlights the importance of a strong doctor-patient partnership and an 
asthma action plan, which will detail the symptoms, triggers, and management plan.     
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2.4 Medication Adherence 
The aim of asthma management is to decrease the levels of asthma morbidity and mortality by 
achieving good control of asthma symptoms [2]. According to the WHO, adherence to prescribed 
medication is defined as “the degree to which the use of medication by a patient corresponds with 
the prescribed regimen” [97]. There are no specific guidelines detailing what constitutes non-
adherence, however it is generally applied to instances where less than 80% of medication is taken 
as prescribed [10]. The WHO has reported that approximately 50% of people in developed 
countries do not take medication as prescribed, across a range of long-term conditions [98]. There 
are further reports that more than 50% of children with asthma do not adhere to their treatment 
plans [9]. Good adherence to asthma medication is difficult to maintain for several reasons, 
including social factors, poor understanding of different medication, the role of the parents, and 
the transition between childhood and adolescence. Adherence to asthma medication has been 
found to be lower than other conditions, such as oncological diseases, possibly as concerns 
regarding asthma medication (e.g. ICS) may outweigh the beliefs about the necessity of the 
treatment. Poor adherence is also seen in people with less severe asthma, suggesting that some 
people underestimate the seriousness of asthma, and the implications of ignoring medication [9].  
The clinical implications of poor adherence to asthma medication include increased levels of 
hospitalisations and poorer asthma control [9]. Heaney and Horne have suggested that, in patients 
with difficult to control asthma, a reduction in hospital admissions could save the NHS up to £43 
million [99]. Poor adherence is also linked to an increase in the risk of an asthma attack and, in 
severe cases, death. Sporadic use of asthma medication can also reduce the effectiveness of the 
medication.  
Global rates of non-adherence with asthma therapies typically range from 30-70%; and there are 
large variations between countries. In developed countries, for example, adherence with 
preventive medication has reportedly been seen to fall as low as 28% [98, 100], and adherence in 
the UK is generally lower than other European countries. According to the Global Asthma 
Physician and Patient survey, 24% of adults in the UK took their asthma medication as prescribed, 
compared with 48% of adults in other European countries [101]. Vermeire et al 2002 also found 
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that ICS use among children with severe asthma in the UK was 23.8%, compared with Sweden, 
where 83.3% of people with severe asthma were using ICS [64]. Of course, adherence may be 
measured differently in different countries, and each country may have their own standards of 
what constitutes nonadherence, therefore it could be that geographical differences explain some 
of the variances in these findings. Global comparisons of adherence among teenagers remains 
relatively scarce, however Desai and Oppenheimer 2011 suggest that adherence is lower among 
children living in an urban minority community [102]. Reasons for this may include increased 
exposure to environmental allergens, such as dust and cockroaches, as well as potentially higher 
levels of stress in these areas. While variation in adherence does exist between countries, 
knowledge of what predicts nonadherence is low. Some variables, such as household income, 
have been thought to act as a predictor, with lower socioeconomic status (SES) being associated 
with poorer adherence [103]; however, barriers to adherence are believed to encompass a range 
of explanations, which will be discussed further.  
Adherence to asthma medication is a complex issue, and one that is the focus of many self-
management interventions. To improve rates of nonadherence, researchers and healthcare 
professionals alike must first understand the barriers to adherence. Horne 2006 has previously 
suggested that there are two types of nonadherence: intentional and unintentional [9]. Intentional 
nonadherence refers to the patient making a conscious decision not to use their medication; 
unintentional nonadherence refers to factors that are outside of the patients’ awareness or control, 
for example poor inhaler technique. Furthermore, the most widely reported reasons for 
nonadherence with asthma medication (e.g. incorrect inhaler technique or forgetfulness) can be 
further understood by considering three main categories: (1) poor understanding; (2) social 
factors; (3) structural factors. Table one displays the most commonly reported barriers to 
adherence, according to these three categories.  
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Barrier to Adherence Category 
Intentional Nonadherence 
Side-effects of medication Poor understanding 
Incorrect beliefs about medication Poor understanding 
Social Stigma Social 
Unintentional Nonadherence 
Inhaler technique Poor understanding 
Complicated treatment plans Poor understanding 
Forgetfulness Poor understanding 
Difficulties obtaining a new prescription Structural 
Parental Roles Social 
Table 1. Categorical barriers to adherence 
As seen in table one, poor understanding of asthma medication explains a large proportion of the 
reasons for both intentional and unintentional nonadherence. Social and structural factors, 
however, are also important to consider, especially when thinking about adherence in children 
and young people.   
Side-Effects 
The side-effects of asthma medication can be unpleasant, as expressed by up to one third of 
asthma patients studied [9]. The use of steroids in treating asthma is also concerning for many 
people, due to the stigma surrounding steroids, and known alternative uses. While this 
apprehension strongly emphasises the importance of a good doctor-patient relationship, most of 
the side-effects are discussed with patients when their medication is prescribed, however it could 
be twelve months before patients attend a review with their doctor, and concerns about side-
effects may only develop once the treatment has started. Other side effects of the medication 
include an unpleasant taste, and feelings of nausea. Although the role of medication, and potential 
side effects, are discussed during the consultation, the unpleasant side effects may act as a stronger 
predictor of adherence behaviour, rather than a desire to control the symptoms, especially if the 
patient is feeling well. 
Incorrect Beliefs 
Unlike reliever inhalers, where the effects of the medication are immediate, controller medication 
requires long-term use, to benefit from the results. Subsequently, some people with asthma fail to 
acknowledge the importance of their controller medication, as they cannot see an immediate 
benefit. Controller therapy may also be taken incorrectly in response to asthma symptoms, if 
people do not understand the differences between inhalers. Similarly, some people with asthma 
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may stop using their inhalers if they are feeling well and do not experience any asthma symptoms. 
In some cases, it may be that they are outgrowing their asthma, and therefore need to step-down 
their medication; however, in other cases, it could be that some people do not understand the role 
of their controller medication in reducing the symptoms of asthma [104]. Conversely, beliefs 
regarding the efficacy of an inhaler can be reduced if asthma sufferers continue to experience 
asthma symptoms, despite using their medication correctly. Instead of speaking to their doctor to 
discuss a possible stepping-up of their treatment, some people may stop using their medication 
and become ‘used’ to living with the symptoms, thus developing a higher threshold for 
experiencing asthma symptoms.  
Social Factors 
Social concerns, for example bullying, is a common barrier among teenagers and young people. 
Adherence to children and young people often falls below 50%, regardless of the level of severity 
[105]. Adherence is also reportedly lower among older adolescents, compared with younger 
children [102]. Among many adolescents, it is important for them to achieve a good social 
standing among their peers, and many may be reluctant to actively avoid asthma triggers, for 
example pets, or use an inhaler in front of their friends [106], due to an unwillingness to deviate 
from social norms. Similarly, feeling reliant on medication can reduce their independence [107], 
and may prompt feelings of weakness or embarrassment for seeming different to their friends. In 
support of this, focus groups conducted in Ohio with 24 asthmatic children revealed that a 
teenagers’ desire to be ‘normal’ and fit in with their social group often outweighed their opinions 
regarding the potentially serious consequences of improper asthma management [107]. The 
findings from Velsor-Friedrich et al [107] also highlighted some valuable insights into how best 
to manage asthma in teenagers. However, given the qualitative nature of the study, the findings 
are open to interpretation, and must be treated with caution. It is unclear from the methods that 
are reported how many researchers were involved in the analysis of the transcripts, and whether 
or not data saturation was reached. Moreover, it is unclear whether the researchers had a 
framework in mind, prior to collecting the data and conducting the analysis. Therefore, it is 
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difficult to know whether the conversation within the focus groups was directed towards certain 
topics.  
Incorrect Inhaler Technique  
Incorrect inhaler technique is common among people with asthma, and can explain reasons for 
poor asthma control [108]. Although unintentional, mistakes in inhaler technique can mean that 
patients are not inhaling the correct dosage of medication into their lungs [109]. Although spacers 
are used to counter this, they are often not used as intended, particularly among teenagers, as they 
can be bulky to carry and are not discrete when being used. A systematic review of inhaler 
technique and patient adherence demonstrated that education programs improved adherence as 
well as inhaler technique [110]. 
Complex Treatment Plans 
The complex nature of asthma treatment plans has also been identified as a barrier to adherence. 
In some cases, people with asthma have multiple inhalers for their asthma, which need to be taken 
at different times for different reasons. For example, prescribed controller medication (also 
referred to as “preventer inhalers” in this thesis) needs to be taken twice a day, morning and 
evening. Not only can this be difficult to remember, particularly when distracted by other tasks, 
such as getting ready for school or homework, but it also places a significant amount of 
responsibility on patients and their families [111], which, as discussed earlier, can act as a barrier 
to self-management. To support this, Cramer et al 1989 identified that lower rates of adherence 
when the number of doses per day were higher [112]. Although this was seen in a sample of 
patients with epilepsy, Bender 2002 agreed that people with asthma are also more likely to adhere 
to a treatment plan that is simple to understand and implement [113]. In addition to controller 
therapies, people with asthma will also have a reliever inhaler, for use only when the symptoms 
of asthma appear. Some people may be unaware of the differences between the different 
medications, and therefore may be using their inhalers incorrectly. It could also be that some 
people fail to understand the need for multiple medications, and believe that they are fine to treat 
their asthma using a single inhaler.  
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Forgetfulness 
Forgetfulness is a common barrier to adherence across a range of chronic conditions. Among 
teenagers and young people with asthma, forgetting to take medication has been widely recorded 
due to homework, extracurricular activities and getting ready for school [114]. Forgetfulness is 
also common among adults, and a study by Rand in 2005 [115] noted that adult patients forgot 
almost half of the information given to them by their doctor, which may include their prescription 
plan and how to use their medication correctly.   
New Prescriptions 
Difficulties in obtaining a new prescription, due to both structural and financial factors, can 
contribute towards unintentional nonadherence. It has previously been reported that people from 
lower SES households often have lower levels of adherence to asthma medication [116]. One 
reason for this could be due to a lack of access to primary or tertiary asthma care [117], 
particularly in countries where healthcare is privatised. Some parents have reported that the 
financial cost of treatment for asthma has previously prevented them from obtaining the correct 
prescription for their child [118]. Difficulties in obtaining a new prescription when an inhaler 
either expires or needs refilling can be costly, and time-consuming to collect, which can reduce 
one’s desire to renew the prescription [113]. It could be, for example, that some people will not 
use their controller medication every day to make it go further, or will avoid using their reliever 
inhaler when they need it to ensure they do not run out quickly.  
Family  
The final barrier to adherence is parental factors, including the role of the parent in managing 
asthma in children and young people. As previously mentioned, adherence to medication is lower 
among older adolescents, compared with young children. As children and young people enter a 
transitional period of adolescence, they classically want to seek independence from their 
parents/carers. McQuaid et al 2003 have suggested that as parents begin to reduce their input into 
their child’s asthma management, children and teenagers may not automatically resume 
responsibility [111]. To overcome this, it may be that, although parents/carers generally have 
overall responsibility for their child’s asthma during their younger years, children should be 
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involved in their disease management from an early age, so that as they reach adolescence and 
their maturity develops, they have the skills necessary to conceptually understand their asthma 
management strategy, and the propensity to remember to take their medication regularly. This is 
supported by the suggestion by McQuaid et al that adherence to medication is dependent, in part, 
on how well one understands asthma and the concept of prevention [111]. Further, although many 
adolescents will assume responsibility for their asthma, their adherence is still largely influenced 
by parental factors and the home environment. For example, if there is a lack of routine within 
the household, and taking their medication was never part of a structured routine growing up, it 
can be easier for teenagers to forget their medication, particularly in the absence of any symptoms. 
It is also important to consider how parental beliefs towards asthma medication can be echoed by 
children during adolescence. Consistent with the literature on adult medication adherence [119], 
parents who have stronger beliefs about the effectiveness of their child’s medication generally 
have higher levels of adherence, compared to parents who have strong concerns about the negative 
effects of treatment [120]. However, the evidence for this comes from a parent-reported study, 
therefore the data may be biased by the parents wanting to be perceived a certain way. There is 
also no qualitative data to subjectively support the findings.  
Following the noted barriers to adherence, there has been a movement towards improving 
adherence, through electronic monitoring. For example, smart inhaler devices are designed to 
record when patients are using their asthma inhalers, by keeping a log of the date and time, which 
is recorded automatically using a smart phone. Other electronic monitoring devices have also 
included a daily text message, to remind people to take their medication. Although these methods 
have seen increases in medication use [10], and there is evidence that electronic monitoring is 
also effective in increasing adherence in other chronic conditions, such as diabetes [121], there is 
no guarantee that the patient is using their inhaler correctly, or indeed at all, as the device will 
only measure that the inhaler has been used, not whether the patient inhaled any medication 
directly. There is also evidence that the impact of such methods is short lived, and subsequently 
drops once the reminder has been removed [122]. Electronic monitoring and reminders are also 
only suitable for those who have a smart phone or device, which may exclude certain population 
groups, such as younger children and those from low SES households. 
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Many of the barriers that have been discussed here point to a poor understanding among patients 
of how to effectively manage their asthma at home. These barriers also highlight the importance 
of a strong doctor-patient relationship, which is also key to effective self-management. Effective 
consultations enable the patient to consolidate their understanding, and make an informed 
decision about their condition. Conversely, people who do not have a good relationship with their 
doctor can feel dissatisfied, or are more likely to forget or misunderstand what they have been 
told [123].   
2.4.1 Knowledge 
To date, there is a limited understanding of why difficulties in asthma management occur, and 
how to overcome them [124]. It has long been suggested, primarily by behavioural psychologists 
and social theorists, that knowledge, attitudes and beliefs are key determinants of health 
behaviour, and there are several models, such as the Theory of Planned Behaviour and the Health 
Belief Model, that support this concept. It is also widely accepted that knowledge is a prerequisite 
for reaching effective asthma management [125]. More recently, researchers have sought to better 
understand the role of knowledge in asthma management. Despite expectations that increased 
knowledge improves asthma management, the evidence to support this is conflicting. Some 
literature reports that knowledge has no effect on health outcomes [111, 126, 127], and other 
research has indeed demonstrated a relationship [124, 128, 129]. 
To date, no standardised measure of knowledge exists, and no single assessment tool has received 
widespread acceptance and validity. Therefore, it is difficult to quantify and compare the 
outcomes of different studies, due to inconsistencies in the way in which knowledge data is 
collected.  
Knowledge of asthma varies widely and, as expected, knowledge is typically higher in older 
teenagers and adults [130], although knowledge of asthma is generally low across all age groups 
[85, 124]. One study by Gibson et al found that, not only was knowledge low among high school 
students with asthma, but it was also low across peers and teachers too [124]. Knowledge on 
prevention, and treatment for exercise-induced asthma was found to be particularly low in this 
study and the authors also found that tolerance towards asthma was moderate (38% of students 
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believed that students with asthma are embarrassed to use their inhalers in class). It is important 
that knowledge is addressed in younger age groups, to reduce the potential impact of poor 
knowledge continuing into adult life. Although these findings do highlight a lack of knowledge 
among teenagers and teachers with asthma, the findings must be treated carefully. The data was 
collected from children aged 13-14 years only, and, as secondary school age covers a wide range 
of developmental ages, their views may not represent those of children lower down the school. 
There was also a lower response rate for teachers, as the questionnaires were self-administered 
and were conducted in their own time. Therefore, the teachers who did complete the questionnaire 
may have had an existing interest in asthma, thus the findings may not be generalizable to the 
wider teacher population of the school. This study was also conducted in 1995, therefore the 
findings could arguably be outdated.  
A more recent study by Sin et al, conducted in 2005, found that, in a sample of 62 African-
American people with asthma, although knowledge was seemingly high, according to an asthma 
knowledge questionnaire (75% correct), 41% of participants did not believe that it was possible 
to prevent an asthma attack [131]. Sin et al also found a significant correlation between 
knowledge of asthma, social support and self-management behaviours, which supports the 
findings of Gibson et al. This study, however, included a small sample size (n = 62), and 
participants were recruited via a convenience sampling method. Given the sample was also 
African-American teenagers, the findings may not be generalizable to teenagers from other ethnic 
groups.     
Conversely, McQuaid et al [111] measured children’s knowledge of basic asthma facts, using the 
Asthma Knowledge Questionnaire [132]. Correct scores ranged between 36% and 96%, with an 
average score of 76% correct. The data also showed that older children knew more about asthma 
than younger children, however this was not reflected in levels of medication adherence. 
Similarly, Velsor-Friedrich et al assessed asthma management in teenagers, using focus groups, 
in a sample of 24 teenagers with asthma from 4 high schools in Chicago. In accordance with the 
barriers to medication adherence that were discussed earlier in this chapter, Velsor-Friedrich et al 
found that although most teenagers in the sample demonstrated knowledge of asthma triggers and 
basic asthma management, they did not always use their knowledge, due to social factors, 
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including a fear of being different [107]. These findings indicate that, even where knowledge is 
seemingly high, a desire to comply with social norms is a bigger driver of behaviour than a desire 
to self-manage asthma symptoms. Although this does provide evidence surrounding adolescent 
management of asthma, both studies described here relied solely on opinions from the teenagers 
themselves, and were not compared with viewpoints from family or friends to validate the social 
concerns. Second, some elements of the asthma medication plans (for example use of reliever 
medications) were not assessed, therefore an accurate assessment of adherence could not be 
conducted.  
Gender and educational attainment are also thought to be associated with knowledge, and there is 
some evidence that increased knowledge is seen in females, as well as in those with a higher level 
of school education [111, 133]. One study of 29 adults with asthma found that, across all age 
groups, females had consistently higher levels of knowledge than males, according to the 
Knowledge, Attitude and Self-Efficacy Asthma questionnaire [133]. Although positive attitudes 
were also linked to knowledge, no effect was seen on adherence. It is noteworthy, however, that 
this study had a low sample size, and the response rate was only 59%. Further, within this sample, 
most of the participants had mild asthma only. Adherence was also assessed using self-report 
measures, therefore some responses may be subject to social desirability bias.  
While knowledge of asthma is generally low, most people with asthma seem to have a basic 
understanding of the pathophysiology of asthma, including triggers and symptoms. Some of the 
commonly reported gaps in knowledge include misperceptions about the role of medication, and 
poor inhaler technique [111], as well as perceptions of asthma control. The National Review of 
Asthma Deaths previously reported that asthma deaths in children were associated with a poorer 
perception of control and inadequate awareness of adverse outcomes [14]. The Room to Breathe 
Survey also noted that parents of asthmatic children can have overly optimistic perceptions of 
their child’s control [74].  
Since medication adherence is dependent, in part, on a good understanding of asthma, it is 
reasonable to consider knowledge when developing interventions to improve asthma 
management, although it is clearly not sufficient on its own to improve outcomes. It is also 
important to consider other factors, such as attitudes and peer awareness, as social norms may be 
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a bigger predictor of behaviour than asthma symptoms, particularly among teenagers. The 
literature also suggests that, although knowledge of asthma improves with age, this does not 
always translate into better adherence behaviours, and knowledge of asthma management and 
prevention remains limited. It is clear that a standardised validated tool for assessing asthma 
knowledge is required, however reasons for why this has not yet been achieved include 
differences in sociodemographic characteristics, which are not typically associated with treatment 
outcomes [125].  
Although the evidence for the role of knowledge in improving outcomes for children with asthma 
is limited, the BTS and SIGN guidelines recommend that asthma consultations should be viewed 
as an opportunity to reinforce and extend patients’ knowledge and skills [16]. The BTS and SIGN 
guidelines recommend that specific knowledge, in particular being able to list all prescribed 
medications and their uses, is an important component of self-management, particularly among 
adolescents. Similar suggestions are also made in the GINA guidelines for global asthma 
management. Although these guidelines do recognise that improved knowledge does not always 
lead to improved outcomes, the guidelines highlight the importance of sufficient knowledge, as it 
can facilitate some self-management behaviours.   
In summary, it is evident from the literature that knowledge of asthma is lower than might be 
expected, which may have an impact on medication adherence and other asthma outcomes. The 
absence of a standardised tool for assessing knowledge of asthma makes it difficult to compare 
data from different studies. However, knowledge is important to consider when included as part 
of a wider intervention, addressing a number of barriers to self-management. 
 
2.5 Asthma Management in Schools 
Historically, the home environment has been commonly considered when thinking about 
interventions to improve asthma management and outcomes away from the clinical environment. 
However, more recently, the school has become an alternative location to consider, given its 
familiarity to children and access to large numbers of children with asthma in one location (as 
discussed earlier in this chapter). Considering this, the Lancet commission recommends a move 
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towards asthma prevention and cure, rather than a treatment-based approach to management. The 
rising prevalence of asthma, both in the UK and globally, reflects poor management of the 
condition. Accordingly, despite the marked variations in asthma prevalence, acute asthma is the 
most common cause of hospital admissions among children of all ages in Europe [17]. The 
objectives of asthma management interventions are to enable people living with asthma to better 
understand asthma, and build their confidence to self-manage their asthma. Self-management is 
an integral part of asthma management, and requires all stakeholders (patients, carers and 
physicians) to work together to improve outcomes.  
As discussed in Section 2.2.1, asthma can be exacerbated by a range of different triggers, and 
each person will have a different combination of medications and management plans. Due to this, 
it can be difficult to develop an intervention that is tailored to the specific needs of each child. 
Tailored interventions are often implemented outside of the school environment, normally in the 
home, as they can focus on the individual environment and discuss targeted allergen exposure 
within the home [134]. However, interventions of this nature can be expensive to run, and may 
exclude people who live in more rural areas. Although rare, there are also some studies which 
have implemented self-management interventions in a clinical setting. The benefit of this 
environment is that it provides direct access to other services, including doctors and nurses, as 
well as community services such as pharmacies. Many studies to date that have conducted studies 
within the primary care setting have used a nurse-led model [56, 135], and have seen 
improvements in unscheduled care, however the findings from Griffiths et al [56] were not 
significant.  
As previously discussed, the school environment is an important space for asthma-focused 
research. The school site, including school policies and school personnel, may be important when 
thinking about successful management of asthma in schools. It is possible that within the school, 
there will be staff members (e.g. teachers), or other students, who are unaware that a child has 
asthma, and will therefore be poorly equipped in identifying and handling worsening asthma 
symptoms [136]. The school environment varies widely between different countries, however in 
the UK, particularly in London, it is not unusual to have either a school nurse in some schools, or 
community nurses taking care of a number of schools within a single borough. It is also notable 
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that different schools will have different policies for managing asthma, including the storage of 
medication. A move towards standardised school asthma policies could be an important first step 
towards achieving improved asthma management within the school environment. Recently, 
different countries have started developing ‘asthma friendly schools’, which incorporate common 
goals to create a knowledgeable and supportive school environment and build a collaborative 
relationship with local authorities. Such programs currently exist in Canada, America, Australia, 
and the UK [136]. Central to the asthma friendly schools initiative is identifying all children with 
asthma in schools, ensuring they have a management plan in place, and a named asthma-
responsible member of staff at each school.  
In addition to moving towards a supportive school environment, the role of the school nurse, or 
healthcare provider within the school, is also an important consideration for asthma management. 
School nurses provide care on a wide spectrum, including direct care, emergency response, and 
acting as the contact between the school and the guardians, and healthcare services. Despite this, 
widespread cuts to school nurses have been reported in recent years, due to budget restraints 
within the education sector. The evidence detailing the role of school nurses in improving 
outcomes for children in schools is limited, however extant research has highlighted the positive 
impact of school nurses on immunisation rates, student health records and continued care for 
children with long-term conditions, including asthma and diabetes [137, 138]. Moreover, a recent 
study from California showed that school absences for children with asthma declined upon 
recruitment of a full-time nurse within the school, and fewer emergency department visits were 
reported by parents [139]. However, this study was not designed to be experimental, therefore the 
schools were not selected on a randomised basis to be either an experimental or control school, 
leading to some differences in school characteristics at baseline.  
Similarly, a European taskforce, published in 2010 by EAACI/GA2LEN published a document 
detailing a model of care for allergic children in schools [140]. In addition to the goals discussed 
within the asthma friendly schools model, this taskforce also recommends that asthma education 
should be provided for staff members, particularly those identified as responsible for asthma 
within the school. It was also suggested that asthma should be included within the curriculum, to 
educate children without asthma about the disease and how to recognise worsening symptoms. 
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According to the taskforce, the recommendations listed within the taskforce document have been 
applied in a number of school interventions for children with asthma, which have seen a positive 
impact across a range of outcomes [140]. 
In summary, the school environment could act as an important ‘third space’ for delivering 
educational self-management interventions aimed at children with asthma. Careful consideration 
needs to be given however, as there is some variation in the way in which schools operate, both 
nationally and internationally, and different school policies and healthcare structures (e.g. the 
presence of a school nurse vs a community nurse) within schools may influence the way in which 
asthma is managed. However, the school could be a good location for delivering interventions, 
not just to children with asthma, but also to their peers, in accordance with the recommendations 
from the 2010 European taskforce.   
 
2.6 Overall conclusion  
Figure three displays a summary of the chapter.  
 
 
 
 
 
 
 
 
Figure 3. Summary of the chapter 
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Hospitalisations and deaths from asthma are much higher in the UK, compared with other 
countries in Europe, however the reason for this is not clear. One reason could be a higher number 
of people in the UK with poor asthma control, compared with other European countries, however 
this has not been directly tested. Investigations into deaths from asthma in the UK have noted a 
number of avoidable factors which have contributed to the death. These factors include the 
absence of an asthma action plan, and non-adherence with medication and clinical advice. 
According to the WHO, medication adherence is a problem around the world, and often falls 
below 50%. Adherence has also been found to be lower in the UK, compared with elsewhere in 
Europe. Poor adherence with medication for asthma can lead to increases in hospitalisations and 
poorer asthma control. There is also an increased risk of experiencing an asthma attack among 
people who do not take their medication correctly.  
According to GINA, people with asthma should be able to control it well and engage in a normal 
active life. However, global trends have shown high rates of poorly controlled asthma, despite 
recommendations from GINA. In response to this, self-management has become an increasingly 
important aspect of asthma treatment and care. Self-management encourages the individual to 
take responsibility for their own health, away from the clinical environment. Good self-
management requires people to have a good understanding of their asthma, which may not always 
be true, and may be a barrier to active self-management. However, it is expected that active self-
management could reduce the burden placed on the NHS, by seeing a reduction in unplanned 
hospital visits.  
Despite self-management relying on a good level of knowledge, the literature regarding the 
impact of knowledge on asthma outcomes is mixed. Some studies have shown improvements 
across a number of outcomes following an intervention, while other studies have not seen an 
effect after increasing asthma knowledge. There is currently no standardised measure for 
assessing knowledge in asthma, which may contribute towards the variation seen in the literature. 
According to the literature, medication adherence is also problematic, particularly as 
nonadherence can be either intentional, for example due to a belief that the medication does not 
work, or unintentional, for example due to incorrect inhaler technique. Such barriers to medication 
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adherence in asthma should be investigated and addressed, in order to improve asthma control 
and overall management of the condition. The current gaps in knowledge indicate that greater 
education is needed surrounding the role of different asthma medications in treating the disease, 
as well as when to take medication, and how to use inhalers properly. Further gaps in knowledge 
are seen in people without asthma, who do not have adequate awareness of how to respond during 
an asthma exacerbation. These gaps can be addressed during an educational intervention, and the 
school environment could be an effective space for delivering this. The school provides access to 
large numbers of children with asthma, regardless of severity, SES or ethnicity. This also includes 
children who do not regularly attend appointments with their GP.  
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Plain Language Summary 
Hospital visits and deaths from asthma are higher among children and young people in the UK 
than other European countries, however the reason for this is currently unknown. It could be that 
there are more children and young people in the UK with poor asthma control, however this has 
not been directly measured. Unplanned visits to medical providers, as well as time spent off work 
and school, somewhat contributes to the financial pressures currently placed on the NHS, 
therefore it is important that children and young people, as well as adults with asthma, learn to 
self-manage their condition at home.  
Self-management has become an important component of asthma treatment over the years, 
however much of the research regarding self-management interventions has been done outside of 
the UK, mainly in America and Canada. However, evidence from research done in America has 
shown that self-management interventions can be an effective way to improve asthma control and 
reduce rates on unscheduled care. Notably though, while knowledge is an important part of these 
interventions, there is no direct evidence that improving knowledge alone is enough to improve 
outcomes for people with asthma. Instead, attitudes and beliefs should also be considered.  
There are several ways to measure asthma control. These include the ACT, the RCP three 
questions, and the AQLQ; and each should be used alongside clinical measures, including lung 
function testing. However, improving asthma control alone may also not be enough to improve 
outcomes. Medication adherence is also an important part of self-management behaviour. 
According to the literature, nonadherence can either be intentional, or unintentional. Many of the 
commonly reported barriers to adherence include forgetfulness, side-effects, incorrect beliefs 
about medication and social concerns, including embarrassment and a fear of being bullied.  
The school has become an important location to consider when designing self-management 
interventions for children. It provides access to large numbers of children with asthma, regardless 
of ethnicity or SES. There is also the possibility of delivering an intervention to children in schools 
without asthma, to raise awareness among peers and address some of the social concerns 
commonly associated with adherence.  
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In chapter two, I discussed the evidence for the disproportionally high prevalence of asthma 
among children in the UK, and concluded that a putative explanation is high prevalence of 
suboptimal asthma control in UK school children. But to date, has been no assessment of asthma 
control in London secondary schools, using the ACT. Therefore, in this chapter I describe 
development of an assessment tool, designed to bridge this gap, as well as the results of a pilot 
and full-scale trial. Specifically, I report the development and resulting data from an online 
assessment tool to assess the current burden of disease in a population of London secondary 
school children with asthma. The first section of this chapter will discuss the development of the 
questionnaire, including the use of Patient and Public Involvement (PPI) and ethics. I will then 
discuss the pilot study, followed by the methods and results of the main questionnaire study. This 
chapter will end with some overall conclusions, based on my findings.  
 
3.1 Development of the questionnaire 
 3.1.1 Sampling 
The target population for this cross-sectional observational study was students with asthma who 
were attending secondary school in any of the thirty-two London boroughs. A key inclusion 
criteria was that students must have received a clinical diagnosis of asthma from their doctor and 
be registered with their school as having asthma. Eligible students were also required to be aged 
between eleven and eighteen years, since the ACT has only been validated in children twelve 
years and older [141]. However, my inclusion criteria allowed recruitment of eleven-year olds, as 
feedback from schools during my pilot study suggested that it would be too challenging to 
differentiate between students who were eleven and students who were twelve years old on the 
school register. The final inclusion criteria was that students must be attending the school where 
they completed the questionnaire. No limits were applied to the type of school that students were 
recruited from; instead, comprehensive, independent and grammar schools were eligible for 
participation. All students who met the inclusion criteria were invited to participate, and were 
recruited over a twelve-month period, from October 2014 to October 2015. A power calculation 
66 
 
was not done; instead all eligible schools in London were invited to participate, and students were 
recruited using a convenience sampling strategy.  
3.1.2 Using Patient and Public Involvement to 
develop the questionnaire 
A key part of the development of the questionnaire was to involve children and young people. 
According to INVOLVE [142], patient and public involvement (PPI) should include people with 
experience of living with the condition being studied, as well as people who are representing their 
loved ones who live with the condition being studied (e.g. caregivers or members of their support 
network). PPI is important in research for many reasons. First, the views of a ‘lay’ person can 
offer a different perspective to academics or clinicians. This includes providing specialist insight 
into the concerns of the population of interest [143]. Second, the views expressed by patients or 
members of the public can complement those of the researchers, and further support the aims of 
the research. However, the views of the patients and public can also challenge those of 
researchers, and can contribute towards a more focused research question and study design.  
In this study (prior to the pilot study), stakeholder engagement was incorporated in several ways. 
During the development of the questionnaire, testing of the tool was conducted with teenagers 
with and without asthma. The primary aims of this were to ensure that the website hosting the 
questionnaire was user-friendly, and to test whether the questions were appropriate for the target 
age-group, and could be completed in a reasonable timeframe. Initially, four workshops were 
conducted. The first two were conducted in collaboration with the Centre of the Cell (COTC), 
and included four young people without asthma in each workshop. The aim of these workshops 
was to discuss the website design and accessibility, to ensure that it was appropriate for the target 
cohort. In all, the children felt that the website was appropriate and could be easily navigated by 
children of all ages within the target age range. The third workshop included 15 young people 
with asthma aged 13-17 years; the final workshop included 14 children with asthma aged 11-13 
years. The focus of these workshops was the content of the questionnaire, to test whether the 
questions were easy to understand, and were appropriate for the target age group. The feedback 
from these workshops indicated that the questions should be specific, particularly when asking 
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about how comfortable students felt when using their inhalers, as inhaler use can vary throughout 
the day. Following this, the questions were amended to make clear whether inhaler use referred 
to inside or outside the school environment. The children also recommended free-text answers to 
be added to some questions about adherence, to enable the students to elaborate on their responses, 
particularly if they felt that the multiple-choice options did not apply, or more than one was fitting.  
In addition to the workshops with children, unstructured consultations were also held with 
healthcare professionals to discuss the questionnaire. These discussions were held with clinical 
nurse specialists, paediatricians, psychologists and researchers. The aim of these discussions were 
to ensure that the questions were capturing clinically appropriate information that was relevant to 
the research objectives. Stakeholder meetings were also arranged, which were attended by 
members of the research team, respiratory specialists (including GP’s and consultants), school 
nurses, psychologists and other London-based researchers working on paediatric asthma. During 
this meeting we discussed the preliminary findings from the pilot study, and how the outcomes 
could be used to inform further research. Gaps in existing asthma management strategies were 
also identified, as well as recommendations for how these gaps could be addressed. This was 
helpful in identifying current clinical concerns, and mapping these concerns to the questionnaire 
data. Key outcomes from the meeting included ideas for the design of a future schools-based self-
management intervention, based on current best practice.  
Finally, the preliminary findings from this study were presented at a lay research advisory panel, 
organised by the PPI lead at the NIHR CLAHRC North Thames. The advisory panel included 
eleven adult members, many of whom had experience of living with asthma, or caring for 
someone with asthma. The key points that were raised by panel members included strategies for 
engaging teenagers in research and identifying barriers to medication adherence among teenagers 
and how to overcome these. Following the meeting, a report was submitted to the CLAHRC to 
detail how these points had been addressed.  
  3.1.3 Ethics 
Ethical approval was obtained from the Exeter Research Ethics Committee (REC) on 3rd June 
2014 (reference number: 14/SW/0120). Although this study was considered extremely low risk, 
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both in terms of children’s health and potential harm to the students, there were several ethical 
considerations that were addressed, prior to conducting the pilot study.  
First was child protection and safeguarding. At least two members of the research team were 
present at the schools during each data collection session. Therefore, all researchers obtained a 
valid Disclosure and Barring Service (DBS) check, prior to entering the schools. All schools were 
aware of this, and could choose whether this satisfied the child protection policy of the school, or 
whether further strategies needed to be enforced. One member of school staff was also asked to 
be present at all times. 
Second was the collection of parental consent and student assent. As the students were aged 18 
years and younger, written assent could not be collected from the students until their parents had 
been informed of the research, and their right to withdraw their child. Parent information sheets 
and withdrawal forms were sent out via the schools two weeks before the scheduled data 
collection. To maintain data protection, the schools were responsible for disseminating the 
information sheets to the parents; however the parents were provided with contact details for the 
research team, should they wish to discuss the research further. During the pilot study, informed 
opt-in consent was collected from parents’ two-weeks prior to the data collection. Recruitment 
via this method was limited, and feedback from the teachers indicated that this was too difficult 
to coordinate, on top of their existing workload, and many schools cited this as a reason for 
withdrawing from the study. Following the pilot study, an amendment was submitted to the REC 
requesting the use of opt-out parental consent, due to the low risk nature of the study. This was 
approved on 22nd September 2014. In total, nine parents (1.1%) withdrew their child from the 
study. Copies of the information sheets for parents and students can be found in appendices one 
and two, respectively.   
All students who had not been withdrawn from the study were subsequently informed about the 
research via a short presentation and information sheet. The students were encouraged to ask any 
questions they had before providing written assent, to confirm they were happy to participate. 
Two students chose not to participate, due to a reluctance to miss class. All students were 
informed of their right to withdraw at any time without consequence. Unless any student objected, 
all data that was collected up the point of withdrawal was retained for analysis.  
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Third was the sensitive nature of the research topic. One of the risks to the psychological well-
being of the students was the potential for embarrassment about answering questions regarding 
their health. All questionnaire data was collected on school computers, therefore there was a risk 
that their peers could see their answers. To overcome this as much as possible, the students who 
completed the questionnaires were reassured that their answers were confidential and anonymous. 
Where possible, the classroom was arranged so that students sat separately, and were unable to 
see other computer screens. However, due to layout in some of the computer classrooms, this was 
not always possible. The REC also expressed concern that participating in research that involved 
thinking about a medical condition may elicit a negative physiological response from students, 
including an asthma attack. Although this was not experienced by any students, this was 
accounted for by ensuring that students were aware of their right to withdraw if they felt 
uncomfortable. All students and their parents were also advised of how to make a complaint, 
should this be necessary.  
Fourth was the inconvenience placed on students, in particular missing lessons. To overcome this, 
the school was given full control over when the data should be collected, to ensure that disruption 
to the school day was kept to a minimum. Refreshments were also provided if the data collection 
occurred during a lunch break, catering for any dietary requirements that were notified by the 
school. In most cases (n = 21), the schools preferred to conducted the data collection sessions 
during lessons, with just three schools opting for an after-school session. Parents were made aware 
of the potential disruption to school lessons, prior to choosing whether to allow their child to 
participate.  
No concerns were reported and no complaints were received by the students, the parents or the 
schools, during this study. Some students queried whether their names would be included in 
publications, however they were reassured that this would not be the case. Hard copies of 
confidential data were filed securely behind two locked doors, with access granted only to 
members of the research team on an ‘as needs’ basis. All online data was secured behind a firewall 
on a password protected computer. To ensure that complete anonymity of the students was 
maintained, all student names and identifiable data were replaced with non-identifiable reference 
70 
 
codes, comprising a sequence of numbers. School names were also replaced with numbers for the 
purposes of publication.  
  3.1.4 Data Collection Tools 
The questionnaire included five compulsory sections and one optional section. There were 37 
questions, including the questions in the optional section. A full copy of the questionnaire can be 
found in appendix three. Demographic information, including gender, age, ethnicity, postcode 
and additional health conditions, were also included. Where students did not know their postcode, 
the postcode of the school was used instead. Where it was not possible to complete the 
questionnaire online (e.g. where the internet went down in schools), a paper version was 
completed and uploaded. Due to technical difficulties with the school computers, 134 students at 
six schools completed the questionnaire on paper. Due to this, the compulsory sections could not 
be enforced, therefore some missing data was encountered. Students who had difficulty using 
computers, or with reading the questions, were supported by a member of school staff. All 
questions were multiple choice, with some additional free-text questions. The questionnaire took 
approximately 15 minutes to complete. Throughout the questionnaire, the terms “reliever” and 
“preventer” inhalers were used instead of SABA and Inhaled Corticosteroids (ICS). 
Asthma Control Test (ACT) 
The validated ACT is a five-item tool, and is a reliable method for assessing asthma control in 
children aged 12 and older [68, 141]. The license to use the ACT was gifted by GlaxoSmithKline 
(GSK) for research purposes. The tool was originally developed as a self-report measure to assess 
asthma control in patients, and it can be used in the clinical environment and at home. The ACT 
is designed to assess symptom frequency, use of short-acting β-agonists (SABA), night-time 
symptoms, activity limitations, and students’ perception of their asthma control over the previous 
month. Each answer denotes a score of one to five. Scores on the ACT range from a minimum of 
five to a maximum of 25. Scores of nineteen or below indicate poor (suboptimal) asthma control; 
scores of twenty or above (optimal) indicate good asthma control. A recent European Respiratory 
Society taskforce recommends that an ACT score of 19 or less should trigger more intense clinical 
monitoring [144].  
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Adherence to Medication and Lifestyle Questionnaire 
This section was developed by the research team. The aim of this section was to assess intentional 
and unintentional medication adherence, knowledge of medication, unscheduled access to 
healthcare services, school attendance and smoking behaviours. Although not validated, this part 
of the questionnaire was subject to rigorous testing, prior to being implemented in schools, as 
discussed above. Students were asked to their medications from a list, which included a picture 
and the clinical name. Students were encouraged to look up their medication on the internet if 
they could not recognise it from the list provided. There was also space provided for students to 
write down their medication if it was not included on the list. The students were also asked if they 
used a spacer.  
The adherence questions assessed how comfortable students felt using their inhalers both inside 
and outside school. The responses were rated on a Likert scale, from one (not at all comfortable) 
to five (completely comfortable). Students were also asked to report if they ever missed their 
inhalers, either accidentally or deliberately. Free-text questions were also included to identify why 
inhalers were not taken as prescribed. The inhalers included the SABA inhaler (referred to as the 
“blue reliever inhaler” in the questionnaire); the ICS inhalers (referred to as the “preventer inhaler, 
often brown” in the questionnaire). Other medications were also included for students who may 
be on combination inhalers, including LABA.  
Three questions were included assessing unscheduled visits to healthcare services over a four-
week period. These questions included unplanned visits to the school nurse/first aider, GP and 
hospital, due to asthma. All responses were multiple choice and ranged from never to four or more 
times. Five school and lesson absences questions were also asked, using the same scale. The 
lifestyle section included three questions about whether the students themselves smoked, or 
whether they lived with anyone who smoked.  
Me and My School Questionnaire (M&MS) 
This section of the questionnaire was optional. The students who did not want to complete this 
section submitted their answers the rest of the questions and returned to class.  
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The M&MS questionnaire is a validated measure which was developed to assess emotional and 
behavioural well-being at school. The tool is validated for use in children aged eight years and 
older. Although used primarily in the school environment, the questionnaire can also be translated 
to the clinical setting [145]. The tool is a measure of a person’s risk of developing any emotional 
or behavioural difficulties. The tool has good internal reliability, according to Cronbach’s alpha, 
for both the emotional (α = .84) and behavioural (α = .82) scales.  
The M&MS tool comprised two sections. In both sections, a statement about feelings was 
presented, and the students were asked to indicate their agreement with the statement. The 
emotion scale included ten items, and scores ranged from zero to 20. Similar to the ACT scoring 
system, a higher score indicates greater emotional difficulty. Scores between zero and nine 
indicate no emotional difficulty; scores of ten or eleven comprise borderline emotional difficulty; 
scores of twelve or above provide evidence of clinical emotional difficulty. The behavioural scale 
included six items, and scores ranged from zero to 12. Scores between zero and five suggest no 
behavioural difficulty; a score of six indicates borderline difficulty and a score of seven or above 
indicates clinical behavioural difficulty.  
The inclusion of this measure within the assessment tool for this study was important, as evidence 
from America suggests that child mental health is a significant predictor of asthma morbidity. 
Children with clinically significant levels of behavioural problems experienced 18 additional days 
of wheeze per year, compared with children without these concerns [146].  
 
3.2 Questionnaire - Pilot Study 
3.2.1 Aims 
There were four aims of the pilot study. The first aim was to confirm that the outcomes of interest 
could be adequately assessed using the online tool. The second aim was to assess the feasibility 
of the recruitment strategy and sample size, to ensure that it was suitable for the estimated 
timeframe. The third aim was to evaluate the accessibility of the online assessment tool for the 
target cohort. The final aim was to conduct preliminary testing on the current levels of asthma 
control and adherence to medication among teenagers with asthma in London secondary schools.  
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3.2.2 Methods 
The pilot study was conducted between September and December 2014 in two East London 
secondary schools, one of which was an all-boys school. The students completed the online 
questionnaire in schools on computers, and the questionnaire took approximately 15 minutes to 
complete. Two members of the research team were present throughout the data collection session. 
Due to the small sample size, the results of the pilot study are descriptive only, and are reported 
separately to the main data. 
   3.2.3 Results 
Demographics 
The sample included 26 students across both schools (25 male and one female). The age of the 
students ranged from 12 to 18 years, with a median age of 13. Half of the students (n = 13) were 
of South Asian ethnicity. Seven students (26.9%) reported additional health concerns, including 
eczema (n = 2), Hayfever (n = 1), and food allergies (n = 2). One of the schools was a selective 
grammar school and the other was a state comprehensive. There was no missing data for any of 
the sections in the pilot sample.  
Asthma Control 
The scores on the ACT ranged from a minimum of nine to a maximum of 24, with a median score 
of 18 (IQR= 7). Suboptimal asthma control was seen in over half of the students (n = 15; 57.7%). 
Figure four depicts the full range of ACT scores from all of the students. Of the 15 students who 
scored 19 or less on the ACT, indicative of poor control, seven students (46.7%) felt that their 
asthma was either well or completely controlled. Three students (20%) recognised that their 
asthma was poorly controlled. 
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     Figure 4. ACT scores from students in the pilot study 
Medication Adherence 
All the students reported having a SABA inhaler, referred to as a “blue reliever inhaler” in the 
questionnaire. Ten students (38.5%) were prescribed a SABA only; 16 students (61.5%) self-
reported having an ICS inhaler, referred to as a “preventer inhaler” in the questionnaire. One 
student reported taking other medication, but was unable to identify it from the list and pictures 
provided. Eight students (30.8%) used a spacer with either some or all of their medications.  
Eleven students (42.3%) felt either “somewhat”, “hardly”, or “not at all” comfortable using their 
reliever inhaler while at school; ten of these students (90.9%) had poor asthma control. Three 
students (11.5%), one of whom had poor asthma control, felt “somewhat” comfortable using their 
inhaler(s) outside school. Seven students (26.9%) said that they forgot to take their preventer 
inhaler either “sometimes”, “most of the time”, or “all of the time”. Four of these students had 
poor asthma control (57.1%). Three students (11.5%) self-reported that they deliberately did not 
take their reliever inhaler, either “sometimes” or “most of the time”; and one of these students 
had poor asthma control. The reasons given by the students for not taking their inhaler(s) as 
prescribed included finding the inhaler a burden and feeling as though their symptoms were not 
severe enough to need an inhaler. 
Unscheduled Care 
In the four weeks prior to completing the questionnaire, seven students (26.9%) had at least one 
unplanned visit to see their GP due to their asthma; all these students had poor asthma control. 
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Six students (23.1%) had at least one unplanned visit to the hospital emergency department due 
to their asthma; five of these students had poor asthma control. Four of these students had also 
visited their GP for their asthma. Three students (11.5%) had also visited the school nurse/first 
aider at least once in the previous four weeks due to their asthma; all these students had poor 
asthma control. One student visited the GP, hospital and school nurse at least twice for their 
asthma in the four weeks prior to completing the questionnaire.   
School Attendance 
Three students (11.5%) had at least one complete school day absence, due to their asthma, in the 
four weeks prior to completing the questionnaire. Three further students reported at least a partial 
school day absence, due to their asthma, during the same time frame. All six of these students had 
poor asthma control. Three students missed all or part of a regular lesson at least once, and ten 
students (38.5%) missed all or part of a PE lesson in the four weeks prior to completing the 
questionnaire. Eleven of these students had poor asthma control. Seven students (26.9%) felt that 
their asthma had either “a little bit” or “some” negative impact on their school performance. All 
these students had poor asthma control.  
Lifestyle and Smoking 
None of the students in the pilot study said that they smoked. Four students (15.4%) reported that 
their parents/carers or anyone else they lived with currently smoked. Five students (22.7%) said 
that their parents/carers or anyone else that they lived with had previously smoked. Four students 
(15.4%) did not answer this question. Six of the students who reported that their 
parents/carers/household members either currently or used to smoke (66.7%) had poor asthma 
control.  
M&MS Questionnaire 
Twenty-one students (80.8%) were happy to answer additional questions about how they felt at 
school. Scores on the emotion scale ranged from zero to eight, with a median score of two (IQR 
= 1.5). The scores on the emotion domain also confirmed that none of the students had any 
borderline or clinical emotional difficulties. Scores on the behaviour domain ranged from zero to 
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ten, with a median score of two (IQR = 2). Eighteen students (85.7%) recorded a score of five or 
less, consistent with no behavioural difficulties. Two students (9.5%) had a score of six, indicating 
borderline behavioural difficulty. One student scored ten on the behaviour scale, indicative of 
clinical behavioural difficulty. Five students (23.8%) reported that they had experienced teasing 
or bullying at school because of their asthma. Three of these students had poor asthma control, 
according to their scores on the ACT.  
  3.2.4 Conclusion – Pilot Study 
The findings from the pilot study showed that an online questionnaire was an effective strategy 
for assessing asthma control in a sample of secondary school students with asthma in London. 
Although preliminary, the findings presented here show concerning levels of poorly controlled 
asthma, according to scores on the ACT, and suggest that further investigation should be 
conducted, to see whether this continues in a larger cohort of teenagers.  
The pilot study established that the online tool was appropriate for the target cohort, and could 
suitably be used to answer the research questions. Although the pilot study also demonstrated that 
the recruitment strategy was feasible, more time should be dedicated to recruiting the schools.  
A key learning point from the pilot study was the absence of any knowledge data. The findings 
presented here are purely descriptive, due to the small sample size, however following analysis 
of the pilot data, it became apparent that the role of knowledge had not been investigated, and 
could be an important factor to include in a larger scale study, particularly when assessing the 
barriers to adherence among teenagers. Some of the free-text responses (e.g. “I think it is less 
likely that I will have to use it [the blue inhaler]”) indicate a lack of knowledge among some of 
the teenagers that participated, which could explain some of the high levels of poor adherence 
and poorly controlled asthma that were seen. To this end, for the full questionnaire, a series of 
three knowledge questions were included, regarding the role of their medication. The 
development of these questions will be discussed further in section 3.3.  
Despite the small data set, these findings suggest that asthma, particularly poorly controlled 
asthma, can impact on quality of life for children and young people. A larger dataset is required 
to further understand some of the barriers to effective asthma management, as well as some of the 
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factors that could be targeted in a future self-management intervention, to improve asthma control 
for children and young people.  
 
 3.3 Questionnaire – Main Study 
  3.3.1 Aims 
There were two primary aims of the main questionnaire study. The first was to assess current 
levels of asthma control among secondary school students in London, using the validated ACT. 
The second primary aim was to investigate the extent to which poorly controlled asthma impacts 
on quality of life for children and young people.  
  3.3.2 Methods 
Recruitment for the main questionnaire started in March 2014 and ended in June 2015, when the 
final school participated. Schools were invited using several recruitment strategies. The project 
was initially advertised in a newsletter, produced by the Centre of the Cell (COTC), and was 
distributed to all schools within the COTC network. Following this, emails were sent to COTC 
partner schools in North and East London boroughs. After an initial low uptake, targeted methods, 
such as personalised emails and phone calls to heads of science, were implemented. The 
recruitment area was also widened to include all schools across London. Personalised emails were 
also sent to schools in London who were part of the QMUL ‘widening participation scheme’ 
[147]. This scheme invites all school students to participate in a variety of activities, including 
school-based workshops and university days at QMUL. The scheme is open to all students who 
are eligible for free school meals, or whose parents are from non-professional occupations, or did 
not attend higher education. Schools were also recruited at a STEM teacher conference in London. 
Table two shows the full recruitment strategy. All schools that showed an interest in the research 
were contacted via telephone to arrange a visit to discuss the project further. 
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Time Frame Recruitment 
Strategy 
London Boroughs Schools 
Contacted 
Participating 
Schools 
March to June 
2014 
Mail and email shot North East London 201 11 
May 2014 Newsletter 
advertisement 
North East London - 1 
May 2014 Email to partner 
schools of SHWRN 
North East London 12 0 
March 2015 Email shot North East and South East 
London 
102 0 
May 2015 Targeted email to 
head of science 
North East and East 
London 
65 2 
May 2015 Email shot North West, South East 
and South West London 
266 0 
May to June 
2015 
Email to COTC 
visitors 
All 26 1 
June 2015 Email to QMUL 
widening scheme 
All 9 5 
June 2015 STEM teacher 
conference 
All - 1 
June 2015 Email to Barts 
partner schools 
East London 20 3 
Total   701 24  
Table 2. School Recruitment Strategy 
As seen in table two, in excess of 700 schools were invited to participate, and 24 schools agreed, 
generating an approximate response rate of 3.4%. The participating secondary schools in the study 
reflected 2.5% of all secondary schools in London, according to government national statistics 
[148], and 5.8% of the secondary schools in participating boroughs [148]. 
Data were not available for the number of schools who received the COTC newsletter, or who 
were represented at the STEM conference. There was no upper limit regarding the number of 
schools that could participate, and the observational nature of the study meant that a power 
calculation for the minimum number of students was not required. However, the sampling was 
limited by a one-year time frame. The low uptake of schools is an important limitation of this 
study, which will be discussed in more detail in the discussion in chapter six. As seen in figure 
five, most of schools also came from North and East London, thereby limiting the generalisability 
of the results to other population groups (e.g. affluent populations in South-West London).  
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Figure 5. Distribution of participating schools  
In addition to the 24 schools that participated, 20 further schools expressed an interest in the 
project, however they did not participate due to the school either being unable to accommodate 
the questionnaire (e.g. due to limited room availability), or the school contact subsided. 
Once the interested schools had been identified, project information and withdrawal forms were 
sent to the designated teacher, for dissemination to the parents. The designated teacher at each 
school was also responsible for ensuring that the head teacher was happy with the school’s 
involvement in the research; identifying eligible children within the school; organising a computer 
room for the data collection; and informing students of the session details. All students who were 
registered as asthmatic were invited to take part, and parents had two weeks to withdraw their 
child if they wished. The students were briefed on the research at the start of the data collection 
session, and they were given an information sheet to read and an assent form to complete, if they 
were happy to participate. The students were encouraged to ask questions, and not complete the 
assent form until they fully understood what was being asked of them. Once students indicated 
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that they were happy, they were directed to the online assessment tool. Figure six shows a 
photograph of the children completing the questionnaire; figure seven shows a screenshot of the 
website.  
 
 
  
 
 
 
 
 
 
 
 
 
 
       Figure 6. Photograph of students completing the questionnaire 
 
 
 
 
 
 
 
      
 
 
Figure 7. Online assessment tool 
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The questionnaire was administered online, and was accessed using a secure website (found here: 
https://www.myasthmaproject.co.uk).  The students received a small goody bag as a thank you 
for their participation. To eliminate the risk of this being considered a bribe, the students were 
unaware of this incentive until after they had completed the questionnaire.  
Attendance data was also requested from each school, to verify the self-report data on absence. 
Six schools sent this data, however the format of the data meant that it could not be used to verify 
student responses as all the information was anonymised. Moreover, the reason for the absence 
was unclear, therefore it did not confirm whether the absences were due to asthma specifically. 
The remaining schools were either unable to provide this information, or could not disclose this 
information to a third-party organisation.  
Following the data collection, participating schools were offered learning opportunities with the 
COTC as compensation for their time. These opportunities included a free educational session at 
QMUL, or a careers workshop in school. It was surprising that uptake of these incentives was 
low; three schools accepted an educational session and three schools requested careers workshops, 
aimed primarily at their year eleven and sixth form students.  
Statistical Analysis 
All quantitative analyses were conducted using IBM SPSS statistical package (version 24). A p 
value of < 0.05 was considered statistically significant. Free text data was analysed qualitatively 
using thematic framework analysis. The data was non-parametric, therefore the findings are 
summarised as median (Interquartile Range (IQR)), unless otherwise indicated.  
Continuous data were analysed using Spearman’s rank order correlation co-efficient. Mann-
Whitney U tests and chi-square analyses were performed on the categorical data to look for 
differences between the groups. Subgroup analyses were also conducted, based on gender, age 
and ethnicity. Previous epidemiological studies have shown differences in asthma control 
between gender and ethnicity groups. For example, being male is considered a risk factor for the 
onset of asthma up to age 16 [149]. Furthermore, in the UK, children from Caucasian and African 
ethnic backgrounds are at greater risk of experiencing asthma symptoms than children from South 
Asian ethnic backgrounds [150]. Conversely, children from South Asian and Black ethnic 
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backgrounds are at higher risk of hospital admissions following complications from their asthma, 
compared with children from Caucasian backgrounds [150].  
  3.3.3 Results 
School Demographics 
The participating schools included 20 state comprehensives, three grammar schools and one 
independent school. Most of the schools (n = 14) were co-educational, five schools were girls 
only, four schools were boys only and one school was mixed, however boys and girls were taught 
separately. Of the participating schools, 17 did not have a specific religion, six schools were 
Roman Catholic and one school was Anglican. The schools ranged in size from 704 pupils to 
2576 pupils, with an average student body of 1323 pupils. According to the data provided by the 
schools, the total number of registered asthmatics in the participating schools ranged from 12 to 
150, with an average of 61 asthmatics in each school. Two schools were unable to provide this 
information, and some schools did not wish to disclose this information. Notably, some schools 
did not have updated records of the registered asthmatic students in their schools, therefore the 
numbers of reported asthmatics are based on estimates and often result in an under-reporting of 
asthmatic children. According to online records, there were an estimated 31753 pupils registered 
across the 24 schools at the time of the data collection; the data provided by each school confirmed 
that there were an estimated 1279 asthmatic children registered across all the schools. This yielded 
an asthma prevalence of 4% across all the participating schools. Figure eight shows the prevalence 
of asthmatic students in the participating schools.  
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Figure 8. Prevalence of asthmatic students in participating schools 
The number of participating students in each school ranged from a minimum of four to a 
maximum of 77, with an average of 32 asthmatic children participating per school. Table three 
gives the details of all of the participating schools. N/A denotes where the total number of students 
with asthma could not be obtained.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Total number of students in participating schools 
N = 29231 
Asthmatic students registered in participating schools 
N = 1339 (4.6%) 
 
N = 29231 
Number of participants from all schools 
N = 766 (57.2%) 
 
N = 29231 
Participants with suboptimal asthma control 
N = 348 (45.4%) 
 
N = 29231 
Participants with optimal asthma control 
N = 418 (54.6%) 
 
N = 29231 
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School 
ID 
Type of 
School* 
Total 
Students 
N 
Method of 
Recording 
Asthmatics† 
Reported 
Asthmatics 
N (%) 
Asthmatic 
Participants 
N (%) 
Suboptimal 
Control 
(%) 
Median 
ACT 
Score 
(Units) 
1 C 1236 TR 55 (4.4) 7 (12.7) 71.4 18 
2 C 1211 I N/A 57 47.4 20 
3 C 1411 TR 40 (2.8) 20 (50) 40.0 20.5 
4 C 1023 TR 68 (6.6) 64 (94.1) 53.1 19 
5 C 2000 TR 20 (1) 15 (75) 60.0 19 
6 C 2576 TR 24 (0.9) 8 (33.3) 37.5 21 
7 C 967 TR 46 (4.8) 22 (47.8) 59.1 18 
8 I 1345 I N/A 17 17.6 21 
9 G 898 TR 150 (16.7) 77 (51.3) 40.3 20 
10 C 1145 TR 78 (6.8) 52 (66.7) 40.4 21.5 
11 C 1518 TR 60 (4.0) 17 (28.3) 29.4 22 
12 C 1104 TR 40 (3.6) 10 (25) 50.0 20 
13 G 888 TR 59 (6.6) 39 (66.1) 38.5 21 
14 C 1256 TR 12 (1.0) 10 (83.3) 50.0 18.5 
15 C 1361 TR 40 (2.9) 30 (75) 40.0 21 
16 C 1972 TR 61 (3.1) 49 (80.3) 49.0 20 
17 C 1659 TR 102 (6.1) 43 (42.2) 44.2 20 
18 G 1185 TR 99 (8.4) 61 (61.6) 39.3 21 
19 C 1130 TR 50 (4.4) 26 (52) 61.5 18.5 
20 C 1341 I N/A 4 50.0 19.5 
21 C 704 TR 34 (4.7) 34 (100) 50.0 19.5 
22 C 1974 TR 90 (4.6) 59 (65.6) 66.1 17 
23 C 951 TR 70 (7.4) 9 (12.9) 22.2 23 
24 C 898 TR 81 (9.0) 36 (44.4) 30.6 21 
 Table 3. Details of participating schools 
 *C = Comprehensive; I = Independent; G = Grammar 
 †TR = Teacher Reported; I = Informal 
Child Demographics 
The main study was conducted from December 2014 to October 2015, and included 799 children 
aged 11 to 18 with asthma. Following the removal of incomplete ACT responses, 766 datasets 
were retained for analysis. In six schools, a temporary lack of internet connectivity prevented the 
questionnaire from being completed online, therefore identical paper versions were disseminated 
in these schools instead. The paper version of the questionnaire could not control instances of 
missing data in the same way as the online questionnaire, therefore 33 students (4.1%) failed to 
answer one or more of the ACT questions, and were subsequently removed from the dataset as 
ACT scores could not be calculated, thereby affecting the primary outcome. Seventy-three 
students with complete ACT datasets had missing data for other questions, representing 9.5% of 
the sample, however these students were not removed from the dataset.  
A table detailing the total number of responses and missing data can be found in appendix four.  
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Within the final cohort, 315 students (41.1%) were female and 446 (58.3%) were male. Five 
students chose not to disclose their gender. The students’ ages ranged from 11 to 18 years, with a 
median age of 13 years. The sample included children of predominantly Black (22.2%) and White 
(16.6%) ethnicity. Twenty-three students did not divulge their age or ethnicity, and five students 
chose not to disclose their gender. In addition to asthma, 506 students (66.1%) self-reported 
having no further health problems. The most commonly reported health concerns included 
Hayfever (n = 79); eczema (n = 77); and allergies (n = 63). Full details of the student’s 
demographic information can be found in table four.  
Demographics N (%) 
Age of Students 
11 92 (12.0) 
12 149 (19.4) 
13 153 (20.0) 
14 143 (18.7) 
15 113 (14.8) 
16 32 (4.2) 
17 39 (5.1) 
18 22 (2.9) 
Missing Data 23 (3.0) 
Gender 
Male 446 (58.2) 
Female 315 (41.1) 
Missing Data 5 (0.7) 
Ethnicity 
White 123 (16.1) 
Black 165 (21.5) 
Bangladeshi 95 (12.4) 
South Asian 34 (4.4) 
East Asian 22 (2.9) 
Mixed 92 (12.0) 
Other 212 (27.7) 
Missing Data 23 (3.0) 
 Table 4. Demographic characteristics of participating students 
Most of the students (n = 689; 89.9%) self-reported using medication for their asthma. Almost all 
the students could identify their medications from the photographs and the list provided in the 
questionnaire; 58 students (7.6%) were unable to identify their medication following an 
examination of the list provided and an internet search. Table five details the prescribed asthma 
therapy of the students.  
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Asthma Therapy* Matched Medication N (%) 
Inhaler   
Blue Salbutamol 648 (84.6) 
Red Ciclesonide 4 (0.5) 
Purple Fluticasone/Salmeterol 57 (7.4) 
Red Budesonide/Formoterol 30 (3.9) 
Brown Budesonide 19 (2.5) 
Brown Beclometasone 328 (42.8) 
Orange Fluticasone 6 (0.8) 
Green Salmeterol 28 (3.7) 
Tablets   
Oral Steroid  14 (1.8) 
Theophylline  0 
Montelukast  25 (3.3) 
No prescribed inhaled or oral 
medication 
 77 (10.1) 
Prescribed medication not identified  58 (7.6) 
Other±  39 (5.1) 
*Colour picture and the name of the medication was included in the questionnaire 
±Students certain that they had medication, but uncertain what it was 
Table 5. Prescribed asthma therapy among participating students 
Asthma Control 
Scores on the ACT ranged from a minimum of six to a maximum of 25. The median score was 
19.3 (IQR = 6). Suboptimal asthma control, indicated by a score of 19 or less on the ACT, was 
seen in 350 students (45.7%). Figure nine highlights the range of asthma control test scores among 
students.  
 
Figure 9. ACT scores of participating students 
Of the 77 students (10.1%) who self-reported that they did not have any prescribed medication 
for their asthma, 36 (46.8%) scored 25 on the ACT, indicating an absence of symptoms; eight 
students (10.4%) scored 19 or less. Table six details the distribution of self-reported prescribed 
medication across the two asthma control groups.  
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 Total 
N (%) 
Suboptimal Control 
N  
Optimal Control 
N 
SABA only 217 (28.3) 75  142  
ICS only 295 (38.5) 160 135 
LABA only 2 (0.3) 1 1 
Combination ICS and LABA  84 (11.0) 61 23 
Could not identify medication 58 (7.6) 33  25 
No prescribed therapy 77 (10.1) 8  69 
Table 6. Distribution of prescribed inhaler medications across the asthma control groups 
Among the students who scored 19 or less on the ACT, 42.3% (n = 148) felt that their asthma was 
either well or completely controlled. Similarly, 15.1% (n = 53) acknowledged that their asthma 
was either poorly controlled, or not at all controlled. Of the students who scored 20 or above on 
the ACT, 1.7% (n = 7) felt that their asthma was either poorly controlled or not controlled at all. 
All students who scored 25 on the ACT (n = 75) identified that their asthma was completely 
controlled; however, 26.4% (n = 19) felt that their asthma had not gone away.  
The students were asked how comfortable they felt using their SABA (blue) inhaler at school; 
592 students responded. As seen in figure ten, 17.1% of students (n = 101) felt either not at all 
comfortable, or hardly comfortable, using their inhaler at school; 38.2% (n = 226) felt completely 
comfortable using their inhaler at school.  
 
 
 Figure 10. Distribution of how comfortable students felt using their SABA inhaler at school 
Table seven compares this data across the two asthma control groups. The children with well 
controlled asthma felt more comfortable (very or completely) using their inhaler at school, 
compared to their peers with poorly controlled asthma (70.4% vs 47.9%). 
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 Total 
N (%) 
Suboptimal 
Control 
N (%) 
Optimal Control 
N (%) 
P value* 
 N = 536 N = 303 N = 233  
<0.01 
Not at all comfortable 26 (4.9) 19 (6.3) 7 (3.0)  
Hardly comfortable 67 (12.5) 50 (16.5) 17 (7.3)  
Somewhat comfortable 134 (25) 89 (29.4) 45 (19.3)  
Very comfortable 106 (19.8) 58 (19.1) 48 (20.6)  
Completely 
comfortable 
203 (37.9) 87 (28.7) 116 (49.8)  
*by chi-square test 
Table 7. Comfort using SABA inhaler at school 
As seen in table eight and figure 11, 60.1% (n = 458) felt completely comfortable using their 
inhaler(s) outside school; 64.1% (n = 25) of those who did not feel comfortable using their 
inhaler(s) outside school had poor asthma control. Furthermore, 36.7% (n = 168) of those who 
felt completely comfortable using their inhaler(s) outside school had poor asthma control.  
 Total 
N (%) 
Suboptimal 
Control 
N (%) 
Optimal Control 
N (%) 
P value* 
 N = 762 N = 347 N = 415  
<0.01 
Not at all comfortable 14 (1.8) 9 (2.6) 5 (1.2)  
Hardly comfortable 25 (3.3) 16 (4.6) 9 (2.2)  
Somewhat comfortable 98 (12.9) 55 (15.9) 43 (10.4)  
Very comfortable 167 (21.9) 99 (28.5) 68 (16.4)  
Completely 
comfortable 
458 (60.1) 168 (48.4) 290 (69.9)  
*by chi-square test 
Table 8. Comfort using inhaler(s) outside school 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Distribution of how comfortable students felt using inhaler(s) outside school 
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Just under half of the students (49.5%; n = 379) self-reported using an inhaled corticosteroid ICS 
inhaler, either alone or with a LABA inhaler (referred to as a “preventer” inhaler in the 
questionnaire, in accordance with the BTS guidelines [151]). When asked what this inhaler was 
for, 37.4% of students (n = 142) were unable to identify the correct answer. Chi-square analysis 
revealed that asthma control was not associated with knowledge about the ICS inhaler (p = .545).  
A spacer was used by 40.8% of students (n = 311); 46.6% (n = 145) used a spacer with some of 
their inhalers; 53.4% of students (n = 166) used a spacer with all their inhalers. Adherence with 
the spacer was low: 38.7% (n = 120) self-reported that they used their spacer either less than half 
the time, or never; one student did not respond. When asked to identify the role of their spacer, 
16.1% of students (n = 48) did not know. Chi-square analysis revealed that there was a significant 
difference between the two asthma control groups and knowledge of the spacer (p = .033); and 
Mann-Whitney U analyses confirmed that knowledge of the spacer was significantly higher 
among students with poor asthma control (p < .05).   
Demographic characteristics, including gender and ethnicity, were not associated with asthma 
control, according to the subgroup analyses. A significant positive correlation was seen between 
ACT scores and age; however, this association was very weak (r = .168, p < .01). The proportion 
of asthmatic students with poor asthma control, according to the ACT, was higher in non-selective 
(otherwise known as comprehensive) schools, compared with selective (grammar and 
independent) schools (48.4% vs 37.6%; p <.05).  
Medication Adherence 
As mentioned above, just under half of the students self-reported using an ICS with or without a 
LABA inhaler. Table nine shows the adherence data for this; figure 12 shows the prevalence of 
non-adherence with this inhaler. More than half of the students (55.4%; n = 247) self-reported 
forgetting to take their inhaler either “sometimes”, “most of the time”, or “all of the time”.  
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 Total 
N (%) 
Suboptimal Control 
N (%) 
Optimal 
Control 
N (%) 
P value* 
 N = 446 N = 253 N = 193  
< 0.01 
All the time 47 (10.5) 21 (8.3) 26 (13.5)  
Most of the time 82 (18.4) 54 (21.3) 28 (14.5)  
Sometimes 118 (26.5) 74 (29.2) 44 (22.8)  
A little of the time 119 (26.7) 71 (28.1) 48 (24.9)  
Never 80 (17.9) 33 (13.0) 47 (24.4)  
*by chi-square test 
Table 9. Adherence with the ICS +/- LABA inhaler, by asthma control group 
 
 
 
 
 
 
 
 
 
Figure 12. Non-adherence with the ICS +/- LABA inhaler 
In addition, 23.0% of students (n = 101) also self-reported that they missed this inhaler 
deliberately either “sometimes”, “most of the time” or “all of the time”. According to the 181 
free-text responses, the most frequently reported reason for nonadherence with this inhaler was 
forgetfulness, with some students expressing difficulty in remembering to take their inhaler in the 
morning when they were getting ready for school, or in the evening when they were doing 
homework or extracurricular activities. Other reasons included a belief that the ICS +/- LABA 
inhaler was necessary because the symptoms were not severe enough symptoms. The full range 
of responses are given in table ten.  
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Reason Example N 
Forgetfulness “I sometimes forget because it is not in my priority list 
of things to do” 
70 
Not needed “I do not really need it all the time” 47 
Inconvenience “It takes a long period of time to get the right exact 
amount of medication” 
23 
Side-effects “It is disgusting and too strong” 6 
Ineffective “I do not feel like it helps much, even when I use it, so 
I tend to forget it is there” 
6 
Use SABA instead “Sometimes I forget because I’m more used to using 
the blue one” 
5 
Misplaced “I can’t find it” 5 
Knowledge “I did not know that I was meant to take a regular 
preventer inhaler” 
5 
Do not want to use it “I want to cope without the help of my medication” 5 
Laziness “I can’t be bothered to take it. I feel like there is no 
point, too much effort” 
4 
Uncomfortable “I do not feel comfortable with it” 3 
Do not know “I do not know, to be honest” 2 
Table 10. Free-text responses to reasons for non-adherence with the ICS +/- LABA inhaler 
Chi-square analysis showed a significant interaction between asthma control and adherence to 
medication. A greater proportion of students with poor asthma control, according to the ACT, 
self-reported that they did not take their ICS +/- LABA inhaler, at least some of the time, 
compared to students with good asthma control, however the difference between the two groups 
was small (58.9% vs 50.8%, p < .01). A significant association was also seen between adherence 
with the ICS +/- LABA inhaler and knowledge of this inhaler (p < .01). A Mann-Whitney u 
analysis showed that adherence was slightly greater among those with increased knowledge of 
the inhaler, however this was not significant (p = .978).  
A blue SABA “reliever” inhaler was reportedly used by 648 students. As seen in table eleven, 
29% (n = 176) did not use their reliever inhaler when they needed it either “sometimes”, “most 
of the time”, or “all of the time”. In total, 256 free-text comments were received detailing the 
reasons for non-adherence with this inhaler. The free-text responses are detailed in table twelve.  
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*by chi-square analysis 
Table 11. Adherence with the SABA inhaler, by asthma control group 
Adherence with the SABA inhaler was significantly lower among students with poor asthma 
control. A greater proportion of students with poor asthma control, according to the ACT, self-
reported that they did not take their SABA inhaler when they needed it, at least some of the time, 
compared with students with good asthma control (35.6% vs 22.2% p < .01). No differences were 
found between adherence with the SABA inhaler and how comfortable students felt using this 
inhaler at school. Among the students who felt either “somewhat”, “very”, or “completely” 
comfortable using their inhaler at school (n = 443), 12.0% used their SABA inhaler when they 
needed it either all the time or most of the time. Among the students who felt either not at all 
comfortable, or hardly comfortable, using their inhaler at school (n = 93), 7.5% used their inhaler 
when they needed it either all the time or most of the time.  
Reason Example N 
Do not need it “I think wheezing will get better on its own. 
I do not need an extra pump” 
59 
Learn to cope without it “I want to learn to cope without my asthma 
pump” 
58 
No access to it “Sometimes I do not have it on me” 45 
Forgetfulness “I forget about it” 32 
Peer response “Sometimes it is embarrassing in front of 
people/friends as you may be considered 
weak” 
20 
Misplaced “I might have lost it” 9 
Inconvenient “When I am out of breath I am too tired to 
get it” 
8 
Side-effects “Sometimes I do not use it because it makes 
me shake so it disrupts me” 
8 
Efficacy “I do not feel it helps that much. I can 
usually get over wheeziness or an attack by 
myself” 
5 
Not sure “I do not know” 4 
Use preventer instead “I usually use the brown inhaler” 4 
Prescription expired “I rarely suffer asthma attacks so my 
prescription was out of date” 
3 
Knowledge “Sometimes I do not know when I need it” 1 
Table 12. Free-text responses to reasons for non-adherence with the SABA inhaler 
 
 
 
 Total 
N (%) 
Suboptimal Control 
N (%) 
Optimal 
Control 
N (%) 
P value* 
 N = 606 N = 309 N = 297  
< 0.01 
All the time 30 (5.0) 18 (5.8) 12 (4.0)  
Most of the time 43 (7.1) 29 (9.4) 14 (4.7)  
Sometimes 103 (17.0) 63 (20.4) 40 (13.5)  
A little of the time 164 (27.1) 77 (24.9) 87 (29.3)  
Never 266 (43.9) 122 (39.5) 144 (48.5)  
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Tablets were prescribed to 39 students, according to the self-report data; 33 students answered 
the questions regarding adherence with their tablets. Over a third of these students (36.4%; n = 
12) self-reported that they forgot to take their tablets at least some of the time. Free-text responses 
regarding reasons for non-adherence with tablets were collected from students and 53 responses 
were recorded. Like the adherence data for inhalers, the most commonly reported reason for non-
adherence, according to the free-text data, was forgetfulness. The free-text responses are shown 
in table thirteen.  
Reason Example N 
Forgetfulness “I forget to take my medication; it is hard to 
remember. These things are not on my mind” 
20 
Side-effects “I do not like tablets. They taste horrible and I 
feel a bit sick” 
9 
Do not need them “Sometimes I do not need them if I have not 
shown any symptoms of asthma” 
8 
Do not want them “I do not like taking tablets because I worry they 
can hurt me” 
7 
Use different medication “It is just easier to take an inhaler” 4 
Do not know “I just do” 2 
Too many medicines “There are too many tablets” 1 
Embarrassment  “I do not want to take them in front of my 
friends” 
1 
Ineffective “The prescription is too little” 1 
Table 13. Free-text responses for reasons for non-adherence with tablets 
Data was collected from 595 students on how they felt at school. A small number of students 
(5.7%; n = 34) reported that they had been bullied because of their asthma either “all the time”, 
“a lot” or “a little bit”. A further 6.8% of students (n = 39) preferred not to answer this question. 
No significant association was found between whether students were bullied at school and their 
adherence with their blue SABA (“reliever”) inhaler. A significant association, however, was 
found between whether students were bullied at school due to their asthma and how comfortable 
students felt using their inhalers at school. The chi-square analyses also showed that a greater 
proportion of students who were bullied at school either “a little bit”, “a lot” or “all the time” felt 
less comfortable taking their inhalers at school, compared with those who reported that they had 
not been bullied due to their asthma (38.5% vs 37.1%, p < .01), however the difference was very 
small. Among the students who reported experiencing being bulled due to their asthma, 88.2% (n 
= 30) had poor asthma control.  
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Unscheduled Care 
Unscheduled care over a four-week period, including visits to a school nurse, GP and hospital 
emergency departments, were recorded by 743 students. At least one unplanned visit to see the 
school nurse was reported by 16% of students (n = 119). Four or more visits to the school nurse 
was reported by seven students (0.9%). At least one unplanned visit to the hospital emergency 
department, due to asthma, was reported by 15.7% of students (n = 117); four or more visits were 
reported by 1.2% of students (n = 9). Unplanned GP visits were much higher; 28.1% of students 
(n = 209) reported visiting their GP at least once. Notably, 2% of these students (n = 15) visited 
their GP four or more times due to their asthma during this period. The rates of unscheduled care 
across the asthma control groups are shown in table fourteen.  
 Total 
N (%) 
Suboptimal 
Control 
N (%) 
Optimal 
Control 
N (%) 
P value* 
Unplanned GP visits N = 743 N = 340 N = 403 < .001 
Never 534 (71.9) 185 (54.4) 349 (86.6)  
1-2 times 160 (21.5) 118 (34.7) 42 (10.4)  
2-3 times 34 (4.6) 26 (7.6) 8 (2.0)  
4 or more 15 (2.0) 11 (3.2) 4 (1.0)  
Unplanned hospital visits N = 743 N = 340 N = 403 < .001 
Never 626 (84.3) 248 (72.9) 378 (93.8)  
1-2 times 88 (11.8) 68 (20) 20 (5.0)  
2-3 times 20 (2.7) 15 (4.4) 5 (1.2)  
4 or more 9 (1.2) 9 (2.6) 0 (0)  
Unplanned school nurse 
visits 
N = 743 N = 340 N = 403 < .001 
Never 624 (84.0) 250 (73.5) 374 (92.8)  
1-2 times 87 (11.7) 60 (17.6) 27 (6.7)  
2-3 times 25 (3.4) 23 (6.8) 2 (0.5)  
4 or more 7 (0.9) 7 (2.1) 0 (0)  
Table 14. Rates of unscheduled care 
Most of the students who had visited their GP four or more times over a four-week period due to 
their asthma 73.3% had poor asthma control (n = 11), based on their ACT scores. All of the 
students who visited the hospital emergency department and the school nurse at least four times 
had poor asthma control, according to the ACT. The distribution of unplanned medical attention 
is shown in figure 13.  
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Figure 13. Unscheduled care over a four-week period 
Higher rates of unscheduled GP visits were seen in students with poor asthma control, compared 
to students with good asthma control (45.6% vs 13.4%; p < .01). A greater proportion of students 
with poor asthma control also reported more visits to the hospital emergency department (27.1% 
vs 6.2%; p < .01) and the school nurse or first aider (25.7% vs 7.0%; p < .01), compared to students 
with good asthma control. 
Chi-square analyses showed a significant association between unplanned GP visits and 
medication adherence. Among the students with at least one unplanned GP visit, 44% (n = 91) 
reportedly did not take their regular preventer inhaler at least some of the time (p < .01). No 
significant association was noted between medication adherence and unplanned hospital visits (p 
= .073); however of those who had at least one unplanned hospital visit (n = 117), 47% reportedly 
did not take their regular preventer inhaler as prescribed, at least some of the time.  
School Attendance 
School attendance data was collected by 738 students. At least one whole school day absence due 
to their asthma was reported by 20.9% of students (n = 154); 10.4% of these students (n = 16) had 
four or more whole school absences due to their asthma. Similarly, 17.6% (n = 130) had at least 
one absence from part of the school day. All or part of a regular lesson was missed at least once 
by 19.5% of students (n = 144); 6 students (4.2%) missed lessons four or more times. All or part 
of a Physical Education (PE) lesson was missed by 28.6% of students (n = 211). Table fifteen and 
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figure 14 show the proportion of school absences, due to asthma, across the two asthma control 
groups.  
Total = 738* Total 
N (%) 
Suboptimal Control 
N (%) 
Optimal Control 
N (%) 
P value 
Whole School Day 
 N = 738 N = 336 N = 402  
Never 584 (79.1) 226 (67.3) 358 (89.1) < 0.01 
1-2 times 120 (16.3) 85 (25.3) 35 (8.7)  
2-3 times 18 (2.4) 15 (4.5) 3 (0.7)  
4+ times 16 (2.2) 10 (3.0) 6 (1.5)  
Part School Day 
 N = 738 N = 336 N = 402  
Never 608 (82.4) 233 (69.3) 375 (93.3) < 0.01 
1-2 times 107 (14.5) 83 (24.7) 24 (6.0)  
2-3 times 15 (2.0) 13 (3.9) 2 (0.5)  
4+ times 8 (1.1) 7 (2.1) 1 (0.2)  
All/Part Lesson 
 N = 738 N = 336 N = 402  
Never 594 (80.5) 224 (66.7) 370 (92.0) < 0.01 
1-2 times 121 (16.4) 90 (26.8) 31 (7.7)  
2-3 times 17 (2.3) 17 (5.1) 0 (0)  
4+ times 6 (0.8) 5 (1.5) 1 (0.2)  
All/Part PE Lesson 
 N = 738 N = 336 N = 402  
Never 527 (71.4) 185 (55.1) 342 (85.1) < 0.01 
1-2 times 166 (22.5) 114 (33.9) 52 (12.9)  
2-3 times 29 (3.9) 26 (7.7) 3 (0.7)  
4+ times 16 (2.2) 11 (3.3) 5 (1.2)  
*Missing data from 28 students 
Table 15. School absences across the asthma control groups 
 
Figure 14. School attendance over a four-week period 
Students with poor asthma control had significantly higher incidences of whole school day 
absences, compared to their peers with good asthma control (32.7% vs 10.9%; p < .01). This was 
also true for absences from PE lessons (44.9% vs 14.9%; p < .01). However, some students with 
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good asthma control were still reporting school and lesson absences, suggesting that their asthma 
may not be as well controlled as the ACT scores might suggest.  
A quarter of the students (n = 4) who missed four or more school days due to their asthma had 
also visited their GP four or more times due to their asthma during the same four-week period; 
31.3% of students (n = 5) who reported four or more school absences had not visited their GP at 
all. Similarly, 25% of students who had four or more school day absences (n = 4) had also visited 
the hospital emergency department at least once because of their asthma.  
As shown in table sixteen, and figure 15, 96.6% of students (n = 740) reported on the impact of 
their asthma on their school performance. Either “some” or a “big” negative impact was felt by 
16.5% of students (n = 12), 66.7% of whom (n = 12) had poor asthma control. Chi-square analyses 
found that a greater proportion of students with poor asthma control felt that their asthma 
negatively impacted on their performance school, compared to those students with good asthma 
control (27.1% vs 7.7%; p < .01). Similarly, 77.7% of students (n = 251) who felt that their asthma 
had no negative impact on their school performance had good asthma control.  
 Total 
N (%) 
Suboptimal Control 
N (%) 
Optimal Control 
N (%) 
P value 
 N = 740* N = 336 N = 404  
None 323 (43.6) 72 (21.4) 251 (62.1) < 0.01 
Hardly 176 (23.8) 88 (26.2) 88 (21.8)  
A Little Bit 119 (16.1) 85 (25.3) 34 (8.4)  
Some 98 (13.2) 75 (22.3) 23 (5.7)  
Big 24 (3.2) 16 (4.8) 8 (2.0)  
*Missing data from 26 students 
 Table 16. Impact of asthma on school performance 
Figure 15. Impact of asthma on school performance 
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Sub-group analyses showed no significant association between ethnicity and whole school day 
absences (p = .232), lesson absences (p = .271) or PE lesson absences (p = .163). Similarly, no 
significant differences were seen between school attendance and gender.  
Lifestyle and Smoking 
A small number of students (5.1%; n = 39) reported that they currently smoked, 64.1% (n = 25) 
of whom had poor asthma control. Within this group, 20.5% (n = 8) reported that they smoked 
every day, and 46.2% (n = 18) said that they smoked less than once a week. Chi-square analysis 
showed no significant association between smoking and asthma control, however the proportion 
of students with poor asthma control who smoked was greater than the proportion of students with 
good asthma control who smoked (7.1% vs 3.4%; p = .177).  
Among the 39 students who said that they smoked, 28.2% (n = 11) had visited their GP at least 
once for their asthma; 11 students had also visited the hospital emergency department. Four 
students who smoked said that they had been bullied because of their asthma, either a little bit, a 
lot, or all the time.  
The students were also asked if their parents/carers/anyone they lived with currently smoked; 
25.2% of students (n = 185) stated that they did. Of the 549 students who answered no to this 
question, 23.9% (n = 131) said that people in their household had previously smoked.  
Emotional and Behavioural Wellbeing 
The students were asked if they were happy to answer some questions about how they felt at 
school, using the validated ‘Me and My School’ (M&MS) questionnaire. Most students (79.9%; 
n = 612) were happy to continue to this section of the assessment tool. These students were aged 
11 to 18 years (median = 13 years) and were 57.7% male.  
Emotion Domain 
Scores on the emotion scale ranged from a minimum of zero to a maximum of 20 (median = 3). 
Data was missing from 15 students. Most students had no clinical emotional difficulties, as 
indicated by the M&MS questionnaire (90.6%; n = 541). In total, 4.7% of students (n = 28) scored 
10 or 11, indicative or borderline emotional difficulties; 4% of students (n = 24) scored 13 or 
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higher, indicative of clinical emotional difficulties, according to this measure. Figure 16 shows 
the range of emotion scores.  
Figure 16. Emotion scores for participating students 
There were 15 females (62.5%) and eight males (33.3%) in the borderline difficulty group. The 
clinical emotional difficulty group comprised mainly females (67.9%; n = 19). No significant 
correlation was seen between age and the scores on the emotion scale (r = .060; p = .148). A 
statistically significant difference was seen between gender and the emotion groups, with females 
showing higher levels of emotional difficulty (p < .01). No significant differences were seen 
between the emotion and ethnicity groupings p = .633).  
A significant negative correlation was seen between scores on the ACT and scores on the emotion 
domain, however the association was weak (r = -.298; p < .01).  
Among the students within the borderline group (n = 24), 20.8% (n = 5) felt that they had been 
bullied because of their asthma, at least a little bit. Among those within the clinical emotional 
difficulty group, 21.4% (n = 6) felt that they had been bullied because of their asthma, at least a 
little bit. 
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Behaviour Domain 
Scores on the behaviour scale ranged from a minimum of zero to a maximum of 12 (median = 2). 
Data was missing from 19 students. Borderline behavioural difficulties, indicated by a score of 
six on the scale, were seen in 4.6% of students (n = 27). Clinical behavioural difficulties, indicated 
by a score of seven or higher, were seen in 7.4% of students (n = 44). Figure 17 shows the range 
of behaviour scores for the students.  
Figure 17. Behaviour scores for participating students 
The students in the borderline clinical difficulty group included seven females (25.9%) and 20 
males (74.1%). The clinical difficulty group included 17 females (38.6%) and 26 males (59.1%). 
Chi-square analyses found a significant difference between behavioural difficulty and gender (p 
< .01). Kruskal-Wallis analysis showed a non-significant association between behavioural 
difficulty and ethnicity (p = .078). No significant correlation was found between the age of 
students and scores on the behaviour scale (r = .029; p = .480). A significant correlation was seen 
between scores on the ACT and scores on the behavioural domain, however the correlation was 
very weak (r = -.130; p < .01).  
Among the students with borderline behavioural difficulty (n = 26), one student (3.7%) self-
reported that they were bullied all the time because of their asthma. Similarly, 6.8% of students 
(n = 3) with clinical behavioural difficulty, according to the M&MS tool, felt that they had been 
bullied because of their asthma either a lot or a little bit.  
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3.3.4 Discussion 
The primary aim of this study was to assess asthma control in London secondary school students. 
The pilot study provided reassurance that an online questionnaire was an appropriate tool for 
collecting these data, and the results (discussed in section 3.3 of this chapter) highlight high levels 
of poorly controlled asthma, low levels of knowledge, and low levels of medication adherence 
among teenagers.  
As discussed above, knowledge questions were included in the main questionnaire, following the 
outcomes of the pilot study. By including questions about knowledge, and allowing space for 
free-text responses for additional questions about medication adherence, this questionnaire begins 
to provide insight into some of the potential drivers of poor asthma control. As will be discussed 
further in section 3.4, additional focus groups will investigate some of these drivers more closely. 
However, what is evident from the questionnaire is that overall knowledge about the spacer is 
good, although knowledge about the ICS +/- LABA inhaler, and recognition of asthma symptoms, 
is concerning, particularly among those students with poor asthma control. This has also been 
seen in previous studies assessing knowledge of asthma among teenagers [152]. Although it can 
be hypothesised that low levels of knowledge may have contributed to the low levels of adherence 
that were seen here (although the existing evidence for this is low), data on the dose for the ICS 
+/- LABA inhaler, and the clinical justification for the medication, were not collected, therefore 
it is still unclear whether the poorly controlled asthma levels seen could also be due to inadequate 
treatment, poor adherence, or a combination of both. It also emerged from the findings that some 
children who scored 25 on the ACT were using a SABA inhaler, despite their responses 
suggesting that they had outgrown their symptoms. However, this only represented 4% of the 
students with asthma.  
Over a third of the students with poorly controlled asthma felt uncomfortable using their SABA 
“reliever” inhaler at school. It could be that feeling uncomfortable taking medication in public 
contributes to rates of non-adherence with medication, and this will be examined further in the 
next steps of the research. However, the free-text responses collected here suggest that poor 
adherence is somewhat a conscious decision, with embarrassment and other social concerns 
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emerging as a leading barrier to good medication adherence. Other barriers included forgetfulness 
and inconvenience, which may be less of a conscious decision. These findings support qualitative 
evidence from Naimi et al [153], who collected adherence data from teenagers aged 15 to 18 
years. Naimi et al also reported forgetfulness and medication ambivalence as frequent barriers to 
adherence among teenagers, as well as an incorrect perception of their own asthma control. As 
discussed earlier, there is also a possibility that some teenagers may normalise their asthma 
symptoms, and consequently have higher thresholds for seeking treatment [154]. This was also 
apparent in the findings presented here, as 42.3% of children believed that their asthma was either 
“well” or “completely” controlled. Although this may be common among young people, a delay 
in seeking treatment was noted in the National Review of Asthma Deaths [14] as a contributory 
factor to asthma-related deaths, therefore this behaviour should be addressed as early as possible 
to prevent any future avoidable mortalities.  
 
3.4 Overall Conclusions 
This study is the first in the UK to assess asthma control in secondary schools using the ACT. 
The results are, however, compatible with an international telephone survey, which was 
conducted in 2009 in children aged 4 to 15 years with poorly controlled asthma [74]. Two studies 
have been conducted in the UK in schools, however neither study assessed asthma control. In one 
study, conducted by McWhirter et al [76], quality of life, spirometry and inhaler technique was 
assessed in primary school children. In the second study, conducted by Patterson et al [155], 
asthma knowledge, school attendance, daily wellbeing, perceived self-efficacy, and quality of life 
were assessed in primary school children. 
One of the strengths of this study (discussed further in chapter six), is that data were collected in 
the school environment. In doing this, the potential for students to be influenced by parents or 
clinicians was eliminated, including the potential of parents to influence the child to incorrectly 
report asthma control.  
The findings of this questionnaire showed that delivering the questionnaire in schools, combined 
with using opt-out consent, was an acceptable and effective way of accessing children with 
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asthma. Therefore, the school could be an important space to consider for delivering interventions 
aimed at improving asthma control. However, the findings did also confirm that further 
investigations are needed regarding the potential barriers to medication adherence, which may be 
targeted in a future self-management intervention.   
3.4.1 Justification for Methodology 
These data were collected using an online questionnaire. This methodology had several 
advantages over a paper questionnaire.  
First, the number of incomplete datasets was controlled and subsequently reduced, since I 
designed the website hosting the questionnaire to ensure that the children were unable to progress 
until all existing questions had been answered. Unfortunately, where technical difficulties in 
going online occurred, paper versions were used instead. It was the use of the paper questionnaire 
in six schools that contributed the vast majority of missing data. The online version also enabled 
students to complete the assessment tool faster, thereby reducing disruption to the school day, and 
potentially reducing boredom.  
Second, the questionnaire was both timely and cost-effective to implement. Although the initial 
development of the software incurred higher expenses than the paper-based questionnaire, online 
questionnaires may elicit a higher response rate as they are more convenient for participants as 
they are completed instantly, with no expense incurred. Online questionnaires also save time in 
entering data manually into a database for analysis, and reduces the risk of error in doing so, as 
well as the risk of the hard copies being misplaced. Due to the immediate online responses, 
preliminary analyses can also be conducted on the data, to identify early trends that may emerge, 
allowing for initial planning of the next steps. The timely nature of the questionnaire also meant 
that multiple schools could be visited in one day, allowing the data collection to progress quickly.  
Third, data collected in this study was more secure since they were immediately secured behind 
a password protected firewall. Anonymity could also be maintained through computer security 
measures.  
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Fourth, I speculate that the online approach enabled students to answer the questions honestly, 
since I was able to reassure students that their responses could not be traced back to them – 
something that I speculate may be less convincing in a paper questionnaire.  
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Plain Language Summary 
The aims of the online questionnaire was to measure the current levels of asthma control and 
medication adherence among secondary school children with asthma. This questionnaire included 
the validated ACT, and questions on healthcare use, school attendance, knowledge of prescribed 
medications, lifestyle and smoking, and emotional and behavioural wellbeing, using the validated 
M&MS questionnaire. All of the questions included multiple choice answers, and some questions 
also included a free-text section. 
The questionnaire was first tested on 25 children with asthma from two secondary schools in East 
London. This showed concerning levels of asthma control among the students, however the small 
sample size stopped any further analyses. The final sample included 766 children with asthma 
from 24 secondary schools in London. Recruitment to the main study took place over a 12-month 
period.  
The findings from the questionnaire showed that 45.7% of the children had poor asthma control, 
according to the ACT. Knowledge of the spacer was generally high, although knowledge of the 
ICS + LABA inhaler was much lower. Adherence with asthma medication was also low among 
most of the children. Some of the barriers to adherence included practical reasons, such as 
forgetfulness and inconvenience, however social barriers, including fears of being bullied, were 
also reported by the children. The findings also showed that children with poorly controlled 
asthma had higher levels of unplanned healthcare use, and more school absences.  
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Chapter 4. Assessing the Barriers to 
Adherence: Qualitative Work 
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 4.1 Background  
In chapter three, I found that asthma control, medication use, and knowledge of medication was 
low in a large proportion of children. I also found that healthcare use was greater, and school 
attendance was lower, among children with poorly controlled asthma, according to the ACT. 
However, a major limitation of these data is that children completed pre-assigned questionnaires 
with little or no options for explanations. To obtain further support of my hypothesis therefore 
requires more detailed exploration on the views and attitudes of affected children. I therefore 
chose to use a focus group format. In this chapter, I therefore discuss the development and the 
findings of the focus groups, and how the findings will be used to inform future work. The 
qualitative analysis that was conducted on this data used a ‘light-touch’ approach, and formal 
analyses were not conducted, although thematic framework analysis is widely recognised among 
qualitative researchers. This approach was used largely as the data collected during the focus 
groups was supplementary to the questionnaire data, and the primary aim was to further 
understand the barriers to medication adherence among teenagers, with a view to using this data 
to inform a future school-based intervention. As will be discussed in the methods section of this 
chapter, two independent researchers analysed the data, and I developed the themes according to 
the methods used in a qualitative paper that I previously worked on [156]. All themes were 
checked and discussed with a Health Psychologist for completeness.  
4.1.1 Rationale for focusing on adherence 
Non-adherence with asthma therapies contributes to increased rates of hospitalisations and deaths 
from asthma. The questionnaire data presented in chapter three showed that 29% of students did 
not take their blue SABA (“reliever”) inhaler, and 56.4% did not take their ICS + LABA inhaler 
as prescribed; of which, 23.2% self-reported that this was deliberate.    
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4.2 Focus Group Development 
4.2.1 Sampling 
The target population for the focus groups were secondary school students with asthma, who had 
participated in the earlier school-based questionnaire. The inclusion criteria was the same as that 
for the questionnaire data (discussed section 3.1.1). It was essential that the students had 
participated in the earlier online questionnaire, as the focus groups discussions were guided by 
the questionnaire content, therefore it was important that the students were familiar with the tool. 
All students who had completed the questionnaire were invited to participate in the focus groups.  
A power calculation was not required for this phase of the study, however Greenbaum [157] 
suggests that focus groups should ideally consist of between eight and ten participants. All schools 
from the first phase of the study were invited to participate, and four schools agreed. Reasons for 
non-participation included timetabling difficulties, including examinations, or a reluctance to take 
the students out of class for a second time. Some schools simply did not respond to the email 
invitation or subsequent phone calls. Two of the participating schools were located in East London 
(Hackney and Newham), one school was in South-West London (Sutton), and one school was in 
North-West London (Brent).  
  4.2.2 Ethics 
Ethical approval for the focus groups was obtained via the Exeter REC (reference 14/SW/0120). 
A major amendment of the original application was submitted to the ethics committee, to include 
the focus groups in the data collection process. Ethical approval was granted on 1st September 
2015. The ethical considerations were largely similar to those in the questionnaire phase, and are 
discussed in chapter three (section 3.1.3). These included child protection, the sensitive nature of 
the research topic, parental consent and disruption to lessons. Additional concerns raised by the 
REC, directly relating to the focus groups, included asking students to discuss their own health, 
and the potential psychological or physiological impact of participating in a discussion about 
asthma (e.g. concerns that the stress of discussing a sensitive topic may trigger an asthma attack). 
However, the focus groups were still considered to carry a low risk of harm to the students.  
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The information and consent procedure operated in the same way as the questionnaire phase 
(parental opt-out consent) and all students provided written assent. One parent withdrew their 
child from the focus groups. A copy of the information sheets can be found in appendices five 
and six. To ensure that the students were comfortable with the discussion topic, they were advised 
at the beginning of the session what would be discussed. All the focus groups were recorded using 
voice recorders only, with no video footage, to ensure that no data was missed during transcription 
and analysis. All parents and students were made aware of this before agreeing to participate. Due 
to the recordings, the students were also advised not to use their own, or anyone else’s name, 
during the discussion, to maintain anonymity. If a name, or other identifiable data was recorded, 
this was replaced with a letter during transcription. All students and teachers were also advised 
that the discussions should not be repeated once students left the room. To ensure that students’ 
did not feel pressured to discuss their own personal health, the discussion topics were kept very 
general, and students were not asked about their own asthma, and were not required to discuss 
their own personal experiences.  
 
4.3 Aims 
The primary aim of the focus groups conducted in this phase of my PhD was to further understand 
the barriers to adherence with asthma medications among teenagers in London. The secondary 
aim was to establish any strategies to improve adherence, which could be addressed in a future 
school-based intervention. 
 
4.4 Methods 
4.4.1 Recruitment and Data Collection 
All schools who had previously participated in the online questionnaire were contacted, initially 
via email, and invited to participate in the focus groups. All emails were followed-up with a phone 
call to the designated teacher. Similar to the methods discussed in the questionnaire phase in 
chapter three, the teachers at participating schools were responsible for identifying the eligible 
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students and disseminating the information sheets to the parents. In all schools, the focus groups 
were conducted during lesson time, and each focus group lasted one hour.  
The focus groups followed a semi-structured approach, facilitated by open-ended questions. The 
framework for the focus groups was informed by the outcomes of the questionnaire. These 
included a discrepancy between perceived and actual asthma control, non-adherence with 
medication, and low levels of knowledge about asthma. Therefore, and in accordance with the 
primary aim, the focus group discussions were primarily focused around barriers to adherence 
with asthma medication, with asthma control and knowledge of asthma used by the facilitators as 
prompts during the conversation. A full description of the focus group can be found in appendix 
seven. 
The focus groups opened with an ‘ice-breaker’ game, in which the students were asked to finish 
a sentence starting “asthma is”. The students were then read an experience of a fictional character 
with poor asthma control, according to the indicators within the ACT. The students were asked 
to identify the level of asthma control, and justify their response. To identify some of barriers to 
medication adherence, the students were asked what percentage of children they believed did not 
take their asthma medicines as prescribed, which was then compared with the data from the 
questionnaire. This triggered a discussion over the potential reasons for non-adherence. The role 
of knowledge in medication adherence was also discussed, as the evidence for this is mixed. 
Finally, ideas for a future school-based self-management intervention were discussed, including 
what topics should be covered during an intervention.  
The sampling for the focus groups was limited by a nine-month time frame, from October 2015 
to July 2016, to coincide with the end of the questionnaire data collection and the end of the 
academic year. A thematic framework approach was used for analysis, and all the data was 
analysed qualitatively using NVivo statistical package (version 11). Ethical approval was 
obtained for the focus group recordings to be transcribed externally by an independent 
transcription agency. A copy of the confidentiality agreement for this can be found in appendix 
eight.  
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  4.4.2 Data Coding and Analysis 
Qualitative analysis of the focus group data was undertaken for six months, from July 2016 to 
January 2017. Using thematic framework analysis, all the comments were coded and analysed by 
two independent researchers, to ensure that the coding framework was both comprehensive and 
not subject to bias by personal opinion. Thematic framework analysis was used as it provides a 
flexible, yet detailed overview of the data, and is considered a more accessible mode of analysis 
for researchers who are less experienced in qualitative research [158]. Thematic analysis is also 
typically used on a more structured dataset [159], such as this one, where the outcomes of interest 
were established in advance of the data being collected. As previously mentioned, the analysis 
methods that were used largely followed those used in a previous study [156], and also followed 
the recommendations made in an article by Smith and Firth, 2011 [160].  
During coding and analysis, one focus group transcription was analysed separately by two 
researchers, one of whom was impartial and not involved in any other aspect of this PhD study, 
and was unaware of the aims of the focus groups. This ensured that all views and insight were 
representative of the data, and all discussions were not led by the desired primary outcome. 
Following analysis of the first transcript, the two researchers discussed their findings, and drafted 
a framework, based on the results. The first transcript was then analysed again, using the 
framework, and the framework was updated accordingly. This process was repeated until data 
saturation had been reached, and no further themes emerged. The same process was applied to all 
of the transcripts, and the framework was continually updated by one researcher, until data 
saturation had been reached on all six transcripts. Once this had been completed, the final 
framework was re-applied to each individual transcription for a final time to ensure that no 
comments or potential themes had been missed. A copy of the framework can be found in 
appendix nine.  
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4.5 Results 
Demographic Characteristics 
The focus groups included 58 students, which represented 7.6% of all those who completed the 
questionnaire and were included in the quantitative analysis. The focus groups were conducted in 
four secondary schools in London, all of which were state comprehensives. Two of the four 
schools were co-educational and the other two were girls only. The focus group sample included 
students aged 11 to 16 years (mean age 12.7 years). The sample was largely female (65.5%; n = 
38). The proportion of female students was higher due to the inclusion of two all-girls schools, 
and is not an accurate reflection of the students in the first phase of the study, where the proportion 
of male students was higher than female students. A total of six focus groups were conducted; 
two schools each hosted two focus groups, and two schools held one focus group each. The size 
of the focus groups varied from eight to eighteen (mean = 15). The largest focus group exceeded 
the recommended maximum number of participants, however the REC advised that all students 
who expressed an interest should be included.  
Descriptive Statistics 
A total of 397 comments were coded and analysed, and five themes emerged. Within each theme, 
a number of sub-themes were also developed. To maintain the anonymity of the study, the free-
text data could only be counted by the number of comments, rather than by the number of 
comments by different students. The five themes to emerge from the analysis included: 
i. Asthma 
ii. Medication adherence 
iii. Communication 
iv. Knowledge 
v. Social impact 
Table seventeen shows the total number of comments that were coded across all of the focus 
groups.  
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School Theme 1: 
Asthma 
Theme 2: 
Medication 
Adherence 
Theme 3: 
Communication 
Theme 4: 
Knowledge 
Theme 5: 
Social 
Impact 
Total 
1 38 16 10 12 11 87 
2 22 33 19 4 20 98 
3 34 10 6 13 1 64 
4 19 10 4 5 1 39 
5 14 12 4 9 2 41 
6 27 18 4 11 8 68 
Total 154 99 47 54 43 397 
Table 17. Total number of comments coded per theme 
  4.5.1 Theme One: Asthma 
This theme referred to all generic comments about asthma. This included describing what asthma 
is and the impact of living with a diagnosis of asthma. This theme also included comments which 
described different levels of asthma control. There was widespread agreement among the students 
that asthma can have a negative impact on daily living and daily functioning, particularly if it is 
not well controlled, and this came through consistently. Asthma was described in several 
comments, many of which were non-specific. For example: 
 “Asthma is a disease that makes you breathe deeply” 
 “Asthma affects your lungs” 
 “Asthma is when you have different coloured pumps” 
Other comments were negatively coded: 
 “Asthma is struggling for us and not everyone knows” 
 “Asthma is tough” 
The remaining comments were more specific and were therefore coded into five sub-themes.  
Table eighteen highlights the sub-themes, accompanied by an example. Figure 18 displays the 
sub-themes as a graphic.  
Sub-Theme Example Quote 
Asthma control “It affects what you normally do, but not so far 
that you go to hospital” 
Consequences “Asthma is difficult sometimes because you can’t 
concentrate on other stuff” 
Embarrassment “Asthma can sometimes make me feel 
embarrassed when I’m talking, like at school” 
Medication “Asthma means you need to take an inhaler to 
stop you from having an asthma attack” 
Symptoms “Asthma stops me from breathing” 
Management “Asthma is something that needs to be dealt 
with” 
    Table 18. Asthma sub-themes 
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Figure 18. Asthma sub-themes 
Asthma Control 
Asthma control was the largest sub-theme. The comments here referred specifically to 
understanding of asthma control, and how asthma control can be characterised according to daily 
experiences. During the discussion, four key factors emerged that the student’s associated with 
asthma control. These included activity limitation, medication use, asthma management, and 
asthma symptoms (figure 16).  
Some students suggested that poorly controlled asthma would limit one’s ability to do even minor 
activities. For example: 
“When you have controlled asthma then you can do stuff like going upstairs and stuff. If 
you don’t then it is kind of hard and makes you get short of breath” 
In accordance with the recommendations in the GINA guidelines for asthma control, some 
students discussed the impact of poorly controlled asthma on school and extra-curricular 
activities, and recognised how well controlled asthma can improve physical activity: 
 “Somewhat controlled wouldn’t wake her up at night, but it is hard for her to do stuff at 
school” 
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“You’re not worried that when you are going to do an activity that you are going to be 
like, oh wait, I might feel breathless because if it is controlled then you really do not need 
to worry”    
A second characteristic of asthma control was the use of medication. Many of the students could 
correctly identify that well controlled asthma should not require the use of the SABA inhaler: 
“Good asthma control is when you can breathe properly, you don’t need to use the blue 
pump regularly” 
However, some of the students believed that good asthma control was characterised by using the 
inhaler to relieve the symptoms of asthma, rather than acknowledging that well controlled asthma 
should have minimal symptoms: 
“I think well controlled is when it doesn’t have to be that you’re fine with it, it is just that 
you are using your asthma pump to help you do it, because then you are still controlling 
it. If your asthma is that bad then it is going to get worse, so at least they are doing their 
best to try and get rid of it” 
Some students were also unable to correctly distinguish between the roles of the different inhalers. 
Instead, some students suggested that any inhaler could be used, instead of recognising the need 
for the inhalers to work together. However, it is unclear whether this comment came from a 
student who had been prescribed the SABA inhaler only or not: 
“Poorly controlled because an inhaler is not helping, so maybe she should switch and 
use the blue one or something” 
A handful of comments also suggested a misperception about asthma control, and demonstrated 
evidence of a higher threshold for symptom severity: 
“I think it is well controlled because she has found out that her asthma is stopping her 
with short breaths, so she is using the blue inhaler” 
“It is well controlled because she has only felt out of breath once or twice a week and it 
doesn’t wake her up at night at all, and she has also been using her reliever inhaler” 
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Conversely, a small number of comments did show an awareness among some of the students of 
the differences between the SABA and ICS +/- LABA inhalers. These students did also 
demonstrate knowledge of how use of the SABA inhaler might alter, depending on level of 
control: 
“Good control would mean that you do not have many of the symptoms and you only need 
to use your brown inhaler” 
 “If your asthma is well controlled, you won’t need your blue inhaler” 
Despite some of the comments above suggesting that some students were unaware of the 
relationship between asthma control and symptoms, there were some comments which showed 
how using medication can prevent asthma symptoms from getting worse. However, from this 
comment, it is unclear which inhaler the student is discussing: 
“You don’t have to wait until you have something to trigger it to use it, you take it not 
religiously, but so it just stops the asthma from happening” 
Some of the comments divulged that students associated good asthma control with an awareness 
of how to manage the symptoms of asthma. Some students considered knowledge an important 
component of maintaining good control of asthma symptoms: 
“Good asthma control means when you know what to do when you think you have the 
symptoms of an asthma attack” 
The final characteristic of asthma control was the experience of asthma symptoms. This sub-
theme referred primarily to the severity of the asthma symptoms, and the frequency of night-time 
awakenings as an indicator of control. This is in accordance with the indicators given in the ACT, 
and demonstrates an awareness of the seriousness of night-time awakenings: 
“Somewhat controlled is finding it hard to breathe, but not getting all woken up. That 
would be poorly controlled if you get woken up. Well controlled is when it doesn’t really 
happen” 
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“Poorly controlled would be not controlled at all. It would be every single morning until 
night and not stopping” 
Consequences of Asthma 
The comments included within this sub-theme described some of the complications that can occur 
as a result of asthma, and the impact that asthma can have on daily well-being: 
 “Asthma is when you might need to go to hospital” 
Within this sub-theme, sleep disturbances emerged, which was previously discussed in relation 
to asthma control as well. Unlike the discussions about asthma control, the comments regarding 
sleep disturbances were in the context of living with asthma, rather than as a result of poorly 
controlled asthma specifically. It is unclear whether the comments came from students with good 
or poor control, however the comments do give insight into the realities of living with asthma: 
 “Asthma is hard because it doesn’t let me sleep at night” 
 “Asthma cannot let me have my rest and peace” 
Some of the comments also highlighted the negative feelings that can be associated with asthma. 
For example: 
 “Asthma is a bad feeling” 
 “Asthma is stressful” 
Asthma Symptoms 
The third sub-theme within the asthma code was the experience of asthma symptoms. Some of 
the comments referred to the challenges of breathing: 
 “Asthma stops me from breathing” 
 “Asthma affects me when I am sick or something” 
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Medication use 
All of the comments that were included here were non-specific and simply described asthma in 
terms of the medication that can be prescribed. For example: 
 “Asthma means that you need to take an inhaler to stop you from having an attack” 
Embarrassment 
Embarrassment about having a diagnosis of asthma emerged during the discussion about asthma 
as a condition, and some students identified feelings of embarrassment in social situations: 
 “Asthma can sometimes make me feel embarrassed when I am talking, say like in school” 
However, some comments did also discuss asthma more positively: 
 “I don’t think anyone should feel embarrassed” 
  4.5.2 Theme Two: Medication Adherence 
The second theme that came out of the coding was medication adherence. Under this theme, the 
most prominent barriers to adherence in adolescents were identified. In contrast to the findings 
from the questionnaire, most of the comments implied a conscious decision for non-adherence. 
Table nineteen shows the barriers to adherence that were discussed. 
Barrier Sample Quotation 
Unpleasant side-effects “The taste makes me feel so sick” 
Inhaler apathy “They just can’t be bothered to take it” 
Forgetfulness “They have to do work and homework and stuff so they forget” 
Embarrassment “Sometimes you might feel embarrassed to take it in front of your 
friends” 
Reluctance to use in public “They might feel embarrassed because loads of people are around” 
Inconvenience “They might be rushing to get somewhere” 
Use a different inhaler “I don’t use my brown one” 
Excuse to miss class “Some people use it to get out of lessons” 
Fear of reliance “You don’t want to rely on an inhaler to have a long-distance run” 
No symptoms “They don’t need it” 
Inhaler efficacy “They can control it without an inhaler” 
Table 19. Barriers to adherence among teenagers 
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Unpleasant side-effects 
Unpleasant side-effects were the most commonly reported barriers to adherence. Most of the 
students commented on the unpleasant side-effects and how these contributed to adherence 
behaviours: 
“Sometimes there are days when I take my inhaler and then I feel sick, so I just don’t take 
it because the taste makes me feel so sick” 
“I hate that feeling when I get shaky after, that’s why I don’t take my pump a lot because 
I don’t like the feeling of being shaky” 
Some other comments referred to the unpleasant side-effects, however the comments did not 
indicate whether this contributed to non-adherence. Indeed, there was also some evidence that the 
side-effects of medication were not a barrier to adherence: 
“I have severe asthma and sometimes when it is really bad I have to take steroids, the 
tablets, and they taste really horrible, so I just hold my nose, and I know it is good for me 
so I just carry on taking it” 
Apathy 
The second barrier to adherence was apathy towards either the medication or asthma. Several of 
the comments suggested that non-adherence may be due to some people not wanting to 
acknowledge their asthma: 
“Maybe they just don’t want to take it because they don’t want to have asthma, so they 
just ignore it” 
A feeling of lethargy also came through in some of the comments. For example: 
“I think most young people wouldn’t take their inhalers because they are not really 
bothered to do it. They probably think it will be wasting their time, and there is no point 
of doing it anyway” 
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Apathy towards the medication appeared to be associated with a lack of awareness about 
medication. The comments highlighted a common belief that teenagers and young people can 
cope without their inhalers, therefore they decide not to use them. 
 “They might think they don’t need to use it, or that it’s a joke or something” 
Forgetfulness 
Some students noted that people may forget their inhaler because of other demands on time, 
particularly for teenagers who have school or homework: 
“Many people forget because of the stuff they do around, like they have work or 
homework and stuff and then they forget to take it” 
“I don’t know anyone who has a brown inhaler who remembers to take it all year round” 
However, some of the comments suggested that forgetfulness is dependent on how seriously 
people take their asthma. For example: 
People might forget their inhaler because some people in the world don’t really care 
about their asthma and their health, whereas some people do” 
Embarrassment 
The social impact of asthma was a clear source of embarrassment. One student also mentioned 
how this is worsened by the way asthma is portrayed in the media: 
“Say if they are hanging out with new friends, they might think that they are trying to 
impress them, they might think if they start taking their asthma pump, their friends might 
judge them” 
“They might think it is a bit uncool to have asthma because in quite a lot of films all of 
the geeks and nerds have asthma” 
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Some students also discussed how teenagers might feel embarrassed about using their inhalers in 
front of people who are not asthmatic. The students discussed how embarrassment can come when 
people do not know how to deal with an asthma exacerbation. For example: 
“If they had shortness of breath and they used their reliever in front of someone who is 
not used to having asthma, they might think oh my gosh it’s a big emergency and we’ve 
got to get everyone, because that happens a lot. People might think it is real, and you just 
need to take a puff of your asthma pump. But then they might feel embarrassed because 
loads of people are crowding around them when they only need to take a tiny bit because 
they are a bit short of breath” 
Some more positive comments were also coded, suggesting that there is no reason to feel 
embarrassed: 
 “I don’t understand what they need to feel embarrassed about” 
“I don’t think anyone should feel embarrassed to take it around other people because if 
you are friends with anybody, or if you want to be friends, then they are going to find out 
you have asthma” 
Using inhalers in public 
The students identified reasons why teenagers may not use their inhaler in public, for reasons 
other than embarrassment. Again, the social impact was a key contributor, and the comments 
highlighted social concerns, including the perceived risk of being bullied: 
 “I think people might just say something unkind. People forget that you have asthma” 
“Some people deliberately don’t take it because they feel scared because they don’t want 
to tell people they have asthma or because they are scared about people teasing them” 
Some of the other comments implied that using an inhaler was a sign of weakness: 
“Some people want to be cool in front of their friends, they might try and act cool, and 
so they won’t take it to show that they are strong and can cope without it” 
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Inconvenience 
This was one of the more practical barriers. Using an inhaler regularly can be inconvenient, 
especially during other activities: 
“Maybe they are going on a sleepover but they find there is no room in their suitcase so 
they just don’t bring it” 
Complex treatment plans 
This barrier highlighted the complexities of having multiple inhalers. Some teenagers do not 
realise they need different inhaler, or that their inhalers have different roles in asthma 
management. From the data, the blue SABA inhaler was used instead of the brown ICS preventer 
inhaler, possibly because there is an immediate benefit. The comments showed incorrect beliefs 
that the brown inhaler was not needed if the blue one had already been used, demonstrating a 
clear gap in knowledge: 
 “I don’t use my brown one, I use the blue one” 
“They might think oh well if I have an asthma attack I could just use my blue one, there’s 
no real point in using it”  
Excuse to miss class 
Some of the students discussed concerns that teachers would view inhaler use as an excuse to 
miss class. There was also some evidence that children had previously used it as an excuse: 
“I used to in primary school to get out of doing PE. I used to be no, I need to take my 
asthma pump, sorry I can’t do PE” 
Fear of reliance 
Some teenagers are reluctant to rely on medication, particularly when participating in sports or 
exercise: 
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“If you’re running and you don’t want to rely on an inhaler to have a long-distance run. 
They want to rely on themselves. That’s why they won’t take it” 
One student also suggested that using an inhaler was counter-productive, especially during 
sporting activities: 
“If I am using an inhaler it is basically giving me my breath back and that’s not going to 
help. So, if I keep training and then it makes my lungs better without using it. So, I get 
used to it without using it, and so my lungs will get better” 
No asthma symptoms 
This barrier further highlighted gaps in knowledge about the role of medication in asthma 
management. The comments demonstrated a belief that inhalers were not needed as there were 
no active symptoms. This barrier is one example of accidental non-adherence: 
 “They might think that they won’t really need it on that day so they just don’t take it” 
“I normally take the brown one when I am ill in the morning and every night, but I don’t 
take it if I am not ill” 
Inhaler efficacy 
The students implied that some people do not believe that their inhaler is effective in managing 
the symptoms of asthma, and believe that the symptoms are better managed independently: 
 “I think they do not take it because they think they can control their asthma without it” 
4.5.2 Theme Three: Communication 
The comments that were coded under this theme demonstrated the challenges of discussing 
asthma, both socially and with healthcare professionals, and some of the comments identified 
how some of these challenges may contribute to non-attendance at routine appointments. Table 
twenty shows the sub-themes that were identified under this code.  
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Sub-Theme 1 Sub-Theme 2 Sample Quotation 
Non-Asthmatics   
 Not taking asthma 
seriously 
“Teachers  don’t take it seriously” 
 Not being listened to “You feel like no one is listening to you” 
 Reluctance to talk “It is frustrating to explain to someone who 
doesn’t understand” 
Healthcare 
Professionals 
  
 Trust in care “My GP is pathetic” 
 Language barriers “They talk in doctor speak” 
 ACT scores “They would know how they can help you 
more” 
Undiagnosed Cases   
 Barriers to diagnosis “They don’t want to tell themselves that 
they might have asthma” 
Table 20. Communication sub-themes 
Non-Asthmatics 
There was a feeling among the students that some people do not take asthma seriously. The 
students spoke about teacher and/or sports instructors specifically, and discussed how they 
sometimes feel like they are not being listened to. Some of the comments also implied that some 
teachers and instructors are naïve about the potential seriousness of the situation. For example: 
 “Teachers do not take it seriously, they’re like oh just control it” 
 “It means that when you are actually having an asthma attack, or when it is really 
serious, people are likely yeah funny, and teachers as well” 
There was also an agreement that some peers without asthma can treat it as a joke, and do not 
recognise the potential seriousness of it. For example: 
“Sometimes when you are taking a pump all of your friends they are like oh let’s have a 
taste, and then try and take it off you and just play around with it. They don’t understand 
that there is a reason why you’ve got an asthma pump. They just think it’s a cool gimmick 
to have. Then they try and mess around with it whenever you need it and they think it is 
a fun thing to play with”  
There was a belief that people without asthma are not able to recognise the symptoms, and some 
of the students felt that this could be due to denial about the potential seriousness of the condition, 
which can make communication difficult: 
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“Sometimes if you have an actual asthma attack, people don’t want to tell themselves that 
if there is someone trying to help you and they don’t want to tell themselves that you’re 
having an asthma attack, sometimes they say oh no you’re probably just having a panic 
attack, you don’t drink enough water. They just don’t really want to face it and say that 
you are having an asthma attack” 
It was also suggested that some people without asthma may not be interested in learning more 
about it. There was a belief too that awareness in schools may be limited, as asthma is not often 
talked about: 
“It wouldn’t be a conversation many people would have with their friends, because they 
don’t want to and they don’t feel comfortable talking to their friends about their health” 
In response to this, the students felt that some people with asthma are reluctant to talk about it for 
a fear of being ridiculed: 
“They might still laugh through knowing about it, like ha you’re the one with asthma and 
we are not, they are different to us” 
Some positive insights also emerged and highlighted that some people can be understanding, 
which can take the pressure off during an emergency: 
“I don’t think they would have a conversation about it, but they would understand. When 
you’re a teenager, you’d understand what other people are going through” 
Healthcare Professionals 
The trust in the level of care that is often received by GP’s was an important conversation point. 
Some students commented that their GP did not explain things fully during the initial consultation 
about their diagnosis and treatment: 
 “I don’t think my GP has ever sat me down and said this is what you have” 
“If my doctor says do this, or I’m going to give you this injection, they don’t ask us what 
it is or anything” 
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However, it is unclear how often these students saw their GP, and how long ago they were 
diagnosed. There was also a suggestion that adherence would be improved if GP’s spent more 
time discussing the implications and potential consequences of poor adherence. For example: 
“If they told me what would happen if I don’t take it, like it will result in an asthma attack, 
or maybe more serious stuff, I would definitely wake up in the morning if I had to” 
Seeing a different GP at each visit was also highlighted as a key unmet need among teenagers, 
and demonstrated a lack of continuity in care, which undermined consistent care: 
“All the doctors say slightly different things and it is so confusing because I never see the 
same GP every time and then you just can’t know” 
Some of the students also questioned whether their GP took their asthma seriously enough: 
“I know my GP is pretty pathetic. I’ll say I feel my asthma is getting worse and ask for a 
new inhaler and he will be like oh just keep using your regular or reliever inhaler, you 
will be fine” 
Notably, there was a resounding agreement that ACT scores should be reported back to GPs to 
improve the level of care that is received.  
Undiagnosed Cases 
Although the comments regarding communication with people who do not have asthma were 
limited, the response from the students indicated that it was important to acknowledge the 
concerns around being diagnosed, and highlighted the need to raise awareness of asthma. The 
students discussed some of the reasons why some people may delay visiting the GP with 
symptoms, primarily due to an underlying fear of not being taken seriously.  
4.5.4 Theme Four: Knowledge 
Gaps in knowledge were an important part of the discussion, with many of the comments 
demonstrating a lack of knowledge around asthma management. The students also agreed that 
improvements in knowledge would be beneficial in encouraging better management of asthma. 
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Although the literature is mixed, the comments here suggested that improved knowledge of 
asthma could improve self-management behaviours. Table twenty-one highlights all the 
knowledge areas that were noted by the students as needing improvement. 
Sub-Theme Sample Quotation 
General information “We don’t know how to explain it” 
Causes “I don’t know what causes it” 
Medication “I don’t know what my pumps do” 
Preventing Exacerbations “How to prevent an asthma attack” 
Side-effects “What are the side-effects” 
  Table 21. Knowledge sub-themes 
General knowledge 
General knowledge about asthma was the most common area in which the students felt they 
wanted to improve their awareness. The students believed they knew a bit about asthma, but not 
as much as they should do, particularly regarding the physiology of asthma: 
“The actual medical side behind it, because I don’t think my GP has ever sat me down 
and said this is what you have” 
There was also a feeling that young people should know more about their condition, particularly 
when trying to talk about it with other people who do not have asthma. For example: 
“For someone who has asthma, and for other people, they need to gain an awareness of 
people with asthma and how they are feeling” 
Some of the other areas of general knowledge that emerged from the comments were how asthma 
affects people during exercise and everyday activities, such as eating.  
Many of the students agreed that if they knew more about asthma, it would help them live with 
their condition more effectively, and they would be able to manage it better. The students also 
agreed that people without asthma should learn more about asthma, as it is extremely common: 
“I think you should know more about asthma, then you know how important it is to take 
it. I know quite a lot, when my doctor gives me a brown inhaler I know that I need to take 
it and that I can’t really miss out because he wouldn’t have given it to me if I didn’t need 
it. I think it is really important to know quite a bit, because if you have asthma then you 
should really know everything there is to know about it” 
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Causes 
The causes of asthma were also highlighted as an area in which the students felt knowledge could 
be improved. For example: 
 “What causes your airways to be smaller than other people’s?” 
Improvements in asthma medication, particularly why people need medication and why it helps 
to relieve the symptoms of asthma, were highlighted as a second area in which knowledge could 
be improved: 
 “What happens when we take the inhaler?” 
Medication 
The students agreed that if understanding of the roles of different medication was improved, 
adherence to medication would also be improved.  
Preventing exacerbations 
Many students wanted to learn more about how to prevent an asthma exacerbation, as well as how 
to help other people if they see someone else have an asthma attack:.  
“If you, or someone else, is having an asthma attack but they don’t have their asthma 
pump. Obviously they won’t be able to medically or professionally help them, but how to 
maybe calm people down, or make them breathe easier” 
Side-effects 
An awareness of the sided-effects may help asthmatics to familiarise themselves with what is 
normal after taking medication, and what should be discussed with their doctor during their 
asthma review. It may also help to reduce the high threshold that many young people seem to 
have regarding the severity of asthma symptoms, and when to seek medical assistance.  
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  4.5.5 Theme Five: Social Impact 
The sub-themes that were analysed under this code are shown in table twenty-two.  
Sub-Theme  Sample Quotation 
  
Peer awareness “People that don’t have asthma don’t know how you 
feel” 
Stigma “They feel if you’ve got asthma you shouldn’t take part” 
       Table 22. Social impact sub-themes 
Peer awareness 
The comments indicated a feeling of frustration among the students about how it feels when the 
people around them do not understand asthma and how it is managed: 
“You start crying because you are frustrated and you are angry and it is just the worst 
feeling because they don’t understand that you’re struggling to breathe, you’re struggling 
to talk” 
Some of the students also discussed some of the negative reactions from other people that have 
been encountered when someone is having an asthma attack. The general consensus was that 
people do not know what to do: 
“There are two extremes. Sometimes people are unsympathetic and other times they panic 
and it’s like, well neither is helping me at all really” 
Although peer awareness was considered important in helping to manage asthma more 
effectively, it was felt that raising awareness would not be effective, due to a lack of engagement 
from people who are not directly affected by asthma. However, there was agreement that people 
without asthma lack an awareness, and therefore it can be difficult to talk about: 
 “They might not understand. I think it is better to talk to someone who has asthma” 
“Some people, they will react in a supportive way, like friends, but then some people they 
might make fun of it and use it as your weakness as their strength” 
Conversely, some students felt that raising awareness among peers would be reassuring, in case 
of an asthma attack: 
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“I like to let people around me aware of it because if I start to cry or something, that’s 
when my asthma and my chest gets tight and stuff, and so if people around me are aware 
of it then obviously it is easier for me to access my pump” 
While it may not be deliberate, some of the students discussed how people with asthma can be 
treated differently because of their condition: 
“Sometimes people try and patronise you and they’re like oh, it’s ok. Sometimes if you’re 
just hanging out with people normally, then they talk to you normally, but if you start 
taking your asthma pump then sometimes people start patronising you and just trying to, 
and they’re trying to be nice, but they don’t really understand that it is just a bad medical 
condition, but I am still the same person” 
Stigma 
There was a misperception regarding the extent to which people with asthma should participate 
in sports. For example: 
“I feel that if you’ve got asthma and you are swimming, they feel that if you’ve got asthma 
you shouldn’t be taking part in so many activities. They think that you are the average 
person and you think that they are right because of your health you shouldn’t go 
swimming or do any activities, just watch people doing stuff instead” 
 4.6 Discussion 
In total, six focus groups were conducted across four London secondary schools, and 58 students 
with asthma participated. The aim of the focus groups was to understand more about the barriers 
to adherence among teenagers with asthma, and ascertain how teenagers characterise poor asthma 
control. Thematic framework analysis was applied to the 397 comments that were collected, and 
these were coded into five themes:  
i. Asthma 
ii. Medication adherence 
iii. Communication 
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iv. Knowledge 
v. Social impact 
Data coded under the asthma theme suggested disconnect between perceived asthma control and 
actual asthma control. Compatible with previous literature, for example the Room to Breathe 
survey by Carroll et al [74], the children surveyed by me showed evidence of high thresholds for 
poor asthma control, with many students indicating that poorly controlled asthma is characterised 
by day-long wheezing and an inability to carry out simple activities, such as climbing stairs. Very 
few students could correctly identify the characteristics of poorly controlled and well controlled 
asthma. Although many of the students did recognise that poorly controlled asthma could lead to 
sleep disturbances, as discussed in the GINA guidelines [2], the severity of the night-time 
awakenings were more extreme than the GINA guidelines would suggest, with some students 
believing that night-time awakenings would occur every night and would not stop. Similarly, 
according to some of the comments, some children believed that even well controlled asthma 
might still require the use of a reliever inhaler to control the symptoms of asthma, and some 
children believed that asthma was well controlled even when symptoms were present, as it meant 
they were using their inhalers. This not only demonstrates inadequate awareness of the role of 
different medication, but also indicates that inappropriate management strategies may currently 
exist. None of the children discussed medication use as a management strategy to prevent future 
asthma attacks. This reflects the findings by McQuaid et al [161]who also found that medication 
use as a prevention strategy was less commonly reported than medication use in response to 
asthma symptoms only.  
The second theme was medication adherence. My earlier questionnaire data highlighted low 
levels of adherence with medication among children, and many of the free-text responses 
suggested that this behaviour was deliberate, rather than accidental. Some of the unintentional 
barriers to adherence, for example forgetfulness, were not discussed as widely as the more 
intentional non-adherent behaviours. Much of the discussion within these theme referred to social 
concerns (e.g. embarrassment or a fear of being bullied), as well as incorrect beliefs regarding the 
efficacy of the medication. Adherence with asthma medication has been widely researched, and 
the findings from these focus group largely mirror those in the literature. For example, Horne, 
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2006 [9], highlighted patient beliefs and unpleasant side-effects as common reasons for non-
adherence.  
The findings from my focus groups did also show that some children may be unaware that they 
are not adhering to their treatment plan, and may genuinely believe that they are acting with the 
best intentions. For example, although failing to use medication due to an absence of symptoms 
is considered intentional nonadherence, the children may believe that this is the correct course of 
action and may therefore be unaware that their behaviours are not adherent. This could also 
explain why the questionnaire data showed a discrepancy in adherence scores; the number of 
children who claimed to be deliberately not taking their medication was much lower than those 
who were not adherent with their medication due to forgetfulness, however the free-text responses 
demonstrated more intentional reasons for non-adherence.  
The third theme to emerge was communication with healthcare professionals and their peers. 
Communication with healthcare professionals was a key unmet need of the children, and many of 
them expressed concerns over a lack of continuity with care, and seeing a different GP or nurse 
at each appointment, which could undermine the care that a child is receiving. This highlights the 
importance of having a clear asthma action plan, which can be brought to each medical 
appointment, and will inform a doctor of the current management plan, even if the usual GP is 
unavailable. The BTS guidelines emphasise the importance of a written action plan to be included 
alongside self-management strategies, to achieve better outcomes [162], however the National 
Review of Asthma Deaths [14] evidenced a distinct lack of asthma action plans among children 
who had a death from asthma. Communication with peers was also important to the children, 
particularly in raising awareness of asthma in schools. However, there were mixed views about 
whether raising awareness among peers would be beneficial or not. While some children felt that 
it would be helpful to raise awareness in schools, so that peers and teachers know how to respond 
to an asthma attack, others were concerned that peers would not be interested, and it may trigger 
bullying. This is something that will be addressed in a future school-based self-management 
intervention, to be piloted in London secondary schools.  
Another theme to emerge was knowledge of asthma. The literature on the role of knowledge in 
improving asthma management behaviours is mixed, however the findings from my earlier 
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questionnaire showed low levels of knowledge regarding the role of the ICS + LABA inhaler. 
The students in the focus groups agreed that they could know more, and felt that improved 
knowledge would lead to improved medication adherence among teenagers. The main gaps in 
knowledge included the causes of asthma and the role of different medications in managing 
asthma symptoms. Although knowledge alone may not be sufficient to change behaviour, and 
attitudes may be more influential in changing healthy behaviours, there was agreement that if 
young people were aware of why they needed to take their medication, particularly their ICS + 
LABA medication, then they would be more inclined to use it properly. Ho et al 2003 [125] 
previously found no sufficient evidence to suggest that knowledge directly improves adherence, 
although concluded that there could be an indirect causal link that should be addressed further. It 
could also be that instead of addressing knowledge alone as the key to improving adherence, 
attitudes should also be considered. These focus groups also give a clearer understanding of where 
some of the gaps in knowledge are among teenagers with asthma in London, and what areas of 
asthma management future self-management interventions should target.  
The final theme to emerge from the data was the social impact of asthma. Many of the comments 
here highlighted a lack of awareness among people without asthma, and the way that young 
people feel they are treated when they try to participate in sport, or when they have an asthma 
attack. In accordance with the findings of the questionnaire, peer attitudes are important in asthma 
management behaviours among teenagers, and could be some of the biggest drivers behind 
medication adherence. The findings from the questionnaire showed that a small number of 
children had been bullied due to their asthma (14%), however this was a fear that was expressed 
by almost all of the students, despite less than a fifth indicating that this was something they had 
experienced in the earlier questionnaire. It could be that the perception among children with 
asthma is different to the behaviours of their peers without asthma, and this is something that 
should be addressed in future research.   
There have been a number of studies to date which have used qualitative methods to assess 
barriers to adherence in asthmatic children, and the findings from these focus groups are largely 
in accordance with those previously reported [102]. Previous studies have also focused on 
family/caregiver influences as a barrier to adherence in children and adolescents [102, 113], 
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however these were not explored under the current framework. The findings from these focus 
groups will be used in conjunction with the questionnaire data presented in chapter three, and the 
outcomes of the systematic review in chapter five, to inform a future self-management 
intervention.  
These focus groups also included a number of limitations. First, the response rate from the schools 
was very low, and constituted 16.7% of the schools that participated in the questionnaire phase of 
the study. It could be that the schools that participated had an existing interest in asthma, therefore 
the generalisability of the findings is reduced. Similarly, as the students had previously 
participated in the questionnaire, it could be that they had some existing knowledge of the aims 
and objectives of the research, and therefore may have been giving responses that they felt were 
appropriate, rather than reflecting what they actually believed.  
Second, due to constraints imposed by the REC regarding the discussion of personal information, 
the students were encouraged not to discuss their own experiences of asthma. While some students 
chose to divulge this information regardless, it is unclear whether any of the comments that were 
given were based on previous experience. This undermines one of the key advantages of focus 
groups in providing subjective data, as the discussions were all based on hypothetical situations.  
Third, some of the views that were expressed, particularly experiences with teachers and 
healthcare professionals, were based on personal opinion and could not be validated. Future 
researchers may wish to explore the attitudes and beliefs of different groups of people involved 
in asthma treatment and care, including family members, friends and healthcare professionals, 
and compare it with the attitudes and beliefs of young people with asthma. A discrepancy may 
exist between how children with asthma believe they are perceived, and the way they are 
perceived in reality by different people, which could contribute to adherence and self-
management behaviours.  
Fourth, formal analysis of the data was no conducted, instead a ‘light-touch’ approach was used. 
This method of analysis was based on previous literature, and my previous experience of 
qualitative research. The analysis methods described in this chapter follow the recommendations 
in the literature [160], and were checked with a Health Psychologist, experienced in qualitative 
research, for completeness. However, the initial analysis was carried out by largely quantitative 
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researchers, and therefore the analysis may be limited in reliability of the findings. The reason 
this data was analysed in this way was to clarify the findings from the questionnaire study, which 
answered the primary research objective, and to inform the development of a future self-
management intervention.  
  4.6.1 Justification for Methodology 
The focus groups collected subjective data on a number of topics relating to the management of 
asthma in young people. The objectives of the focus groups (highlighted earlier in this chapter) 
could be addressed primarily using subjective data, therefore either focus groups or individual 
interviews were considered the most appropriate methodology. Focus groups were subsequently 
selected above interviews and quantitatively equivalent methods for several reasons.   
The aims of the focus groups were to further understand the barriers to adherence among teenagers 
with asthma, as well as identify their understanding of good and poor asthma control. Although 
focus groups and interviews both offer insights in behaviours and experience, and allow the 
researcher to observe non-verbal responses, such as emotions, and facial expressions, focus 
groups have the added advantage of observing responses to comments from other members of the 
group. The students in the focus groups shared a mutual diagnosis of asthma, however the severity 
and experiences were different for each student. The interactive nature of the focus group enabled 
the students to respond to each other both verbally and non-verbally, and use responses from other 
people to spark conversations that may have otherwise not occurred in individual interviews. The 
focus groups also enabled the students to reflect on the opinions of others in the group and 
compare them with their own opinions and experiences.  
Although interviews typically lack the conversational nature of a focus group, and there is no 
opportunity to build a discussion with other people, they do enable a more professional 
relationship to develop between the interviewer and the participant, which is rarely seen during a 
focus group as the facilitator is often less involved in the discussion. This enables a relationship 
to develop between the interviewer and the participant, which potentially reassures the participant 
and develops their confidence to discuss certain topics. Despite this, interviews do not allow the 
conversation to deviate away from the pre-defined interview question, even if the interview 
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appears to take an alternative path. One benefit of this is that it gives the interviewer more control 
over the discussion topic, and therefore ensures that all of the data that is collected is relevant to 
the research question [163]. The structured nature of interviews also allows the data to be 
aggregated and analysed more easily, compared with semi-structured interviews and focus 
groups. Although semi-structured interviews offer the flexibility of a focus group, and encourage 
participants to elaborate on their responses, the lack of structure often means that it is difficult to 
compare and code responses from all individuals.  
There is also an added risk with focus groups that the students may not express their honest views 
on a topic, for fear of deviating from the social norm. During the focus groups, the facilitators 
tried to account for this by running an ice-breaker game in the beginning, to help the students get 
to know each other and feel more comfortable in their surroundings. The focus groups were also 
held in school, therefore the students were familiar with the environment, and may have 
recognised a few of the other students participating in the group. The students were also reminded 
to keep all discussions confidential, and not to repeat anything outside of the focus group.  
A clear advantage of focus groups is the ability to collect large amounts of data from a larger 
number of children than interviews would allow, therefore making them more costly and time 
efficient. In this way, the quality of the data could also be richer, as there are more opinions and 
comments to code during the analysis.  
  4.6.2 Overall Conclusions 
The primary aim of the focus groups was to further understand the barriers to adherence among 
teenagers, following the outcomes of the questionnaire data. Thematic framework analysis was 
used to analyse the comments, and two independent researchers coded and analysed each 
transcript, before the coding framework was developed. The comments from the focus groups 
demonstrated a number of unmet needs among children and young people with asthma, such as 
inadequate communication with healthcare professionals and peers, and a number of barriers to 
adherence that need to be addressed. The students desire to learn more about asthma, and to raise 
awareness in schools about asthma also highlights key limitations in current self-management 
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strategies that could be addressed in a future school-based intervention, which will be further 
discussed in chapter six.   
Some notable limitations have arisen from this part of my thesis, however despite these 
limitations, the findings discussed here contribute towards understanding the reasons behind non-
adherence among teenagers in London with asthma, and the ways in which these barriers can be 
addressed. The focus groups have further supported the findings from the questionnaire study, 
and further highlight the importance of the school environment as a space to consider for future 
research.  
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Plain Language Summary 
The primary aim of the focus groups was to further understand some of the barriers to medication 
adherence among children and young people, given the high levels of non-adherence that came 
out of the questionnaire data. A total of six focus groups were conducted in four secondary 
schools, and 58 children took part. The comments were analysed qualitatively using thematic 
framework analysis, and five themes came out of the data.  
The most commonly coded theme was asthma. This included opinions of asthma, as well as the 
children’s understanding of poor asthma control. There was a difference between their 
understanding of poor asthma control, compared with the clinical explanation, and a higher barrier 
to experiencing symptoms was seen, before considering asthma to be poorly controlled.  
The second theme was medication adherence. Similar to the free-text data from the questionnaire, 
the most commonly reported barriers to adherence included forgetfulness, incorrect beliefs about 
the medication, and social concerns. There was a real concern among the children about using 
inhalers at school, in case they were bullied, or seen as weak.  
The third theme was communication. Most of the comments here referred to communication with 
healthcare professionals, and seeing different doctors each time. Some students also showed 
concern that they did not understand the medical terminology that was sometimes used. 
Communication with people who do not have asthma was also important. Many children felt that 
awareness among people without asthma was low, and should be improved. However, some other 
children felt that unless someone has asthma, it would not be helpful to teach them about the 
condition.  
The fourth theme was knowledge. Although the evidence for this is limited, the children all agreed 
that adherence to medication would be better if they had greater knowledge about their medication 
and why it was important. The general causes of asthma and what happens in the lungs was also 
an area in which the children thought knowledge should be improved.  
The final theme was the social impact of asthma. From the adherence data it was clear that this 
was important in adherence behaviours. However, the children also discussed the reaction that is 
sometimes received when they use an inhaler in public, or have an asthma attack.  
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Chapter 5. School-based Self-Management 
Interventions for Children with Asthma 
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In this chapter, I perform a systematic review of school-based self-management interventions for 
children with asthma. This review uses a mixed-methods approach, and includes two components. 
The first component is a process evaluation, which seeks (change everything to present tense) to 
identify the factors of an intervention which are associated with successful implementation. This 
used Qualitative Comparative Analysis (QCA; discussed later in the chapter) to assess both 
quantitative and qualitative studies. Process evaluations can help to shape and strengthen future 
interventions, through using qualitative comparative analysis (QCA) to highlight the components 
of interventions that may be most important to their success. The second component was a meta-
analysis of randomised controlled trials (RCTs), to identify if school-based self-management 
interventions for children with asthma are successful at improving children’s outcomes, such as 
hospitalisations and quality of life. A mixed-methods approach to this review contributes to the 
literature both empirically and methodologically. First, it will help in improving understanding of 
both the processes involved in implementing an intervention, and whether school-based self-
management interventions for children with asthma are effective. The findings from the QCA 
generated hypotheses regarding whether interventions are effective, and how they should be 
implemented in the future, which were later tested in the meta-analyses. Second, the results of 
this review will directly inform the development of a school-based self-management intervention, 
to be tested in a London-based feasibility study; the results of this review will directly inform the 
intervention design.  
 
 5.1 Background 
Although asthma is the most common chronic condition in children in the UK, the risk of 
developing asthma is not the same for all children. Instead, there are several characteristics which 
are thought to contribute to the overall risk of the disease. For example, in the UK, children from 
White and Black ethnic backgrounds are at higher risk of developing asthma, compared with 
children from South Asian backgrounds [150]; and within these groups further variations have 
been identified. For example, although children from South Asian populations are at a lower risk 
of developing asthma, their risk of being admitted to hospital following a complication from 
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asthma is greater. Children from black backgrounds are also at increased risk of hospitalisation 
due to asthma, compared with children from white ethnicities. Socioeconomic status has also been 
shown to be associated with health outcomes. For example, the risk of developing asthma is 
thought to be higher among children from low-income families living in the UK. 
The main purpose of this systematic review is to evaluate the evidence on school-based self-
management interventions for children with asthma. As discussed in chapter two, self-
management is the process of educating patients and enabling them to control their asthma 
symptoms away from the clinical environment, and reduce the risk of future exacerbations [79].  
According to the BTS, self-management is defined as “the tasks that individuals must undertake 
to live with chronic conditions, including having the confidence to deal with medical 
management, role management and emotional management of their conditions” [162]. In terms 
of asthma, this includes good inhaler technique and being able to recognise and respond to the 
symptoms of asthma. For this systematic review, self-management studies were only included if 
they included education on asthma alone. The focus was on studies that were delivered in schools 
as it is a familiar learning environment for children. The focus on the school is also encouraged 
by advisory groups to UK policymakers, who view the integration of health, educational and 
social care services as important in improving the quality of life of children with chronic 
conditions such as asthma, and in reducing differences in outcomes such as school attendance 
[93].  
Although previous literature has shown that school-based self-management interventions for 
asthma are successful in improving some health-related outcomes, including reducing rates of 
unscheduled care and school absences, no systematic review to date has tested the effectiveness 
of schools as a potential space for delivering interventions [164].  
Some school-based self-management intervention components that may be important are shown 
in the logic model in figure 19. The logic model, developed by the review authors, shows the 
outcomes of interest within this review, and how these outcomes fit within the review objectives. 
The logic model was developed on the basis of published literature and systematic reviews, and 
by establishing the outcomes of interest from school-based self-management interventions and 
working backwards to highlight the causal chain necessary to achieve these outcomes. Using a 
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logic model in this way helps to identify the types of data that may be needed to gain an 
understanding of the different intervention components and implementation processes  
[165]. This matches the objectives of the review in terms of identifying both the impact of school-
based asthma interventions and the components associated with change and impact. The 
intervention implementation outcomes are shown in figure 19 as ‘process metrics’. The ‘action’ 
part of the model included the external school context, and inputs already in place to run the 
intervention. The ‘change’ part of the model shows the stages of change and processes necessary 
to reach the intended outcomes.  
 
Figure 19. Logic Model 
Previous reviews of paediatric asthma self-management interventions, for example by Guevara et 
al 2003, have shown improvements in lung function, school absenteeism, emergency hospital 
visits, and patient self-efficacy [166]. A separate review by Boyd et al also found that targeted 
interventions can lead to improvements in hospital admissions among those who are most at risk 
of hospitalisation [167]. While many reviews have suggested that educational interventions that 
are delivered to children with asthma can be effective, these reviews have largely included 
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interventions which have been delivered in the school, as well as in the home and clinical 
environments [168, 169]. Recognising this, Welsh et al has highlighted that no widespread 
agreement currently exists on the most effective setting for delivering asthma interventions to 
children [170]. To date, two systematic reviews have evaluated the evidence for interventions 
delivered exclusively within the school environment. Both reviews found that school-based 
interventions improved school absences, however the evidence showing the effectiveness of these 
interventions on other outcomes, such as hospitalisations, was limited [83, 94]. A third review, 
conducted by Al Aloola et al also examined the effect of a school-based intervention on children’s 
outcomes, however this review considered studies that involved primary school aged children 
only [164].  
To date, few reviews have included an analysis of ‘process-level’ measures, such as changes in 
school policy. One exception to this is a review by Pinnock et al [171], which assessed how 
asthma self-management interventions should be implemented, however this did not focus on 
schools alone. Nonetheless, an analysis from two studies conducted in schools showed that high 
school turnover and a lack of parental involvement could be challenges to implementation. An 
analysis of such process level factors would further highlight the components of interventions that 
may be most important in understanding the success of an intervention.  
In this review, the aim was to combine the evidence of school-based self-management 
interventions for children with asthma, for the first time, using a mixed-methods approach. 
Although other reviews have aimed to include a mixed-methods approach [172, 173], this review 
sought to include both meta-analyses of quantitative studies, and qualitative studies. The process 
evaluation data was analysed using Qualitative Comparative Analysis (QCA).  
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 5.2 Objectives 
This review has two primary objectives: 
1. To identify the intervention components and processes that are associated with successful 
intervention implementation 
2. To assess the effectiveness of school-based interventions for the improvement of asthma 
self-management on children’s outcomes 
The first objective will be addressed using Qualitative Comparative Analysis (QCA; described 
later in the chapter) of process evaluation studies, to identify the combination of intervention 
components and processes that are associated with successful implementation. This approach 
aims to highlight the extent to which an overlap exists between a set of studies that are successful 
in their implementation and sets of studies that share different combinations of intervention 
characteristics.  
The second objective will be addressed through conducting meta-analyses of outcomes collected 
within RCT studies. The link between how well interventions are implemented and their 
effectiveness is explored in separate models, as well as through undertaking additional subgroup 
analyses.  
 
 5.3 Methods 
  5.3.1 Criteria for considering studies for this review 
Identifying process evaluation studies 
Process evaluation studies seek to explore the implementation, receipt, and setting of an 
intervention, and assess whether an intervention was delivered the way it was intended [174]. 
QCA is currently a novel technique in systematic reviewing, however it is steadily gaining more 
interest from researchers due to how it addresses the weaknesses in correlational/associational 
analyses. For example, correlational approaches test for the success and failures of covariates 
simultaneously, and cannot identify the importance of a single component in an intervention, due 
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to a small number of available studies [175]. This means that some of the reasoning for why a 
certain condition did not occur in an intervention may be lost in correlational analyses. Moreover, 
QCA does not need to assume linear effects. Instead, it can understand that a particular condition 
may be associated with both positive and negative outcomes, depending on context and the 
presence or absence of other conditions.  
The terms “process” and “qualitative” are often used interchangeably, however data for a process 
evaluation can be either quantitative and qualitative [176]. Although there is no ‘gold-standard’ 
definition of what a process evaluation is, they can be used to develop theories around how 
interventions works. The Medical Research Council (MRC) [177] provide some guidance on how 
to conduct process evaluations, and recommend that the core components of a process evaluation 
include: 
i. A clear description (and evaluation) of the implementation and processes of 
intervention implementation 
ii. A clear analysis of mechanism of impact (participant responses to and interactions 
with the intervention) 
iii. A clear description of the context and analysis of how contextual factors affect 
mechanisms and implementation 
For the purposes of this systematic review, process evaluations were considered to involve 
systematic measurements to determine the extent to which an intervention was implemented as 
planned, following the guidance from the MRC. Implementation measures focused on fidelity, 
attrition, adherence and dosage, and process evaluation studies were identified as: 
i. A study that was self-defined as a process evaluation, or; 
ii. A study that included the elements of a process evaluation in a defined section of an 
outcome evaluation, or; 
iii. A study where process evaluation data were integrated within an outcome evaluation, 
but where measures around processes were detailed and extractable within the results 
Where studies did not directly identify themselves as a process evaluation, they must have 
contained the following components: 
i. An assessment of core components (implementation, mechanisms, context) 
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ii. Clear research questions guiding the process evaluation 
iii. Use of recognised evaluation methods (described by Moore et al [177]) 
Studies were also included if they had a focus on the presence/development of school asthma 
policies, and this was later extended to studies measuring broader school-level commitment (e.g. 
teacher involvement). 
Previous systematic reviews of process evaluation studies have often only included process 
evaluation studies linked to an outcome evaluation [178]. In this review, some process evaluation 
studies were linked to RCTs that assessed the effectiveness of an intervention, but studies were 
also included that evaluated the implementation of several study designs, if they met the other 
inclusion criteria. This allowed the process evaluation data to contribute towards theory 
development, tested within a mixed-method framework.  
Identifying outcome evaluation studies 
To measure the effectiveness of interventions on children’s outcomes (to achieve the second 
review objective), studies were included if they comprised a randomised parallel group design, 
involving randomisation at either the individual or school level (cluster-randomised trials).  
Publication date and language 
Exclusion criteria were applied to the date in which studies were published, to help ensure that 
the content of the self-management interventions were relevant to current recommendations. 
Recommendations on self-management practices were first developed in the UK in 1990, based 
on publications in the British Medical Journal and Archives of Diseases in Child Health [179]. 
These recommendations were also developed in the USA around the same time [180], and were 
published in the GINA guidelines soon after. Considering this, studies were only included if they 
were published from 1995 onwards, to correspond with the publication of the first GINA 
guidelines. Studies were also only included if they were published in English. The potential 
impact of this restriction was assessed through conducting explorations of the impact of 
publication bias.  
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Types of participants 
Participants included school-aged children and young people (5-18 years old) with asthma, who 
participated in the intervention within their school. If the intervention included young people and 
adults (e.g. in a further education college), these studies were only included if most of the 
participants were aged 18 years or younger. Interventions were also included if they delivered 
some components to peers, teachers, and/or guardians/families, however only where they 
involved at least partial delivery of the intervention to school-aged participants with asthma within 
the school environment. No criteria were imposed over the type of educational institutions that 
were included in the review, as long as it represented the location where participants received 
most of their education.  
Types of interventions 
Interventions were selected that aimed to develop and improve self-management of asthma among 
children through at least one of the following: 
i. Increasing knowledge of asthma and it’s self-management 
ii. Enhancing self-management skills 
iii. Improving self-management behaviours and practice 
Among studies that sought to improve asthma self-management, the intervention was only 
included if it involved teaching at least one aspect of self-management, as outlined below: 
i. Reinforcement of regular monitoring of lung function 
ii. Emphasis on the importance of self-management practice and behaviour 
iii. Development of a partnership/alliance between patient and primary care/healthcare 
practitioners (including school nursing staff) for the management of asthma 
iv. Instruction on inhaler technique 
v. Reinforcement/provision of an individualised written asthma management plan 
vi. Emphasis on the importance and appropriate use of reliever therapies such as beta2-
agonists (SABA) [16] 
148 
 
vii. Emphasis on the importance and appropriate use of regular preventer therapies such 
as inhaled corticosteroids (ICS) and combination inhaled corticosteroid and long-
acting beta2-agonist therapies [16]  
viii. Non-pharmacological self-management strategies focused on avoiding or reducing 
the risk of experiencing asthma or asthma attacks, including lifestyle and behavioural 
modifications [16]  
Interventions could also focus on changing asthma management within schools, for example by 
changing school policies. However, these studies were only eligible if they also included the 
development and evaluation of asthma self-management behaviours and skills among children. 
No criteria were applied to the intervention facilitator. Instead, the intervention could be delivered 
by a trained educator, nurse, doctor, peer, or social worker, or a combination of these.  
Comparison 
For the outcome evaluation studies, the comparison groups were either usual care or an 
intervention that did not focus on asthma. For the process evaluation studies, the comparison 
group could have received another asthma intervention, or studies may not have included a 
comparison group at all.  
  5.3.2 Types of Outcome Measures 
Outcomes for meta-analyses 
The primary outcomes were based on those identified by the BTS as indicators of good asthma 
control [16]: 
i. Asthma symptoms or exacerbations leading to admission to hospital (children with 
one or more admissions or admission rates) 
ii. Asthma symptoms or exacerbations leading to emergency hospital visits 
iii. Parent-reported absence from school 
iv. Days of restricted activity 
There were also several secondary outcomes of interest: 
i. Unplanned visit to hospital or GP due to asthma symptoms 
ii. Experience of day and night-time symptoms  
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iii. Lung function 
iv. Use of reliever therapies such as beta2-agonists 
v. Corticosteroid dosage and/or adherence to add-on therapies 
vi. Health-related quality  of life (HRQoL) as measured by a validated questionnaire 
vii. Study withdrawal  
Outcomes for QCA: Defining a successful intervention 
QCA is a method of analysis that develops understanding of which combinations of intervention 
components and processes trigger successful outcomes. QCA is based on set theory, and explores 
the degree of overlap between a set of successfully implemented studies, and a set of studies with 
a particular range of intervention components and processes. 
The first step in the QCA used in this review was to identify ‘successful’ implementation studies. 
Currently, there is no standardised approach to assessing whether an intervention is ‘successful’ 
or not [181]. Instead, several steps were followed, in accordance with the literature. First, the 
features of intervention implementation that were related to intervention fidelity were examined, 
as well as the evidence around attrition, dosage and adherence. A literature review of 
implementation scoring methods in public health interventions [181] included one study by 
Rosecrans et al that examined the implementation of a complex intervention that included a 
school component [182], which subsequently formed the basis of the coding scheme within this 
review. The authors here used the following criteria: low implementation (0-49%); moderate 
implementation (50-74%); or high implementation (75-100%)’ [182]. The 75% or above 
threshold also corresponds with the 25% attrition rate that is often incorporated within study 
sample size calculations for public health trials involving children, and indicated a high 
implementation score, and was considered to be a ‘successful’ intervention.  
For each of these indicators above, a combination of direct and transformational assignment was 
used to set values (shown in table 23). Numerical values were assigned to qualitative data, and all 
the data was adjusted using transformational assignment. In doing this, all of the qualitative and 
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quantitative data could be combined into a single measure. The data was combined by totalling 
each value and standardising the total score.  
 Field Instructions for 
extractors 
Coding values and method 
Setting and Participants 
1 No. of children Record total number 
of children involved in 
intervention 
Transformational assignment: 
Interventions with 15 or fewer children = 
0; Interventions with 90 children = 0.5; 
Interventions with 300 or more children 
= 1 
2 Multiple settings Evidence if delivered 
at more than one 
school 
Direct assignment: Yes = 1; No = 0 
3 Single sex school Evidence  if delivered 
in a single sex school 
Direct assignment: Yes = 1; No = 0 
4 Type of school High school; 
Primary/Elementary; 
Junior/Middle; Other 
Direct assignment: High school = 1; 
Middle/Junior = 0.66; 
Elementary/Primary = 0.33; Missing = 
0.5; Mixture of high and middle schools 
= 0.75 
5 Ethnicity of children Whether minority 
ethnic children are 
targeted 
Transformational assignment: 
Interventions with 25% or fewer children 
from ethnic minority = 0; Interventions 
with 33.3% from ethnic minority = 0.5; 
Interventions with 50% or more from 
ethnic minority = 1. Where there is 
missing values, assume not targeted 
(0.25) 
6 SES of children Where children from 
lower SES groups 
targeted? Indicators: 
Parents with low 
levels of education; 
low household 
income; receipt of free 
school meals 
Transformational assignment: 
Interventions with 25% or fewer children 
from low SES groups = 0; Interventions 
with 33.3% of children from low SES 
group = 0.5; Interventions with 50% or 
more children from low SES group = 1. 
Where there is missing values, assume 
not targeted (0.25) 
7 Child age Age group/classes 
targeted: age 5-10 
Direct assignment: Yes = 1; No = 0 
  Age group/classes 
targeted: age 11-14 
Direct assignment: Yes = 1; No = 0 
  Age group/classes 
targeted: age 15-18 
Direct assignment: Yes = 1; No = 0 
8 Direct recipients Children Direct assignment: Yes = 1; No = 0 
  Teachers Direct assignment: Yes = 1; No = 0 
  Parents Direct assignment: Yes = 1; No = 0 
  School nurse Direct assignment: Yes = 1; No = 0 
Programme Design 
9 Theory driven Does the study name a 
theoretical framework 
which underpins the 
intervention design or 
delivery style 
Direct assignment: Yes = 1; No = 0 
10 Intensity of the 
programme 
High intensity = 6+ 
sessions; Medium = 3-
5 sessions; Low = 1-2 
sessions; Unclear. 
Variable transformed 
to reflect whether the 
Direct assignment: High intensity = 1; 
Medium = 0.66; Low = 0.33. Where no 
evidence, this was coded as 0.33 
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intervention was of a 
high intensity 
11 Personalisation/Tailoring Did the programme 
include individual 
sessions or use 
personalisation in any 
way to alter 
curriculum to 
individual students’ 
needs 
Direct assignment: All sessions 
personalised = 1; Some sessions 
personalised = 0.66; Minor component 
personalised = 0.5; No evidence = 0. 
This is personalised by or individual 
sessions with an instructor; self-study 
components no included here 
12 Timing of the 
intervention 
Does the intervention 
interfere with the 
child’s free time? 
Direct assignment: All sessions do = 1; 
Some sessions do = 0.75; Missing data = 
0.5; Not interfering with free time = 0 
  Does the intervention 
interfere with the 
child’s lessons? 
Direct assignment: All sessions do = 1; 
Some sessions do = 0.75; Missing data = 
0.5; Not interfering with education = 0 
13 Information about control 
condition 
Whether trialists were 
also providing a 
control for the main 
intervention 
Direct assignment: An equivalent control 
= 1; not an equivalent = 0.66; No control 
= 0 
14 Instructor or facilitator Teacher Direct assignment: Main instructor = 1; 
Secondary instructor = 0.66; Not 
mentioned as an instructor = 0 
  Peer Direct assignment: Main instructor = 1; 
Secondary instructor = 0.66; Not 
mentioned as an instructor = 0 
  School nurse Direct assignment: Main instructor = 1; 
Secondary instructor = 0.66; Not 
mentioned as an instructor = 0 
  Self-directed/child-
directed 
Direct assignment: Main instructor = 1; 
Secondary instructor = 0.66; Not 
mentioned as an instructor = 0 
  Parent Direct assignment: Main instructor = 1; 
Secondary instructor = 0.66; Not 
mentioned as an instructor = 0 
  Other Direct assignment: Main instructor = 1; 
Secondary instructor = 0.66; Not 
mentioned as an instructor = 0 
Programme Content 
15 Curriculum Lung 
physiology/asthma 
biology 
Direct assignment: Yes = 1; No = 0 
  Asthma acceptance Direct assignment: Yes = 1; No = 0 
  Symptom monitoring 
and medication use 
Direct assignment: Yes = 1; No = 0 
  Avoiding triggers Direct assignment: Yes = 1; No = 0 
  General health  Direct assignment: Yes = 1; No = 0 
  Strengthening 
alliances  
Direct assignment: Yes = 1; No = 0 
  Focus on smoking Direct assignment: Yes = 1; No = 0 
  Personalised/tailored Direct assignment: Yes = 1; No = 0 
  School performance Direct assignment: Yes = 1; No = 0 
  Emergencies Direct assignment: Yes = 1; No = 0 
  Unknown Direct assignment: Yes = 1; No = 0 
  Focus on breathing 
techniques 
Direct assignment: Yes = 1; No = 0 
16 Learning styles Problem solving 
component 
Direct assignment: Yes = 1; No = 0 
  Self-directed Direct assignment: Yes = 1; No = 0 
  Peer-delivery 
component 
Direct assignment: Yes = 1; No = 0 
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  Interactive Direct assignment: Yes = 1; = 0 
  Didactic component Direct assignment: Yes = 1; No = 0 
  Other style/unclear Direct assignment: Yes = 1; No = 0 
17 Program ethos/aims Emphasis on social 
benefit 
Direct assignment: Yes = 1; No = 0 
  Emphasis on 
improving wellbeing 
Direct assignment: Yes = 1; No = 0 
  Emphasis on having 
fun 
Direct assignment: Yes = 1; No = 0 
  Emphasis on fostering 
independence/personal 
responsibility 
Direct assignment: Yes = 1; No = 0 
  Emphasis on 
developing children’s 
knowledge 
Direct assignment: Yes = 1; No = 0 
  Emphasis on 
collaboration 
Direct assignment: Yes = 1; No = 0 
  Emphasis on tailoring 
for specific group 
needs 
Direct assignment: Yes = 1; No = 0 
  Emphasis on breathing 
technique 
Direct assignment: Yes = 1; No = 0 
  Unclear Direct assignment: Yes = 1; No = 0 
18 Additional components 
on school asthma policy 
Additional support 
provide for developing 
school policy 
Direct assignment: Yes = 1; No = 0 
  School asthma policy 
developed organically 
Direct assignment: Yes = 1; No = 0 
Additional processes undertaken – planned and unplanned 
19 Recruitment methods 
school 
Ad hoc/convenience 
sample of schools 
Direct assignment: Yes = 1; No = 0 
  Census of school 
district 
Direct assignment: Yes = 1; No = 0 
  Unspecified methods 
of school recruitment 
Direct assignment: Yes = 1; No = 0 
20 Additional processes to 
improve/attenuate 
attrition/enrolment 
Marketing materials 
sent to parents 
Direct assignment: Yes = 1; No = 0 
  Low motivation of 
students 
acknowledged  
Direct assignment: Yes = 1; No = 0 
  Incentives used (child 
or parent) 
Direct assignment: Yes = 1; No = 0 
Incentives for teachers and no evidence 
for children/teachers  = 0.5 
  Make-up/catch-up 
sessions provided 
Direct assignment: Yes = 1; No = 0 
  Reminders sent to 
parents/children 
Direct assignment: Yes = 1; No = 0 
21 Relationships/engagement Did teachers engage or 
participate in the way 
in which they were 
expected to? 
Direct assignment: Good reported 
throughout = 1; Some weaker evidence 
of good relationships = 0.75; 
Missing/NA/Unclear = 0.5; Weaker 
evidence of poorer relationships = 0.25; 
Poor relationships = 0 
  Did parents engage in 
the way in which they 
were expected to? 
Direct assignment: Good reported 
throughout = 1; Some weaker evidence 
of good relationships = 0.75; 
Missing/NA/Unclear = 0.5; Weaker 
evidence of poorer relationships = 0.25; 
Poor relationships = 0 
153 
 
  Did school nurses 
engage in the way in 
which they were 
expected to? 
Direct assignment: Good reported 
throughout = 1; Some weaker evidence 
of good relationships = 0.75; 
Missing/NA/Unclear = 0.5; Weaker 
evidence of poorer relationships = 0.25; 
Poor relationships = 0 
  Did other stakeholders 
engage in the way in 
which they were 
expected to? 
Direct assignment: Good reported 
throughout = 1; Some weaker evidence 
of good relationships = 0.75; 
Missing/NA/Unclear = 0.5; Weaker 
evidence of poorer relationships = 0.25; 
Poor relationships = 0 
Process Outcomes 
22 Child satisfaction Level of satisfaction 
(%) or record 
qualitative statement 
on child satisfaction 
with the intervention. 
Indicators of 
satisfaction included 
children reporting that 
they enjoyed the 
intervention; whether 
children would 
recommend the 
intervention; whether 
children found the 
intervention helpful. 
Knowledge 
development not 
included here 
Elements of direct and transformational 
assignment. 
Direct assignment: Where there is a 
qualitative statement indicating positive 
agreement = 0.66; where a qualitative 
statement indicating negative agreement 
= 0.33; no data = 0.5 
Transformational assignment: 
Interventions with 25% or fewer children 
satisfied = 0; interventions with 50% 
children satisfied = 0.5; missing data = 
0.5; interventions with 75% or more 
children satisfied 
23 Child attrition Put in level of 
completion (%) or 
record qualitative 
statement on child 
completion rate 
Elements of direct and transformational 
assignment. Note thresholds are higher 
than satisfaction as there are fewer 
missing data. 
Direct assignment: Where there is a 
qualitative statement indicating high 
level of completion = 0.83; where a 
qualitative statement indicating 
problematic completion = 0.66; missing 
data = 0.75 
Transformational assignment: 
Interventions with 66% or fewer children 
completing the intervention = 0; 
interventions with 75% of children 
completing the intervention = 0.5; 
intervention with 83% or more children 
completing the intervention = 1. Missing 
data = 0.5 
24 Child dosage level Did the children 
receive the intended 
dosage of the 
intervention (%) or 
record qualitative 
statement? 
Elements of direct and transformational 
assignment. Note thresholds are higher 
than satisfaction as there are fewer 
missing data. 
Direct assignment: Where there is a 
qualitative statement indicating high 
level of dosage = 0.83; where a 
qualitative statement indicating 
problematic dosage = 0.66; missing data 
= 0.75 
Transformational assignment: 
Interventions with 66% or fewer children 
receiving the full dosage = 0; 
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interventions with 75% of children 
receiving the full dosage = 0.5; 
interventions with 83% or more children 
receiving the full dosage = 1; missing 
data = 0.5 
25 Child adherence Did the children 
adhere to the 
intervention 
instructions? 
Elements of direct and transformational 
assignment. Note thresholds are higher 
than for satisfaction as there are fewer 
missing data. 
Direct assignment: Where there is a 
qualitative statement indicating high 
level of adherence = 0.83; where a 
qualitative statement indicating 
problematic adherence = 0.66; missing 
data = 0.75 
Transformational assignment: 
Interventions with 66% or fewer children 
adherent = 0; interventions with 75% of 
children adherent = 0.5; interventions 
with 83% or more children adherent = 1; 
missing data = 0.5 
26 Consolidated process 
variable 
Summation of 
attrition, adherence 
and dosage scores as a 
marker of 
implementation 
success 
Transformational assignment: 
Implementation not successful = 0; mid-
point between successful and 
unsuccessful implementation = 1.5; full 
implementation success = 3 
Table 23. Detailed coding framework for conditions and outcomes 
  5.3.3 Search Methods for Identification of Studies 
Electronic searches 
The Cochrane airways group specialised register was searched using the search strategy included 
in appendix 10. This strategy was developed by the Cochrane Airways Information Specialist (Liz 
Stovold). The searches were conducted in April 2015 and updated in April 2016 and August 2017.  
Searching other resources 
As this review included process evaluation studies for the QCA, the search was expanded to 
identify process evaluation studies as well as RCTs for the meta-analyses. Thee searches were 
based on the search criteria included in appendix 10, however they were adjusted to account for 
the different search syntax/parameters used in additional databases. The search strategies can be 
found in appendix 11. The databases included: 
i. Database of Promoting Health Effectiveness Reviews (DoPHER) 
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ii. Cochrane Database of Systematic Reviews (CDSR) 
iii. Database of Abstracts of Reviews of Effects (DARE) 
iv. The Campbell Library 
v. National Institute for Health Research (NIHR) Health Technology Assessment 
(HTA) programme website/journals library 
vi. HTA Database 
Search strategies were also applied to a comprehensive search of the databases below from 1995 
to present: 
i. Applied Social Sciences Index and Abstracts (ASSIA) 
ii. BiblioMap (EPPI-Centre Database of Health Promotion Research) 
iii. CDSR 
iv. Cochrane Central Register of Controlled Trials (CENTRAL) 
v. Health Management Information Consortium (HMIC) 
vi. International Bibliography of the Social Sciences (IBSS) 
vii. National Health Service Economic Evaluation Database (NHS EED) 
viii. PubMed 
ix. Sociological Abstracts (SOCABS) 
x. Social Policy and Practice (SPP) 
xi. Social Services Abstracts 
xii. Web of Knowledge 
Google Scholar, Social Policy Digest and other sources such as the BTS and Asthma UK were 
also hand searched.  
Integral process evaluations (sibling studies) were identified through backwards and forwards 
citation searches initially.  
  5.3.4 Data Collection and Analysis 
Selection of studies 
The inclusion criteria were applied to titles, abstracts, and full reports, which were entered into 
EPPI-Reviewer [183]. Studies that met the inclusion criteria based on title and abstract 
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screening, or studies that did not provide enough information in the abstract to decide, were 
included, and the inclusion criteria were applied to the full-text reports. The inclusion criteria 
are outlined below: 
(i) Population (children aged 5-18 years) 
(ii) Disease status (physician diagnosis of asthma) 
(iii) Intervention (school-based, with a focus on self-management) 
(iv) Comparison (lower intensity or usual care) 
(v) Study design (RCT) 
(vi) Date (published after 1995) 
(vii) Language (English) 
For process evaluation studies, additional screening criteria were applied. This included the use 
of recognised tools to collect the data, and excluded studies that did not include the core 
components that would be expected within a process evaluation (as identified by the MRC and 
described above).  
During the pilot screening process, two review authors independently screened a random 
selection of studies on title and abstract, and participated in moderation exercises to discuss the 
screening results, and ensure consistency in applying the review exclusion criteria. 
Disagreements were discussed and resolved accordingly. An agreement rate of 90% or above 
was required, and was achieved in three consecutive samples, before independent screening on 
the rest of the studies began. 
  5.3.5 Data Extraction and Management 
Data management 
The studies that were identified in the searches were uploaded to EPPI-Reviewer 4 for duplicate 
stripping and screening [183]. Using EPPI-Reviewer 4, the outcome of the screening process 
was recorded, with reasons for exclusion. The included studies were subsequently exported into 
StataCorp 2013 and RevMan 5.3, for analysis. 
Outcome measures – data extraction 
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Two review authors independently extracted the study characteristics and numerical outcome 
data from studies meeting the eligibility criteria of the review. No disagreements were 
encountered that needed to be resolved by senior members of the review team. Where missing 
data was found, the study authors were contacted for further information.  
Process Evaluation measures – Data selection 
The aim of the process evaluation component of this review was to identify the combinations of 
components and processes within interventions that are associated with successful intervention 
implementation.  
Two review authors independently extracted conditions of interest from the process evaluation 
studies that met the eligibility criteria of this review. The first step was to build a data table of 
information supporting several conditions (over 90) for each study. These data represented both 
quantitative indicators, which represented the degree to which a condition was present (e.g. the 
number of students from an ethnic minority in an intervention); binary indicators, which 
represented whether a condition was present or not (e.g. asthma curriculum contained information 
on lung physiology); or qualitative statements (e.g. published quotes of student satisfaction with 
the intervention). An example from this review includes whether an intervention took place within 
a high school. Interventions that took place exclusively within high schools were assigned a value 
of 1 (fully within the set); those that took place exclusively within primary/elementary schools 
were assigned a value of 0. Where values were directly assigned in this way, no further adjustment 
was required. In other cases, a combination of direct and transformational assignment was 
required. In direct assignment, values were directly assigned, which are typically based on 
categorical or binary source indicators. In transformational assignment, rules are developed for 
how continuous values are coded between 0 and 1. A score of 1 indicates full set-membership, 
and 0 indicates that the study is out of the set. Membership scores of 0.5 indicate that the study is 
neither in nor out of a set, and this value was used for some of the missing data that was seen in 
this review.   
More data was extracted than could be supported by any of the QCA models (known as limited 
diversity). Many of the conditions that were extracted were binary indicators of concepts relating 
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to the same condition; therefore cluster analyses were applied, to create natural groupings and 
reduce the number of conditions in some of the models [175]. The original and reduced data are 
displayed for these conditions in table 24.  
Curriculum – Original Conditions Curriculum – Reduced Conditions 
i. Lung physiology 
ii. Asthma acceptance 
iii. Symptom monitoring and treatment 
iv. Trigger avoidance 
v. General health 
vi. Forming alliances 
vii. Smoking 
viii. Tailored/personalised 
ix. School performance 
x. Emergencies 
xi. Unknown content 
i. Symptom monitoring and alliances 
ii. Lung physiology and general health 
iii. Symptom monitoring and trigger 
avoidance 
iv. Other various foci 
v. Unknown 
Pedagogical Delivery Style – Original 
Conditions 
Pedagogical Delivery Style – Reduced 
Conditions 
i. Problem solving 
ii. Self-direct 
iii. Peer delivery 
iv. Interactive 
v. Didactic 
vi. No information/other focus 
i. Interactive focused style 
ii. Diverse style 
iii. Unknown style 
Intervention Emphasis – Original Conditions Intervention Emphasis – Reduced Conditions 
i. Emphasis on social benefit 
ii. Emphasis on wellbeing 
iii. Emphasis on having fun 
iv. Emphasis on personal responsibility 
v. Emphasis on children’s knowledge 
vi. Emphasis on collaboration 
vii. Emphasis on 
tailoring/personalisation 
viii. Emphasis unclear 
i. Emphasis on 
tailoring/personalisation 
ii. Emphasis on personal responsibility 
iii. Diffuse emphasis/other 
Table 24. Original and reduced conditions for curriculum content, delivery style and programme emphasis 
Although the cluster analysis reduced the number of conditions, the focus of the review was on 
studies that were either high or medium intensity, as this is consistent with indicators such as 
attrition and dosage. Therefore, six reports of interventions that involved one or two face-to-face 
sessions [184-189] were excluded from the analysis. 
  5.3.6 Assessment of risk of bias in included studies 
The sources of bias below were assessed in terms of how they were believed to affect the results 
of an individual outcome evaluation study: 
 Sequence generation: studies that used a computer-generated allocation procedure, a 
random number table, or other recognised low-risk means were deemed to be at low risk 
of bias (per the tool of the Cochrane Collaboration for assessing risk of bias). Studies that 
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used procedures such as clinic visit date or date of birth, where the order of treatment 
group assignment was predictable or open to external influence, were deemed to be at 
high risk of bias. Where the method of randomisation could not be identified, the study 
was classified as having an unclear risk of bias. Due to the potential impact of 
socioeconomic imbalance between cluster sites within the same study, consideration was 
also given to whether stratification on socioeconomic variables was undertaken.  
 Allocation concealment: Studies for which measures were taken to prevent disclosure 
of treatment group assignment, such as off-site allocation or allocation by a third part not 
involved in the study, were deemed to be at low risk of bias. For cluster-randomised 
studies, an additional consideration was timing of recruitment into the study in relation 
to assignment.  
 Blinding (performance bias and detection bias): Studies for which measures were 
taken to ensure that personnel collecting data were unaware of participants’ treatment 
group assignment were low risk of bias. However, given the nature of the intervention 
and the difficulty involved in blinding recipients, a degree of performance bias may have 
impacted some outcomes, and particularly patient reported outcomes, which was 
unavoidable.  
 Handling of missing data and attrition: Studies for which data sets were complete, or 
for which reasons for missing data were not related to treatment, were low risk of bias. 
When attrition rates were high, imbalanced or unexplained, and only an available study 
set is presented, the study was deemed to be at high risk of bias. Studies for which the 
attrition rate was not reported separately for treatment and control groups, and for which 
the reasons for withdrawal could not be ascertained were also deemed high risk of bias.  
 Selective reporting: Assessments of selective reporting were restricted to examination 
of the availability of data related to outcomes included in the summary of findings (SoF) 
table in table 25.  
 Other bias: Baseline imbalances were examined in the characteristic of participants for 
potential bias. The evidence of contamination between intervention and control groups 
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was also considered. Sensitivity analysis was restricted to the primary outcomes of the 
review. The overall judgements for each study were derived at the outcome level.
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Outcomes Anticipated Absolute Effects* 
(95% CI) 
Relative Effect 
(95% CI) 
Participants 
(Studies) 
GRADE Comments 
Risk with Usual 
Care 
Risk with 
Intervention 
Hospitalisations 
(follow-up: 1 week 
to 12 months) 
Mean 
exacerbations 
leading to 
hospitalisation 
was 0.26 episodes 
(per 12 months) 
MD 0.16 
episodes (per 12 
months) lower 
(0.294 lower to 
0.034 lower) 
- 1873 (6) Moderate Meta-analysis based on SMD 
including data transformed from 
IR; transformation to MD 
undertaken based on data from 
Horner 2015 [190] using baseline 
hospitalisation level in control 
group 
ED visits (follow-
up: 1 week to 12 
months) 
Moderate 
75 per 1,000 
 
High 
281 per 1,000 
54 per 1,000 (41 
to 69) 
 
 
215 per 1,000 
(172 to 264) 
OR 0.70 (0.53 to 
0.92) 
3883 (13) Low Assumed risk based on rates over 
12 months. Less than 10% based 
on 3 studies [191-193]; more than 
10% based on 2 studies [194, 
195] 
Unplanned visit to 
hospital or GP 
(follow-up: 1 week 
to 12 months) 
Low 
 
 
Moderate 
318 per 1,000 
 
210 per 1,000 
(177 to 244) 
 
257 per 1,000 
(219 to 296) 
OR 0.74 (0.60 to 
0.90) 
3283 (5) Moderate Unplanned visits over 6-9 months 
based on 2 studies [195, 196]; 
Unplanned visits over 12 months 
based on 2 studies [192, 194] 
Absence from 
school (follow-up: 
1 week to 15 
months) 
Mean absence = 
4.3 school days 
missed annually 
MD 0.399 
school days 
missed annually 
lower (1.254 
lower to 0.456 
higher) 
- 4609 (10) Low Meta-analysis based on SMD 
including data transformed from 
OR; transformation to MD 
undertaken based on data from 1 
study [197] 
Experience of day 
time symptoms 
(follow-up: 2 
months to 12 
months) 
Mean experience 
of symptoms was 
3 days 
experienced in 
past 2 weeks 
MD 0.377 days 
experienced in 
past 2 weeks 
lower (0.828 
lower to 0.05 
higher) 
- 1065 (5) Moderate The CI for this pooled estimate 
crossed the line of no effect by a 
small margin. Original meta-
analysis based on SMDs, 
including transformations from 
ORs. SMD to MD based on 1 
study [95] 
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Use of reliever 
therapies (follow-
up: 1 week to 15 
months) 
Study population 
228 per 1,000 
133 Per 1,000 
(42 to 349) 
OR 0.52 (0.15 to 
1.81) 
437 (2) Very Low - 
HRQoL (follow-up: 
1 week to 12 
months) 
Mean HRQoL 
was 4.96 PAQLQ 
points 
MD 0.36 
PAQLQ points 
higher (0.06 
higher to 0.64 
higher) 
- 2587 (7) Moderate Two studies provided 
information on change in QoL. 
Both showed positive 
intervention effects, but with high 
heterogeneity. Risk with usual 
care based on follow-up scores 
*The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI)  
 
CI: Confidence Interval; ED: Emergency Department; HRQoL: Health-Related Quality of Life; RR: Risk Ratio; OR: Odds Ratio; QoL: Quality of Life; SMD: Standardised 
Mean Difference; PAQLQ: Paediatric Asthma Quality of Life Questionnaire 
 
GRADE: High: very confident that the true effect lies close to that of the estimate of the effect; moderate: moderately confident in the effect estimate. The true effect is likely 
to be close to the estimate of effect, but there is a possibility that it is substantially different; low: confidence in the effect estimate is limited. The true effect may be substantially 
different from the estimate of the effect; very low: very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect 
 
Table 25. Summary of Findings for the Main Comparison  
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The quality of the process evaluation studies were assessed using two tools. The first tool was 
developed at the EPPI-Centre [198] to assess the methodological rigour of ‘views’ studies that 
aimed to collect information on people’s experiences from trials. This tool considers seven 
criteria: 
i. Whether the study includes an explicit theoretical framework and/or literature 
review; 
ii. Clearly state aims and objectives; 
iii. A clear description of context; 
iv. A clear description of the sample and how it was recruited; 
v. A clear description of methods used to collect and analyse data; 
vi. Attempts made to establish the reliability or validity of data analysis; 
vii. Inclusion of sufficient original data to mediate between evidence and interpretation 
The second tool, which was developed by the EPPI-Centre to assess the quality of process 
evaluation data [199], assesses: 
i. Methods of data collection; 
ii. A description of process evaluation participants; 
iii. Timing of the process evaluation with respect to the intervention; 
iv. Process evaluation data collection methods; 
v. Process evaluation data analysis methods; 
vi. Whether findings were supported by the data; 
vii. Breadth and depth of findings; 
viii. The extent to which the process evaluation gave privilege to the views of participants; 
ix. Reliability of findings; 
x. Usefulness of process evaluation 
As some of the domains from these tools overlap, elements from both tools were combined to 
assess the quality of process measures. 
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  5.3.7 Assessment of bias in conducting the review 
The review was conducted in accordance with the published protocol [200]. 
  5.3.8 Measures of treatment effect 
Continuous Data 
As recommended in the Cochrane Handbook for Systematic Reviews of Interventions [201], 
mean differences (MDs) were intended to be calculated when continuous data were measured by 
the same scale or unit. However, this did not occur for most of the outcomes in this review. 
Therefore, when similar outcomes were measured by different scales or units, standardised mean 
differences (SMDs) were used. 
Dichotomous Data 
For dichotomous (binary) data, odds rations (ORs) were calculated, and when appropriate, 
combined results from different trials 
Ordinal Data 
As set out in the Cochrane Handbook for Systematic Reviews of Interventions [201], ordinal 
outcomes (e.g. quality of life scales) were to be analysed as continuous variables. When 
appropriate thresholds were identified, these were analysed as dichotomous variables.  
Count Data 
Rate ratios were calculated for all count data that were encountered that represented the ratio of 
events experienced between two groups, such as hospitalisations or absences from school.  
  5.3.9 Unit of analysis issues 
Cluster-Randomised Studies 
Cluster-randomised controlled studies were included in which schools or classes within schools, 
rather than individual with asthma, were the unit of allocation. Variation in response to treatment 
between clusters may also be influenced by cluster membership, meaning that cluster members’ 
data can no longer be considered independent of one another. Therefore, data were extracted when 
study authors had adjusted for a clustered design in the analysis. Where no Intracluster Correlation 
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Coefficient (ICC) was provided, an ICC of 0.05 was chosen, based on the ICC estimate used in 
one of the included papers to calculate the sample size [187]. Effect estimates were adjusted using 
the methods described in the Cochrane Handbook [201]. 
Choice of Measurement Point 
For trials that reported outcomes at multiple time points, such as post-test with longer follow-up, 
all data extracted and combined in meta-analyses were the follow-up point most consistently 
reported among trials.  
  5.3.10 Dealing with missing data 
When data were missing from studies, the authors were contacted directly to obtain the missing 
information. Table 26 highlights the details of the studies which had missing data and were 
therefore excluded from the meta-analysis.  
Study Included as Outcome Reason Data not Included in Meta-Analysis 
Bruzzese 2004 Feasibility study using RCT design with no quantitative data 
presented 
Bruzzese 2010 Abstract only located and outcomes not presented in an 
extractable format 
Clark 2004 Published effect sizes that were extractable but of a different 
effect size from other studies 
Clark 2010 No outcome measured in the study matched the review protocol 
McCann 2006 Outcomes were not presented in an extractable format 
(disaggregated data for asthmatic children unavailable) 
Monforte 2012 Abstract only located and outcomes not presented in an 
extractable format 
Monsnaim 2011 No outcome measured in the study matched the review protocol 
Praena-Crespo 2010 Abstract only located and outcomes not presented in an 
extractable format 
Pulcini 2007 No outcome measured in the study matched the review protocol 
Srof 2012 Outcomes were not presented in an extractable format (QoL data 
were not presented in full) 
Table 26. Outcome evaluation studies not included in the analysis 
  5.3.11 Assessment of heterogeneity 
Statistical heterogeneity was assessed by using the I2 measure [202]. Pre-specified sensitivity and 
subgroup analyses were conducted to explore possible sources of variation. 
The relatively low number of studies in the meta-analysis models (the largest model included 13 
studies) meant that random-effects multivariate meta-regression models could not be constructed, 
without comprising the underlying assumptions of the models. 
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  5.3.12 Assessment of reporting biases 
The number of studies in which the analysis of data related to the primary outcomes of this review 
could not be identified was recorded. The distribution of effect sizes for each outcome study was 
plotted against the study standard errors (SE) as a funnel plot for the primary outcomes, and the 
publication bias assessment was based on a visual inspection, if 10 or more studies contributed to 
the outcome. Formal tests for small-study publication bias were also conducted, using Egger’s 
test [203].   
  5.3.13 Data Synthesis 
Outline of approach to synthesis 
The synthesis in this review takes a multifaceted approach to understanding (i) the components 
that are required to successfully deliver a school-based asthma intervention, and (ii) the impact 
that school-based interventions can have on children’s outcomes.  
In the analysis one, QCA was conducted to highlight which combinations of intervention 
characteristics (known as conditions) are associated with successful implementation. The QCA 
aimed to generate hypotheses about the importance of different intervention components and 
processes that were later tested in the meta-analyses. The conditions that were identified not only 
helped to identify which conditions are important for successfully implementing an intervention, 
but also helped to structure the meta-analysis and identify their potential impact on the overall 
effectiveness of interventions on children’s outcomes. The possibility that hypotheses were 
generated and tested on the same dataset was avoided due to little overlap between studies being 
included in the QCA and studies being included in the meta-analyses. Studies included in the 
QCA included a wide range of study designs.  
In part two of the analyses, the effectiveness of school-based asthma self-management 
interventions in improving children’s outcomes were examined by conducting meta-analyses of 
the primary and secondary outcomes. Only those with an RCT design were included in the meta-
analysis of outcome evaluation studies. Additional subgroup analyses, based on the results of the 
QCA, were also conducted.  
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In part three of the analyses, the link between implementation and effectiveness was examined, 
through estimating whether interventions defined as ‘successful’ in terms of their implementation 
were also those with higher effect sizes. These analyses took place on a subgroup of studies 
adopting varied study designs.  
Process-level measurements using QCA 
QCA takes a study-based approach (accounting for several study characteristics simultaneously), 
so that the focus is on different combinations of conditions [175]. Notably, this approach is 
relatively new to systematic reviewing. The QCA approach used in this review aimed to generate 
theories about components that were ‘sufficient’ to trigger successful implementation ‘Sufficient’ 
relationships indicate that an outcome is triggered in the presence of a condition or condition set; 
however, other pathways to achieving the outcome may also exist’.  
The QCA analyses presented in this review are fuzzy-set QCA (fsQCA), which reflects both the 
concepts being tested, and the data that is being used. In fsQCA, the main interest is establishing 
set membership scores, which indicates the extent to which studies below to a set, with values 
falling between 0 and 1 (as described above). A set membership score for each study was 
calculated based on the study conditions from the data table, and these were analysed against the 
outcome membership scores.  
During the data analysis, the recommendations given by Ragin [204] and Thomas [175] were 
followed. First, a data table for each study was developed, which displayed its assigned values. 
Following this, a truth table was developed, which showed the data on each combination of 
conditions, instead of just showing the data for each study. Combinations could be supported by 
multiple studies, or a single study. Possible combinations could also not be supported by any data 
(referred to as a logical remainder). A consistency score was also included in the truth table, which 
showed the degree that membership in the combination of conditions is a subset of the degree of 
membership in the outcome set. A fairly high value of 0.875 was applied before a combination 
could be considered to trigger an outcome. The quality of the truth table was then checked and 
contradictory combinations (where the same combination supports the outcome and its negation) 
were resolved. Boolean minimisation was then included, which identifies the simplest explanation 
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of the results. Where logical remainders were found, these were incorporated into further models 
to simplify the solution and maintain its theoretical consistency.  
Quantitative Data 
Data were combined which explored the effect of an intervention compared to either usual care 
or an intervention that did not include asthma education. Two studies compared the intervention 
to a placebo intervention, instead of usual care, therefore no further disaggregation of this 
comparison was made.  
The data was combined in Review Manager 5.1 [205], however some analyses and data 
transformations were also conducted in Stata (where cluster-randomised trials were encountered 
the standard errors were converted using EPPI-Reviewer; [183]). Several variations were seen, 
and Chinn’s formulae [206] was used to convert effect sizes and standard errors between SMDs 
and ORs.  
Occasionally, some data could not be included in the meta-analyses due to methodological 
difficulties in combining the data. This included data based on the median. Some other changes 
and forms of imputation for missing data included: 
i. Basing the effect size for quality of life for Al-Sheyab 2012 [207] on the p-value 
because of uncertainty regarding the effect size derived from the point estimates and 
precision provided; 
ii. Basing the effect sizes for Cicutto 2013 [194] on approximations of the number of 
participants in control and treatment groups; 
iii. Estimating the number in the treatment and control arms for Clark 2005 [208], 
assuming an equal distribution of the overall sample size. For this study, an OR of 
0.996 was also inputted for a value reported as 1.00 for emergency department (ED) 
visits, in order to be able to combine the information in models.  
  5.3.14 Rating the quality of the evidence 
The quality of the evidence was rated using methods developed by the Grades of 
Recommendation, Assessment, Development and Evaluation (GRADE) Working Group 
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(http://www.gradeworkinggroup.org/publications/JCE_series.htm). The possible impact of each 
of the following were factors on each of the outcomes of interest were explored: 
 Risk of bias 
 Imprecision 
 Inconsistency 
 Indirectness 
 Publication bias 
The GRADE ratings were entered in a table alongside absolute and relative effects in the summary 
of findings table in table 25 for the following outcomes: 
 Asthma symptoms or exacerbations leading to admission to hospital 
 Asthma symptoms or exacerbations leading to ED visits 
 Unplanned visit to hospital or GP due to asthma symptoms 
 School absence 
 Experience of daytime symptoms 
 Use of reliever therapies 
 Health-related quality of life (HRQoL) 
  5.3.15 Subgroup analysis and heterogeneity 
An I2 statistic was used to calculate heterogeneity across subgroups. The aim was to develop a 
multi-variate meta-regression model, based on the results for the different outcomes. However, 
the low number of studies did not allow for this. Instead, subgroup analyses were conducted to 
investigate heterogeneity on the basis of the following characteristics: 
 Setting 
 Age 
 Socioeconomic level 
 Delivery of intervention 
 Other factors (e.g. theory-driven) 
Some indicators, such as socioeconomic status, were measured differently, therefore the 
groupings were based on income, social class, or other indicators of social position, such as being 
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in receipt of means tested benefits, were used. None of the interventions were based on asthma 
severity, therefore sensitivity analyses were not conducted on this basis.  
The process evaluation analysis was conducted before the RCTs to remain blinded to the possible 
impact of specific measures.  
  5.3.16 Sensitivity Analyses 
Sensitivity analyses were based on the following: 
 Risk of bias assessment: All studies were included in the primary analysis and then 
restricted included studies to those that were not classified as having a high risk of bias 
for any single domain 
 Fixed-effect modelling 
 Exclusion of cluster study data from outcomes 
An equivalent was not applied for the QCA modelling, however checks for robustness were 
conducted, including whether solutions predicted the negation of the outcome.  
 
 5.4 Results 
  5.4.1 Description of Studies 
Thirty-three process evaluation studies, and thirty-three separate outcome evaluation studies, met 
the inclusion criteria and were included in the review. The characteristics of all included studies 
are reported in the characteristics of included studies tables in table 27 and table 28.  
An additional table summarises how the process evaluations met the inclusion criteria (table 29). 
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 Methods Participants Intervention  
Author Design Setting Sample Size Age Ethnicity SES Gender Asthma 
Status 
Description Control Intensity Instructor Theory Outcomes 
Al-Sheyab 
2012 
Cluster parallel 
RCT 
Jordan High 
Schools 
261  Years 
8-10 
None None 43.3% 
female 
70.5% 
diagnosis 
Triple-A Usual Care 3 Lessons Peers Self-Efficacy HRQoL, 
Withdrawal 
 
Atherly 2009 Cluster parallel 
RCT 
Junior High and 
High Schools 
458 Mean 
age 
13.9 
None None 48% 
female 
Asthma 
only 
Power 
Breathing 
Not Reported 3 Lessons Teachers and 
School 
Nurses 
None Hospital 
admissions, Day 
and night-time 
symptoms, ED 
visits 
Bartholomew 
2006 
Cluster parallel 
RCT 
Texas 
Elementary 
Schools 
503 Mean 
age 7.7 
45% African 
American 
Most 
<$20,0
00 
annual 
income 
52.1% 
Male 
None Asthma 
education 
Usual Care Not 
Reported 
Computer 
Programme 
Social 
Cognitive 
Theory 
Withdrawal 
Bruzzese 
2004 
RCT High School 45 9th and 
10th 
grade 
None None None Asthma 
only 
OAS Usual Care 3 Lessons Health 
Educator 
Self-
Regulation 
Theory 
None 
Bruzzese 
2008 
 
 
 
Parallel RCT NYC Middle 
School 
24 Mean 
age 
12.8 
41% 
Hispanic 
71% 
Full-
time 
work  
54% male None OAS, ASMA, 
Caregiver 
Education 
Usual care Six weekly 
sessions 
Psychologist Social 
cognitive 
theory  
 
Symptoms, 
withdrawal 
Bruzzese 
2010 
Parallel RCT NYC Public 
School 
288 14-16 
Years 
45.5% 
Hispanic 
75% 
Free 
School 
Meals 
None Asthma 
only 
ASMA. 
Academic 
Detailing 
Usual care 6 Lessons Not Reported Social 
Cognitive 
Theory 
Withdrawal 
Bruzzese 
2011 
Parallel RCT NYC High 
Schools 
345  Mean 
age 
15.10 
45.5% 
Hispanic 
None 70.4% 
female 
Asthma 
only 
ASMA Usual care Three 
sessions 
over 8 
weeks 
Health 
Educators 
Social 
Cognitive 
Theory 
Hospital 
admissions, 
hospital visits, 
school absence, 
restricted activity, 
unplanned GP or 
hospital visit, 
symptoms, 
corticosteroid 
dosage, 
withdrawal 
 
Cicutto 2005 Cluster parallel 
RCT 
Elementary 
schools in 
Toronto 
256  Mean 
age 8.6 
None None 59.6% 
male in 
control 
 Roaring 
Adventures of 
Puff 
Usual care Six weekly 
sessions 
Asthma 
educator 
Social 
Cognitive 
Theory; Self-
Regulation 
Theory 
Hospital 
admissions, 
hospital visits, 
school absence, 
restricted activity 
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Cicutto 2013 Cluster RCT Elementary 
schools 
1316 8 years None None 57.4% 
male 
Asthma 
only 
Roaring 
Adventures of 
Puff 
Usual care Six weekly 
sessions 
Public health 
nurse 
Social 
Cognitive 
Theory 
Hospital visits, 
school absence, 
restricted activity, 
unplanned GP or 
hospital visit, 
HRQoL, 
withdrawal 
               
               
Clark 2004 Cluster parallel 
RCT 
High schools in 
Detroit 
835 Grade 
2 to 5 
98% African-
American 
45% 
<$15k  
None Asthma 
only 
Open Airways 
for Schools 
Usual care Six weekly 
sessions 
None None School absence, 
symptoms 
               
               
               
Clark 2005 Cluster parallel 
RCT 
Elementary 
schools in 
Beijing 
639 7-11 
years 
None None None Asthma 
only 
Open Airways 
for School 
Usual care Five 
weekly 
sessions 
Teachers Social 
Cognitive 
Theory 
Hospital 
admission, 
hospital visits 
               
               
               
               
               
Clark 2010 Cluster parallel 
RCT 
Middle schools 
in Detroit 
1292 Mean 
age 
11.6 
93% African-
American 
44%-
50% 
<15k 
48% 
female 
Asthma 
only 
Open Airways 
for School 
Usual care Six weekly 
sessions 
Graduate 
students and 
community 
leaders 
None Symptoms 
 
 
 
 
 
               
               
Gerald 2006 Parallel group Elementary 
schools 
736 Grade 
1-4 
97% Black None 5% male 
control 
None Open Airways 
for School 
Usual care Six weekly 
sessions 
Teachers and 
study 
personnel 
None Hospital 
admissions, 
hospital visit, 
school absence 
 
Gerald 2009 Parallel group None 290 Mean 
age 
11.0 
91% Black None 57% male Asthma 
only 
Asthma 
education 
(unspecified) 
Usual care Single 
session 
Study 
personnel 
None School absence, 
lung function, use 
of reliever 
therapy, 
withdrawal 
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Henry 2004 Cluster parallel 
RCT 
Secondary 
schools 
Australia 
4475 13-14 
years 
Majority 
Caucasian 
None 52% male None Asthma 
education 
(unspecified) 
Usual care Three 
lessons 
Teacher None HRQoL 
               
               
Horner 2008 Cluster parallel 
RCT 
Elementary 
schools 
183 Mean 
age 
8.78 
 
47% Mexican None 108 males None Asthma self-
management 
plan 
Health 
education 
16 sessions Health 
educators 
Theoretical 
Model of 
Asthma  
Hospital 
admissions, 
withdrawal 
Horner 2015 Cluster parallel 
RCT 
Elementary 
schools in 
Texas 
292 Mean 
age 8.8 
60.8% 
Hispanic 
30% 
low 
SES 
60% male Asthma 
only 
Asthma Plan for 
Kids 
Health 
education 
16 sessions 
over 5 
weeks 
Health 
educators 
Theoretical 
Model of 
Asthma 
Hospital 
admissions, 
hospital visits, 
withdrawal 
 
 
Howell 2005 Cluster parallel 
RCT 
Syracuse 
Elementary 
Schools 
25 8-11 
Years 
75% African-
American 
None 63% Male Asthma 
only 
Quest for the 
Code 
Usual care 4 Lessons Computer 
Programme 
Learning 
Theory 
None 
Kintner 2009 Cluster parallel 
RCT 
Schools in 
Michigan 
66 Mean 
age 
10.5 
32% African-
American 
None 52% male Asthma 
only 
Staying 
Healthy-Asthma 
Responsible and 
Prepared 
 
Usual care 10 sessions None Lifespan 
Development 
HRQoL, 
withdrawal 
Levy 2006 Cluster parallel 
RCT 
Elementary 
schools in 
Memphis 
243 6-10 
years 
98% African-
American 
83% 
TennCa
re 
58% male None Open Airways 
for School 
Usual care Weekly 
sessions 
School nurse None Hospital 
admissions, 
hospital visits, 
withdrawal 
               
McCann 2006 Cluster parallel 
RCT 
Primary schools 
in England 
219 7-9 
years 
None 20% 
low 
SES 
122 males Asthma and 
non-asthma 
Asthma 
education 
(unspecified) 
Health 
education 
One session School nurse None None 
               
McGhan 
2003 
Cluster parallel 
RCT 
Elementary 
schools in 
Canada 
162 5-13 
years 
77.8% White None 59.2% 
male 
Asthma 
only 
Roaring 
Adventures of 
Puff 
Usual care Six weekly 
sessions 
Nursing and 
pharmacy 
students 
Social 
Cognitive 
Theory 
Hospital visits, 
school absence, 
unplanned GP or 
hospital visit, 
symptoms, 
withdrawal 
               
McGhan 
2010 
Cluster parallel 
RCT 
Elementary 
schools in 
Canada 
162 7-12 
years 
78% 
Caucasian 
None 60% male Asthma 
only 
Roaring 
Adventures of 
Puff 
Usual care Six weekly 
sessions 
Nursing and 
pharmacy 
students 
Social 
Cognitive 
Theory 
Hospital visits, 
school absence, 
unplanned GP or 
hospital visit, 
symptoms, 
withdrawal 
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Monforte 
2012 
Cluster parallel 
RCT 
Elementary 
schools 
90 Grade 
3 to 6 
None None None Asthma 
only 
Open Airways 
for Schools 
None None None None HRQoL 
               
Mosnaim 
2011 
Cluster parallel 
RCT 
Elementary 
schools in 
Chicago 
552 5-10 
years 
Majority 
African-
American 
None 43% 
female 
None Individual 
asthma 
education 
Usual care Four daily 
sessions 
Asthma 
educators 
None None 
 
 
 
               
Patterson 
2005 
Cluster parallel 
RCT 
Primary schools 
in Belfast 
176 Mean 
age 9.0 
None 27% 
low 
SES 
50% male None Asthma 
education 
(unspecified) 
Usual care 8-weekly 
sessions 
School nurse PRECEDE 
model 
Restricted 
activity, lung 
function, HRQoL, 
withdrawal 
 
Persaud 1996 Parallel group 
RCT 
Schools in 
Texas 
36 Mean 
age 
10.2 
69% African-
American 
69% 
low 
SES 
64% male Asthma 
only 
Asthma 
education 
(unspecified) 
Usual care 3 lessons School nurse None Hospital visits, 
school absences 
               
Praena-
Crespo 2010 
Cluster parallel 
RCT 
High schools 3827 13-14 
years 
None None Mixed Asthma and 
non-
asthmatic 
Asthma 
education 
(unspecified) 
None 3 lessons Teacher None None 
               
Pulcini 2007 Cluster parallel 
RCT 
Middle schools  40 Grade 
6-8 
None None None None Peak flow 
education 
Usual care 2 weeks’ 
daily 
School nurse None None 
               
Shah 2001 Cluster parallel 
RCT 
High schools in 
Tamworth 
272 Years 
7-10 
None None Majority 
female 
69%-80% 
asthmatic 
Asthma 
education 
(unspecified) 
Usual care None Peers None Symptoms, lung 
function, HRQoL, 
withdrawal 
 
Splett 2006 Cluster parallel 
RCT 
K-8 schools in 
Minneapolis 
1561 None 66% African-
American 
73% 
low 
SES 
58% male None Asthma 
education 
(unspecified) 
Usual care None School nurse None School absences, 
unplanned GP or 
hospital visit 
 
Srof 2012 Parallel group 
RCT 
High schools 39 Mean 
age 
15.7 
None None 11 females None Asthma diary 
and coping 
skills 
Usual care Daily 
sessions for 
5 weeks 
PI Health 
Promotion 
Model 
None 
               
Velsor-
Friedrich 
Cluster parallel 
RCT 
Elementary 
schools 
73 Mean 
age 10  
100% 
African-
American 
None 50% male Asthma 
only 
Open Airways 
for schools 
Usual care 6 group 
sessions 
PI and nurse  Self-Care 
Deficit 
Theory 
Hospital visits, 
symptoms, lung 
function 
Table 27. Characteristics of included studies: Outcome Evaluation 
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 Methods Intervention Participants Intervention Outcomes Notes 
Author Design Unit of 
Allocation 
Process 
Evaluation 
Methods 
Country Age Characteristics Asthma 
Status 
Recipients School Description Control Theoretical 
Framework 
Core 
Processes 
Evaluated 
Process 
Evaluation 
Category 
Breadth 
or Depth 
Child’s 
Voice  
Al-Sheyab 
(2012) 
Case 
study 
n/a Unstructured 
analysis 
Jordan 7-11 
years 
None None Children High Triple A n/a None, but 
based on 
development 
stages and 
peer impact 
 
None Standalone Neither 
broad or 
deep 
Featured, 
but not 
sufficient 
 
Berg (2004) Quasi; 
post-
test 
n/a Descriptive/ 
bivariate 
(surveys), 
thematic or 
grounded 
theory 
 
USA 15-18 
years 
46.2% African-
American 
Asthma 
only 
Children High Power 
Breathing, 
individual 
coaching 
n/a Social 
Learning 
Theory 
Attrition, 
adherence 
Integrated Neither 
broad or 
deep 
Sufficient 
Bignall 
(2015) 
RCT 
Parallel 
Group 
Child Descriptive/ 
bivariate 
(quantitative) 
and 
descriptive 
(qualitative) 
 
USA 12-17 
years 
100% African-
American 
Asthma 
only 
Children High Single 
workshop for 
children 
Non-
equivalent 
None Attrition, 
dosage, 
adherence 
Named 
section 
Neither 
broad or 
deep 
Featured, 
but not 
sufficient 
 
Brasler 
(2006) 
Case 
study 
n/a Univariate 
analysis 
USA 11-13 
years 
None Asthma 
only 
Children Junior/ 
Middle 
Power 
Breathing 
n/a None Attrition, 
dosage, 
adherence 
Named 
section 
Breadth 
and 
depth 
Featured, 
but not 
sufficient 
 
Bruzzese 
(2004) 
RCT 
Parallel 
Group 
Child Descriptive/ 
bivariate 
(quantitative) 
USA 14-16 
years 
None Asthma 
only 
Children High Open Airways 
for School 
(OAS), 
Academic 
Detailing 
 
Usual care Self-
Regulation 
Theory 
Attrition, 
adherence 
Standalone Neither 
broad or 
deep 
Sufficient 
Bruzzese 
(2008) 
RCT 
Parallel 
Group 
Child Descriptive/ 
bivariate 
USA Mean: 
12.9 
years 
41% Hispanic Asthma 
only 
Children 
and 
parents 
Junior/ 
Middle 
OAS, ASMA, 
Caregiver 
education 
Usual care Social 
Cognitive 
Theory 
Attrition, 
dosage, 
adherence 
Named 
section 
Neither 
broad or 
deep 
Featured, 
but not 
sufficient 
 
Bruzzese 
(2010) 
RCT 
Parallel 
Group 
Child Descriptive/ 
bivariate and 
multivariate 
USA 14-16 
years 
45.51% 
Hispanic; 75% 
free school 
meals (FSM) 
Asthma 
only 
Children High ASMA, 
Academic 
Detailing 
Usual care Social 
Cognitive 
Theory 
Attrition, 
dosage, 
adherence 
Integrated Neither 
broad or 
deep 
Featured, 
but not 
sufficient 
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Carpenter 
(2016) 
Quasi; 
pre-
post 
n/a Descriptive/ 
bivariate 
USA 7-17 
years 
72% Non-
Hispanic White 
Asthma 
only 
Children 
and nurses 
All Multiple 
session 
workshops 
for children 
n/a Thematic 
Grounded 
Theory 
Adherence Named 
section 
Neither 
broad or 
deep 
Sufficient 
 
 
 
 
Cicutto 
(2013) 
Cluster 
RCT 
School Descriptive/ 
bivariate 
Canada 8 years 25% deprived Asthma 
only 
Children 
with 
asthma and 
the broader 
community 
of schools 
Primary Roaring 
Adventures of 
Puff (RAP) 
Usual care Social 
Cognitive 
Theory 
Attrition Standalone 
and 
Integrated 
(two 
papers) 
Breadth, 
not 
depth 
Not 
featured 
Crane 
(2014) 
Quasi; 
pre- 
post 
School Quantitative USA 8-12 
years 
None Asthma 
only 
Children Primary Modified OAS OAS 
(standard) 
Piaget’s 
educational 
theory 
Attrition, 
dosage 
Standalone Depth, 
not 
breadth 
Featured, 
but not 
sufficient 
 
Dore-Stites 
(2007) 
Quasi; 
pre-
post 
n/a Descriptive/ 
bivariate 
(hypothesis 
testing) 
USA 5-10 
years 
39% African-
American; 
34.6% low 
income family 
Asthma 
only 
Children 
and 
parents 
Primary OAS, Quest 
for the Code, 
Materials for 
parents 
 
n/a None Attrition Integrated Neither 
broad or 
deep 
Sufficient 
coverage 
Engelke 
(2013) 
Quasi; 
pre-
post 
n/a Bivariate USA Grades 
1-12 
40.6% 
Caucasian; 
63.6% Medicaid 
Asthma 
only 
Children, 
teachers, 
parents, 
nurses 
All Case 
management, 
additional 
nurse 
meetings, 
multiple 
session 
workshop for 
children and 
staff 
 
n/a None None Named 
section 
Depth, 
not 
breadth 
Not 
featured 
Gerald 
(2006) 
Cluster 
RCT 
School Descriptive/ 
bivariate 
(hypothesis 
testing) 
USA 6-10 
years 
97% African-
American 
Asthma 
only 
Children 
and 
teachers 
Primary OAS, 
integrated 
into 
curriculum, 
multiple 
session 
workshop for 
children and 
staff 
 
Usual care None Attrition, 
dosage, 
adherence 
Named 
section 
Neither 
broad or 
deep 
Not 
featured 
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Henry 
(2004) 
Cluster 
RCT 
 
 
 
School Descriptive/ 
bivariate 
Australia 13-14 
years 
Predominantly 
Caucasian 
Asthma 
and non-
asthma 
Children 
and 
teachers 
High Multiple 
session 
workshop for 
children 
Usual care None Adherence Integrated Depth, 
not 
breadth 
Featured, 
but not 
sufficient 
Horner 
(2015) 
Cluster 
RCT 
School Multivariate 
(latent class 
analysis) 
USA Grades 
2-5 
21.2% African-
American; 
30.7% lower 
SES 
Asthma 
only 
Children Primary Multiple 
session 
workshop for 
children 
(asthma plan) 
 
Equivalent Theoretical 
Model of 
Asthma Self-
management 
 
Attrition, 
adherence 
Integrated Neither 
broad or 
deep 
Featured, 
but not 
sufficient 
Howell 
(2005) 
Cluster 
RCT 
School Descriptive/ 
bivariate 
USA 8-11 
years 
75% African-
American 
Asthma 
only 
Children 
and 
parents 
Primary Quest for the 
Code 
Usual care Learning 
Theory 
Principles and 
Behaviour 
modification 
Attrition, 
dosage, 
adherence 
Named 
section 
Neither 
broad or 
deep 
Featured, 
nut not 
sufficient 
Jackson 
(2006) 
Quasi; 
pre-
post 
n/a Descriptive/ 
bivariate 
USA 8-9 
years 
None Asthma 
and non-
asthma 
Children Primary Single 
workshop for 
children 
 
n/a None Attrition, 
dosage, 
adherence 
Integrated Breadth, 
not 
depth 
Sufficient 
Joseph 
(2010) 
Parallel 
Group 
RCT 
Child Multivariate 
(logistic 
regression) 
USA Mean: 
15.3 
years 
52% eligible for 
FSM 
Asthma 
only 
Children High Puff City, 
multiple 
session 
workshop for 
children 
Equivalent None Attrition, 
dosage, 
adherence 
Standalone 
and 
Integrated 
(two 
papers) 
 
Breadth 
and 
depth 
Featured, 
but not 
sufficient 
Joseph 
(2013) 
Parallel 
Group 
RCT 
Child Multivariate 
(logistic 
regression) 
USA Mean: 
15.9 
years 
98% African-
American; 73% 
Medicaid 
Asthma 
only 
Children High Puff City Equivalent Behaviour 
Theory, 
Health Belief 
Model, 
Attribution 
Theory, 
Motivational 
Interviewing 
 
Attrition, 
dosage, 
adherence 
Standalone 
and 
Integrated 
(two 
papers) 
Breadth 
and 
depth 
Featured, 
but not 
sufficient 
Kintner 
(2012) 
Quasi, 
pre-
post 
n/a Descriptive/ 
bivariate 
USA 6-7th 
Grade 
53.6% African-
American; 
35.7% lower 
SES 
Asthma 
only 
Students, 
members 
of social 
network 
High SHARP, 
community 
coalition 
component 
n/a Asthma 
model and 
lifespan 
development 
 
Dosage, 
adherence 
Standalone Breadth 
and 
depth 
Sufficient 
178 
 
Kouba 
(2012) 
Quasi, 
pre-
post 
n/a Descriptive/ 
bivariate 
USA 9-12th 
Grade 
92% African-
American 
Asthma 
only 
Children High Quest for the 
Code, FAN, 
nurse 
meetings, 
single 
workshop for 
staff, multiple 
workshops 
for children 
n/a Orem’s Self-
Care 
Deficient 
Theory 
Attrition, 
dosage 
Integrated Depth, 
not 
breadth 
Not 
featured 
Langenfeld 
(2010) 
Quasi, 
pre-
post 
n/a Bivariate, 
thematic/ 
grounded 
theory 
USA 5-10 
years 
63% African-
American; 
majority eligible 
for FSM 
Asthma 
only 
Children 
and 
teachers 
Primary OAS, case 
management, 
standalone 
respiratory 
therapy, 
multiple 
session 
workshops 
for children 
 
n/a None Dosage Standalone Depth, 
not 
breadth 
Not 
featured 
Lee (2011) Quasi, 
pre-
post 
n/a Descriptive/ 
bivariate, 
narrative 
data analysis,  
 
USA 8-11 
years 
None Asthma 
only 
Children Primary OAS n/a Thematic/ 
grounded 
theory 
None Integrated Neither 
broad or 
deep 
Featured, 
but not 
sufficient 
Levy (2006) Cluster 
RCT 
School Descriptive/ 
bivariate 
(hypothesis 
testing 
included) 
 
USA 6-10 
years 
Over 97% 
African-
American; over 
80% Medicaid 
Asthma 
only 
Children 
and 
teachers 
Primary OAS, case 
management, 
teacher 
education 
Usual care None Attrition Integrated Breadth, 
not 
depth 
Not 
featured 
Magzamen 
(2008) 
Quasi, 
pre-
post 
n/a Descriptive/ 
bivariate 
 
 
 
 
USA 11-16 
years 
None Asthma 
only 
Children 
and 
teachers 
Junior/ 
Middle 
and High 
Kickin’ 
Asthma 
n/a None Attrition, 
dosage, 
adherence 
Standalone 
and Named 
Section 
(two 
papers) 
Depth, 
not 
breadth 
Not 
featured 
Mickel 
(2016) 
Quasi, 
pre-
post 
n/a Descriptive/ 
bivariate, 
descriptive 
qualitative 
analysis 
 
USA Mean: 
9.3 
years 
63.6% African-
American 
Asthma 
only 
Children Primary Iggy, single 
workshop for 
children 
n/a None Attrition, 
dosage, 
adherence 
Named 
section 
Breadth 
and 
depth 
Sufficient 
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Mujuru 
(2011) 
Quasi, 
pre-
post 
n/a Descriptive/ 
bivariate 
USA Grades 
3-5 
39% Medicaid Asthma 
only 
Children 
and 
parents 
Primary OAS n/a None Attrition Integrated Breadth 
and 
depth 
Featured, 
but not 
sufficient 
 
 
 
 
Pike (2011) Quasi, 
pre-
post 
Class Descriptive/ 
bivariate 
(hypothesis 
testing) 
USA 9-11 
years 
81% control 
and 69% 
intervention 
African-
American; 78% 
intervention 
and 86% 
control FSM 
 
Asthma 
and non-
asthma 
Children 
and 
teachers 
Primary Multiple 
session 
workshop for 
children 
Usual care None Dosage Standalone Depth, 
not 
breadth 
Not 
featured 
Richmond 
(2011) 
Quasi, 
pre-
post 
n/a Descriptive/ 
bivariate 
USA 5-10 
years 
100% African-
American, 80% 
FSM 
Asthma 
only 
Children Primary Breathe Your 
Best 
n/a None Attrition, 
adherence 
Standalone Neither 
broad or 
deep 
 
Not 
featured 
Spencer 
(2000) 
Quasi, 
pre-
post 
n/a Descriptive/ 
bivariate 
USA 6-13 
years 
34% FSM Asthma 
only 
Children 
and 
parents 
Primary OAS n/a None Adherence Integrated Neither 
broad or 
deep 
 
Not 
featured 
 
 
 
 
 
Splett 
(2006) 
Cluster 
RCT 
School Multivariate 
for school 
absence, 
narrative 
otherwise 
USA None 66% African-
American; 73% 
eligible for FSM 
Asthma 
only 
Children, 
with 
component 
of 
enhanced 
training for 
school 
health staff 
All Multiple 
session 
workshop for 
staff, school 
nurse 
education 
 
 
 
Usual care None None Standalone, 
Named 
section 
(two 
papers) 
Neither 
broad or 
deep 
Not 
featured 
Terpstra 
(2012) 
Quasi, 
pre-
post 
School Multivariate USA Mean: 
12 
years 
44% 
intervention 
56% control 
Latino; income 
<$20,000 
Asthma 
only 
Children 
and 
parents 
Junior 
/Middle 
Multiple 
workshops 
for children, 
materials for 
parents 
Equivalent Social 
Cognitive 
Theory 
Attrition, 
dosage, 
adherence 
Integrated Neither 
broad or 
deep 
Not 
featured 
Table of 28. Characteristics of included studies: Process Evaluation 
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Study Type of Study Approach* Process Evaluation Elements 
Al-Sheyab 2012 Feasibility Qualitative Thematic analysis of student 
perceptions 
Berg 2004 Outcome and process 
evaluation 
Mixed Thematic analyses of student 
perceptions 
Bignall 2015 Feasibility Mixed Thematic analyses of student 
perceptions 
Brasler 2006 Feasibility/case study of 
implementation 
Quantitative 
data and trialists 
reports 
Implementation challenges and 
facilitators identified 
Bruzzese 2004 Feasibility Mixed Section evaluating the intervention 
reach, dosage and student 
satisfaction 
Bruzzese 2008 Feasibility Mixed Standalone section on process 
evaluation results assessing 
implementation and student 
perceptions 
Bruzzese 2011 Outcome evaluation with 
section of process 
evaluation 
Quantitative Section evaluating the intervention 
reach (dosage) 
Carpenter 2016 Outcome and process 
evaluation 
Mixed Thematic analyses of student 
perceptions 
Cicutto 2013 Outcome and process 
evaluation 
Mainly 
quantitative 
In addition to information on other 
processes of interest, provides a 
description of wider school support 
through policy changes 
Crane 2014 Feasibility Quantitative Represented an implementation 
study through a focus on the impact 
of changing dosage schedule 
Dore-Stites 
2007 
Feasibility Quantitative In addition to information on other 
processes of interest, provides 
information on student satisfaction 
Engelke 2013 Feasibility Quantitative Detailed process/implementation 
information provided 
Gerald 2006 Outcome and process 
evaluation 
Mainly 
quantitative 
In addition to information on other 
processes of interest, provides a 
description of implementation 
challenges 
Henry 2004 Outcome and process 
evaluation 
Mainly 
quantitative 
In addition to information on other 
processes of interest, provides a 
description of wide school support 
through policy changes and an 
assessment of sustainability 
Horner 2015 Outcome evaluation with 
process evaluation 
information 
Quantitative Includes detailed information on 
attrition and cost-effectiveness 
Howell 2005 Outcome and process 
evaluation 
Quantitative In addition to information on other 
processes of interest, provides 
information on student satisfaction 
Jackson 2006 Outcome evaluation with 
process evaluation 
information 
Quantitative In addition to information on other 
processes of interest, provides 
information on student satisfaction 
Joseph 2010 Outcome and process 
evaluation 
Quantitative In addition to information on other 
processes of interest, provides 
detailed information on non-
adherence 
Joseph 2013 Outcome and process 
evaluation 
Quantitative Included detailed studies of non-
adherence and the relationship with 
student characteristics 
Kintner 2012 Feasibility Quantitative In addition to information on other 
processes of interest, provides 
information on student satisfaction 
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Kouba 2012 Outcome evaluation with 
process evaluation 
information 
Quantitative In addition to information on other 
processes of interest, provides 
detailed information on dosage 
Langenfeld 
2010 
Implementation Quantitative In addition to information on other 
processes of interest, provides 
detailed information on dosage 
Lee 2011 Implementation Qualitative In addition to information on other 
processes of interest, provides 
detailed information on instructor 
experiences 
Levy 2006 Outcome evaluation with 
process evaluation 
information 
Quantitative In addition to information on other 
processes of interest, provides 
information on parental adherence 
to intervention protocol 
Magzamen 2008 Outcome evaluation with 
process evaluation 
information 
Quantitative In addition to information on other 
processes of interest, provides 
information on attrition 
McCann 2006 Outcome evaluation with 
process evaluation 
information 
Quantitative In addition to information on other 
processes of interest, provides 
information on teachers 
adherence/school-level 
commitment 
Mickel 2016 Outcome and process 
evaluation 
Mixed Thematic analyses of student 
perceptions 
Mujuru 2011 Outcome and process 
evaluation 
Mainly 
quantitative 
In addition to information on other 
processes of interest, provides a 
description of parental satisfaction 
Pike 2011 Outcome and process 
evaluation 
Mainly 
quantitative 
In addition to information on other 
processes of interest, provides 
information on teachers 
adherence/school-level 
commitment 
Richmond 2011 Outcome and process 
evaluation 
Mainly 
quantitative 
Includes detailed information on 
adherence and awareness 
Spencer 2000 Outcome and process 
evaluation 
Quantitative In addition to information on other 
processes of interest, provides 
information on instructor 
satisfaction and school-level 
commitment 
Splett 2006 Outcome and process 
evaluation 
Quantitative In addition to information on other 
processes of interest, provides 
information on adherence and 
school-level commitment 
Terpstra 2012 Outcome and process 
evaluation 
Quantitative In addition to information on other 
processes of interest, represents an 
implementation study through a 
focus on the impact of parental 
involvement/increasing parental 
awareness 
*Mixed = Qualitative and Quantitative 
Table 29. Included process evaluation studies: Methodological characteristics and processes described 
Results of the search 
The first search was conducted in April 2015, and an update search was performed in April 2016. 
Further searches were conducted in August 2017. Using EPPI-Reviewer software, duplicate 
studies were identified and removed. Further duplicate studies were identified during the 
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screening process. The searches for the process evaluation studies were conducted by two 
members of the review team. The search for the outcome evaluation studies was conducted by the 
Cochrane trials coordinator, Liz Stovold. After de-duplication, 29,384 titles and abstracts of 
potential process evaluation studies were screened; 350 title and abstracts were screened for 
eligibility as outcome evaluations. Following application of inclusion criteria on title and abstract, 
the remaining 1066 full-text process evaluation records, and 105 full-text outcome evaluation 
records were assessed independently for eligibility for inclusion. Fifty-four papers, from thirty-
three different process evaluation studies were included for further analysis; forty-four papers 
from thirty-three outcome evaluation studies were also included.  
Included Studies 
There was little overlap between the studies included in both the process evaluation and outcome 
evaluation analyses (n = 11 [95, 187, 190, 194, 196, 209-214]). However, Bruzzese 2004 [209] 
and McCann 2006 [187] did not contribute data to the meta-analyses.   
Characteristics of Process Evaluation Studies 
Nine studies included evaluations of the effectiveness of Open Airways for Schools (OAS) 
interventions, or modifications to this programme. OAS includes six 40-minute sessions, aimed 
at groups of children aged 8-11, who learn different topics including general information about 
asthma, how to recognise and manage asthma symptoms, and problem solving and decision-
making about asthma medication. Other intervention models described included Power Breathing, 
Staying Healthy-Asthma Responsible and Prepared (SHARP), and Asthma Self-Management for 
Adolescents (ASMA), although these were common to no more than two included studies.  
Across all studies, a diverse curriculum was taught. While most studies mentioned that the 
intervention developing knowledge and skills around asthma physiology and the monitoring and 
treatment of symptoms, fewer studies explicitly mentioned that they aimed to develop alliances 
between children/parents and their care provider(s), although a greater number did involve parents 
in the intervention in other ways. Most interventions were reliant on trialists, research staff, and 
others from outside schools to deliver the intervention, however some interventions were 
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primarily delivered, or supported, pivotally, by school nurses [196, 214-217], teachers [211, 218, 
219], or peers [217].    
Five of the studies evaluated implementation of interventions involving delivery of self-
management education in part or mainly through electronic games or training provided through 
computers [212, 220-223]. In two of these interventions [220, 221] the information provided was 
tailored to students based on their input. In total, nine interventions had components where content 
was tailored towards the needs of an individual child, either through being delivered on a one-to-
one basis or through delivering personalised content.  
Most of the studies took place in the USA (n = 29), and several of these studies explicitly 
mentioned that the intervention took place within an urban or inner city area, or explicitly made 
reference to the diverse socioeconomic or ethnic background. In contrast, two studies specifically 
explored implementation in rural areas [190, 219]. Fewer studies took place in high schools (n = 
14), compared with junior, middle, or elementary/primary schools.  
Twenty-one studies collected data before and after the evaluation. Four studies collected post-test 
data only [189, 207, 209, 224]. Several studies collected data immediately after the intervention 
or within three-months of the intervention ending. The longest follow-up data collection was 12-
months post-test [95, 187, 190, 194, 220, 221]. In fewer studies, the follow-up duration was 
unclear [189, 207, 214-216, 222, 225]. 
Evidence that attrition was not problematic was shown in 18 studies. Attrition was substantial in 
five studies [189, 209, 213, 214, 217], with levels of attrition exceeding over 20% and/or reported 
by the trial authors as substantial challenge.  
Pupil adherence was reported in 21 studies. Evidence that pupil adherence was not problematic 
was seen in 14 studies. Evidence that adherence was not problematic among other stakeholders 
was highlighted in six studies [95, 186, 194, 196, 221, 226]. Pupil adherence was problematic in 
eight studies [189, 212, 213, 217, 220, 223, 227, 228]; these judgements were based on reports 
from authors, as well as on reports of completion rates of intervention modules and/or completion 
of evaluation instruments.  
Participants received the intended dose of the intervention in nine studies [95, 184, 186-188, 218, 
221, 225, 226]. In one study, a dose-response relationship was seen [223]. In seven studies, the 
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intended dose was not achieved [210, 212, 213, 215, 217, 220, 227], with many children not 
receiving the intervention. In one study [213], this was based on reports of a shortening of 
sessions. In another study where parental involvement was an integral component, additional 
problems in dosage received were reported for caregivers [210]. In one study comparing an 
individualised intervention model compared to a generic intervention model [220], the 
individualised model had higher levels of dosage, however both models had fairly low levels of 
completion of all modules.  
Further details of the inclusion criteria for all process evaluation studies is shown in table 28.   
Characteristics of Outcome Evaluation Studies 
Most of the studies took place in the USA (n = 22), and few studies took place in high schools (n 
= 8), compared with junior, middle, or elementary/primary schools. There was substantial 
variation in the intervention model, however nine studies included evaluations of the effectiveness 
of the OAS, or modifications to this model. There was also variation in the way in which the 
interventions were delivered. Children received long programmes of sessions in some 
interventions, with 16 sessions delivered in two studies [190, 191], and 10 sessions [226] and 
eight sessions [75] in others. Three interventions delivered a single group session to children [187, 
212, 213], although the interventions were supported by other activities, including nurse visits or 
staff training.  
Outcome data were collected immediately after the intervention or within three months in a 
number of studies [75, 191, 209, 210, 212, 213, 229-234], or appeared to be collected alongside 
the intervention delivery [196]. The longest period between the intervention ending at data 
collection was 36 months [235] and 24 months [236, 237]. Many studies were included on the 
basis of study design, however this did not contribute to the meta-analyses as they did not collect 
the outcomes of interest or did not collect these data in an extractable format (see table 26). 
Primary Outcomes 
Six outcome evaluation studies provided data that assessed exacerbations leading to 
hospitalisations, which were combined in meta-analyses [95, 190, 191, 208, 214, 229]. One study 
also collected this data, however the information was not disaggregated by treatment status [235]; 
185 
 
one further study provided data on median hospitalisations, which could not be included in the 
meta-analyses [213]. Two studies assessed hospitalisations using hospital or school medical 
records [213, 214]; three studies used parent reports [190, 191, 208]; and two studies used child 
reports [95, 229]. Most of the studies collected this outcome data after a substantial period of time 
had elapsed between receipt of the intervention and assessment of the outcome; three studies 
collected this data after 12 months [95, 190, 208] and one study collected this data after seven 
months [191]. The remaining two studies collected this data within three months of the 
intervention.  
Asthma symptoms leading to an emergency department visit were collected in 15 outcomes 
evaluation studies. However, data from Bartholomew et al [235] was not used because it was not 
disaggregated by treatment status. The data from Gerald et al [213] was also not included in the 
meta-analyses as the data collected was not compatible with the rest of the included studies. Three 
studies used school or hospital records to assess emergency department visits [213, 214, 232]. 
One study collected this information using tracking sheets completed by the parents [194] and 
another study used parent interviews [197]. Six further studies using parental self-completion 
questionnaires [190-192, 195, 208, 212]. The Usherwood symptom questionnaire was used in one 
study only [235]. Student asthma diaries were used to collect this data in one study [193]; two 
other studies collected this data from children’s reports [95, 229].  
Most of the studies that collected information on emergency department visits collected the data 
after 12 months had passed since receipt of the intervention [95, 190, 192, 194, 195, 197, 208]. 
One study collected this information after seven months [191]; and 20 weeks in one further study 
[232]. In three studies, this information was collected within three months of the intervention 
[212, 214, 229]. 
Twelve studies assessed school absence or school attendance. Four studies used administrative 
school records to collect this information [196, 213, 232, 235]. Parent/guardian completed 
tracking sheets were used in one study [194] and five studies used parent interviews or 
questionnaires [192, 194, 195, 212, 236]. Tracking sheets completed by school staff were used in 
one further study [238]. Bruzzese et al [95] collected this information directly from the children. 
One study did not present disaggregated data [235] and was therefore not included in this meta-
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analytic model. One additional study [236] presented information on school absences in the form 
of a risk difference, which was not combined in the meta-analyses, although significant 
improvements in school absences were seen at three and 12 months. Of the ten studies that were 
included in the meta-analysis models, seven collected the follow-up data nine months or longer 
after the intervention [95, 192, 194-197, 238]. In two studies, the follow-up data was collected 
after three months or less [196, 232], and in one study this information was unclear [213]. Three 
studies considered any instance of recorded absence from school [192, 194, 195], while the 
remaining studies measured mean number of days of absence. Most of the studies collected data 
on any form of absence; one study [238] collected information on school absences related 
specifically to asthma/respiratory illness.  
Days of restricted activity was reported on in three studies [95, 194, 197]. One study used parental 
recorded tracking sheets/diaries to record days of restricted activity due to asthma [194], one study 
used parent interviews [197] and one study collected this information directly from the children 
[95]. All three studies collected this data at 12 months follow-up. Two studies collected data on 
the mean number of days of restricted activity [95, 197], while one study collected data on any 
instance of a day of restricted activity [194]. 
Secondary Outcomes 
Five studies reported on unplanned visits to a hospital or GP due to asthma symptoms [95, 192, 
194-196]. One study used tracking sheets, completed by parents, to collect this information [194]; 
two studies used parental questionnaires [192, 195], and one study collected this information 
directly from children [95]. Administrative records were used in the final study [196]. 
One study originally collected information on the mean number of unscheduled visits [95], while 
the remaining studies collected information on any instances of unscheduled visits to a medical 
provider. All of the studies collected this data after a substantial amount of time had passed since 
receipt of the intervention. In four studies, this information was collected 9-12 months after the 
intervention [95, 192, 194, 195]; the final study collected this information longitudinally over a 
period of six months [196]. 
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Nine studies collected information on day and night-time symptoms [95, 193, 195, 210, 212, 229, 
233, 236, 237]. The data from two studies [236, 237] were not included in the meta-analyses as 
the data was not compatible with the other units of analysis [236], and due to statistical and 
conceptual differences between post-test and change in post-test outcome data [237]. Among the 
seven studies included in the meta-analysis, five studies reported on incidence of daytime 
symptoms [95, 193, 210, 229, 233]; four studies reported on night-time awakenings [95, 195, 210, 
212]. Two studies reported on both day and night-time symptoms [95, 210]. Four of the studies 
reported on intervention effects between six and 12 months after the intervention [95, 193, 195, 
233]; the remaining studies collected this information two to three months post-intervention. 
There was an even split between those studies reporting on the mean level of asthma 
symptomology occurring in the day/night-time [95, 210, 212, 229], and those focused on 
measuring any reported incidence of day/night-time symptomology [193, 195, 233]. 
Lung function information was collected in five studies [75, 190, 193, 233, 238]. One study [238] 
assessed lung function using peak expiratory flow rate, and focused on the occurrence of poor 
readings. Spirometry was measured in a second study through the measurement of the percentage 
predicted change in forced expiratory volume (FEV) over one second [75]. FEV was also used in 
one further study [233], however this was measured before the use of a bronchodilator. A further 
study [193] measured peak flow increases as a percentage of pre-test peak (e.g. change in peak 
flow), and the final study [190] measured airway inflammation. Due to conceptual differences in 
the outcomes collected, these were not included in the meta-analysis. As shown in table 30, the 
individual effects extracted showed considerable heterogeneity in the direction and magnitude of 
effect. This confirmed that meta-analyses were also not possible due to statistical heterogeneity. 
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Study Indicator Collectio
n Point 
Mean 
Cluster 
Size 
ICC 
Applie
d* 
Data 
Transforma
tion 
Origin
al 
Effect 
Size 
and 
Standa
rd 
Error 
Final or 
Transfor
med 
Effect 
Size and 
Standard 
Error 
Hospitalisations 
Atherly 
2009 
Hospitalisatio
ns in previous 
4 weeks 
3-months 
post-
interventi
on 
45.8 0.05 Transformed 
from OR to 
SMD 
OR 
(0.7736
); SE 
(InOR) 
(1.385) 
SMD (-
0.141); SE 
(0.764) 
Bruzzese 
2011 
Hospitalisatio
ns in the past 
2 months 
12-
months 
post-
interventi
on 
N/A N/A No N/A SMD (-
0.219); SE 
(0.120) 
Clark 
2005 
Hospitalisatio
ns 
12-
months 
post-
interventi
on 
Deeme
d that 
analysi
s 
method
s 
account
ed for 
clusteri
ng 
Deeme
d that 
analysi
s 
method
s 
account
ed for 
clusteri
ng 
Transformed 
from OR to 
SMD 
Or 
(1.43); 
SE 
(InOR 
0.39) 
SMD (-
0.197); SE 
(0.215) 
Gerald 
2006 
Median 
hospitalisation
s [not 
combined] 
N/A N/A N/A N/A N/A N/A 
Horner 
2008 
Any hospital 
stays in 
previous 12 
months 
7-month 
follow-up 
10.1 0.05 Yes – 
Transformed 
from OR to 
SMD 
OR 
(0.882)
; SE 
(InOR) 
(0.791) 
SMD (-
0.069); SE 
(0.436) 
Horner 
2015 
Mean number 
of 
hospitalisation
s since 
previous data 
collection 
12-month 
follow-up 
8.9 0.05 No N/A SMD (-
0.057); SE 
(0.169) 
Levy 2006 Mean hospital 
days 
At end of 
interventi
on 
17.36 0.05 No N/A SMD (-
0.293); SE 
(0.174) 
 
 
 
Emergency Department Visits 
Atherly 
2009 
ED visits in 
previous 4 
weeks 
3-month 
follow-up 
45.8 0.05 No N/A OR 
(1.036); 
SE (InOR) 
(0.916) 
Bruzzese 
2011 
ED visits in 
previous 2 
months 
12-month 
follow-up 
N/A N/A Yes – 
Transformed 
from SMD 
to OR  
SMD (-
0.289); 
SE 
(0.120) 
OR 
(0.592); 
SE (InOR) 
(0.218) 
Cicutto 
2005 
ED visits in 
the past year 
12-month 
follow-up 
9.85 0.05 No N/A OR 
(0.697); 
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SE (InOR) 
(0.407) 
Cicutto 
2013 
ED visits in 
the past year 
12-month 
follow-up 
7.7 0.05 No N/A OR 
(0.318); 
SE (InOR) 
().317) 
Clark 
2005 
ED visits 12-month 
follow-up 
Analysi
s 
account
ed for 
clusteri
ng 
Analysi
s 
account
ed for 
clusteri
ng 
No N/A OR 
(1.002)*; 
SE 
(estimated 
from p-
value 
(InOR)) 
0.072 
Gerald 
2006 
Medina ED 
visits [not 
combined] 
N/A N/A N/A N/A N/A N/A 
Horner 
2008 
ED visits in 
the past year 
7-month 
follow-up 
10.1 0.05 No N/A OR 
(0.857); 
SE (InOR) 
(0.461) 
Horner 
2015 
Mean number 
of ED visits 
since the 
previous data 
collection 
12-month 
follow-up 
8.9 0.05 Yes – 
Transformed 
from SMD 
to OR 
SMD (-
0.331); 
SE 
(0.578) 
OR 
(0.549); 
SE (1.049) 
Howell 
2005 
Mean ED 
visits since 
previous data 
collection 
12-month 
follow-up 
8.9  0.05 No N/A SMD = 0; 
SE = 
0.169 
Levy 2006 Mean ED 
visits 
Duration 
unclear 
17.36 0.05 No N/A SMD = -
0.286; SE 
= 0.174 
McGhan 
2003 
Any ED visits 
in past year 
9-month 
follow-up 
9 0.05 Transformed 
from OR to 
SMD 
OR = 
1.283; 
SE 
(InOR) 
= 0.649 
SMD = 
0.1375; 
SE = 
0.358 
McGhan 
2010 
Any ED visits 
in past year 
12- month 
follow-up 
8.3 0.05 Transformed 
from OR to 
SMD 
OR = 
2.64; 
SE 
(InOR) 
= 0.707 
SMD = 
0.537; SE 
= 0.390 
Persaud 
1996 
ED visits in 
20 weeks 
period post-
intervention 
Post 
interventi
on 
N/A N/A Transformed 
from OR to 
SMD 
OR = 
0.286; 
SE 
(InOR) 
= 0.737 
SMD = -
0.691; SE 
= 0.407 
Velsor-
Friedrich 
2005 
Any urgent 
doctor visits 
in previous 12 
months 
12-month 
follow-up 
13 0.05 Transformed 
from OR to 
SMD 
OR = 
0.683; 
SE 
(InOR) 
= 0.933 
SMD = -
0.252; SE 
= 0.515 
 
 
 
 
School Absences 
Bruzzese 
2011 
Mean absence 
in previous 2 
weeks 
12-month 
follow-up 
N/A N/A No N/A SMD = -
0.382; SE 
= 0.121 
Cicutto 
2005 
Any absence 
over a year 
12-month 
follow-up 
9.85 0.05 No N/A SMD = -
0.256; SE 
– 0.151 
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Cicutto 
2013 
Any absence 
over a year 
12-month 
follow-up 
7.7 0.05 Transformed 
from OR to 
SMD 
OR = 
0.660; 
SE 
(InOR) 
= 0.129 
SMD = -
0.229; SE 
= 0.071 
Gerald 
2006 
Absence 
recorded on 
school records 
Duration 
unclear 
Analysi
s 
method
s 
account
ed for 
clusteri
ng 
Analysi
s 
method
s 
account
ed for 
clusteri
ng 
No N/A SMD = -
0.199; SE 
= 0.084 
Gerald 
2009 
Absence from 
school due to 
asthma/respira
tory illness 
15-month 
follow-up 
N/A N/A Transformed 
from OR to 
SMD 
OR = 
1.1667; 
SE 
(InOR) 
= 0.364 
SMD = 
0.085; SE 
= 0.227 
Howell 
2005 
School days 
missed in 
previous 6 
weeks 
3-month 
follow-up 
3.25 0.05 No N/A SMD = 
0.152; SE 
= 0.635 
McGhan 
2003 
Any missed 
school days in 
previous 12 
months 
 12-month 
follow-up 
8.3 0.05 Transformed 
from OR to 
SMD 
OR = 
0.640; 
SE 
(InOR) 
= 0.353 
SMD = 
0.246; SE 
= 0.195  
McGhan 
2010 
Mean absence 
in previous 2 
weeks 
12-month 
follow-up 
N/A N/A No N/A SMD = -
0.382; SE 
= 0.121 
Persaud 
1996 
Mean school 
absence on 
school records 
Immediat
ely after 
interventi
on 
N/A N/A No N/A SMD = -
0.236; SE 
= 0.335 
Splett 
2006 
Mean 
percentage of 
days attended 
12-month 
follow-up 
Analysi
s 
method
s 
account
ed for 
clusteri
ng 
Analysi
s 
method
s 
account
ed for 
clusteri
ng 
 
 
 
 
No N/A SMD = 
0.019; SE 
= 0.051 
Days of Restricted Activity 
Bruzzese 
2011 
Mean self-
reported days 
of restricted 
activity in 
previous 2 
weeks 
12-month 
follow-up 
N/A N/A No N/A SMD = -
0.349; SE 
= 0.120 
Cicutto 
2005 
Days of 
restricted 
activity due to 
asthma 
12-month 
follow-up 
9.85 0.05 No N/A SMD = -
0.318; SE 
= 0.151 
Cicutto 
2013 
Percentage of 
students 
reporting days 
of restricted 
activity 
12-month 
follow-up 
7.7 0.05 Analysis 
methods 
accounted 
for 
clustering 
OR = 
0.612; 
SE 
(InOR) 
= 0.130 
SMD = -
0.271; SE 
= 0.072 
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Unplanned Visits to Medical Providers 
Bruzzese 
2011 
Mean acute 
care visits in 
the previous 2 
months 
12-month 
follow-up 
N/A N/A Transformed 
from SMD 
ratio to OR 
SMD = 
-0.283; 
SE = 
0.120 
OR = 
0.598; SE 
= 0.217 
Cicutto 
2013 
Unscheduled 
care in the 
past year 
12-month 
follow-up 
7.7 0.05 No OR = 
0.703; 
SE 
(InOR) 
= 0.143 
SMD = -
0.194; SE 
= 0.079 
McGhan 
2003 
Any 
unscheduled 
doctor visits 
9-month 
follow-up 
9 0.05 No OR = 
0.886; 
SE 
(InOR) 
= 0.426 
SMD = -
0.067; SE 
= 0.235 
McGhan 
2010 
Any 
unscheduled 
GP visits over 
previous 12 
months 
12-month 
follow-up 
8.3 0.05 No OR = 
1.169; 
SE 
(InOR) 
= 0.397 
SMD = 
0.086; SE 
– 0.219 
Splett 
2006 
Episodic 
asthma to 
school health 
office 
Over 6 
months 
following 
start of 
interventi
on 
97.6 0.05 No OR = 
0.913; 
SE 
(InOR) 
= 0.282 
SMD = -
0.046; SE 
= 0.156 
Daytime Symptoms 
Atherly 
2009 
Mean days 
with asthma 
symptoms 
3-month 
follow-up 
45.8 0.05 No N/A SMD = -
0.026; SE 
= 0.168 
Bruzzese 
2008 
Mean days 
with 
symptoms in 
previous 2 
weeks 
2-month 
follow-up 
45.8 0.05 No N/A SMD = -
0.026; SE 
= 0.168 
Bruzzese 
2011 
Mean days in 
previous 2 
weeks with 
asthma 
symptoms 
12-month 
follow-up 
N/A N/A No N/A SMD = -
0.210; SE 
= 0.120 
Shah 2001 Number of 
students 
reporting 
attacks in 
school at 
follow-up 
6-month 
follow-up 
41.8 0.05 Transformed 
from OR to 
SMD 
OR = 
0.647; 
SE 
(InOR) 
= 0.488 
SMD = -
0.240; SE 
= 0.269 
Velsor-
Friedrich 
2005 
Symptom 
days in 
previous 2 
weeks 
12-month 
follow-up 
13 0.05 Transformed 
from OR to 
SMD 
OR = 
0.846; 
SE 
(InOR) 
= 0.705 
SMD = -
0.030; SE 
= 0.413 
Night-time Symptoms 
Bruzzese 
2008 
Mean night 
awakenings in 
previous 2 
weeks 
2-month 
follow-up 
N/A N/A No N/A SMD = -
0.433; SE 
= 0.423 
 
Bruzzese 
2011 
Mean self-
reported 
night-time 
awakenings in 
previous 2 
weeks 
12-month 
follow-up 
N/A N/A No N/A SMD = -
0.388; SE 
= 0.121 
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Howell 
2005 
Mean night-
time 
awakenings in 
previous 6 
weeks 
3-month 
follow-up 
4.25 0.05 No N/A SMD = 
0.253; SE 
= 0.478 
McGhan 
2003 
Two or more 
night-time 
awakenings in 
previous 2 
weeks 
9-month 
follow-up 
9 0.05 Transformed 
from OR to 
SMD 
OR = 
1.237; 
SE 
(InOR) 
= 0.412 
SMD = 
0.117; SE 
= 0.227 
 
 
 
 
Use of Reliever Therapies 
Gerald 
2009 
Rescue 
medication 
use over twice 
a week 
15-month 
follow-up 
N/A N/A N/A OR = 
0.228; 
SE 
(InOR) 
= 0.582 
N/A 
McGhan 
2003 
Number of 
students with 
appropriate 
use of reliever 
medication 
9-month 
follow-up 
9 0.05 N/A OR = 
3.48; 
SE 
(InOR) 
= 0.565 
N/A 
McGhan 
2010 
Use of SABA 
in previous 2 
weeks 
12-month 
follow-up 
8.3 0.05 N/A OR = 
0.878; 
SE 
(InOR) 
= 0.356 
N/A 
Splett 
2006 
Students with 
access to 
reliever 
medication 
visiting health 
office 
Over 6 
months 
following 
start of 
interventi
on 
97.6 0.05 N/A OR = 
1.28; 
SE 
(InOR) 
= 0.282 
N/A 
Use of Corticosteroids and/or Add-on Therapies 
Bruzzese 
2011 
Use of 
controller 
medication 
12-month 
follow-up 
N/A N/A No N/A OR = 
1.451; SE 
(InOR) = 
0.240 
Horner 
2015 
ICS 
adherence 
5-month 
follow-up 
8.9 0.05 No N/A SMD = -
0.605; SE 
= 0.173 
Howell 
2005 
ICS 
adherence as 
prescribed 
during 
previous week 
3-month 
follow-up 
4.25 0.05 No N/A SMD = 
0.953; SE 
= 0.546 
McGhan 
2003 
Currently 
using ICS 
9-month 
follow-up 
9 0.05 No N/A OR = 
1.112; SE 
(InOR) = 
0.418 
McGhan 
2010 
Currently 
using ICS 
12-month 
follow-up 
8.3 0.05 No N/A OR = 
0.962; SE 
(InOR) = 
0.376 
Splett 
2006 
Students with 
controller 
medication 
visiting health 
office 
Over 6 
months 
following 
start of 
interventi
on 
97.6 0.05 N/A OR = 
1.703; 
SE 
(InOR) 
= 0.806 
SMD = 
0.293; SE 
= 0.445 
Lung Function 
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Gerald 
2009 
Poor peak 
flow measures 
(red/amber 
readings) 
15-month 
follow-up 
N/A N/A No 
 
OR = 
0.94; 
SE 
(InOR) 
= 0.334 
OR = 
0.94; SE 
(InOR) = 
0.334 
Horner 
2015 
Airway 
inflammation 
12-month 
follow-up 
8.9 0.05 No N/A SMD = -
0.011; SE 
= 0.169 
Shah 2001 FEV1: FVC 
before 
bronchodilato
r 
3-month 
follow-up 
Analysi
s 
method
s 
account
ed for 
clusteri
ng 
Analysi
s 
method
s 
account
ed for 
clusteri
ng 
No N/A SMD = 
0.074; SE 
= 0.127 
Patterson 
2005 
FEV1 
(percentage 
predicted 
change) 
2-month 
follow-up 
Analysi
s 
method
s 
account
ed for 
clusteri
ng 
Analysi
s 
method
s 
account
ed for 
clusteri
ng 
No N/A SMD = -
0.05; SE = 
0.177 
Velsor-
Friedrich 
2005 
Peak flow 
increases as a 
percentage of 
pre-test peak 
flow (change) 
12-month 
follow-up 
13 0.05 No N/A SMD = -
5.905; SE 
= 0.839 
Health-Related Quality of Life 
Al-Sheyab 
2012 
Arabic 
PAQLQ 
3-month 
follow-up 
Analysi
s 
method
s 
account
ed for 
clusteri
ng 
Analysi
s 
method
s 
account
ed for 
clusteri
ng 
No N/A SMD = 
0.299; SE 
= 0.129 
Cicutto 
2005 
Juniper 
PAQLQ 
overall QoL 
2-month 
follow-up 
9.85 0.05 No N/A SMD = 
0.356; SE 
= 0.151 
Cicutto 
2013 
Juniper 
PAQLQ 
overall QoL 
12-month 
follow-up 
7.7 0.05 No N/A SMD = 
0.308; SE 
= 0.064 
Henry 
2004 
Juniper 
PAQLQ 
overall QoL 
6-month 
follow-up 
15.2 0.05 No N/A SMD = 
0.128; SE 
= 0.114 
Horner 
2008 
Juniper 
PAQLQ 
overall QoL 
7-month 
follow-up 
10.2 0.05 No N/A SMD = 
0.083; SE 
– 0.196 
 
Howell 
2005 
Juniper 
PAQLQ 
overall QoL 
3-month 
follow-up 
6 0.05 No N/A SMD = 
0.020; SE 
= 0.484 
Kintner 
2009 
Participation 
in life 
activities 
scale 
Immediat
ely post-
interventi
on 
Analysi
s 
method
s 
account
ed for 
clusteri
ng 
Analysi
s 
method
s 
account
ed for 
clusteri
ng 
No N/A SMD = 
0.583; SE 
= 0.263 
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Patterson 
2005 
Change in 
Juniper 
PAQLQ 
overall QoL 
Change in 
QoL 
between 
baseline 
and 4 
months 
post-
interventi
on 
Analysi
s 
method
s 
account
ed for 
clusteri
ng 
Analysi
s 
method
s 
account
ed for 
clusteri
ng 
No N/A SMD = 
0.064; SE 
= 0.152 
Shah 2001 Juniper 
PAQLQ 
overall QoL; 
percentage of 
students with 
clinically 
significant 
improvements 
3-month 
follow-up 
Analysi
s 
method
s 
account
ed for 
clusteri
ng 
Analysi
s 
method
s 
account
ed for 
clusteri
ng 
No N/A SMD = 
0.470; SE 
= 0.187 
Withdrawal 
Al-Sheyab 
2012 
Withdrew 
between 
baseline and 
outcome 
collection 
3-month 
follow-up 
65.25 0.05 No N/A OR = 
0.511; SE 
(InOR) = 
1.074 
Bartholo
mew 2006 
Lost to 
follow-up at 
post-test 
Duration 
unclear 
11.2 0.05 No N/A OR = 
0.237; Se 
(InOR) = 
0.145 
Bruzzese 
2008 
Withdrew 
between 
baseline and 
outcome 
collection 
Immediat
ely post-
interventi
on 
N/A N/A No N/A OR = 
0.307; SE 
(InOR) = 
1.683 
Bruzzese 
2011 
Withdrew 
between 
baseline and 
outcome 
collection 
12-month 
follow-up 
N/A N/A No N/A OR = 
1.313; SE 
(InOR) = 
0.279 
Cicutto 
2005 
Withdrew 
between 
baseline and 
outcome 
collection 
6-month 
follow-up 
9.85 0.05 No N/A OR = 
1.788; SE 
(InOR) = 
0.629 
Gerald 
2009 
Withdrew 
between 
baseline and 
outcome 
collection 
6-month 
follow-up 
N/A N/A No N/A OR = 
1.788; SE 
(InOR) = 
0.613 
Horner 
2008 
Withdrew 
between 
baseline and 
outcome 
collection 
7-month 
follow-up 
10.2 0.05 No N/A OR = 
1.333; SE 
(InOR) = 
0.531 
Horner 
2015 
Failed to 
complete final 
data 
collection 
12-month 
follow-up 
8.9 0.05 No N/A OR = 
0.75; SE 
InOR) = 
0.486 
Kintner 
2009 
Withdrew 
during 
intervention 
and between 
completion 
and follow-up 
12-month 
follow-up 
13.2 0.05 No N/A OR = 
30.176; 
SE (InOR) 
= 1.860 
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Levy 2006 Failure to 
complete 
outcome 
evaluation 
12-month 
follow-up 
17.36 0.05 No N/A OR = 
0.357; SE 
(InOR) = 
0.3881 
McGhan 
2003 
Withdrew 
between 
baseline and 
outcome 
collection 
9-month 
follow-up 
9 0.05 No N/A OR = 
1.147; SE 
(InOR) = 
0.5381 
McGhan 
2010 
Withdrew 
between 
baseline and 
interim 
outcome 
collection 
6-month 
follow-up 
8.3 0.05 No N/A OR = 
1.007; Se 
(InOR) = 
0.387 
Patterson 
2005 
Withdrew 
during 
intervention 
Post-
interventi
on 
(immediat
ely 
following 
interventi
on) 
7.95 0.05 No N/A OR = 
5.675; SE 
(InOR) = 
1.087 
Shah 2001 Withdrew 
between 
baseline and 
outcome 
collection 
3-month 
follow-up 
45.3 0.05 No N/A OR = 
1.343; SE 
(InOR) = 
0.475 
 
 
*ICC = Intracluster Correlation Coefficient 
Table 30. Details of data transformations and adjustments made for meta-analyses
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Four outcome evaluation studies assessed uses of reliever therapies [192, 195, 196, 238]. Two 
studies reported on the use of rescue mediation [238] and short-acting bronchodilators [192], 
respectively. Both of these studies measured long-term intervention effects at twelve [192] and 
fifteen months [238] and were considered similar enough to combine in a meta-analysis. The 
remaining two studies measured appropriate use of reliever medication [195] and access to 
reliever medication [196]. Due to conceptual differences in the way in which the use of reliever 
therapies were measured among the studies, information from just two studies were included in 
the meta-analyses [192, 238]. Information from the other two studies can be found in table 30.  
Corticosteroid usage and dosage was measured in six studies [95, 190, 192, 195, 196, 212]. One 
study measured whether students had access to controlled medication while visiting the school 
health office [196]. Two further studies measures whether children were adhering to guidance 
provided around correct corticosteroid usage [190, 212]. Three of the studies measured any 
reported use of corticosteroid or controller medication [95, 192, 195]. Data from these studies 
were analysed separately as adherence [190, 212] was considered to differ conceptually from 
usage [95, 192, 195]. Two studies [190, 212] collected information from children at five and three 
months, respectively, in the meta-analysis of adherence. All three studies in the second meta-
analysis on medication usage collected information either nine or 12-months post-intervention. 
Data from all six studies are shown in table 30.  
Health-related quality of life was measured in 12 outcome evaluation studies. The data from three 
studies [187, 192, 237] were not presented in a way that could be extracted, the data from one 
further study [75] measured change in quality of life and one study [233] measured clinically 
significant improvements. In the nine studies that had an effect size, eight were based on the 
Juniper Paediatric Quality of Life Questionnaire overall Quality of Life [239]. An Arabic version 
of this questionnaire was used in one study [207]. Kintner et al [230] measured quality of life 
through responses to the participation in life activities scale.  
Two sets of meta-analyses were conducted for a model measuring changes in quality of life. One 
of these used effect sizes calculated through SMDs, to allow data from Kintner et al [230] to be 
included. A second model of mean differences was conducted to allow the incorporation of data 
from two studies [75, 233], which collected data on change scores. Therefore, data from six 
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studies was common to both models. Quality of life was measured within four months of the 
intervention in most of the studies. Two studies collected this information at six to seven months 
after the intervention [191, 211] and one study collected data 12 months after the intervention 
[194].  
Withdrawal data was frequently presented, however not always in a format that could be extracted 
to form an effect size. Often, this was due to studies reporting overall numbers lost in the study 
without disaggregating by treatment arm [193, 194] or studies reporting no losses [232]. Fourteen 
studies provided enough data for an effect size (odds ratio) to be calculated. Few studies reported 
on active withdrawal processes occurring during the intervention, but reported on a failure to 
collect children’s data at follow-up instead. Data were collected at different points between the 
intervention and follow-up, including at four months or less [75, 207, 210, 233], at six to seven 
months [191, 192, 197, 238], and at nine to twelve months [95, 190, 195, 214, 230]. One study 
had an unclear duration [235]. 
Excluded Studies 
From the title and abstract screening, 28,318 records were excluded for being outside of the remit 
of the review of process evaluations. Following full-text screening, 1029 records were excluded, 
with reasons detailed in the PRISMA diagram in figure 20 from the review of process evaluation 
studies. Based on title and abstract screening, 274 records were excluded as being outside of the 
remit of the review of outcome evaluation studies. Following full-text screening, a further 67 
records were excluded, and the reasons are detailed in the PRISMA diagram in figure 21 from the 
outcome evaluation studies.  
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Figure 20. PRISMA diagram for process evaluation studies 
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Records identified through database 
searching  
(n = 38109) 
Additional records identified through 
other sources  
(n = 0) 
Records after duplicates removed  
(n = 29384) 
Title and abstract records 
screened  
(n = 29384) 
Title and abstract records 
excluded  
(n = 28318) 
Full-text articles assessed for 
eligibility  
(n = 1066) 
Full-text records excluded, 
with reasons  
(n = 1029) 
Duplicates = 157 
Published before 1995 = 8 
Asthma not the focus = 14 
Children aged 5-18 years not 
the primary recipients = 66 
Not school-based = 236 
Does not meet the BTS self-
management criteria = 77 
No intervention reported = 
253 
Not English language = 23 
Non-standard educational 
setting = 1 
Did not meet the criteria for a 
process evaluation = 194  
54 articles included for 
further analysis  
(from 33 studies) 
4 studies awaiting 
classification 
1 study ongoing 
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Figure 21. PRISMA diagram for outcome evaluation studies 
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Records identified through database 
searching  
(n = 374) 
Additional records identified through 
other sources  
(n = 5) 
Records after duplicates removed  
(n = 379) 
Title and abstract records 
screened  
(n = 379) 
Title and abstract records 
excluded  
(n = 274) 
Full-text articles assessed for 
eligibility  
(n = 105) 
Full-text records excluded, 
with reasons  
(n = 67) 
Duplicates = 13 
Published before 1995 = 1 
Asthma not the focus = 1 
Not an intervention study = 4 
Children aged 5-18 years not 
the primary recipients = 7 
Not school-based = 13 
Does not meet the BTS self-
management criteria = 4 
Study design not an RCT = 8 
Exclude on comparison = 15 
Not English language = 1 
44 articles included for 
further analysis  
(from 33 studies) 
1 study awaiting 
classification 
4 studies ongoing 
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  5.4.2 Risk of Bias in Included Studies 
The risk of bias judgements are shown in figure 22 as percentages across each of the risk of bias 
domains.  
 
Figure 20. Risk of bias graph 
Process Evaluation Studies 
The quality of the process evaluation studies was assessed across five areas:  
i. Transparent and clearly stated aims (0 high; 27 low; 6 unclear) 
ii. Explicit theories underpinning the intervention (10 high; 14 low; 9 unclear) 
iii. Transparent and clearly stated methods and tools (4 high; 17 low; 12 unclear) 
iv. Selective reporting (10 high; 8 low; 15 unclear) 
v. Harmful effects (8 high; 5 low; 20 unclear) 
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Population and selection factors were assessed across four areas: 
i. Population and sample described well (8 high; 8 low; 17 unclear) 
ii. Continuous evaluation (3 high; 8 low; 22 unclear) 
iii. Evaluation participation equity and sampling (9 high; 7 low; 17 unclear) 
iv. Design and methods overall approach (6 high; 10 low; 16 unclear) 
Reliability and transferability of the findings were assessed across two areas: 
i. Reliability of findings and recommendations (11 high; 8 low; 14 unclear) 
ii. Transferability of the findings (13 high; 5 low; 15 unclear) 
Overall risk of bias for the process evaluation studies included 10 high risk studies, five low risk 
studies and 18 unclear 
Outcome Evaluation Studies 
In five studies, allocation concealment generated a low risk of bias decision [95, 194, 197, 233, 
238]. In eight outcome evaluation studies, the allocation concealment risk of bias was high [191, 
192, 212, 214, 230, 231, 237, 240]. 
Blinding of participants and personnel generated a low risk of bias in three studies [190, 194, 
214]; a high risk of bias was seen in two studies [191, 230]. Seven studies recorded a low risk of 
bias for blinding of outcome assessment [95, 190, 194, 197, 214, 230, 232]; two studies yielded 
a high risk of bias for blinding of outcome assessment [234, 237]. 
A low risk of bias for incomplete outcome data was seen in seventeen studies. A high risk of bias 
was seen in seven studies [192, 195, 209, 214, 229, 235, 241]. 
Selective reporting was low in twenty studies. In twelve studies, selective reporting yielded a high 
risk of bias.  
Other Potential Sources of Bias 
Missing data recorded a low risk of bias in thirteen studies, and a high risk of bias in seven studies 
[192, 197, 209, 212, 214, 235, 242]. 
A low risk of bias for baseline imbalance was seen in fifteen studies; a high risk of bias was seen 
in six studies [187, 195, 207, 212, 229, 237]. 
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Risk of contamination was low in twenty-nine studies. In five studies, a high risk of bias was seen 
[209, 210, 232, 234, 238]. 
  5.4.3 Part 1: QCA of Determinant Conditions for  
  Successful Intervention Implementation 
Across the 27 included studies, eight had high implementation scores on the combined outcome 
(attrition, adherence and dosage), and were considered as being mainly or fully in a set of studies 
marked as being successfully implemented [95, 207, 210, 211, 221, 224-226]. Eight studies had 
low implementation success scores and were identified as being mainly or entirely out of the 
successfully implemented set of studies [209, 212, 213, 215, 217, 223, 227, 228]. The remaining 
studies had higher levels of missing data or conflicting results, therefore their implementation 
success was unclear.  
In many of the studies with lower implementation success, the difficulty of building an 
intervention into the school curriculum and into pupil’s schedules were viewed as undermining 
the intervention [209, 212, 213, 223, 227]. Additional factors included difficulties with high staff 
turnover [213]; high pupil turnover and/or chaotic families [212, 227] and low student motivation, 
particularly in the absence of incentives [217]. Varied explanations were also seen for successful 
implementation. These included high levels of school commitment [211, 226]; high levels of 
student and teacher motivation [207, 224]; the development of group cohesion [210]; tailoring of 
messages to pupils [95, 220]; and additional communications with parents [225]. Table 31 shows 
a summary of the QCA findings. 
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Mod
el 1 
School 
Health 
Centre 
High 
School 
Parent 
Interventi
on 
Recipients 
Teachers 
Interventio
n 
Recipients 
Others 
Interventi
on 
Recipients 
 Successful 
Interventi
on 
1       x x    
2 x   x - -    
3 x - x x x    
Mod
el 2 
Addition
al 
marketi
ng 
material
s 
Incentives Catch-up 
Sessions 
Reminders   Successful 
Interventi
on 
 - - - - -  No 
combinatio
ns 
Mod
el 3 
Alliance
s with 
care 
provider
s 
Symptom 
recognitio
n or 
manageme
nt 
Tailored 
content 
Personal 
responsibil
ity 
Interactiv
e 
pedagogic
al style 
Diverse 
pedagogic
al style 
Successful 
Interventi
on 
 - - - - -  No 
combinatio
ns 
Mod
el 4 
Theory 
driven 
Run in 
class time 
Run in 
free time 
School 
nurse 
involved in 
delivery or 
teaching 
Personalis
ed or 
individual 
one-to-one 
teaching 
 Successful 
Interventi
on 
1   - x x -    
2   - -   x    
Mod
el 5 
School 
asthma 
policy 
Child 
satisfactio
n 
Teacher 
engageme
nt 
Parent 
engagemen
t 
School 
nurse 
engageme
nt 
 Successful 
Interventi
on 
1 x - -   x    
2 -   - - x    
Mod
el 6 
Theory 
driven 
Run in 
free time 
Child 
satisfactio
n 
Parents 
engaged 
High 
school 
 Successful 
Interventi
on 
1   -   -      
2   - -        
3   x - -      
4   x     -    
 = Condition needs to be present; x = condition needs to be absent; - = Condition not 
important 
Table 31. Summary of QCA Results
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For each model, an indicator of consistency and coverage was created, according to the level of 
certainty that the combination triggered the outcome, and according to how much of the outcome 
was explained by the combination. Different areas of implementation were first explored 
separately, before bringing the evidence together in the final model (model six). This strategy was 
mainly due to limited diversity, where too many possible combinations of characteristics were 
not supported by studies. No combinations of characteristics were found to consistently trigger 
successful implementation, with respect to recruitment and retention (model two), and 
pedagogical factors (model three). The data and truth tables for the models below can be found 
in appendix 12.  
Model One: Setting and Participant Characteristics 
Included within this model were the presence of existing health facilities within schools (e.g. a 
school nurse or first aider), the type of school, whether teachers or other school personnel 
(including school nurses) received additional training, and whether parents received the 
intervention. Three essential pathways were identified to running a successful intervention, of 
which, two suggested different ways of running a successful intervention in a high school. In the 
first pathway, which was supported by evidence from two studies [207, 211], successful 
interventions were seen where there was no school-based health facilities (e.g. a school 
nurse/nurses office) and no direct involvement from parents. However, evidence from two other 
studies [210, 225] suggested that interventions were successful where there were school-based 
health facilities and direct parental involvement, but no additional training for teachers. Two 
further pathways were also identified. The first of these (inessential) suggested that, where 
interventions took place away from high schools (e.g. junior/middle school), additional teacher 
training, and training for other stakeholders, were enough to generate a successful outcome. A 
second (essential) pathway suggested that, regardless of whether or not the intervention took place 
in a high school, no health facilities within the school, and no additional training for teachers and 
stakeholders, as well as no additional parental involvement, were sufficient to generate an 
outcome.  
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Model Two: Recruitment and Retention Processes 
A truth table was attempted to explore the possible number of conditions that contributed to 
successful implementation, based on recruitment and retention processes. This focussed on the 
use of incentives, marketing materials, reminders and providing make-up sessions. However, no 
configurations were found that were potential subsets of the outcome. Therefore, these were not 
included in the final consolidated model.  
Model Three: Curriculum, Pedagogy and Intervention Emphasis 
A model exploring the impact of the curriculum content, pedagogical (teaching) style, and 
description of the emphasis of the intervention was developed, however no configuration showed 
sufficient levels of consistency. Therefore, these components were not included in the final 
consolidated model.  
Model Four: Further Modifiable Intervention Design Features 
The first condition in this model reflected the extent to which the authors reported that their 
interventions included a named theoretical framework, which underpinned the intervention. Two 
conditions reflected whether the students own time was interrupted (e.g. the intervention was 
conducted during lunchtime or after school) or whether the intervention was delivered during 
their normal lessons. A condition was also included which reflected the extent to which the 
intervention was delivered, or facilitated, by a school nurse. This was to establish the importance 
of having medical personnel involved in the intervention, as a condition for successful 
implementation. It was hypothesised that running personalised or individualised sessions may 
reduce the ability of trialists to successfully deliver an intervention, as it may be difficult to 
balance individualised sessions across a larger cohort of students.  
The intermediate solution confirmed the importance of the intervention being theory driven, and 
two pathways were identified. The first pathway suggested that a school nurse is needed for 
successful implementation if the intervention does not involve personalised or individualised 
sessions. The second pathway, however, suggested that, where interventions are provided outside 
of students’ free time (e.g. during lesson time), successful implementation is achieved when a 
school nurse is not involved.  
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Model Five: Stakeholder Involvement and Engagement 
Levels of stakeholder involvement and engagement was explored across the school level (through 
the development of school policies for asthma), the child level (through measuring satisfaction) 
and at the levels of other stakeholders (through exploring teacher, parent and school nurse 
engagement). These conditions reflected whether instances of problematic or enthusiastic 
engagement were reported. The intermediate solution showed two essential pathways which were 
sufficient to produce a positive outcome. One of these pathways included child satisfaction, and 
the other pathway included reporting good levels of engagement with parents, however these were 
only sufficient when in the presence, or absence, of other conditions. Each of these pathways had 
high levels of consistency, which suggested sufficient configurations, however individual 
pathways showed low levels of coverage.  
Model Six: Final Consolidated Model 
In the consolidated model, priority was given to the conditions that were part of combinations 
with high consistency and coverage scores, and evidence from models one, four and five were 
used, to understand some of the important conditions to consider when designing an intervention. 
Based on the raw data in table 32, a truth table was created (table 33) which showed the extent to 
which sets of studies with certain combinations of conditions overlapped with a set of studies in 
the successful intervention set.  
 
 
 
 
 
 
 
 
 
 
 
207 
 
 
 Successful 
Intervention 
High 
School 
Child 
Satisfaction 
Theory 
Driven 
Took Place in 
Students’ Free Time 
Good Engagement with 
Parents 
Joseph 
2010 
0.52 1 0 1 0.33 0 
Kouba 
2012 
0.33 1 0 1 1 0 
Dore-Stites 
2007 
0.67 0 1 1 0.33 0.75 
Joseph 
2013 
1.00 1 0 1 0.75 1 
Mujuru 
2011 
0.67 0 0 0 0 0.25 
Henry 
2004 
0.83 1 0 0 0 0 
Pike 2011 0.67 0 0 0 0 0 
Spencer 
2000 
0.33 0 0 0 0.33 1 
Engelke 
2013 
0.50 0.5 0 0 0.33 1 
Splett 2006 0.50 0.5 0 0 0.33 0 
Kintner 
2012 
0.83 1 1 1 1 0.25 
Berg 2004 0.83 1 1 1 0.33 0 
Howell 
2005 
0.33 0 1 1 0.33 0.75 
Gerald 
2006 
0.33 0 0 0 0.33 0 
Langenfeld 
2010 
0.33 0 0 0 0.33 0 
Al-Sheyab 
2012 
0.83 1 1 1 0.33 0 
Levy 2006 0.52 0 0 0 0.3 0 
Terpstra 
2012 
1.00 0.66 1 1 1 0.25 
Horner 
2015 
0.67 0 1 1 1 0 
Bruzzese 
2008 
0.94 0.66 1 1 0.33 1 
Lee 2011 0.50 0 1 1 0 0 
Bruzzese 
2004 
0.33 1 1 1 0.75 0 
Cicutto 
2013 
0.67 0 1 1 1 0 
Brasler 
2006 
0.00 0.66 0 0 0.75 0 
Crane 
2014 
0.50 0 1 1 1 0 
Bruzzese 
2011 
0.88 1 1 1 0.33 0 
Magzamen 
2008 
0.19 0.75 0 0 1 0 
Table 32. Data table for QCA model 6: Consolidated model 
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High 
School 
Child 
Satisfaction 
Theory 
Driven 
Students’ 
Free 
Time 
Good 
Parent 
Engagement 
Outcome 
Code 
(based on 
consistency 
score) 
Studies with 
Membership 
in Causal 
Combination 
>0.5 
Consistency 
Score with 
Subset 
Relationship 
Proportional 
Reduction in 
Inconsistency 
Cases 
1 1 1 0 0 1 2 1 1 Al-Sheyab 2012; Berg 2004 
1 0 1 1 1 1 1 1 1 Joseph 2013 
1 1 1 0 1 1 1 1 1 Bruzzese 2008 
1 0 1 0 0 1 2 0.924 0.841 Bruzzese 2011; Joseph 2010 
1 1 1 1 0 1 2 0.853 0.752 Bruzzese 2004; Kintner 2012 
0 1 1 0 1 1 2 0.815 0.668 Dore-Stites 2007; Howell 
2005 
1 0 1 1 0 0 2 0.768 0.595 Kouba 2012; Terpstra 2012 
0 0 0 0 1 0 1 0.763 0 Engelke 2013; Spencer 2000 
1 0 0 0 0 0 1 0.762 0.615 Henry 2004 
0 0 1 1 0 0 3 0.675 0.463 Cicutto 2013; Crane 2014; 
Horner 2015 
0 0 0 0 0 0 5 0.67 0.322 Gerald 2006; Langenfeld 
2010; Levy 2006; Mujuru 
2011; Pike 2011; Splett 2006 
0 0 1 0 0 0 1 0.6 0 Lee 2011 
1 0 0 1 0 0 1 0.358 0 Magzamen 2008 
1 1 0 1 0 0 1 0 0 Brasler 2006 
 Table 33. Truth table for QCA model 6: Consolidated model  
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Four combinations of conditions were found to trigger the outcome. The solution emphasises the 
importance of being theory-driven across all settings for an intervention to be successfully 
implemented. Three of these pathways were specific to high schools. Here, the evidence suggests 
that in addition to being theory-based, having good levels of engagement with parents, or having 
high levels of child satisfaction, as well as running the intervention outside the students’ own time 
lead to a successfully implemented intervention. A pathway that was not specific to high schools 
also reinforces these findings, and found that being theory-based, fostering high levels of student 
satisfaction, reporting good levels of parental engagement, and running an intervention outside 
the students’ own time are sufficient conditions for triggering a positive outcome.  
These pathways had a consistency score of 0.862, which suggested that they were sufficient to 
achieve the outcome. Interventions that are designed with these sets of characteristics are 
therefore likely to be successfully implemented. No evidence was found for whether any of the 
combinations also predicted the negation of the outcome. However, a modest coverage score of 
0.432 suggests that other pathways also exist in triggering successful implementation.  
Based on the results of the QCA analyses, the following conditions were intended to be included 
in the meta-analyses, either as subgroup analyses or as covariates in meta-regression: 
i. Type of school: High; primary/elementary; junior/middle; other 
ii. Theory-driven: Does the study name a theoretical framework which underpins the 
intervention design or delivery style? 
iii. Parental engagement: Did parents engage or participate in the way in which they were 
expected? 
iv. Child satisfaction: Did at least 75% of children report satisfaction with the 
intervention, or did the study authors report high levels of satisfaction? 
v. Timing of the intervention: Does the intervention interfere with the child’s free time? 
However, due to data constraints, child satisfaction could not be explored in the meta-analyses, 
as very few studies collected this information. Parental engagement was also included as parental 
involvement (i.e. whether parents were actively included in the intervention) for similar reasons. 
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  5.4.3 Part 2: Meta-Analyses of Effectiveness 
Meta-analyses were presented for eleven outcomes. The main comparison explored the effect of 
school-based asthma interventions compared with usual care. For each outcome, the effect sizes 
for each of the pre-specified subgroup analyses were presented. These included school type, age 
of children, SES of the children, and the main instructor, which reflected whether school staff 
were involved in the delivery of the intervention.  
Where heterogeneity was seen, additional subgroup analyses were conducted, based on the results 
of the QCA. Additional sensitivity analyses were also conducted.  
Primary Outcome One: Exacerbations leading to hospitalisation 
Effect sizes were extracted from seven studies [95, 190, 191, 208, 213, 214, 229], six of which 
were included in the meta-analysis. The evidence showed that school-based self-management 
interventions for children with asthma were effective in reducing levels of hospitalisations among 
children ((SMD -0.19, 95% CI -0.35 to -0.04); figure 23). The effect sizes from all six studies 
were in the same direction, and the I2 and Q-statistic values provided no evidence of statistical 
heterogeneity.  
Figure 23. School-based interventions vs usual care: Exacerbations leading to hospitalisations 
Subgroup analyses were not conducted, due to the lack of heterogeneity, and an increased chance 
that the studies would be underpowered. Sensitivity analyses could also not be conducted due to 
the small number of studies included in the models. All but one of the studies [95] reported on 
cluster RCTs, and half of the studies originally reported on binary outcomes [191, 229, 237], 
however no significant difference in effect size was seen. Egger’s test for publication bias showed 
no evidence of publication bias (p = 0.626), although the small number of studies meant that the 
test was underpowered.  
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Two of the largest studies [95, 190] contributed three-fifths of the weighting to the pooled effect 
size, and had a low or unclear risk of bias across all the domains. In the study by Horner et al 
[190], a low risk of bias was seen for each domain, apart from the blinding of participants and 
personnel, which was unclear. 
Primary Outcome Two: Exacerbations leading to ED visits 
Effect sizes from 13 studies were included in the meta-analysis, and there was evidence that the 
interventions were effective in reducing the frequency of ED visits (OR 0.70, 95% CI 0.53 to 
0.92; figure 24).  
Figure 24. School-based interventions vs usual care: ED visits 
Among these studies, there was substantial heterogeneity, both in the magnitude and direction of 
effect, with three studies have effect size close to one [190, 208, 229], and two studies suggesting 
a negative intervention effect [192, 195]. This resulted in an I2 value of 26%.  
The school type (figure 25), age, SES of the children and intervention deliverer involved in the 
intervention did not explain the observed heterogeneity seen. There was also no evidence that any 
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of the intervention conditions that consistently predicted successful implementation in the QCA 
analyses explained any of the heterogeneity seen.  
Figure 25. School-based interventions vs usual care sub-grouped by school type: ED visits 
Due to difficulties in identifying levels of parental engagement, proxy analysis examined a 
simplified variable reflecting whether parents/carers were active participants, however this did 
not substantially explain the heterogeneity.  
Studies that replicated one of the combinations that was found to trigger successful intervention 
implementation (five studies that were theory-driven, took place outside students’ free time, and 
did not involve school nurses) had inconclusive effect sizes (OR 0.85, 95% CI 0.47 to 1.52), 
which differed significantly from studies that did not replicate a combination found to trigger 
successful implementation in the earlier QCA analyses (OR 0.67, 95% CI 0.47 to 0.94). Finally, 
subgroup analyses based on three of the conditions that were found to trigger successful 
implementation were conducted (theory-driven, took place outside students’ free time, and 
parental engagement). All of the studies included in the meta-analyses had included at least one 
of these conditions, and subgroup analyses suggested that the number of components was 
inversely related to the effect size, with studies with one (OR 0.56, 95% CI 0.33 to 0.97) or two 
(OR 0.67, 95% CI 0.49 to 0.94) components having lower effect sizes than the three studies that 
included all three components (OR 1.48, 95% CI 0.65 to 3.40). However, the test for difference 
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between subgroups did not suggest that these were significant differences and there remained 
substantial heterogeneity within the subgroups.  
Sensitivity analyses were conducted to explore the impact of decisions to transform or combine 
the data. No differences were detected in the effect sizes of studies that were originally measured 
through binary effect sizes (OR) and those originally measured through continuous measures 
(SMDs). No differences were detected by whether studies assessed intervention effects at 12 
months, 4-7 months, or three months or less. All but two of the studies [95, 232] had randomised 
children at the school level, although there was little evidence that this distinction explained 
heterogeneity in effect sizes.  
Supplementary analyses were conducted to assess the impact of study quality on effect sizes; 
categories of high and unclear risk of bias were combined. None of the included studies here had 
a high risk of bias for generation of a random sequence generation, although eight studies had an 
unclear risk. The results of the sensitivity analyses provided moderate evidence that studies that 
had a high or unclear risk of selection bias, with respect to breaches in allocation concealment, 
had significantly different effect sizes (OR 0.86, 95% CI 0.64 to 1.16), compared to the three 
studies that had a low risk of bias (OR 0.51, 95% CI 0.33 to 0.78). There was also evidence that 
studies with a low risk of bias for the collection of outcome data and the blinding of collectors 
were significantly more effective (OR 0.58, 95% CI 0.41 to 0.81) than the seven studies with an 
unclear or high risk of bias (OR 1.04, 95% CI 0.69 to 1.58). Differences in the risk of bias 
classification for other domains did not significantly explain heterogeneity in the effect sizes 
between studies.  
Although based on a relatively small number of studies, Egger’s test or the funnel plot indicated 
any evidence of publication bias.  
Primary Outcome Three: School Absences 
Ten studies were included in this meta-analysis, and there was no evidence that school-based self-
management interventions were effective in reducing school absences (SMD -0.06, 95% CI -0.22 
to 0.08; figure 26).  
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Figure 26. School-based interventions vs usual care: School absences 
Among the studies, there was high heterogeneity between the effect size estimates, with an I2 of 
70%. Effect sizes from half of the included studies indicated that the intervention had a negative 
impact in increasing the number of school absences in the intervention group, relative to the 
control [192, 196, 212, 213, 238]. 
One study included in the meta-analysis focused on high schools [95], and was highly effective 
in reducing school absences (SMD -0.38, 95% CI -0.62 to -0.15); this study also seemed to drive 
much of the heterogeneity explained by subgroup analyses examining school type and children’s 
age (figure 27).  
 
Figure 27. School-based interventions vs usual care sub-grouped by school type: School absences 
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Studies that included moderately high levels of children from lower socioeconomic backgrounds 
(between 25-50% of children) were significantly more effective in reducing levels of school 
absence (SMD -0.23, 95% CI -0.36 to -0.09) than studies with high levels of children from 
deprived backgrounds (over 50%), where the effect size was negligible (SMD 0.01, 95% CI -0.09 
to 0.11) and studies where less than 25% of children were from deprived backgrounds, or where 
this was unclear (SMD -0.02, 95% CI -0.29 to 0.24).  
Studies that included existing school staff in the delivery of the intervention were less effective 
(SMD 0.08, 95% CI -0.08 to 0.24) than studies that were mainly delivered and facilitated by 
external stakeholders (SMD -0.17, 95% CI -0.32 to -0.02; figure 28).  
 
Figure 28. School-based interventions vs usual care sub-grouped by configuration of conditions: School 
absences 
Subgroup analyses involving the conditions and combinations found to be sufficient to trigger 
successful implementation in earlier QCA analyses did not significantly explain the heterogeneity 
in effect sizes, with two exceptions. Interventions that took place during children’s free time had 
greater impacts on school absences (SMD -0.23, 95% CI -0.36 to -0.11) than those that took place 
at another point in the school day (SMD -0.01, 95% CI -0.18 to 0.16), although a high level of 
heterogeneity remained among this latter group of studies (I2 = 62%). Strong evidence was also 
seen around the role of theory, where studies that reported on a framework had a greater impact 
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on the pooled effect size (SMD -0.20, 95% CI -0.36 to -0.04) than those that did not (SMD 0.08, 
95% CI -0.05 to 0.20), although some heterogeneity remained for studies that drew upon theory 
(I2 = 41%) and those that did not (I2 = 28%).  
Sensitivity analyses showed no evidence that the transformations in effect sizes helped explain 
heterogeneity, and there was also no evidence that the unit of randomisation explained variation 
in effect sizes. The three studies that collected absence data within three months or less post-
intervention, or where this was unclear [212, 213, 232] showed a weaker effect in reducing school 
absences, with two studies showing a negative effect [212, 213], although this was not 
significantly different from studies that assessed absences 12-months post-intervention. There 
was also no evidence that the risk of bias impacted the effect size. However, studies that had taken 
steps to blind the assessment of outcomes and avoid detection bias had a greater impact on school 
absences (SMD -0.27, 95% CI -0.38 to -0.17) than studies where steps had not been taken (SMD 
-0.07, 95% CI -0.02 to 0.16).  
There was no evidence from the funnel plot of Egger’s test that these data were impacted by 
publication bias.  
Primary Outcome Four: Days of Restricted Activity 
Three studies were included in the meta-analysis of days of restricted activity [95, 194, 197]. 
These provided evidence that the intervention mode could reduce the number of days of restricted 
activity experienced (SMD -0.30, 95% CI -0.41 to -0.18; figure 29), although the number of 
included studies is limited, and two studies evaluated the same intervention design. All three 
studies provided consistent evidence around the direction and magnitude of the effect.  
 
Figure 29. School-based interventions vs usual care: Days of restricted activity 
Due to the low heterogeneity and the low number of studies, subgroup and sensitivity analyses 
were not reported. Notably, however, none of the included studies had a high risk of bias for any 
domain.  
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Secondary Outcome One: Unplanned Visits to a Medical Provider 
Five studies were included in the meta-analysis here, and there was evidence that school-based 
self-management interventions did reduce the number of unplanned or unscheduled visits to a 
medical provider (OR 0.74, 95% CI 0.60 to 0.90; figure 30).  
 
Figure 30. School-based interventions vs usual care: Unplanned visits to a medical provider 
Despite some inconsistency in the magnitude of effect, there was little evidence of statistical 
heterogeneity. Due to the small number of studies, subgroup and sensitivity analyses were not 
meaningful. However, two studies contributed almost 75% towards the pooled effect size [95, 
194] and neither study had a high risk of bias on any domain.  
Secondary Outcome Two: Experience of day and night time symptoms 
There was no evidence that school-based self-management interventions reduced the level of 
daytime symptoms that were experienced (SMD -0.15, 95% CI -0.32 to 0.02; figure 31), with the 
confidence interval just crossing the line of no effect.  
 
Figure 31. School-based interventions vs usual care: Experience of daytime symptoms 
However, there was consistency in the direction of effects reported. There was even less evidence 
that school-based self-management interventions reduced the level of night-time symptoms that 
were experienced (SMD -0.18, 95% CI -0.51 to 0.16), with two studies providing weak evidence 
that night-time symptoms increased among children receiving the intervention. Sensitivity 
analyses found that night-time symptoms decreased (SMD -0.26, 95% CI -0.46 to -0.06), although 
due to the inconsistency in the direction of effect, the underlying assumptions of the fixed effects 
model cannot be validated. 
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Due to the low number of studies, subgroup and sensitivity analyses were not meaningful. 
However, one study that measured change in daytime symptoms [237] showed a weak effect that 
the intervention lowered the level of daytime symptoms.  
Secondary Outcome Three: Lung Function 
Outcomes measuring the impact on lung function were extracted from five studies, however these 
were not included in the meta-analyses due to conceptual and statistical heterogeneity.  
Secondary Outcome Four: Use of Reliever Therapies (e.g. SABA) 
Two studies were included in the meta-analysis here. The pooled OR provided uncertain evidence 
on the effect of school-based self-management intervention on the use of reliever therapies (OR 
0.48, 95% CI 0.13 to 1.80; figure 32).  
Figure 32. School-based interventions vs usual care: Use of reliever therapies 
There was a high level of heterogeneity between the studies (I2 = 74%), although both studies 
were consistent in the direction of effect indicating a lower odds of (frequent) reliever therapy 
use). One of the studies [238] had a low or unclear risk of bias across all the domains, while the 
other study [192] had a high risk of bias in terms of attrition and selective reporting.  
Secondary Outcome Five: Corticosteroid Dosage (ICS usage) 
Two sets of meta-analyses were initially constructed to reflect the studies that measured either 
usage, or appropriate use, or corticosteroids and add-on therapies. In the second model, two 
studies were included, although the direction of the findings differed and resulted in high levels 
of heterogeneity (I2 = 87%) and therefore a pooled effect size was not estimated.  
There was no evidence for the effect of school-based self-management interventions on children’s 
use of corticosteroids and add-on therapies (OR 1.25, 95% CI 0.88 to 1.79; figure 33). There was 
no evidence of statistical heterogeneity between these studies, therefore reporting on subgroup 
analyses was not meaningful. One study in the model [95] had a low risk of bias on all domains 
except for the blinding of participants and personnel, where the risk was unclear. The two other 
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studies had a high risk of bias on one [195] and two domains [192], respectively; both studies had 
a high risk of attrition bias from incomplete and unexplained drop outs at outcome data collection.  
 
Figure 33. School-based interventions vs usual care: Corticosteroid dosage and use of add-on therapies 
Secondary Outcome Six: Health-Related Quality of Life (HRQoL) 
Due to conceptual differences in the way in which this outcome was measured, one meta-analysis 
of seven studies explored intervention impact on quality of life, measured through SMDs (figure 
34), and provided evidence of effectiveness (SMD 0.27, 95% CI 0.18 to 0.36). This model showed 
no evidence of statistical heterogeneity in effectiveness, with all studies providing estimates of 
positive improvements, although these were not statistically significant in all studies.  
Figure 34. School-based interventions vs usual care: HRQoL 
The low level of heterogeneity and low number of studies meant that subgroup analyses were not 
conducted. Five of the included studies [191, 207, 211, 212, 230] had a high risk of bias on at 
least one domain, although the two studies with a low or unclear risk of bias on all domains [194, 
197] contributed over 60% of the weighted effect size. Explorations of publication bias were 
underpowered and could not be properly tested.  
A second meta-analysis, including eight studies, also provided evidence that children in 
intervention groups had higher levels of health-related quality of life at follow-up than children 
in control groups (MD 0.35, 95% CI 0.06 to 0.64). The mean difference, while indicating that the 
impact did not cross the line of no effect, fell below 0.5 (the threshold indicating a clinically 
significant change in quality of life). There was high heterogeneity (I2 = 81%) among the studies. 
One study [207] had high levels of baseline imbalance on this outcome, and sensitivity analyses 
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removing this value resulted in a lower point estimate, but much lower levels of heterogeneity 
(MD 0.21, 95% CI 0.07 to 0.32; I2 = 24%). Due to a low number of studies, further exploration of 
the heterogeneity was not explored, and an assessment of publication bias could not be conducted. 
Four of the included studies had a high risk of bias for at least one domain.  
Secondary Outcome Seven: Study Withdrawal 
There was no evidence that participation in the intervention was linked to study withdrawal (OR 
1.14, 95% CI 0.92 to 1.42; figure 35).  
Figure 35. School-based interventions vs usual care: Study withdrawal 
No substantial heterogeneity was seen, although there were some qualitative differences between 
studies that had low levels of withdrawal among treatment, relative to control groups [210], and 
those with very high levels [75, 230]; in neither case would the level of withdrawal be considered 
problematic (did not exceed 25% of participants) and the stark relative effect was driven by a 
small sample size in some studies [210, 230]. 
Despite the low level of heterogeneity, subgroup analyses were presented due to the link between 
withdrawal and the earlier stages of this review. When one set of combinations was replicated in 
the subgroup analyses to mirror the QCA findings, there was weak/uncertain evidence to suggest 
that studies that used theory, alongside running the intervention in students’ free time and having 
no substantial school staff involvement, were less likely to have children drop out before the 
outcome assessment (OR 0.88, 95% CI 0.55 to 1.40) than studies with other combinations of 
conditions (OR 1.23, 95% CI 0.95 to 1.58). There was also no evidence that withdrawal from the 
study was associated with school type (figure 36). 
 
221 
 
 
Figure 36. School-based interventions vs usual care sub-grouped by school type: Study withdrawal 
Subgroup analyses aimed at understanding patterns of heterogeneity in the odds of withdrawal 
did not show that the timing of the assessment, the unit of randomisation, or the risk of bias 
explained patterns of withdrawal. This included risk of attrition bias assessments, although the 
meta-analysis explored differential patterns of attrition and did not account for instances where 
both intervention and control groups had high levels of attrition. There was no evidence that 
publication bias was a problem in terms of withdrawal.  
  5.4.5 Part Three: Adjunct Meta-Analyses 
Adjunct meta-analyses were conducted to explore whether interventions that were successful in 
terms of implementation were also successful in terms of their effectiveness, using a subset of 
studies contained within the process evaluations. The studies here included a control group; 
however studies could have used a range of study designs, and control group children could have 
received an alternative intervention that may have included an asthma component.  
Due to conceptual and methodological differences in study design, these studies only provide 
indicative evidence as to the impact of school-based self-management interventions on children’s 
outcomes. Successful implementation was defined in the same way as the QCA analysis, and 
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represented a combined indicator around attrition, adherence and dosage. Two outcomes were 
considered – ED visits and school absences, where sufficient studies existed to form a meta-
analysis. Both models included effect sizes from seven studies.  
A meta-analysis of ED visits showed that the included interventions were successful in reducing 
the number of ED visits (figure 37), although with a high I2 value of 52%, indicating high levels 
of heterogeneity.  
 
Figure 37. Adjunct analyses: Impact of implementation on ED visits 
Subgroup analyses, based on implementation scores, showed that studies classified as being 
successfully implemented had a greater impact on ED visits (SMD -0.26, 95% CI -0.48 to -0.04) 
than those that were not as successful (SMD -0.09, 95% CI -0.28 to 0.10), although this difference 
was not significant (p = 0.26). A meta-analysis on the impact of school-based self-management 
interventions provided uncertain evidence that these interventions were successful in reducing 
school absences (SMD -0.12, 95% CI -028 to 0.04; figure 38).  
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Figure 38. Adjunct analyses: Impact of implementation on school absences 
However, subgroup analyses based on the combined implementation score indicated that studies 
that were successfully implemented had significantly higher effect sizes (SMD -0.28, 95% CI -
0.39 to -0.18) than those that were not (SMD 0.04, 95% CI -0.09 to 0.18). 
 
 5.5 Discussion 
  5.5.1 Summary of the QCA Results 
Having a named theoretical framework underpinning the intervention was one of the most 
consistently positive conditions that appeared in combinations of conditions that triggered a 
successful intervention. However, it is unclear whether a successful intervention could be 
attributed to a single theory; it is also unclear whether the theories that were used were suitable 
for the intervention, as it could not be ascertained how the theory was used to inform the 
intervention. Instead, the use of a named theory, in conjunction with other conditions, led to better 
implementation. The other conditions included running interventions outside of children’s own 
time, reporting good levels of engagement from parents, and good satisfaction from children. The 
findings also showed that some combinations of conditions were specific to high schools only.  
High levels of parental engagement was measured using high levels of cooperation in providing 
the information to trialists, as noted by the study authors [221, 222], cooperation with home or 
school visits [212, 216], attendance at seminars [210], or receiving telephone appointments from 
the trialists [216]. Conversely, some other studies reported difficulties with parental engagement, 
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particularly in obtaining consent or data collection [213, 224, 225], difficulties in participation 
[194, 214, 223, 226, 227], or in adherence or behaviour change [219]. Child satisfaction was also 
important in successful implementation; four studies showed that most children were satisfied 
with the intervention, based on qualitative statements based on stakeholder perceptions [207, 209, 
212, 227]. None of the studies that were included in the QCA analyses reported low levels of 
child satisfaction, however one study that was not included in the QCA analyses delivered a low 
intensity intervention and reported low levels of satisfaction for some indicators [186]. 
The inclusion of school nurses in interventions also appeared to be important in achieving a 
successful intervention, where children were not engaged in personalised or tailored 
interventions. The timing of the intervention was also important, with interventions that were 
delivered outside of students’ free time triggering successful implementation in two different 
combinations of conditions.  
No single condition alone was sufficient for triggering a successful intervention, highlighting the 
complexity in achieving a successfully implemented intervention. This also highlights the use of 
the QCA approach in capturing complex pathways to achieving intervention implementation 
success. This is further indicated through the modest levels of coverage of any of the pathways 
reported.  
  5.5.2 Summary of the Meta-Analyses Results 
The results from the meta-analyses showed that school-based self-management interventions can 
lead to small improvements in several outcomes, including hospitalisations, ED visits, and quality 
of life. A smaller number of studies suggested positive improvements in unplanned medical visits 
and days of restricted activity. The effects on school absences, experiences of asthma-related 
symptoms, and the use of medication were small, however the certainty for these outcomes was 
low or very low, and the confidence intervals included small or no effects. The strength of the 
evidence for the effectiveness of the intervention was stronger for urgent care contact and quality 
of life that it was for symptoms.  
The most important intervention impacts were seen for outcomes involving healthcare use. These 
were measured in a number of ways, therefore several transformations of the data were required 
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to facilitate the meta-analyses. The magnitude of effect sizes for hospitalisations, ED visits and 
other instances of unplanned healthcare use were small across all three outcomes, when 
considered in absolute terms. However, it indicates that the intervention effect can reach to both 
primary and secondary care. Conversely, it was expected that a greater effect would be seen for 
school absences than the data showed. Heterogeneity was substantial in this outcome (70%), and 
subgroup analyses indicated that the way in which the intervention was implemented may impact 
on this.  
The effects of the intervention were consistent across the outcomes, apart from school absences 
and ED visits. Although most of the investigations into heterogeneity was uninformative or 
inconclusive, there was an indication that school type and age could contribute towards explaining 
some of the heterogeneity seen for school absences, with the intervention having a greater impact 
on older children, although this was derived from a single study [95]. Two studies showed that 
interventions with moderate to high numbers of children from lower SES backgrounds [194, 195] 
resulted in fewer school absences for children in the intervention group, however the relationship 
between the proportion of children from lower SES backgrounds and the effect size was not linear.  
  5.5.3 Contribution of a Mixed-Methods Approach 
The mixed-methods approach used in this review enabled further understanding of the design and 
implementation processes associated with more successful implementation of asthma 
interventions. This design also furthered the development of careful and theory-driven hypotheses 
for testing in meta-analyses, and explored the links between successful implementation and 
intervention outcomes. Adjunct analyses showed links between intervention implementation and 
more effective interventions. The meta-analyses were based on the QCA findings, and assessed 
the impact of school-based self-management interventions for asthma in improving outcomes, 
including school absence. This analysis also showed that individual conditions were often part of 
combinations that triggered successful intervention implementation, and explained some of the 
between-study heterogeneity. Notably, the studies that were theory-driven had a greater impact 
on reducing school absences than those that were not.  
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Further meta-analyses suggested that interventions that did not involve existing school staff in a 
substantial delivery or facilitating role were also those that achieved the greater levels of impact 
in lowering school absence. This echoes the QCA findings that involvement of school staff may 
not be effective under certain conditions. Interventions that are well implemented and are 
supported by theory can be implemented independently of school staff, appear to be sufficient for 
lowering levels of school absences.  
  5.5.4 Overall Completeness and Applicability 
As mentioned above, most of the studies that were included in this review were conducted in the 
USA; very few studies came from either the UK or Europe. It is expected that additional factors 
relating to context (e.g. health policy and access to healthcare) are likely to influence the design 
and implementation of an intervention, however the impact of such factors was not analysed in 
this review. Nonetheless, while it is reasonable to expect that there would be little impact 
regarding the applicability of the intervention to a wide range of schools in middle and higher 
income settings, as the way in which children attend schools is fairly standard, the US focus of 
the studies may have implications in the transferability of the findings. The nature of access to 
healthcare, and the high number of people without suitable healthcare coverage, could mean that 
the intervention has a greater impact in US settings, particularly among those from low income 
populations, with high levels of under-diagnosis and restricted access to the correct medication 
plans. Several of the interventions were developed on this basis, and selected schools as the 
delivery site because education is universal, rather than on the basis of healthcare. It could mean 
that weaker effect sizes are seen in areas with better healthcare coverage, higher rates of diagnosis, 
and equal access to medication (e.g. the UK, where healthcare is free at the point of access).  
Where there was stronger evidence of an intervention effect was commonly seen in those 
outcomes experienced by children with fairly severe asthma. For example, the study by Atherly 
et al [229] took place in high schools among children with mild to severe asthma. Around 3% of 
children had been hospitalised due to their asthma at baseline, and less than 10% had visited an 
ED. Unplanned visits to secondary healthcare is relatively rare in paediatric populations, as the 
findings later in this thesis will show. Further, while many of the studies examined the differences 
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between the intervention and control groups at baseline, it was unusual for the trials to assess 
whether the differences were according to whether children’s asthma was well controlled, 
compared to poorly controlled, at baseline or at follow-up.  
Many of the studies that were included were cluster-RCTs, however few of the studies reported 
on the effect of this clustering. School-level randomisation is important in terms of study 
feasibility, as well as in reducing the risk of contamination of treatment impact. However, the 
opportunity to explore this is not one that is commonly taken by researchers. This means that no 
comment can be made on the generalisability of the findings regarding different school cultures.  
There was a better representation of high schools among studies included as process evaluations, 
than those included in the meta-analyses. This could reflect the difficulties of implementing RCTs 
in high schools compared with primary schools, however this was not addressed in the studies 
that were included in this review. Despite what the findings from the QCA showed, the meta-
analyses showed little qualitative impact of conducting interventions in high schools, compared 
to other school types, although this is based on a low number of high schools included in subgroup 
analyses, and low heterogeneity for many of the healthcare use outcomes.  
Many of the studies did not report on the outcomes that were specified in the review protocol, and 
further issues were encountered in the incompatibility of some of the reported effect sizes. The 
largest meta-analytic model included 13 studies, and all the models provided only a partial 
account of the activity. This means that some models could have been underpowered. The 
development of a core outcome set for future school-based asthma interventions may partially 
overcome this. Future systematic reviewers evaluating public health interventions may also wish 
to include a narrative analysis of all studies included on study design, which may examine the 
nature of the intervention, the types of outcomes collected, and the impact of the intervention on 
these outcomes [243], to achieve a more complete understanding of the impact and feasibility of 
the model.  
Finally, since studies that delivered other asthma interventions were excluded, the value of 
running an intervention in school, compared with running an intervention in a hospital or 
community setting, is unknown. However, schools clearly provide access to large numbers of 
children with asthma in one place, including those who are considered ‘hard-to-reach’. Therefore, 
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schools can be considered an important environment for delivering interventions that can improve 
both children’s outcomes and overall healthcare use. The findings from the review have shown 
that school-based interventions for asthma are effective in improving several outcomes, and future 
interventions should consider a number of configurations, including instructor, theory, and 
timing, in the study design. The outcomes of this review will work in conjunction with the 
findings of this thesis (discussed in chapters four and five) to directly inform the development of 
a school-based self-management intervention for children with asthma in London secondary 
schools.  
  5.5.5 Quality of the Evidence 
The summary of findings table references the quality of the evidence for the outcome evaluation 
studies, while the process evaluations were considered separately. While all the studies employed 
a robust randomised study design, there were problems with the implementation. A number of 
studies had a high or unclear risk of bias, although these did not seem to increase the effect size, 
and in most cases, did not systematically influence the direction of effect. Studies that had a low 
or medium risk of bias may have contributed to lower judgements around the quality of the 
evidence due to other factors, including the directness of the indicators. For example, school 
absences were measured in several ways, and not all approaches were specific to asthma-related 
school absences.  
The quality of the evidence was moderate for two outcomes in the summary of findings table, 
pertaining to healthcare use, quality of life, and experience of daytime symptoms. Each of these 
outcomes showed positive intervention effects, however they were based on a moderate number 
of studies. For two further outcomes, the quality of the evidence was low (school absences and 
ED visits), and very low for medication use. The indirectness and the unexplained heterogeneity 
were the main reasons for this.  
Further consideration should be taken when looking at the quality of the evidence that are not 
captured in the summary of findings table above. First, some cluster-RCTs which had a low 
number of clusters were not included in the analyses. These studies were comparatively small and 
therefore did not contribute significantly to the pooled effect sizes. The effect sizes were adjusted 
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to account for the impact of ICCs, and sensitivity analyses were conducted, however the 
possibility that the intervention effects are exaggerated, compared to individually randomised 
trials or large cluster-RCTs remains a risk. This risk should, however, be balanced against the 
potential bias introduced by overlooking information from smaller trials. Similarly, the effect 
sizes were consistent for most outcomes, with the most substantial transformations involving 
conversion between SMDs and ORs to develop a common metric. While this seemed to have little 
impact, and different effect sizes tended to be consistent in direction and impact, this is further 
evidence of the indirectness in the outcome measures, which suggests lower quality evidence. 
Conversely, the quality of the process evaluation studies was almost consistently poor, with most 
studies having a high or unclear risk of bias across several domains. This could be due to many 
reasons, but possibly highlights the lack of guidance around how to conduct a process evaluation, 
as well as the difficulties in identifying process evaluations in the literature. Just four studies were 
deemed to have a low risk of bias on most domains, of which only one study was considered a 
stand-alone evaluation [226]. The main weakness of the process evaluation studies that were 
included was that they lacked breadth and considered only a single process of importance in depth. 
A commonly occurring risk of bias among the included process evaluation studies was that the 
tools and methods of collecting and analysing the data were not always credible or reliable.  
  5.5.6 Potential Biases in the Review 
This review has several limitations which need consideration. First, is the potential measurement 
error. There was variation in the way in which the number of outcomes were measured, for 
example lung function and school absences. There is no ‘gold-standard’ for measuring school 
absences, and a lack of continuity across the studies may reduce the validity of the findings. The 
data for both school absences and healthcare use may also be subject to substantial measurement 
error; for example, it cannot be said with certainty that all of the school absences and healthcare 
visits were due to asthma specifically, or were authorised by the school or medical centre. 
Measurement error may also be a factor with some of the covariates within the subgroup analyses. 
For example, SES can be measured in different ways (e.g. through household income, or evidence 
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of free school meals), and it was not possible to explore these differences in measurement within 
the scope of the review.  
Second, is the effect size transformations. The review aimed to include as much trial data within 
the meta-analyses as possible, while maintaining construct validity across the effect sizes. This 
often required conducting data transformations to ensure the data were compatible. While 
attempts were made to ensure transparency in presenting disaggregated effect sizes alongside 
those that had been consolidated, there was potential for these analyses (and sensitivity analyses) 
to be confounded, and the underlying assumptions around the transformation of effect sizes may 
not hold with further investigation. While this is important to consider, it needs to be balanced 
against a loss of information from excluding studies that use different approaches to measure the 
outcomes.  
Third was the potentially underpowered analyses and treatment of heterogeneity. A low number 
of studies were included in many of the meta-analysis models, and for random-effects models, 
the models may have been underpowered [244]. Heterogeneity was also encountered, and the low 
number of studies either meant that the subgroup analyses were unsuitable, or that the subgroups 
themselves contained a low number of studies.  
Fourth was the identification of process evaluation studies. While guidance does exist on how to 
conduct process evaluations [177], this did not support the identification of process evaluation 
studies from a systematic review position. All of the process evaluation studies included an 
examination of the given process and implementation outcomes of interest, and their relationship 
with context; however, these spanned a range of studies. Although an inclusive strategy was 
developed around the identification of process evaluation studies, it is possible that some authors 
may not have considered their study as a process evaluation. Further, the guidance for process 
evaluations states that they can adopt a range of data collection methods, however many of the 
studies that were included did not use vigorous qualitative methods of data collection, which may 
have limited the understanding of some of the issues surrounding implementation.  
Fifth was the issue of harmful effects. Some studies reported negative intervention impacts among 
children, such as increased levels of ED visits. Negative effects such as these may reflect the 
content of self-management information delivered to children, which may, for example, have 
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recommended greater contact with healthcare providers when experiencing asthma attacks. A 
narrative approach to the analysis of the outcome evaluation data may have led to a more nuanced 
understanding of why some interventions led to more negative outcomes among children.  
Sixth was the issue of alternative explanations. Many other factors could have influenced the 
results of the review, which have not been considered. For example, although these are school-
based asthma interventions, few of the studies considered the seasonality of asthma exacerbations 
and the relationship with the school year.   
Finally, the low number of clusters was also a limitation in this review. Some of the cluster-RCTs 
that were included only had a small number of schools. While there is agreement that randomising 
one cluster per arm would conflate the randomisation/intervention and clustering effect, there is 
less guidance on the minimum number of clusters needed for a study to qualify as a cluster-RCT. 
Studies involving low numbers of clusters typically indicate a small trial, and often contribute 
only a small amount of data. Sensitivity analyses for studies with a low number of clusters per 
arm (2-3) were conducted to account for this. The results were generally inconclusive, and the 
inclusion/exclusion of these studies did not change the results of the meta-analyses, with the 
exception of one study [207], in one HRQoL model. These studies may be at risk of baseline 
imbalances, as well as further bias.  
  5.5.7 Implications for Practice 
Asthma is a common condition in children that can hinder transition into adulthood, and place a 
huge financial burden on individuals and countries. The results of this review show that school-
based asthma interventions are an effective way of easing this burden and reducing rates of 
unscheduled care. Over the course of a year, and among a group of 1000 children receiving the 
intervention with low baseline risks, the number expected the experience at least one ED visit due 
to asthma could be between 6 and 34 fewer, compared with children who do not receive the 
intervention. While the direction and magnitude of the results are generally positive, they should 
be taken in the context of the quality of the evidence, which was generally moderate for any 
outcome, and in the context of the high diversity of data encountered, which required a number 
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of transformations. The clinical significance of these reductions is also difficult to calculate, 
although quality of life improvements was not estimated to be clinically significant.  
For health-policy makers, these findings highlight that schools may be an important location for 
delivering asthma self-management interventions to large numbers of children. Further, many of 
the included studies tested the intervention among financially deprived and marginalised children, 
who are often hard-to-reach. This suggests that the results may be generalizable to fairly diverse 
populations.  
The results also indicate that delivering interventions outside of the clinical environment is 
effective, and this has implications for healthcare professionals and the type of relationship that 
they hold with the school and wider community, which follows recommendations from policy 
makers. Some of the interventions within this review did include fostering better links between 
schools and healthcare providers, however the majority involved trialists entering schools to 
deliver the intervention themselves. If this model were further developed, it may require 
healthcare professionals and/or teachers to deliver the intervention. School nursing in some 
schools may help this strategy; however, in settings where there is no school nurse present, this 
could be a challenge.  
The mixed methods design in this review highlighted important features of interventions that are 
of interest to educational. The overall results suggest that gains in school absences are marginal, 
however a subset of theory driven interventions did achieve modest decreases in this outcome. 
  5.5.8 Implications for Research 
There is evidence within this review that school-based interventions can help children to self-
manage their asthma, and can result in fewer asthma attacks. The updated logic model in figure 
twenty-three summarises where the evidence has been found, and highlights where uncertainties 
remain. The positive results seen in healthcare use demonstrate that the intervention could be 
implemented in other settings with a limited degree of certainty that the intervention will achieve 
a small positive impact, and future reviews may have a larger evidence base to further establish 
this trend. However, heterogeneity was observed, in both the magnitude of effect sizes and the 
direction of effect, in studies collecting data on ED visits. Research conducted to specifically 
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understand how these interventions generated this effect would be useful for future trialists. For 
example, while baseline imbalances may contribute to this, further analyses may reveal the 
context and mechanisms that explain the effectiveness in other settings.  
The review identified a heterogeneous group of process evaluation studies which were often of 
low quality and did not give a broad understanding of the processes undertaken and mechanisms 
of action which reflect the complexity of the intervention. Previous authors have noted the quality 
of the process evaluation literature [176], which is important for understanding the causal chains 
of actions occurring within public health interventions. This review also highlights that many 
researchers do not adequately assess the implementation and context of their interventions 
according to the MRC guidance on process evaluations, and few studies appeared in both sets of 
analysis conducted in this review. Further research to understand the barriers to preventing 
process evaluations being conducted is needed. A key outcome from this review is the need for 
the development of a tool or checklist that can be used to identify process evaluation studies 
during the searching and screening process.  
One of the key differences in this review was that 33 studies were identified based on study design, 
but the largest meta-analysis models included just thirteen studies. The need for a more 
standardised approach to evaluating this model is clear. Models and principles for developing 
core outcome sets have been developed [245], however these have been primarily for clinical trial 
purposes. Some work has been conducted to consider which domains should be captured in 
paediatric asthma trials [246], however this review highlights that many studies continue to 
capture outcomes that have little value, both clinically and from a policy standpoint.  
Finally, subgroup analyses suggested that intervention impacts were generally consistent across 
different types of school, for outcomes that supported subgroup analyses, and that school type did 
not explain heterogeneity. However, further studies are needed to fully understand the effect of 
school type on intervention impact, particularly in high schools. These findings should also be 
considered in light of the results from the process evaluation, which indicated that the distinction 
between school types was important for implementation.  
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  5.5.9 Overall Conclusions 
This review has shown that schools can be effective settings for self-management interventions 
that reduce healthcare use. However, the optimal setting for delivering self-management 
interventions has not been explored, and could be a direction for future research. Further, while 
the intervention aims and setting have been similar across all of the included studies, the 
interventions themselves differed substantially, and a further review may be needed to explore 
whether differences in outcomes are seen across different modes of asthma intervention. This 
could include exploring the effectiveness of different programmes (e.g. Open Airways for 
Schools). Further research may also establish a better understanding of the links between 
intervention inputs and more distal outcomes, which may be more important for public health 
decision-makers. The feasibility of this research is dependent on a more mature evidence base 
emerging for this type of intervention, both in terms of the number of studies available, as well as 
improvements in the collection of standardised outcomes and reporting of processes undertaken 
and implemented.  
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Plain Language Summary 
Asthma is common in children and young people. Improving children’s ability to self-manage 
asthma is important in reducing the harmful effects of asthma. Schools are a potential site for 
developing self-management skills, but the evidence that school-based interventions improve 
asthma control has not been reviewed in a systematic way.  
The aim was to review school-based self-management interventions for children with asthma. 
The systematic review addressed two questions: (i) what parts of an intervention are more likely 
to make it successful, and (ii) what effect do interventions have on children’s asthma control, their 
school attendance, and their attendance at GP and hospital settings.  
A total of 66 studies were included; 33 studies were included to understand the best way to deliver 
an asthma intervention, and 33 different studies were included to understand whether the 
interventions were successful in improving children’s health and well-being.  
Twenty-four studies were included in quantitative models measuring outcomes. School-based 
self-management interventions improved outcomes including hospitalisations, emergency 
department visits and health-related quality of life. Fewer studies improved unplanned medical 
visits and days of restricted activity. The interventions were not effective in reducing school 
absences, experience of day and night time symptoms, and medication use. Including parents in 
the intervention, and making sure the children were happy with the intervention, were also 
important in delivering interventions within schools.  
The quality of the evidence varied across the studies. The studies measures whether an 
intervention had a strong study design, but there were some issues in the way that some had been 
delivered and the outcomes had not been measured accurately in all studies. The studies that were 
included to understand how to deliver an intervention could sometimes be biased, therefore the 
quality of the evidence was generally lower for these studies.  
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Chapter Six: Overall Discussion and Future Research 
 
 
 
 
 
 6.1 Overall Messages 
In this thesis I have generated novel data on current levels of asthma control and medication adherence 
among children and young people with asthma in London secondary schools. The potential for these data 
to inform effective school-based interventions is supported by the findings supported by my Cochrane 
systematic review of school-based self-management interventions, using a mixed-methods approach to 
analysis, which provides the first robust evidence that school-based interventions can successfully improve 
some outcomes in children. These improvements are, albeit, mainly relating to healthcare use, since there 
was no evidence was seen for outcomes such as school absences and day and night time symptoms. 
Furthermore, data from the process evaluation in the Cochrane review suggest that the best interventions 
are ones that adopt a theory-driven approach.  
A key finding from data from the online questionnaire is that despite suboptimal asthma control, by the 
validated ACT, in just under half of asthmatic children surveyed, many of these students with poor control 
believed that their asthma was well controlled – a finding that was accompanied by a high prevalence of 
poor adherence (irrespective of level of asthma control). This finding already has had impact with reports 
in the London press (https://www.standard.co.uk/news/health/toxic-air-warnings-must-include-reminder-
for-children-to-use-inhalers-a3500881.html, accessed 21/6/18). Other key findings include high levels of 
unplanned medical attention and school absences, particularly among those with poorly controlled asthma, 
according to the ACT, and gaps in knowledge regarding the ICS + LABA inhaler, and the spacer, with 
many students being unaware of the role of these in their treatment plan.  
I was able to add further ‘depth’ to questionnaire data by running a series of focus groups, which further 
elucidated some of the barriers to adherence among teenagers with asthma in London. These focus group 
data strongly suggested that there were several practical and social barriers to medication adherence in 
teenagers. One putative and unexpected barrier to overall good self-management was a lack of awareness, 
both among themselves and among peers. Thus, the question remains is how I can use these novel data to 
improve asthma outcomes in London children. One way is to directly address key knowledge gaps and 
damaging perceptions in schools in order to improve control. In this final chapter, I therefore describe the 
potential for my findings to inform such an intervention – the feasibility of which is currently being 
evaluated in a grant funded study.  
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6.2 Future Research - Proposed Intervention   
Three major themes that need to be addressed in a school-based intervention emerge from my data: 
i. A better understanding of the current levels of asthma control in secondary schools 
in London 
ii. Improved understanding of the barriers to medication adherence and asthma self-
management among secondary school students 
iii. A requirement for a school-based self-management intervention, to be piloted in 
London secondary schools.  
The key unmet needs that will be addressed in a pilot school-based self-management intervention cover 
those that emerged during the focus group component of this thesis. This includes peer awareness, 
knowledge about asthma medications, GP communication, and general asthma management. Challenging 
incorrect beliefs are important during childhood and adolescence, particularly as young people prepare for 
the transition to adult care. The effects of poor self-management and non-adherence can also last into 
adulthood, if they are not addressed early.  
Using my data, and working with my supervisor Professor Grigg, I devised a preliminary theory-based 
multifaceted intervention, in accordance with the Medical Research Council (MRC) framework for 
complex interventions [247]. The aim of this intervention is to improve asthma control, through improved 
self-management behaviours, in young people. The PRECEDE-PROCEED model was used to conduct the 
initial social epidemiological, educational and administrative diagnoses. This model works backwards from 
the desired outcomes of an intervention to identify the most appropriate strategies for achieving the 
objectives. The behaviour change wheel [248] was subsequently used as a framework to translate the key 
behaviours into the intervention using behaviour change techniques.  
The intervention aims engage both teenagers with asthma and their peers, and it will be delivered in three 
components: 
i. A theatre workshop for all year seven and eight students. The aim of this component is 
  to raise awareness of asthma in schools among peers; 
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ii. A series of four self-management workshops for children with asthma only. The aim of 
  this is to teach children with asthma about the disease, using interactive elements,  
  including games and role plays.  
iii. The children will be followed-up for 12 months after the intervention 
 6.2.1 Intervention Framework 
Intervention Objectives 
The intervention includes one primary objective: To test the effectiveness of an intervention to improve 
asthma control in adolescents with asthma, through a targeted school-based self-management intervention. 
The secondary objective is to raise awareness of asthma in schools among peers. This will be addressed 
through the delivery of a theatre workshop (not developed as part of this thesis), in collaboration with 
Greenwich and Lewisham Young People’s Theatre (GLYPT) Company.  
Study Design 
The intervention will be a cluster-randomised trial, with schools acting as the unit of allocation. There will 
be three intervention arms: 
i. Asthma workshop and theatre group 
This group will receive the theatre performance, to be delivered to all children in 
years seven and eight. This group will also receive the self-management workshops 
for all children with asthma in years seven and eight.  
ii. Theatre only group 
This group will receive the theatre performance only. This was included as a 
treatment arm as peer awareness was an important barrier to adherence, as identified 
in my earlier focus groups. This arm will identify whether raising peer awareness in 
schools is sufficient to change self-management behaviours among children with 
asthma, without the self-management workshops.  
iii. Control group 
This group will receive usual care for the duration of the intervention. The control 
schools will receive the intervention at the end of the study when all the data has 
been collected.  
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The intervention will take place in secondary schools. The theatre performance will be delivered to the 
children first, and this will take approximately two hours. At the end of the performance, the main character 
will stay in role, and the children in the audience will have a discussion with her about her behaviours, 
including why she hides her asthma from her friends. The self-management workshops will be delivered a 
maximum of two-weeks later, and will take place over one school day. Baseline data will be collected, 
followed by 3, 6 and 12 month follow-up post-intervention. All data will be collected using an online 
questionnaire, which will be based on the questionnaire used in this thesis, with added scales on beliefs 
about medicines, knowledge of asthma (rather than medication only), and attitudes towards asthma.  
In line with the methods discussed in this thesis, opt-out consent will be obtained for this study. For the 
children without asthma, consent to participate in the theatre workshop will be provided by the school as 
part of a learning tool. It is anticipated that the results of this pilot feasibility study will inform the 
development of a larger trial, to be delivered in secondary schools nationwide. Figure 39 shows a figure of 
the planned intervention. 
 
 
 
 
 
  
 
 
 
 
 
 
                 Figure 39. Planned intervention 
Trial Group Theatre Group Control Group 
(Re)- register asthmatics of year groups 7 and 8 in schools 
Baseline questionnaire 
Workshop 1: Theatre performance (whole 
year group) 
Workshop 2: 
Asthma general 
knowledge 
(asthmatics) 
Workshop 3: 
Symptoms and 
triggers 
(asthmatics) 
Workshop 4: 
Medication and 
emergencies 
(asthmatics) 
Workshop 5: 
Management and 
planning 
(asthmatics) 
Follow-up questionnaire (immediately post, 3, 6 and 12 months) 
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Recruitment 
The target population for this study is children with asthma in years seven and eight, who are attending 
secondary school in London. Recruitment will use the same strategy as the recruitment process discussed 
in this thesis. Maintaining allocation concealment, the schools will be randomised to one of the three 
intervention arms. As per my PhD research, the schools will be responsible for disseminating the 
information sheets and withdrawal forms to parents.  
Methodology  
The primary outcome will be asthma control, which will be measured using the ACT. The secondary 
outcomes will be medication adherence, which will be measured using the Medication Adherence Rating 
Scale [249]; unscheduled care, which will be measured using the questionnaire from this thesis (found in 
appendix three); asthma attitudes, which will be measured using the Brief Illness Perception Questionnaire 
[250]; school absences, which will be measured using the questionnaire from this thesis; asthma knowledge, 
which will be measured using a scale adapted from an earlier study about asthma [251]; and beliefs about 
asthma medication, which will be measured using the Beliefs about Medicine Questionnaire [252].  
As part of the theatre workshops, a play about asthma will be delivered to all students in years seven and 
eight, to facilitate awareness and understanding of asthma among the direct peer group. At the end of the 
theatre workshop, the main character will stay in role to encourage audience participation and discussion. 
As identified in the focus groups (discussed in chapter four), peer awareness was a key barrier to adherence 
among teenagers in schools. Through changing attitudes and awareness among peers, it is expected that 
students with asthma should feel less concerned about the social barriers that currently prevent positive 
self-management behaviours.  
Following the play, four self-management workshops will be delivered to children with asthma. Each 
workshop will last approximately one hour, and will include a series of games, role play, short films, and 
discussions. The main topics will include asthma general knowledge and understanding, GP 
communication, asthma triggers and symptoms, medication and emergency response, and self-management 
techniques and goal setting. The schools will also receive a toolkit, including emergency response posters, 
and advice on asthma friendly schools.  
Statistical Analysis and Study Power 
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Adjusting for a 15% attrition rate, a minimum of 360 children will be required for this study, from 18 
schools (six schools in each intervention arm; 20 students with asthma from each school). This sample size 
was calculated using my ACT score data (described in chapter three) as the primary outcome measure. This 
calculation is based on 80% power and a significance level of 5%, to test a 3-point difference in ACT 
scores. This was chosen as this is the minimal important difference. The standard deviation (SD = 4.3) that 
was used in the power calculation comes from the questionnaire data discussed in chapter three. The ACT 
was chosen to assess the outcome measure as this is a continuous outcome and is therefore more sensitive 
to differences in asthma control.  
The power calculation is adjusted to allow for Intracluster correlation (ICC), as is required for cluster 
randomised trials. An ICC of 0.07 was chosen, taken from a study of asthmatics where a questionnaire was 
the outcome measure, but the clusters were randomised to GP surgeries, rather than schools. This means 
that the ICC is likely to be a conservative estimate for this intervention, as children in different schools are 
likely to be less heterogeneous than patients in different GP surgeries. A fully copy of the protocol can be 
found in appendix 13 and is registered on the ClinicalTrials.gov database (reference MGU0400). 
6.3 Summary of Thesis Findings 
The findings from this study show concerning levels of asthma control, knowledge of asthma, and 
medication adherence among children and young people in London secondary schools. The findings from 
the focus groups also highlighted some of the barriers to medication adherence, including social concerns 
and incorrect medication beliefs. The levels of poorly controlled children with asthma seen in this thesis 
may contribute, at least in part, to furthering understanding of the reasons for excess paediatric deaths from 
asthma in the UK, compared with other European countries. The findings from the systematic review also 
showed that school-based self-management interventions can be effective in improving outcomes, 
particularly rates of unscheduled care and quality of life, however consideration must be given to the study 
design, in accordance with the outcomes of the process evaluation analysis.  
The findings from this thesis highlight the impact of poorly controlled asthma on quality of life, and the 
data from the questionnaire showed that the children with poorly controlled asthma, according to the ACT, 
had higher incidences of unplanned healthcare use and school absences. This mirrors existing findings, for 
example, Chapman et al [44] found that, in a sample of 10428 people with doctor-diagnosed asthma in 
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Toronto, 59% of those with uncontrolled asthma required at least one urgent care, or specialist visit, 
compared with 26% of those with well controlled asthma, and 15% of those with completely controlled 
asthma. The GINA guidelines ascertain that, in achieving good asthma control, rates of unscheduled care 
should reduce, therefore reducing the financial burden currently based on global healthcare systems. There 
is evidence from this thesis, given the findings of the systematic review, that school-based interventions 
may also contribute to a reduction in healthcare use, which may also ease the financial burden currently 
placed on healthcare systems.   
The National Review of Asthma Deaths, published in 2014 [14], found that incorrect beliefs about the risk 
of an adverse outcome was seen in children and young people who suffered a preventable death from 
asthma. This has also been shown in the Room to Breathe Survey [74], where parents also demonstrated 
highly optimistic views of their child’s asthma control, which could translate to the opinions of the children 
as they progress into adolescence. The children in the focus groups also revealed high thresholds when 
defining asthma control. Improvements in perceived asthma control, to correspond more closely with actual 
levels of control, have been associated with a reduction in asthma symptoms and other clinical markers of 
asthma control [253], and could be a step towards improving asthma self-management behaviours.  
Considering medication use, 2.3% of the students (n = 18) in this study were prescribed a SABA inhaler 
only, and scored the maximum of 25 on the ACT, concurrent with no asthma symptoms. This indicates that 
some students may have outgrown their asthma, or may have been incorrectly diagnosed, and suggests that, 
although small, there is evidence that some children with asthma are over-treated, and potentially need a 
step-down approach to treatment. Similarly, 9.8% of the children in this sample (n = 75) scored 19 or less 
on the ACT, indicative of suboptimal control; however these children also self-reported having a SABA 
inhaler only, and may therefore need to step-up their treatment. However, these conclusions are based on 
responses to the ACT only and would require further investigation by a doctor. Evidence of over and under 
treatment for asthma has also been reported in Denmark; one study found that 50% of people had been 
incorrectly diagnosed [254]. The absence of a gold-standard diagnostic test for asthma may be a possible 
explanation for over-treating asthma, and inhalers can be prescribed based on the presence of symptoms 
alone, without further testing for airway inflammation [34]. Under-treatment of asthma may originate from 
a historical reluctance from doctors to diagnose asthma too quickly, and provoking anxiety in parents and 
children.  
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Medication adherence was also concerning, with over half of the sample self-reporting that they do not 
always adhere with their treatment plans. Although it cannot be determined whether poor asthma control is 
related to inadequately prescribed treatment, or poor adherence to treatment plans, non-adherence in this 
sample was higher among students with poorly controlled asthma, despite knowledge of asthma 
medications being higher in this group. This suggests that poor adherence to medication may be 
contributing to the levels of control. The qualitative data found that non-adherence with asthma medication 
is more intentional than the questionnaire data indicated. Although not directly measured in this thesis, it 
could be that incorrect attitudes and beliefs towards medication are a contributing factor to adherent 
behaviours.  
                  6.3.1 Successes and Limitations 
This thesis is the first the UK to assess asthma control using the ACT in London secondary schools. One 
of the key successes of this study is the large dataset that was obtained (n = 766), and the broad geographical 
location of participating schools. However, data from the Governmental Department for Education 
indicates that there are approximately 495,665 students attending secondary school in London [148, 255]; 
according to Asthma UK, there are an average of three children in every school classroom with a diagnosis 
of asthma [6]. Therefore, there are an estimated 49,566 students in London secondary schools with asthma, 
based on an average class of 30 students [256]. Accordingly, the final sample of 766 children is 
representative of just 1.5% of all secondary school students with asthma in London, therefore the 
generalisability of the findings is limited.  
A second key strength of this study is the collection of data within the school environment. The school is 
an important location to consider for future research as it provides access to large numbers of children with 
asthma in one location, regarding of ethnicity, SES, or asthma severity. This includes children who do not 
regularly attend medical appointments. Collecting data in schools also reduces potential bias from 
parents/carers and/or clinicians regarding responses to questions. It is important that parental input was not 
included in the data collection, as children spend a large proportion of their day at school, away from their 
parents/carers.  
A third strength of this thesis is the qualitative data that was collected through the free-text part of the 
questionnaire, and subsequent focus groups. This provides greater insight into the attitudes and beliefs of 
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young people, which cannot be achieved through quantitative data alone. However, the ‘light-touch’ 
approach to the analysis of the qualitative data, as discussed in chapter four of this thesis, may arguably 
reduce the validity of the conclusions that were reached.  
Despite the notable successes of this thesis, there are also several limitations that should be considered. 
First, the data that was collected was self-reported, therefore the reliability of the findings may be reduced. 
The prescribed medication data was collected from the students, however it was not validated with clinical 
reports. Therefore, it is unclear whether the students were accurate in their reporting. For example, one 
student self-reported being on an unopposed LABA. This could be their genuine medication, however it is 
unlikely as it would not be recommended by a clinician; therefore may also indicate that some of the 
children could be unable to accurately recall their medication, despite being supported by photographs and 
a google search. Some students also self-reported that they had an ICS + LABA inhaler, however selected 
the option in the questions about this medicine that stated that they did not take this medication. This 
discrepancy in responses accounted for 5.7% of the total responses from children who reported using a 
preventer inhaler, however it is still an important consideration in the context of the findings.  
The self-reported data regarding prescribed medication was not validated by clinical records, as the 
questionnaire responses were anonymous, in line with the ethical considerations outlined in chapter three. 
Data was also not obtained regarding the prescribed dose of ICS medicine, nor the clinical justification for 
the dose. Therefore, it is unclear from the findings whether or not poorly controlled asthma is due to an 
inadequate medication prescription, poor adherence with the prescribed medication, or a combination of 
both of these factors.  
The self-reported data also raises questions about the reliability of the asthma control scores, as asthma 
control was measured using the ACT alone. Some of the students who scored 20 or above on the ACT, 
indicative of good asthma control, still self-reported days off school and instances of unplanned medical 
attention. It would be expected that children with well controlled asthma, according to the ACT, would not 
experience school absences due to their asthma, or unplanned medical visits. While this could be due to 
incorrect reporting from the students, it also raises questions about the reliability of the ACT measure. The 
ACT is not a perfect measure of asthma control, however it was chosen for this study as it was clinically 
validated in the target age group, and it can be completed by the children away from the clinical 
environment. It also covers a wider range of aspects related to asthma, with a scoring scale, therefore the 
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ACT provides a more detailed overview of a person’s asthma control. However, the ACT is limited in that 
the scores towards the cut-off point of 19 are subjective, and the clinical difference between a score of 19 
and a score of 20 is small, and the ACT does not consider differences in reporting between different people 
around this score point. A limitation of this study is that the ACT scores were not supported by spirometry, 
to give a better indication of clinical state.  
The self-report nature of the data also limits the reliability of the findings, as it remains possible that some 
students were not honest with their responses, therefore increasing risk of social desirability bias. Some 
students could have answered the questions, based on how they wished to be perceived, rather than based 
on true experience. Although this risk was reduced where possible by ensuring that all responses were 
anonymous, and could not be linked back to them, due to the layout of some classrooms, it is possible that 
the students could see each other’s computer screens, which may have influenced the data that was reported.  
The recruitment process also served as a key limitation to this thesis, particularly the generalisability of the 
findings. An opportunistic sampling method was used for recruitment, and schools were only included if 
they were interested. All of the secondary schools in London were contacted and were invited to participate, 
however only 24 schools accepted the invitation. This yielded a very low response rate, and represented 
4% of all the eligible schools in London. Therefore, the results may therefore not be generalizable to the 
wider London secondary school population. The individual asthma policies for each school were also not 
considered, nor was any history of the school participating in any other research separate to this one.  
There was also a low response rate from the students within the participating schools. The total sample size 
represented 57.2% of all eligible students across all the schools. Therefore, the findings in this thesis are 
only reflective of just over half of the student body across all the participating schools. The proportion of 
children with poor asthma control, or with unplanned medical visits, for example, would likely be very 
different if the response rate across the participating schools had been closer to 100%. Among the students 
who did participate, there was a 40% non-response bias, which also significantly reduces the representation 
of the findings. Similarly, the generalisability of the findings is also limited due to the increased proportion 
of black and ethnic minority students in the sample, compared with the London population [257]. However, 
the ethnic diversity in the current sample does reflect the ethnic variation in some areas of London, 
particularly in East London boroughs, where a large proportion of the schools were recruited from.  
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The ethical approval obtained by the REC stipulated that students were only eligible if they had doctor-
diagnosed asthma, and were identified by the school. Therefore, no screening process was imposed for 
children before their participation. Students were identified either by an official school register, or by school 
staff. Therefore, it is likely that some eligible children were not invited to participate, due to inaccurate 
reporting by the schools. This study did highlight a problem with the recording of asthmatics in the 
participating secondary schools, with many schools reporting far fewer asthmatics than would be expected. 
Currently, no data exists on the prevalence of children with asthma in London secondary schools, however 
data from Scotland indicates that the prevalence of asthma in Scottish primary schools is 14% of the student 
body [74]. The current data found that the lowest asthma prevalence in the schools was 4.6% of the student 
body, and one school reported just 12 asthmatics out of 1256 enrolled students. On speaking with the 
teachers about their methods of recording health data for the students, it is understood that medical 
information is collected when the students join the school, however it is not clear whether these records are 
updated regularly. This highlights a need for a more comprehensive registration of asthmatic children in 
London schools. However, it may also be that some children and/or their parents are reluctant to identify 
as asthmatic.  
Despite some major limitations, the research reported in this thesis clearly showed that an online 
questionnaire is a highly effective way of obtaining data on asthma from large numbers of children in 
secondary schools. When combined with parental opt/out consent, and student assent, I argue that this 
method of data collection is a useful way of accessing large numbers of children to generate large amounts 
of data in a cost-effective way. An estimation of the costings has shown that the intervention will cost 
approximately £458,000 (including researcher costs and hosting the intervention), amounting to 
approximately £420 per child. Combined with the findings from the systematic review, the school 
environment can be considered an important third space for delivering interventions aimed at improving 
outcomes for children with asthma. Despite the limitations regarding the representativeness of the data, the 
findings highlight a concern regarding asthma control and medication adherence in London secondary 
schools, and support the need for a school-based self-management intervention to address this.  
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  6.4 Final Conclusions 
The level of poorly controlled asthma in children attending London secondary schools is of significant 
concern, I found evidence that poor control may be due to a number of barriers, both social and practical, 
which contribute to improper management of the condition. Although the study was a small sample and 
non-random, of asthmatic children in London, it still provides an indication to the disease burden of asthma 
unselected (by willingness of clinical centres to engage with research), young people, and it therefore 
provides some insights into the drivers for disproportionally high rates of asthma-related morbidity and 
mortality in the UK, compared with elsewhere in Europe. My findings support the current literature 
evidencing high rates of poorly controlled asthma, and ineffective management strategies, in children. Thus, 
a school-based self-management intervention could be an effective means of improving asthma control, 
through improved awareness in schools and improved education for asthma sufferers.  
In addition to bridging the gap in the current UK literature, this study has also demonstrated impact in 
several ways. First, the team have worked collaboratively with the Healthy London Partnership on an 
asthma toolkit for schools (found here: https://www.healthylondon.org/resource/london-asthma-toolkit/). 
This toolkit is an online resource for healthcare professionals, school staff, parents/guardians, and children 
and young people. Within the toolkit are a number of resources for individuals, including links to school 
asthma policies, latest evidence, video resources describing what asthma is, what to do in an emergency, 
downloadable PDF files of asthma action plans, to support the management of asthma away from the 
clinical environment. The research team have worked with the Healthy London Partnership to develop the 
school’s component of the toolkit. Included within this are an asthma board game, to be included as part of 
the intervention to teach children about when to use asthma medication. The Healthy London Partnership 
also acted in an advisory role to support the development of the intervention to be piloted in schools. During 
the piloting of the intervention, the Healthy London Partnership will support the research team to 
disseminate information about the project and aid with the recruitment of schools through including 
information about the project on their website and on their twitter account.   
 
 
 
249 
 
Bibliography 
1. Masoli M, Fabian D, Holt S, Beasley R: The global burden of asthma: executive 
summary of the GINA Dissemination Committee report. Allergy 2004, 59(5):469-478. 
2. (GINA) GIfA: Global Strategy for Asthma Management and Prevention, 2016. . In.; 
2016. 
3. Forno E, Celedón JC: Predicting asthma exacerbations in children. Current opinion in 
pulmonary medicine 2012, 18(1):63. 
4. Reddel HK, Taylor DR, Bateman ED, Boulet L-P, Boushey HA, Busse WW, Casale TB, 
Chanez P, Enright PL, Gibson PG: An official American Thoracic Society/European 
Respiratory Society statement: asthma control and exacerbations: standardizing 
endpoints for clinical asthma trials and clinical practice. American journal of 
respiratory and critical care medicine 2009, 180(1):59-99. 
5. Bahadori K, Doyle-Waters MM, Marra C, Lynd L, Alasaly K, Swiston J, FitzGerald JM: 
Economic burden of asthma: a systematic review. BMC pulmonary medicine 2009, 
9(1):24. 
6. UK A: Asthma Facts and FAQ. 2014. 
7. Moonie SA, Sterling DA, Figgs L, Castro M: Asthma status and severity affects missed 
school days. Journal of School Health 2006, 76(1):18. 
8. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X: Interventions for enhancing 
medication adherence. Cochrane database syst Rev 2008, 2(2). 
9. Horne R: Compliance, adherence, and concordance: implications for asthma 
treatment. CHEST Journal 2006, 130(1_suppl):65S-72S. 
10. Strandbygaard U, Thomsen SF, Backer V: A daily SMS reminder increases adherence 
to asthma treatment: a three-month follow-up study. Respiratory medicine 2010, 
104(2):166-171. 
11. Aronson JK: Compliance, concordance, adherence. British journal of clinical 
pharmacology 2007, 63(4):383-384. 
12. Colice GL: Categorizing asthma severity: an overview of national guidelines. Clinical 
medicine & research 2004, 2(3):155-163. 
13. Holgate ST: A brief history of asthma and its mechanisms to modern concepts of 
disease pathogenesis. Allergy, asthma & immunology research 2010, 2(3):165-171. 
14. Levy M, Andrews R, Buckingham R, Evans H, Francis C, Houston R, Lowe D, Nasser S, 
Paton J, Puri N: Why asthma still kills: The national review of asthma deaths (NRAD): 
Royal College of Physcians; 2014. 
15. Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, Cullinan P, Custovic A, 
Ducharme FM, Fahy JV: After asthma: redefining airways diseases. The Lancet 2017. 
16. SIGN BTS: British guideline on the management of asthma. A national clinical 
guideline. In.; 2014. 
17. Braman SS: The global burden of asthma. Chest Journal 2006, 130(1_suppl):4S-12S. 
18. Bousquet J, Mantzouranis E, Cruz AA, Aït-Khaled N, Baena-Cagnani CE, Bleecker ER, 
Brightling CE, Burney P, Bush A, Busse WW: Uniform definition of asthma severity, 
control, and exacerbations: document presented for the World Health Organization 
Consultation on Severe Asthma. Journal of Allergy and Clinical Immunology 2010, 
126(5):926-938. 
19. Ait‐Khaled N, Odhiambo J, Pearce N, Adjoh K, Maesano I, Benhabyles B, Bouhayad Z, 
Bahati E, Camara L, Catteau C: Prevalence of symptoms of asthma, rhinitis and 
eczema in 13‐to 14‐year‐old children in Africa: the International study of asthma and 
allergies in childhood phase III. Allergy 2007, 62(3):247-258. 
20. Network GA: The Global Asthma Report. In. Aukland, New Zealand; 2014. 
250 
 
21. Lai C, Beasley R, Crane J, Foliaki S, Shah J, Weiland S: Global variation in the 
prevalence and severity of asthma symptoms: phase three of the International Study 
of Asthma and Allergies in Childhood (ISAAC). Thorax 2009. 
22. Mallol J, Crane J, von Mutius E, Odhiambo J, Keil U, Stewart A, Group IPTS: The 
International Study of Asthma and Allergies in Childhood (ISAAC) phase three: a 
global synthesis. Allergologia et immunopathologia 2013, 41(2):73-85. 
23. To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, Boulet L-P: Global 
asthma prevalence in adults: findings from the cross-sectional world health survey. 
BMC public health 2012, 12(1):204. 
24. D'Amato G, Cecchi L, D'Amato M, Liccardi G: Urban air pollution and climate change 
as environmental risk factors of respiratory allergy: an update. Journal of 
investigational allergology & clinical immunology 2010, 20(2):95-102; quiz following 
102. 
25. Luks VP, Vandemheen KL, Aaron S: Confirmation of asthma in an era of overdiagnosis. 
European Respiratory Journal 2010, 36(2):255-260. 
26. Van Weel C: Underdiagnosis of asthma and COPD: is the general practitioner to 
blame? Monaldi archives for chest disease 2002, 57(1):65-68. 
27. Speight A, Lee D, Hey E: Underdiagnosis and undertreatment of asthma in childhood. 
Br Med J (Clin Res Ed) 1983, 286(6373):1253-1256. 
28. (NICE) NIfHaCE: Asthma Quality Standard. 2013. 
29. Bush A, Grigg J, Saglani S: Managing wheeze in preschool children. BMJ 2014, 
348:g15. 
30. Taussig LM, Wright AL, Holberg CJ, Halonen M, Morgan WJ, Martinez FD: Tucson 
children's respiratory study: 1980 to present. Journal of Allergy and Clinical 
Immunology 2003, 111(4):661-675. 
31. Speight AN, Lee DA, Hey EN: Underdiagnosis and undertreatment of asthma in 
childhood. BMJ 1983, 286(6373):1253-1256. 
32. Marchant JM, Masters IB, Taylor SM, Cox NC, Seymour GJ, Chang AB: Evaluation and 
outcome of young children with chronic cough. CHEST Journal 2006, 129(5):1132-
1141. 
33. LindenSmith J, Morrison D, Deveau C, Hernandez P: Overdiagnosis of asthma in the 
community. Canadian respiratory journal: journal of the Canadian Thoracic Society 
2004, 11(2):111-116. 
34. Bush A, Fleming L: Is asthma overdiagnosed? Archives of Disease in Childhood 
2016:archdischild-2015-309053. 
35. Mundasad S: Asthma 'over-diagnosed and trivialised'. In. BBC; 2016. 
36. Chronic Repsiratory Diseases, Deaths per 100 000 Data by country  
37. Network GA: The Global Asthma Report; 2014. Auckland, New Zealand 2014. 
38. Ebmeier S, Thayabaran D, Braithwaite I, Bénamara C, Weatherall M, Beasley R: Trends 
in international asthma mortality: analysis of data from the WHO Mortality Database 
from 46 countries (1993–2012). The Lancet 2017, 390(10098):935-945. 
39. Wolfe I, Thompson M, Gill P, Tamburlini G, Blair M, Van Den Bruel A, Ehrich J, 
Pettoello-Mantovani M, Janson S, Karanikolos M: Health services for children in 
western Europe. The Lancet 2013, 381(9873):1224-1234. 
40. Anagnostou K, Harrison B, Iles R, Nasser S: Risk factors for childhood asthma deaths 
from the UK Eastern Region Confidential Enquiry 2001–2006. Primary Care 
Respiratory Journal 2012, 21(1):71-77. 
41. Chilmonczyk BA, Salmun LM, Megathlin KN, Neveux LM, Palomaki GE, Knight GJ, 
Pulkkinen AJ, Haddow JE: Association between exposure to environmental tobacco 
smoke and exacerbations of asthma in children. New England journal of medicine 
1993, 328(23):1665-1669. 
42. Millett C, Lee JT, Laverty AA, Glantz SA, Majeed A: Hospital admissions for childhood 
asthma after smoke-free legislation in England. Pediatrics 2013, 131(2):e495-e501. 
251 
 
43. Beasley R, Crane J: Reducing asthma mortality with the asthma self-management 
plan system of care. American journal of respiratory and critical care medicine 2001, 
163(1):3-4. 
44. Chapman K, Boulet L, Rea RM, Franssen E: Suboptimal asthma control: prevalence, 
detection and consequences in general practice. European Respiratory Journal 2008, 
31(2):320-325. 
45. Control CfD, Prevention: Vital signs: asthma prevalence, disease characteristics, and 
self-management education: United States, 2001--2009. MMWR Morbidity and 
mortality weekly report 2011, 60(17):547. 
46. Wilson DH, Adams RJ, Appleton SL, Hugo G, Wilkinson D, Hiller J, Ryan P, Cheek J, 
Ruffin RE: Prevalence of asthma and asthma action plans in South Australia: 
population surveys from 1990 to 2001. Medical journal of Australia 2003, 
178(10):483-485. 
47. Cazzoletti L, Marcon A, Janson C, Corsico A, Jarvis D, Pin I, Accordini S, Almar E, Bugiani 
M, Carolei A: Asthma control in Europe: a real-world evaluation based on an 
international population-based study. Journal of allergy and clinical immunology 
2007, 120(6):1360-1367. 
48. Levy ML: The national review of asthma deaths: what did we learn and what needs 
to change? Breathe 2015, 11(1):14. 
49. Society ER: Adult Asthma. In: European Lung White Book. edn.; 2011. 
50. Childhood Asthma. In: The European Lung Whitebook. edn.: European Respiratory 
Society; 2011. 
51. Murray CS, Poletti G, Kebadze T, Morris J, Woodcock A, Johnston S, Custovic A: Study 
of modifiable risk factors for asthma exacerbations: virus infection and allergen 
exposure increase the risk of asthma hospital admissions in children. Thorax 2006, 
61(5):376-382. 
52. Mitchell E: International trends in hospital admission rates for asthma. Archives of 
disease in childhood 1985, 60(4):376-378. 
53. Godard P, Chanez P, Siraudin L, Nicoloyannis N, Duru G: Costs of asthma are 
correlated with severity: a 1-yr prospective study. European Respiratory Journal 2001, 
19(1):61-67. 
54. Herjavecz I, Boszormenyi Nagy G, Gyurkovits K, Magyar P, Dobos K, Nagy L, Alemao E, 
Ben-Joseph R: Cost, morbidity, and control of asthma in Hungary: The Hunair Study. 
Journal of Asthma 2003, 40(6):673-681. 
55. Antonicelli L, Bucca C, Neri M, De Benedetto F, Sabbatani P, Bonifazi F, Eichler HG, 
Zhang Q, Yin D: Asthma severity and medical resource utilisation. European 
Respiratory Journal 2004, 23(5):723-729. 
56. Griffiths C, Foster G, Barnes N, Eldridge S, Tate H, Begum S, Wiggins M, Dawson C, 
Livingstone AE, Chambers M: Specialist nurse intervention to reduce unscheduled 
asthma care in a deprived multiethnic area: the east London randomised controlled 
trial for high risk asthma (ELECTRA). BMj 2004, 328(7432):144. 
57. Kamps A, Roorda R, Kimpen J, Overgoor-van de Groes A, van Helsdingen-Peek L, Brand 
P: Impact of nurse-led outpatient management of children with asthma on 
healthcare resource utilisation and costs. European Respiratory Journal 2004, 
23(2):304-309. 
58. Asthma [http://www.who.int/mediacentre/factsheets/fs307/en/] 
59. (GINA) GIfA: From the Global Strategy for Asthma Management and Prevention. 
2015. 
60. Gustafsson P, Watson L, Davis K, Rabe K: Poor asthma control in children: evidence 
from epidemiological surveys and implications for clinical practice. International 
journal of clinical practice 2006, 60(3):321-334. 
252 
 
61. Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB, Weiss ST: Worldwide 
severity and control of asthma in children and adults: the global asthma insights and 
reality surveys. Journal of Allergy and Clinical Immunology 2004, 114(1):40-47. 
62. Liebl A, Neiss A, Spannheimer A, Reitberger U, Wagner T, Görtz A: [Costs of type 2 
diabetes in Germany. Results of the CODE-2 study]. Deutsche medizinische 
Wochenschrift (1946) 2001, 126(20):585-589. 
63. Peyrot M, Rubin RR, Lauritzen T, Snoek FJ, Matthews DR, Skovlund SE: Psychosocial 
problems and barriers to improved diabetes management: results of the Cross‐
National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabetic medicine 
2005, 22(10):1379-1385. 
64. Vermeire P, Rabe K, Soriano J, Maier W: Asthma control and differences in 
management practices across seven European countries. Respiratory medicine 2002, 
96(3):142-149. 
65. Network BTSSIG: British Guideline on the Management of Asthma. In.; 2014. 
66. Thomas M, Gruffydd-Jones K, Stonham C, Ward S, Macfarlane TV: Assessing asthma 
control in routine clinical practice: use of the Royal College of Physicians '3 
questions'. Prim Care Respir J 2009, 18(2):83-88. 
67. Andrews G, Lo D, Richardson M, Gaillard E: S63 Do the royal college of physicians 
‘three questions’ predict symptom control in paediatric asthma? Thorax 2017, 
72(Suppl 3):A40-A40. 
68. Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA, Kosinski M, Pendergraft 
TB, Jhingran P: Asthma Control Test: reliability, validity, and responsiveness in 
patients not previously followed by asthma specialists. Journal of Allergy and Clinical 
Immunology 2006, 117(3):549-556. 
69. Ko FW, Hui DS, LEUNG TF, CHU HY, Wong GW, Tung AH, Ngai JC, Ng SS, Lai CK: 
Evaluation of the asthma control test: a reliable determinant of disease stability and 
a predictor of future exacerbations. respirology 2012, 17(2):370-378. 
70. Pijnenburg MW, Baraldi E, Brand PL, Carlsen K-H, Eber E, Frischer T, Hedlin G, Kulkarni 
N, Lex C, Mäkelä MJ: Monitoring asthma in children. European Respiratory Journal 
2015:ERJ-00888-02014. 
71. Olajos-Clow J, Minard J, Szpiro K, Juniper EF, Turcotte S, Jiang X, Jenkins B, Lougheed 
MD: Validation of an electronic version of the Mini Asthma Quality of Life 
Questionnaire. Respiratory Medicine 2010, 104(5):658-667. 
72. Juniper EF, Guyatt GH, Cox FM, Ferrie PJ, King DR: Development and validation of the 
Mini Asthma Quality of Life Questionnaire. The European respiratory journal 1999, 
14(1):32-38. 
73. Demoly P, Paggiaro P, Plaza V, Bolge S, Kannan H, Sohier B, Adamek L: Prevalence of 
asthma control among adults in France, Germany, Italy, Spain and the UK. European 
Respiratory Review 2009, 18(112):105-112. 
74. Carroll W, Wildhaber J, Brand P: Parent misperception of control in 
childhood/adolescent asthma: the Room to Breathe survey. European Respiratory 
Journal 2012, 39(1):90-96. 
75. Patterson EE, Brennan MP, Linskey KM, Webb DC, Shields MD, Patterson CC: A cluster 
randomised intervention trial of asthma clubs to improve quality of life in primary 
school children: the School Care and Asthma Management Project (SCAMP). Arch Dis 
Child 2005, 90(8):786-791. 
76. McWhirter J, McCann D, Coleman H, Calvert M, Warner J: Can schools promote the 
health of children with asthma? Health education research 2008, 23(6):917-930. 
77. Bateman E, Hurd S, Barnes P, Bousquet J, Drazen J, FitzGerald M, Gibson P, Ohta K, 
O'byrne P, Pedersen S: Global strategy for asthma management and prevention: 
GINA executive summary. European Respiratory Journal 2008, 31(1):143-178. 
253 
 
78. Barlow J, Wright C, Sheasby J, Turner A, Hainsworth J: Self-management approaches 
for people with chronic conditions: a review. Patient education and counseling 2002, 
48(2):177-187. 
79. Kotses H, Creer TL: Asthma self-management. In: Asthma, Health and Society. edn.: 
Springer; 2010: 117-139. 
80. Gibson PG, Powell H, Coughlan J, Wilson A, Abramson M, Haywood P, Bauman A, 
Hensley M, Walters E: Self-management education and regular practitioner review 
for adults with asthma. Cochrane Database Syst Rev 2002, 3. 
81. Guevara JP: Effects of educational interventions for self management of asthma in 
children and adolescents: Systematic review and meta-analysis. British Medical 
Journal (BMJ) 2003, 326(7402):1308-1309. 
82. Gibson PG, Powell H, Coughlan J, Wilson A, Hensley M, Abramson M, Bauman A, 
Walters E: Limited (information only) patient education programs for adults with 
asthma. Cochrane Database Syst Rev 2002, 2. 
83. Coffman JM, Cabana MD, Yelin EH: Do school-based asthma education programs 
improve self-management and health outcomes? Pediatrics 2009, 124(2):729-742. 
84. Brown N, Gallagher R, Fowler C, Wales S: Asthma management self-efficacy in parents 
of primary school-age children. Journal of Child Health Care 2014, 18(2):133-144. 
85. Mancuso CA, Sayles W, Allegrante JP: Knowledge, attitude, and self-efficacy in 
asthma self-management and quality of life. Journal of Asthma 2010, 47(8):883-888. 
86. Rhee H, Belyea MJ, Ciurzynski S, Brasch J: Barriers to asthma self‐management in 
adolescents: Relationships to psychosocial factors. Pediatric pulmonology 2009, 
44(2):183-191. 
87. Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M, Nieminen MM, 
Kontula E, Laitinen LA: A 10 year asthma programme in Finland: major change for the 
better. Thorax 2006, 61(8):663-670. 
88. Gibson P, Powell H: Written action plans for asthma: an evidence-based review of the 
key components. Thorax 2004, 59(2):94-99. 
89. Sulaiman N, Barton C, Abramson M, Liaw T, Harris C, Chondros P, Dharmage S, Clarke 
D: Factors associated with ownership and use of written asthma action plans in 
North-West Melbourne. Primary Care Respiratory Journal 2004, 13(4):211-217. 
90. Partridge M: Written asthma action plans. Thorax 2004, 59(2):87-88. 
91. Price D: Delivery of asthma care: patients' use of and views on healthcare services. 
Asthma Journal 2000, 5:141-143. 
92. Morrison D, Mair FS, Yardley L, Kirby S, Thomas M: Living with asthma and chronic 
obstructive airways disease: Using technology to support self-management–An 
overview. Chronic respiratory disease 2016:1479972316660977. 
93. Lewis I, Lenehan C: Report of the children and young people’s health outcomes 
forum. In: London: Children and Young People’s Health Outcomes Forum: 2012; 2012. 
94. Ahmad E, Grimes DE: The effects of self-management education for school-age 
children on asthma morbidity: a systematic review. The Journal of school nursing : the 
official publication of the National Association of School Nurses 2011, 27(4):282-292. 
95. Bruzzese JM, Sheares BJ, Vincent EJ, Du Y, Sadeghi H, Levison MJ, Mellins RB, Evans D: 
Effects of a school-based intervention for urban adolescents with asthma. A 
controlled trial. Am J Respir Crit Care Med 2011, 183(8):998-1006. 
96. Jones MA: Asthma self-management patient education. Respiratory care 2008, 
53(6):778-786. 
97. Organization WH: Adherence to long-term therapies: Evidence for action. Geneva: 
World Health Organization; 2003. In.: WHO/MNC/03.01; 2014. 
98. Sabaté E: Adherence to long-term therapies: evidence for action: World Health 
Organization; 2003. 
99. Heaney LG, Horne R: Non-adherence in difficult asthma: time to take it seriously. 
Thorax 2012, 67(3):268-270. 
254 
 
100. Pearson M: Measuring clinical outcomes in asthma: a patient centred approach. In.: 
London, Royal College of Physicians; 1999. 
101. Journal TP: Survey reveals poor compliance with asthma therapy in UK patients. In. 
Online; 2005. 
102. Desai M, Oppenheimer JJ: Medication adherence in the asthmatic child and 
adolescent. Current allergy and asthma reports 2011, 11(6):454-464. 
103. Bender B, Wamboldt F, O'Connor SL, Rand C, Szefler S, Milgrom H, Wamboldt MZ: 
Measurement of children's asthma medication adherence by self report, mother 
report, canister weight, and Doser CT. Annals of Allergy, Asthma & Immunology 2000, 
85(5):416-421. 
104. Main J, Weinman J, Horne R: Explaining adherence to preventer medication in 
asthma. Int J Behav Med 2004, 11(Suppl):72. 
105. Gillissen A: Patients' adherence in asthma. Journal of physiology and pharmacology 
2007, 58(5):205-222. 
106. Dinwiddie R, Müller W: Adolescent treatment compliance in asthma. Journal of the 
Royal Society of Medicine 2002, 95(2):68-71. 
107. Velsor-Friedrich B, Vlasses F, Moberley J, Coover L: Talking with teens about asthma 
management. The Journal of School Nursing 2004, 20(3):140-148. 
108. Baddar S, Jayakrishnan B, Al-Rawas OA: Asthma control: importance of compliance 
and inhaler technique assessments. Journal of asthma 2014, 51(4):429-434. 
109. Haughney J, Price D, Kaplan A, Chrystyn H, Horne R, May N, Moffat M, Versnel J, 
Shanahan ER, Hillyer EV: Achieving asthma control in practice: understanding the 
reasons for poor control. Respiratory medicine 2008, 102(12):1681-1693. 
110. Cochrane MG, Bala MV, Downs KE, Mauskopf J, Ben-Joseph RH: Inhaled 
corticosteroids for asthma therapy: patient compliance, devices, and inhalation 
technique. Chest 2000, 117(2):542-550. 
111. McQuaid EL, Kopel SJ, Klein RB, Fritz GK: Medication adherence in pediatric asthma: 
reasoning, responsibility, and behavior. Journal of pediatric psychology 2003, 
28(5):323-333. 
112. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL: How often is 
medication taken as prescribed?: A novel assessment technique. Jama 1989, 
261(22):3273-3277. 
113. Bender BG: Overcoming barriers to nonadherence in asthma treatment. Journal of 
Allergy and Clinical Immunology 2002, 109(6):S554-S559. 
114. Buston KM, Wood SF: Non-compliance amongst adolescents with asthma: listening to 
what they tell us about self-management. Family Practice 2000, 17(2):134-138. 
115. Rand CS: Non-adherence with asthma therapy: more than just forgetting. The Journal 
of pediatrics 2005, 146(2):157-159. 
116. Apter AJ, Reisine ST, Affleck G, Barrows E, ZuWallack RL: Adherence with twice-daily 
dosing of inhaled steroids: socioeconomic and health-belief differences. American 
Journal of Respiratory and Critical Care Medicine 1998, 157(6):1810-1817. 
117. Haas JS, Cleary PD, Guadagnoli E, Fanta C, Epstein AM: The impact of socioeconomic 
status on the intensity of ambulatory treatment and health outcomes after hospital 
discharge for adults with asthma. Journal of general internal medicine 1994, 9(3):121-
126. 
118. Mansour ME, Lanphear BP, DeWitt TG: Barriers to asthma care in urban children: 
parent perspectives. Pediatrics 2000, 106(3):512-519. 
119. Apter AJ, Boston RC, George M, Norfleet AL, Tenhave T, Coyne JC, Birck K, Reisine ST, 
Cucchiara AJ, Feldman HI: Modifiable barriers to adherence to inhaled steroids 
among adults with asthma: it's not just black and white. Journal of Allergy and Clinical 
Immunology 2003, 111(6):1219-1226. 
120. Conn KM, Halterman JS, Lynch K, Cabana MD: The impact of parents' medication 
beliefs on asthma management. Pediatrics 2007, 120(3):e521-e526. 
255 
 
121. Cramer JA: A systematic review of adherence with medications for diabetes. Diabetes 
care 2004, 27(5):1218-1224. 
122. Vervloet M, Linn AJ, van Weert JC, De Bakker DH, Bouvy ML, Van Dijk L: The 
effectiveness of interventions using electronic reminders to improve adherence to 
chronic medication: a systematic review of the literature. Journal of the American 
Medical Informatics Association 2012, 19(5):696-704. 
123. Jimmy B, Jose J: Patient medication adherence: measures in daily practice. Oman 
medical journal 2011, 26(3):155. 
124. Gibson P, Henry R, Vimpani G, Halliday J: Asthma knowledge, attitudes, and quality of 
life in adolescents. Archives of disease in childhood 1995, 73(4):321-326. 
125. Ho J, Bender BG, Gavin LA, O'Connor SL, Wamboldt MZ, Wamboldt FS: Relations 
among asthma knowledge, treatment adherence, and outcome. Journal of Allergy 
and Clinical Immunology 2003, 111(3):498-502. 
126. Tettersell MJ: Asthma patients’ knowledge in relation to compliance with drug 
therapy. Journal of advanced nursing 1993, 18(1):103-113. 
127. Bernard-Bonnin A-C, Stachenko S, Bonin D, Charette C, Rousseau E: Self-management 
teaching programs and morbidity of pediatric asthma: a meta-analysis. Journal of 
Allergy and Clinical Immunology 1995, 95(1):34-41. 
128. Bender B, Milgrom H, Rand C, Ackerson L: Psychological factors associated with 
medication nonadherence in asthmatic children. Journal of Asthma 1998, 35(4):347-
353. 
129. Mancuso CA, Rincon M: Impact of health literacy on longitudinal asthma outcomes. 
Journal of General Internal Medicine 2006, 21(8):813-817. 
130. Barton C, Abramson M, Aroni R, Stewart K, Thien F, Sawyer S: What determines 
knowledge of asthma among young people and their families? Journal of Asthma 
2002, 39(8):701-709. 
131. Sin M-K, Kang D-H, Weaver M: Relationships of asthma knowledge, self-management, 
and social support in African American adolescents with asthma. International 
journal of nursing studies 2005, 42(3):307-313. 
132. Fitzclarence C, Henry R: Validation of an asthma knowledge questionnaire. Journal of 
paediatrics and child health 1990, 26(4):200-204. 
133. Scherer YK, Bruce S: Knowledge, attitudes, and self-efficacy and compliance with 
medical regimen, number of emergency department visits, and hospitalizations in 
adults with asthma. Heart & Lung: The Journal of Acute and Critical Care 2001, 
30(4):250-257. 
134. Crocker DD, Kinyota S, Dumitru GG, Ligon CB, Herman EJ, Ferdinands JM, Hopkins DP, 
Lawrence BM, Sipe TA: Effectiveness of home-based, multi-trigger, multicomponent 
interventions with an environmental focus for reducing asthma morbidity: a 
community guide systematic review. American journal of preventive medicine 2011, 
41(2):S5-S32. 
135. Newcomb P: Results of an asthma disease management program in an urban 
pediatric community clinic. Journal for Specialists in Pediatric Nursing 2006, 11(3):178-
188. 
136. Cicutto L: Supporting successful asthma management in schools: the role of asthma 
care providers. Journal of Allergy and Clinical Immunology 2009, 124(2):390-393. 
137. Baisch MJ, Lundeen SP, Murphy MK: Evidence‐Based Research on the Value of School 
Nurses in an Urban School System. Journal of School Health 2011, 81(2):74-80. 
138. Guttu M, Engelke MK, Swanson M: Does the School Nurse‐to‐Student Ratio Make a 
Difference? Journal of School Health 2004, 74(1):6-9. 
139. Rodriguez E, Rivera DA, Perlroth D, Becker E, Wang NE, Landau M: School nurses' role 
in asthma management, school absenteeism, and cost savings: a demonstration 
project. Journal of School Health 2013, 83(12):842-850. 
256 
 
140. Muraro A, Clark A, Beyer K, Borrego L, Borres M, Lødrup Carlsen K, Carrer P, Mazon A, 
Rancè F, Valovirta E: The management of the allergic child at school: EAACI/GA2LEN 
Task Force on the allergic child at school. Allergy 2010, 65(6):681-689. 
141. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft 
TB: Development of the asthma control test: a survey for assessing asthma control. 
Journal of Allergy and Clinical Immunology 2004, 113(1):59-65. 
142. What is public involvement in research? [http://www.invo.org.uk/find-out-
more/what-is-public-involvement-in-research-2/] 
143. Staley K: There is no paradox with PPI in research. Journal of medical ethics 2013, 
39(3):186-187. 
144. Pijnenburg MW, Baraldi E, Brand PLP, Carlsen KH, Eber E, Frischer T, Hedlin G, Kulkarni 
N, Lex C, Mäkelä MJ et al: Monitoring asthma in children. European Respiratory 
Journal 2015, 45(4):906-925. 
145. Patalay P, Deighton J, Fonagy P, Vostanis P, Wolpert M: Clinical validity of the Me and 
My School questionnaire: a self-report mental health measure for children and 
adolescents. Child and adolescent psychiatry and mental health 2014, 8(1):1-7. 
146. Weil CM, Wade SL, Bauman LJ, Lynn H, Mitchell H, Lavigne J: The relationship between 
psychosocial factors and asthma morbidity in inner-city children with asthma. 
Pediatrics 1999, 104(6):1274-1280. 
147. Widening Participation and Access 
[http://www.qmul.ac.uk/undergraduate/teachers/wp/index.html] 
148. National Statistics: Schools, Pupils and their Characteristics: January 2012 
[https://www.gov.uk/government/statistics/schools-pupils-and-their-characteristics-
january-2012 ] 
149. Postma DS: Gender differences in asthma development and progression. Gender 
Medicine 2007, 4:S133-S146. 
150. Netuveli G, Hurwitz B, Levy M, Fletcher M, Barnes G, Durham SR, Sheikh A: Ethnic 
variations in UK asthma frequency, morbidity, and health-service use: a systematic 
review and meta-analysis. The Lancet 2005, 365(9456):312-317. 
151. White J, Paton JY, Niven R, Pinnock H: Guidelines for the diagnosis and management 
of asthma: a look at the key differences between BTS/SIGN and NICE. Thorax 
2018:thoraxjnl-2017-211189. 
152. Edgecombe K, Latter S, Peters S, Roberts G: Health experiences of adolescents with 
uncontrolled severe asthma. Archives of disease in childhood 
2010:archdischild171579. 
153. Naimi DR, Freedman TG, Ginsburg KR, Bogen D, Rand CS, Apter AJ: Adolescents and 
asthma: why bother with our meds? Journal of Allergy and Clinical Immunology 2009, 
123(6):1335-1341. 
154. Mammen JR, Rhee H, Norton SA, Butz AM: Perceptions and experiences underlying 
self-management and reporting of symptoms in teens with asthma. The Journal of 
asthma : official journal of the Association for the Care of Asthma 2016:0. 
155. Patterson E, Brennan M, Linskey K, Webb D, Shields M, Patterson C: A cluster 
randomised intervention trial of asthma clubs to improve quality of life in primary 
school children: the School Care and Asthma Management Project (SCAMP). Archives 
of disease in childhood 2005, 90(8):786-791. 
156. Wiseman T, Lucas G, Sangha A, Randolph A, Stapleton S, Pattison N, O'Gara G, Harris K, 
Pritchard-Jones K, Dolan S: Insights into the experiences of patients with cancer in 
London: framework analysis of free-text data from the National Cancer Patient 
Experience Survey 2012/2013 from the two London Integrated Cancer Systems. BMJ 
open 2015, 5(10):e007792. 
157. Greenbaum TL: The handbook for focus group research: Sage; 1998. 
158. Braun V, Clarke V: Using thematic analysis in psychology. Qualitative research in 
psychology 2006, 3(2):77-101. 
257 
 
159. King N: Using templates in the thematic analysis of text. Essential guide to qualitative 
methods in organizational research 2004, 2:256-270. 
160. Smith J, Firth J: Qualitative data analysis: the framework approach. Nurse researcher 
2011, 18(2):52-62. 
161. McQuaid EL, Howard K, Kopel SJ, Rosenblum K, Bibace R: Developmental concepts of 
asthma: Reasoning about illness and strategies for prevention. Journal of applied 
developmental psychology 2002, 23(2):179-194. 
162. British guideline on the management of asthma. A national clinical guideline 
[https://www.brit-thoracic.org.uk/document-library/clinical-
information/asthma/btssign-asthma-guideline-2016/] 
163. Kajornboon AB: Using interviews as research instruments. E-journal for Research 
Teachers 2005, 2(1). 
164. Al Aloola NA, Naik-Panvelkar P, Nissen L, Saini B: Asthma interventions in primary 
schools–a review. Journal of Asthma 2014, 51(8):779-798. 
165. Kneale D, Thomas J, Harris K: Developing and Optimising the Use of Logic Models in 
Systematic Reviews: Exploring Practice and Good Practice in the Use of Programme 
Theory in Reviews. PLoS One 2015, 10(11):e0142187. 
166. Guevara JP, Wolf FM, Grum CM, Clark NM: Effects of educational interventions for 
self management of asthma in children and adolescents: systematic review and 
meta-analysis. Bmj 2003, 326(7402):1308-1309. 
167. Boyd M, Lasserson TJ, McKean MC, Gibson PG, Ducharme FM, Haby M: Interventions 
for educating children who are at risk of asthma-related emergency department 
attendance. Cochrane Database Syst Rev 2009, 2. 
168. Smith J, Mugford M, Holland R, Candy B, Noble M, Harrison B, Koutantji M, Upton C, 
Harvey I: A systematic review to examine the impact of psycho-educational 
interventions on health outcomes and costs in adults and children with difficult 
asthma. 2005. 
169. Wolf FM, Guevara JP, Grum CM, Clark NM, Cates CJ: Educational interventions for 
asthma in children. The Cochrane Library 2004(2):-. 
170. Welsh EJ, Hasan M, Li P: Home-based educational interventions for children with 
asthma. Cochrane Database Syst Rev 2011, 10. 
171. Pinnock H, Epiphaniou E, Pearce G: Implementing supported self-management for 
asthma : a systematic review and suggested hierarchy of evidence of 
implementation studies. BMC Medicine 2015, 13(127). 
172. Hurley M, Dickson K, Walsh N, Hauari H, Grant R, Cumming J, Oliver S: Exercise 
interventions and patient beliefs for people with chronic hip and knee pain: a mixed 
methods review. Cochrane Database of Systematic Reviews 2013, 12. 
173. Husk K, Lovell R, Cooper C, Garside R: Participation in environmental enhancement 
and conservation activities for health and well‐being in adults. The Cochrane Library 
2013. 
174. Shepherd J, Kavanagh J, Picot J, Cooper K, Harden A, Barnett-Page E, Jones J, Clegg A, 
Hartwell D, Frampton G: The effectiveness and cost-effectiveness of behavioural 
interventions for the prevention of sexually transmitted infections in young people 
aged 13-19: a systematic review and economic evaluation. Health Technology 
Assessment 2010, 14(7):1-230. 
175. Thomas J, O’Mara-Eves A, Brunton G: Using qualitative comparative analysis (QCA) in 
systematic reviews of complex interventions: a worked example. Systematic reviews 
2014, 3(1):1. 
176. Oakley A, Strange V, Bonell C, Allen E, Stephenson J, Team RS: Health services 
research: process evaluation in randomised controlled trials of complex 
interventions. BMJ: British Medical Journal 2006, 332(7538):413. 
258 
 
177. Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, Moore L, O’Cathain A, 
Tinati T, Wight D: Process evaluation of complex interventions: Medical Research 
Council guidance. bmj 2015, 350:h1258. 
178. Murta SG, Sanderson K, Oldenburg B: Process evaluation in occupational stress 
management programs: a systematic review. American Journal of Health Promotion 
2007, 21(4):248-254. 
179. The British Guidelines on Asthma Management<br/>1995 Review and Position 
Statement. Thorax 1997, 52(suppl 1):S1-S20. 
180. Guidelines for the Diagnosis and Management of Asthma (EPR-3). 
[http://www.nhlbi.nih.gov/health-pro/guidelines/current/asthma-guidelines] 
181. Schellenberg J, Bobrova N, Avan B: Measuring implementation strength: Literature 
review draft report 2012. Measuring implementation strength: Literature review draft 
report 2012 2012. 
182. Rosecrans A, Gittelsohn J, Ho L, Harris S, Naqshbandi M, Sharma S: Process evaluation 
of a multi-institutional community-based program for diabetes prevention among 
First Nations. Health education research 2008, 23(2):272-286. 
183. Thomas J, Brunton J, Graziosi S: EPPI-Reviewer 4.0: software for research synthesis. 
2010. 
184. Bignall WJ, Luberto CM, Cornette AF, Haj-Hamed M, Cotton S: Breathing retraining for 
African-American adolescents with asthma: a pilot study of a school-based 
randomized controlled trial. Journal of asthma 2015, 52(9):889-896. 
185. Carpenter DM, Alexander DS, Elio A, DeWalt D, Lee C, Sleath BL: Using Tailored Videos 
to Teach Inhaler Technique to Children With Asthma: Results From a School Nurse-
Led Pilot Study. Journal of Pediatric Nursing-Nursing Care of Children & Families 2016, 
31(4):380-389. 
186. Jackson TL, Stensland SL, Todd TJ, Lullo A, Mazan J, Masood AM: Evaluation of a 
pediatric asthma awareness program. Journal of Asthma 2006, 43(4):311-317. 
187. McCann D, McWhirter J, Coleman H, Calvert M, Warner J: A controlled trial of a 
school-based intervention to improve asthma management. European Respiratory 
Journal 2006, 27(5):921-928. 
188. Mickel CF, Shanovich KK, Evans MD, Jackson DJ: Evaluation of a School-Based Asthma 
Education Protocol: Iggy and the Inhalers. The Journal of school nursing : the official 
publication of the National Association of School Nurses 2016. 
189. Richmond CM, Hobson A, Pike E, Kleiss J, Wottowa J, Sterling DA: Breathe Your Best 
for School Success: evaluation of an initiative to enhance asthma action plans in the 
school setting. J Urban Health 2011, 88 Suppl 1:68-72. 
190. Horner SD, Brown A, Brown SA, Rew DL: Enhancing Asthma Self-Management in Rural 
School-Aged Children: A Randomized Controlled Trial. Journal of rural health 2015. 
191. Horner SD, Fouladi RT: Improvement of Rural Children’s Asthma Self‐Management by 
Lay Health Educators. Journal of School Health 2008, 78(9):506-513. 
192. McGhan SL, Wong E, Sharpe HM, Hessel PA, Mandhane P, Boechler VL, Majaesic C, 
Befus AD: A children’s asthma education program: Roaring Adventures of Puff (RAP), 
improves quality of life. Canadian respiratory journal 2010, 17(2):67-73. 
193. Velsor-Friedrich B, Pigott T, Srof B: A practitioner-based asthma intervention program 
with African American inner-city school children. Journal of Pediatric Health Care 
2005, 19(3):163-171. 
194. Cicutto L, To T, Murphy S: A randomized controlled trial of a public health nurse‐
delivered asthma program to elementary schools. Journal of School Health 2013, 
83(12):876-884. 
195. McGhan S, Wong E, Jhangri G, Wells H, Michaelchuk D, Boechler V, Befus A, Hessel P: 
Evaluation of an education program for elementary school children with asthma. 
Journal of Asthma 2003, 40(5):523-533. 
259 
 
196. Splett PL, Erickson CD, Belseth SB, Jensen C: Evaluation and sustainability of the 
healthy learners asthma initiative. Journal of School Health 2006, 76(6):276-282. 
197. Cicutto L, Murphy S, Coutts D, O’rourke J, Lang G, Chapman C, Coates P: Breaking the 
access barrier: evaluating an asthma center’s efforts to provide education to children 
with asthma in schools. CHEST Journal 2005, 128(4):1928-1935. 
198. Harden A, Garcia J, Oliver S, Rees R, Shepherd J, Brunton G, Oakley A: Applying 
systematic review methods to studies of people’s views: an example from public 
health research. Journal of Epidemiology and Community Health 2004, 58(9):794-800. 
199. O'Mara-Eves A, Brunton G, McDaid G, Oliver S, Kavanagh J, Jamal F, Matosevic T, 
Harden A, Thomas J: Community engagement to reduce inequalities in health: a 
systematic review, meta-analysis and economic analysis. Public Health Research 
2013, 1(4). 
200. Harris KM, Kneale D, Lasserson TJ, McDonald VM, Grigg J, Thomas J: School‐based self 
management interventions for asthma in children and adolescents: a mixed methods 
systematic review. The Cochrane Library 2015. 
201. Higgins JP, Green S: Cochrane handbook for systematic reviews of interventions, vol. 
4: John Wiley & Sons; 2011. 
202. Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-
analyses. Bmj 2003, 327(7414):557-560. 
203. Harbord RM, Harris RJ, Sterne JA: Updated tests for small-study effects in meta-
analyses. Stata Journal 2009, 9(2):197. 
204. Ragin CC: Qualitative comparative analysis using fuzzy sets (fsQCA). Rihoux, B 2009. 
205. RevMan: The Nordic Cochrane Centre, The Cochrane Collaboration. In: Review 
Manager (RevMan). vol. 5; 2014. 
206. Chinn S: A simple method for converting an odds ratio to effect size for use in meta-
analysis. Statistics in medicine 2000, 19(22):3127-3131. 
207. Al-Sheyab NA, Gallagher R, Roydhouse JK, Crisp J, Shah S: Feasibility of a peer-led, 
school-based asthma education programme for adolescents in Jordan. Eastern 
Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-
Majallah al-sihhiyah li-sharq al-mutawassit 2012, 18(5):468-473. 
208. Clark NM, Gong M, Kaciroti N, Jimmy YU, Guixian WU, Zeng Z, Zeng Z, Zhaosu WU: A 
trial of asthma self-management in Beijing schools. Chronic illness 2005, 1(1):31-38. 
209. Bruzzese J-M, Bonner S, Vincent EJ, Sheares BJ, Mellins RB, Levison MJ, Wiesemann S, 
Du Y, Zimmerman BJ, Evans D: Asthma education: the adolescent experience. Patient 
Education and Counseling 2004, 55(3):396-406. 
210. BRUZZESE J, Unikel L, Gallagher R, Evans D, Colland V: Feasibility and impact of a 
school‐based intervention for families of urban adolescents with asthma: Results 
from a randomized pilot trial. Family process 2008, 47(1):95-113. 
211. Henry RL, Gibson PG, Vimpani GV, Francis JL, Hazell J: Randomized controlled trial of a 
teacher-led asthma education program. Pediatr Pulmonol 2004, 38(6):434-442. 
212. Howell KJ: " Quest for the Code": A study of a computer based education program for 
children with asthma. 2005. 
213. Gerald LB, Redden D, Wittich AR, Hains C, Turner‐Henson A, Hemstreet MP, Feinstein 
R, Erwin S, Bailey WC: Outcomes for a Comprehensive School‐Based Asthma 
Management Program. Journal of School Health 2006, 76(6):291-296. 
214. Levy M, Heffner B, Stewart T, Beeman G: The efficacy of asthma case management in 
an urban school district in reducing school absences and hospitalizations for asthma. 
Journal of School Health 2006, 76(6):320-324. 
215. Langenfeld NA, Mast DK, Rasberry CN, Cheung K, Luna P, Buckley R, Merkle S, Huhman 
M, Robin L: Strategies for Identifying Students in Need of School-Based Asthma 
Services Challenges and Questions That Emerged From a Rapid Evaluation of a 
School-Based Asthma Program. Journal of Asthma & Allergy Educators 2010, 1(3):109-
116. 
260 
 
216. Engelke MK, Swanson M, Guttu M: Process and outcomes of school nurse case 
management for students with asthma. The Journal of School Nursing 2014, 
30(3):196-205. 
217. Magzamen S, Patel B, Davis A, Edelstein J, Tager IB: Kickin’Asthma: School‐Based 
Asthma Education in an Urban Community. Journal of School Health 2008, 
78(12):655-665. 
218. Pike EV, Richmond CM, Hobson A, Kleiss J, Wottowa J, Sterling DA: Development and 
evaluation of an integrated asthma awareness curriculum for the elementary school 
classroom. Journal of Urban Health 2011, 88(1):61-67. 
219. Mujuru P, Salana H, Kellam N, Howell C: Challenges to Childhood Asthma Intervention 
Delivery in Hard-to-Reach Small Rural Communities: A School-Based Approach. 
Journal of Asthma & Allergy Educators 2011, 2(5):225-232. 
220. Joseph CL, Havstad SL, Johnson D, Saltzgaber J, Peterson EL, Resnicow K, Ownby DR, 
Baptist AP, Johnson CC, Strecher VJ: Factors associated with nonresponse to a 
computer-tailored asthma management program for urban adolescents with 
asthma. The Journal of asthma : official journal of the Association for the Care of 
Asthma 2010, 47(6):667-673. 
221. Joseph CL, Ownby DR, Havstad SL, Saltzgaber J, Considine S, Johnson D, Peterson E, 
Alexander G, Lu M, Gibson-Scipio W et al: Evaluation of a web-based asthma 
management intervention program for urban teenagers: reaching the hard to reach. 
The Journal of adolescent health : official publication of the Society for Adolescent 
Medicine 2013, 52(4):419-426. 
222. Dore-Stites DJ: Evaluation of a school-based program targeting pediatric asthma self-
management skills in an urban population: Western Michigan University; 2007. 
223. Kouba J, Velsor-Friedrich B, Militello L, Harrison PR, Becklenberg A, White B, Surya S, 
Ahmed A: Efficacy of the I Can Control Asthma and Nutrition Now (ICAN) pilot 
program on health outcomes in high school students with asthma. The Journal of 
School Nursing 2013, 29(3):235-247. 
224. Berg J, Tichacek MJ, Theodorakis R: Evaluation of an educational program for 
adolescents with asthma. The Journal of School Nursing 2004, 20(1):29-35. 
225. Terpstra JL, Chavez LJ, Ayala GX: An intervention to increase caregiver support for 
asthma management in middle school-aged youth. Journal of Asthma 2012, 
49(3):267-274. 
226. Kintner E, Cook G, Allen A, Meeder L, Bumpus J, Lewis K: Feasibility and benefits of a 
school-based academic and counseling program for older school-age students with 
asthma. Res Nurs Health 2012, 35(5):507-517. 
227. Brasler M, Lewis M: Teens: Taking control of asthma. Journal of school health 2006, 
76(6):269-272. 
228. Spencer GA, Atav S, Johnston Y, Harrigan JF: Managing childhood asthma: the 
effectiveness of the open airways for schools program. Family & Community Health 
2000, 23(2):20-30. 
229. Atherly A, Nurmagambetov T, Williams S, Griffith M: An economic evaluation of the 
school-based “power breathing” asthma program. Journal of Asthma 2009, 46(6):596-
599. 
230. Kintner EK, Sikorskii A: Randomized clinical trial of a school-based academic and 
counseling program for older school-age students. Nurs Res 2009, 58(5):321-331. 
231. Mosnaim GS, Li H, Damitz M, Sharp LK, Li Z, Talati A, Mirza F, Richardson D, 
Rachelefsky G, Africk J: Evaluation of the Fight Asthma Now (FAN) program to 
improve asthma knowledge in urban youth and teenagers. Annals of Allergy, Asthma 
& Immunology 2011, 107(4):310-316. 
232. Persaud DI, Barnett SE, Weller SC, Baldwin CD, Niebuhr V, McCormick DP: An asthma 
self-management program for children, including instruction in peak flow monitoring 
by school nurses. Journal of Asthma 1996, 33(1):37-43. 
261 
 
233. Shah S, Peat JK, Mazurski EJ, Wang H, Sindhusake D, Bruce C, Henry RL, Gibson PG: 
Effect of peer led programme for asthma education in adolescents: cluster 
randomised controlled trial. Bmj 2001, 322(7286):583. 
234. Srof BJ, Velsor-Friedrich B, Penckofer S: The effects of coping skills training among 
teens with asthma. Western journal of nursing research 2012, 34(8):1043-1061. 
235. Kay Bartholomew L, Sockrider MM, Abramson SL, Swank PR, Czyzewski DI, Tortolero 
SR, Markham CM, Fernandez ME, Shegog R, Tyrrell S: Partners in School Asthma 
Management: Evaluation of a Self‐Management Program for Children With Asthma. 
Journal of School Health 2006, 76(6):283-290. 
236. Clark NM, Brown R, Joseph CL, Anderson EW, Liu M, Valerio MA: Effects of a 
comprehensive school-based asthma program on symptoms, parent management, 
grades, and absenteeism. CHEST Journal 2004, 125(5):1674-1679. 
237. Clark NM, Shah S, Dodge JA, Thomas LJ, Andridge RR, Little RJ: An evaluation of 
asthma interventions for preteen students. Journal of School Health 2010, 80(2):80-
87. 
238. Gerald LB, Gerald JK, Gibson L, Patel K, Zhang S, McClure LA: Changes in 
environmental tobacco smoke exposure and asthma morbidity among urban school 
children. CHEST Journal 2009, 135(4):911-916. 
239. Juniper EF, Guyatt GH, Feeny DH, Ferrie P, Griffith LE, Townsend M: Measuring quality 
of life in children with asthma. Quality of life research 1996, 5(1):35-46. 
240. Pulcini J, DeSisto MC, McIntyre CL: An intervention to increase the use of asthma 
action plans in schools: A MASNRN study. The Journal of school nursing 2007, 
23(3):170-176. 
241. Bruzzese J-M, Stepney C, Gallagher R, Wang J, Petkova E, Evans D: Reducing Morbidity 
And Urgent Health Care Utilization In Urban Pre-adolescents With Asthma: Results 
Of A Randomized Control Trial Of Asthma: It’s A Family Affair. In: A92 IDENTIFYING 
BARRIERS AND DEVELOPING INTERVENTIONS TO IMPROVE PEDIATRIC ASTHMA CARE. 
edn.: Am Thoracic Soc; 2010: A2250-A2250. 
242. Praena-Crespo M, Fernandez-Truan J, Gálvez-González J, Murillo-Fuentes A, Castro-
Gómez L, Cenizo-Benjumea J: Randomised controlled trial of educational intervention 
directed by physical education teachers in high schools. Allergy: European Journal of 
Allergy and Clinical Immunology 2010, 65:190-191. 
243. Thomson HJ, Thomas S: The effect direction plot: visual display of non‐standardised 
effects across multiple outcome domains. Research synthesis methods 2013, 4(1):95-
101. 
244. Jackson D, Turner R: Power analysis for random‐effects meta‐analysis. Research 
synthesis methods 2017, 8(3):290-302. 
245. Williamson PR, Altman DG, Blazeby JM, Clarke M, Devane D, Gargon E, Tugwell P: 
Developing core outcome sets for clinical trials: issues to consider. Trials 2012, 
13(1):132. 
246. Sinha IP, Gallagher R, Williamson PR, Smyth RL: Development of a core outcome set 
for clinical trials in childhood asthma: a survey of clinicians, parents, and young 
people. Trials 2012, 13(1):103. 
247. Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, Tyrer 
P: Framework for design and evaluation of complex interventions to improve health. 
BMJ: British Medical Journal 2000, 321(7262):694. 
248. Michie S, van Stralen MM, West R: The behaviour change wheel: a new method for 
characterising and designing behaviour change interventions. Implementation science 
2011, 6(1):42. 
249. Thompson K, Kulkarni J, Sergejew AA: Reliability and validity of a new Medication 
Adherence Rating Scale (MARS) for the psychoses. Schizophrenia research 2000, 
42(3):241-247. 
262 
 
250. Broadbent E, Petrie KJ, Main J, Weinman J: The brief illness perception questionnaire. 
Journal of psychosomatic research 2006, 60(6):631-637. 
251. Rodríguez Martínez C, Sossa MP: Validation of an Asthma Knowledge Questionnaire 
for Use With Parents or Guardians of Children With Asthma. Archivos de 
Bronconeumología ((English Edition)) 2005, 41(8):419-424. 
252. Horne R, Weinman J, Hankins M: The beliefs about medicines questionnaire: The 
development and evaluation of a new method for assessing the cognitive 
representation of medication. Psychology & Health 1999, 14(1):1-24. 
253. Janson SL, McGrath KW, Covington JK, Cheng S-C, Boushey HA: Individualized asthma 
self-management improves medication adherence and markers of asthma control. 
Journal of Allergy and Clinical Immunology 2009, 123(4):840-846. 
254. Nolte H, Nepper-Christensen S, Backer V: Unawareness and undertreatment of 
asthma and allergic rhinitis in a general population. Respiratory medicine 2006, 
100(2):354-362. 
255. Team ISCRaI: ISC Census and Annual Report. In. Edited by Team IRaI; 2016. 
256. Economics EaAT: Class size and education in England evidence report. In.; 2016. 
257. Ethnicity and National Identity in England and Wales 2011 
[http://www.ons.gov.uk/ons/rel/census/2011-census/key-statistics-for-local-
authorities-in-england-and-wales/rpt-ethnicity.html] 
258. Harris K, Mosler G, Williams SA, Whitehouse A, Raine R, Grigg J: Asthma control in 
London secondary school children. Journal of Asthma 2017:1-8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
263 
 
Appendices 
Appendix 1: Parental Information and Withdrawal Form: 
Questionnaire 
PARENT INFORMATION SHEET version 1.7 07.01.2015 
To be read by parents and the young person at the same time 
Dear Parent or Guardian 
Your child is being invited to take part in a research study. Before you decide whether or not to 
agree to your child to taking part, it is important for you to understand why the research is being 
done and what it will involve. Please take time to read the following information carefully, and 
discuss it with others if you wish.  
 PART 1: Tells you the purpose of this study and what will happen to your child if they 
take part. 
 PART 2: Gives you more detailed information about the conduct of the study. 
 PART 3: Asks if you agree that your child takes part in the study. 
 PART 4: Gives you a withdrawal form to fill in and send back to us if you do not want 
your child to fill out a questionnaire. 
Ask us if there is anything that is not clear, or if you would like more information. Take time to 
decide whether or not you wish for your child to take part. 
 
PART 1: Purpose of this study and what will happen to your child if they take part. 
What is the purpose of the study? 
This study aims to see how much asthma has an effect on the school life of children and young 
people. We are hoping to recruit around 560 young people to help us answer this question. 
Why has my child been chosen?  
Your child has been asked to take part because their school, youth forum or clinic has agreed to 
take part in the study. 
Does my child have to take part? 
No. It is up to you and your child to decide whether or not to take part. If you and your child 
decide to take part you are free to withdraw them from the study at any time without giving a 
reason. If you withdraw your child, unless you object, we will still keep records relating to their 
participation up to that point, as this is valuable to the study. A decision to withdraw at any time, 
or a decision not to take part, will not affect the quality of any care you or your child may require 
from us in the future. 
What will happen to my child if they take part? 
Trained researchers will be coming to your child’s school in the summer or autumn term to ask 
your child to complete an online questionnaire, which we expect will take no longer than 20-30 
minutes. We will also work with your child’s school to offer educational resources and 
opportunities from the research team. 
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Most children get information about this study through their school. Your child may however 
have been given information about this study via their asthma clinic or the Centre of the Cell. In 
this case they will be invited to Barts and The London School of Medicine and Dentistry to take 
part in the online questionnaire. 
Young people will log on to a specially-designed website using their email address (or a unique 
username). They will then be able to complete the questionnaire. The questionnaire will collect 
information on; 
1. Demographics (e.g. Age, ethnicity, location) 
2. Asthma control (using a validated ‘Asthma Control Test™’) 
3. Use of asthma medication 
4. Unplanned medical attention 
5. Asthma at school 
6. Smoking and parental smoking 
7. Emotional and behavioural well-being (using a validated ‘Me & My School’ test) 
 
We will also ask your child’s school for information about their attendance and sick leave. This 
information will be very helpful in working out whether asthma has an impact on attendance.  
What do I have to do?  
If you are happy for your child to take part in our research project you don’t need to do anything. 
If you do not want your child to take part in this project please fill out the withdrawal form at the 
bottom of this information and hand it back to your child’s teacher. On the day we visit your 
child’s school or they come to the medical school your child can then take part in the questionnaire 
if they are still happy to do so. 
What are the disadvantages and risks of taking part? 
We do not anticipate any risks from taking part in the study. We will work with schools to avoid 
disruption to school timetables. 
What are the possible benefits of taking part?  
We hope children and families will benefit from increased knowledge and understanding of 
asthma research. We also hope that the results of our research will aid us in designing an 
intervention to help children with asthma improve their engagement at school.  
What happens when the research study stops? 
Your child’s anonymised data will be analysed and published in a medical journal. 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak with the researchers 
who will do their best to answer your question.  Our contact details can be found at the bottom of 
this sheet. If you remain unhappy and wish to complain formally, you can do this through either 
the NHS Complaints Procedure (details can be found under: 
http://www.nhs.uk/choiceintheNHS/Rightsandpledges/complaints/Pages/NHScomplaints.aspx). 
You can also contact the Patient Advice and Liaison Service (see contact details below) or the 
Joint Research Management Office (JRMO) at Barts and The London School of Medicine and 
Dentistry (which is part of Queen Mary, University of London). 
Will my child taking part in this study be kept confidential? 
Yes.  All the information about your child’s participation in this study will be kept confidential.  
The details are included in Part 2. 
265 
 
This completes Part 1 of the Information Sheet. 
If the information in Part 1 has interested you and you would like your child to participate, please 
continue to read the additional information in Part 2 before making any decision. 
 
PART 2: Further details about the conduct of the study 
What if new information becomes available? 
Sometimes during the course of a study, new information becomes available on the procedures 
that are being studied (such as new techniques for collecting information). If this happens, we 
will tell you about it and discuss with you whether you want to or should allow your child to 
continue in the study. If you decide to withdraw, you and your child will suffer no adverse effects 
as a result. If you decide your child should continue in the study you will be asked to sign a 
withdrawal form. On receiving new information, we might consider it to be in your child’s best 
interests to withdraw them from the study. If so, we will explain the reasons and arrange for their 
care to continue. If the study is stopped for any other reason, you will be told why. 
What will happen if I don’t want my child to carry on with the study? 
We will seek your permission to include your child’s results within the study. We will not do so 
without your permission. 
Will my child’s part in this study be kept confidential? 
The records obtained while they are in this study as well as related health and attendance records 
will remain strictly confidential at all times. The information will be held securely on paper and 
electronically at the research centre and on secure servers in the UK under the provisions of the 
1998 Data Protection Act. Their name will not be passed to anyone else outside the research team 
or the sponsor. They will be allocated a trial number, which will be used as a code to identify 
them on all trial forms. 
Their questionnaire results and records will be available to researchers authorised to work on the 
trial but may also need to be made available to people authorised by the Research Sponsor, which 
is the organisation responsible for ensuring that the study is carried out correctly.  
The information collected about your child may also be shown to authorised people from the UK 
Regulatory Authority and Independent Ethics Committee; this is to ensure that the study is carried 
out to the highest possible scientific standards.  All will have a duty of confidentiality to you and 
your child as a research participant. 
If you withdraw consent from further study involvement, unless you object, your child’s data will 
remain on file and will be included in the final study analysis. 
In line with Good Clinical Practice guidelines, at the end of the study, your child’s data will be 
securely archived for a minimum of 20 years. Arrangements for confidential destruction will then 
be made.  
What will happen to any information my child gives? 
Information will be stored and processed as stated above.   
What will happen to the results of this study? 
The results of the study will be available after it finishes and will usually be published in a medical 
journal or presented at a scientific conference. The data will be anonymous and none of the 
children involved will be identified in any report or publication.  
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How can I access the results of the study? 
We aim to inform you and your child about the overall results via written information and 
presentations. Should you or your child in addition wish to see the results, or the publication, 
please ask the research team. We will however not be able to give access to individual results, as 
the information is confidential. 
Who is organising and funding this study? 
The study is co-sponsored by Barts and the London School of Medicine and Dentistry, and it is 
funded by the National Institute for Health Research’s Collaboration for Leadership in Health 
Research and Care North Thames (http://www.uclpartners.com/our-work/nihr-collaboration-for-
leadership-in-applied-health-research-and-care). 
Who has reviewed the study? 
This study was given favourable ethical opinion for conduct in the NHS by the National Research 
Ethics Service Committee South West – Exeter (http://www.nres.nhs.uk/contacts/nres-
committee-directory/?entryid27=18577). 
Please contact us for further information 
You are encouraged to ask any questions you wish, before, during or after the study. If you wish 
to read the research on which this study is based, please ask the research team. If you require any 
further information or have any concerns while taking part in the study please contact the research 
team (contact details are at the end of this sheet). 
Thank you for taking the time to read this information sheet and to consider this study. 
 
Contact Details: 
Research Team: 
Chief Investigator: Professor Jonathan Grigg, 07787 550775, j.grigg@qmul.ac.uk  
Outreach and Learning Officer: Dr Gioia Mosler, 020 7882 2361, g.mosler@qmul.ac.uk 
PhD Student: Katherine Harris, 020 7882 2361, k.harris@qmul.ac.uk 
Research Team Address: 
Centre for Paediatrics 
The Blizard Institute 
Blizard Building 
4 Newark Street 
London E1 2AT 
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For advice about taking part in research in the NHS: 
INVOLVE 
Wessex House 
Upper Market Street 
Eastleigh 
Hampshire 
SO50 9FD 
Telephone: 023 8065 1088 
Textphone: 023 8062 6239 
Fax: 023 8065 2885 
Email: admin@invo.org.uk 
For advice about research and patient issues at The Royal London Hospital and Barts Health NHS 
Trust: 
Patient Advice and Liaison Service (PALS):  
Ground Floor, Front Block  
The Royal London Hospital  
Whitechapel Road  
London E1 1BB   
Tel: 020 3594 2040 
E-mail:  pals@bartshealth.nhs.uk 
 
PART 3: Do you agree that your child takes part in the study? 
We hope you and your child are happy to take part in our research project. If you agree for your 
child to take part, then you don’t need to do anything. You should keep this information sheet as 
reference in case you or your child have questions later on. 
If you do not want your child to take part in this project please fill out the withdrawal form 
below and return it to your child’s school or directly to the researchers. 
 
PART 4: Withdrawal Form 
 
You only need to complete this form if you do not wish your child to take part in the study. 
 
If you are happy for your child to take part you don’t need to do anything. 
 
If you do not want your child to take part (please tick): 
I wish to withdraw my child from this study 
Child’s 
name:………………………………………………………................................................. 
 
268 
 
 
Parent or carer’s name: 
…………………………………………………………………………………………………… 
 
Signature:……………………………………….............................................................................. 
 
Date: 
……………………………………….............................................................................................. 
Completed forms should be returned to the child’s school or to one of the researchers. 
 
A copy of all filled out forms will be filed with the study records and one may be sent to the 
Research Sponsor. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To be filled out by researcher: 
Researchers Name: ………………………………………………………………………………………………………… 
 
Researcher’s Signature: ………………………………………………………………………………………………….. 
 
 
Date: ………………………………………………………………………………………………………………………………. 
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Appendix 2: Participant Information and Assent: Questionnaire 
 
School-based Asthma Project 
YOUNG PERSON INFORMATION SHEET: AGE 12-16 
To be read by parents and the young person at the same time 
 
Hello! 
We are asking if you would join in a research project to find the answer to the question, 
“how much difference does asthma make to your school life?” 
Before you decide if you want to join in, it‘s important to understand why the research is 
being done and what happens if you take part. Please take time to read the following 
information carefully, and discuss it with others if you want to. 
Part 1: Why we do this research and what happens if you take 
part 
WHY ARE WE DOING THIS RESEARCH? 
Asthma affects lots of children and young people. We are trying to find out more about how 
asthma can effect young people at school. Our research project will hopefully show us how we 
could make school life better for young people with asthma. 
WHY ME?  
We want to involve children and young people who have asthma and attend secondary school, 
like you. We think the questions we ask are best understood by people with asthma of your age. 
We hope to include around 560 young people in the research. 
DO I HAVE TO TAKE PART? 
No. It is up to you. We will ask you to write down if you agree to take part in an assent (agreement) 
form. We will give you a copy of this information sheet and your signed form to keep. You are 
free to stop taking part at any time during the research without giving a reason. If you decide to 
stop, this will not affect how people help you if you ever need to go to hospital – it’s your choice 
and we don’t mind. 
WHAT WILL HAPPEN TO ME IF I TAKE PART? 
We are going to come to your school and if you are interested in taking part in our research we 
will ask you if you can answer some questions on a computer. We will work with your school 
and may even give you a fun lesson about medical research.  
If you did not hear about this project in school, but from your asthma clinic or the Centre of the 
Cell, we will invite you to Barts and The London School of Medicine and Dentistry to take part 
in the online questionnaire. 
 
 WHAT WILL I BE ASKED TO DO? 
 If you chose to take part, we will ask you to fill in an assent (agreement) form. Then we will     
ask you to complete an online questionnaire we have on a specially-made website. You will log 
on to the website using your email address (or a unique username). Then you will be able to 
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complete the questionnaire. Answering the questions will take no longer than 20 minutes and will 
ask you about: 
1. General questions (for example age, ethnicity, and location) 
2. Asthma control  
3. Use of asthma medication 
4. Unplanned visits to doctors or hospitals 
5. Asthma at school 
6. Smoking and smoking in your home 
7. Emotional and behavioural well-being 
 
We will also ask your school for information about your attendance and sick leave. This 
information will be very helpful in working out whether asthma has an impact on school 
attendance. If you would prefer us not to collect this information from the school, you can say 
this on the assent (agreement) form. 
WILL THIS HELP ME? 
We cannot promise the study will help you, but the information we get might help us understand 
how asthma affects children and young people’s school life. 
Thank you for taking time to read this information sheet – if you are still interested please 
read part 2.  
 
Part 2: Further information 
WHAT HAPPENS WHEN THE RESEARCH PROJECT STOPS? 
We feel it is unlikely that the project stops, but if the study stops we will tell you about it and why 
this happend. 
WHAT HAPPENS IF THERE IS A PROBLEM OR SOMETHING GOES WRONG? 
If you are worried about any part of this study, you should speak with the researchers who will 
do their best to answer your question (their phone number and email is written at the bottom of 
this information). You can also ask your parents or teacher to contact the researchers for you. 
Your parents also have information how to contact other people, for example from the NHS 
(National Health Service), who can help if there is a problem.  
WHAT WILL YOU DO WITH THE INFORMATION? 
The information that you give us in the questionnaire will be changed to protect your name and 
who you are by changing information into a secret code. We will then keep it in a secure server 
(a big computer) in the UK. Any printed or written information will be kept at the research 
institute at Barts and The London School of Medicine and Dentistry. Only members of the 
research team will be able to look at the data on this server as it will be protected with passwords 
and ‘firewalls’. The server will have a special certificate to prove the information is safe. When 
we have analysed the information we need to store the data for 20 years, just in case the 
information needs to be checked.  
 
WILL I BE ABLE TO SEE THE INFORMATION YOU COLLECT? 
When our project is finished we want to make the results public in a science paper. We also want 
to send you information about the results or show you a presentation. You can call or email us, if 
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you want to know more about the results. All results we will show are for groups of young people. 
We will not show you your own answers or answers of your friend, as they are secret.  
WHO IS ORGANISING AND FUNDING THE RESEARCH? 
The study is co-sponsored by Barts and the London School of Medicine and it is funded by the 
National Institute for Health Research’s Collaboration for Leadership in Health Research and 
Care North Thames (http://www.uclpartners.com/our-work/nihr-collaboration-for-leadership-in-
applied-health-research-and-care is their web address). 
WHO HAS REVIEWED THE STUDY? 
Before any research can start it is checked by an independent Research Ethics Committee. They 
make sure that the research is fair. This study was checked by the National Research Ethics 
Service Committee South West – Exeter (http://www.nres.nhs.uk/contacts/nres-committee-
directory/?entryid27=18577). 
Thank you for reading this – please ask any questions if you want to. 
 
CONTACT DETAILS 
Gioia Mosler (Outreach and Learning Officer) 
Telephone 020 7882 2361                              Email:  g.mosler@qmul.ac.uk 
ASSENT FORM FOR YOUNG PERSON  
To be completed by the child/young person and their parent/guardian  
Child (or if unable, parent on their behalf) /young person to circle all they agree with:  
Has somebody else explained this project to you? Yes/No  
Do you understand what this project is about? Yes/No  
Have you asked all the questions you want? Yes/No  
Have you had your questions answered in a way you understand? Yes/No  
Do you understand it is OK to stop taking part at any time? Yes/No  
Are you happy to take part? Yes/No  
If any answers are ‘no’ or you don’t want to take part, don’t sign your name!  
If you do want to take part, you can write your name below  
Your name  
Date:  
The person who explained this project to you needs to sign too:  
Print Name:  
Sign: 
Date: 
Thank you for your help. 
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Appendix 3: Questionnaire 
Registration and Agreement to take part 
 
First Name(s): __________________________________________ 
Last Name: _____________________________________________ 
Email: _________________________________________________ 
Date of Birth: ___________________________________________ 
 
Many thanks for taking the time to complete the questionnaire.  
This questionnaire asks about you, your asthma and how it affects your school life. Your 
answers are important to us as they will help with research into how we can help young people 
with asthma have a better time at school. 
The questionnaire will take no longer than 20-30 minutes and will ask you about: 
 General information (e.g. age, what area you live in etc.) 
 How well your asthma is controlled 
 Use of asthma medication 
 Unplanned medical attention 
 Asthma at school 
 Smoking and parental smoking 
 Emotional and behavioural well-being 
 
We will also ask your school for information about your attendance and sick leave. This 
information will be very helpful in working out whether asthma has an impact on attendance. If 
you would prefer us not to collect this information from the school, you can indicate this below. 
All the information you give us will be kept in a secure database by our research team. 
Everything you tell us will be kept strictly confidential and at no time will we share any of your 
personal details with anybody not connected to the research.  
If you have any questions about the survey or our research, please contact us at 
g.mosler@qmul.ac.uk. 
I declare that (please tick) 
 I have read the study information and any questions I had about the study were answered. 
 I understand that I can stop taking part at any time. 
 I agree for the research team to collect information from my school. 
 I am happy to take part in the study. 
Section 1 (Personal details) 
 
1. Are you male or female? 
 Male 
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 Female 
 
2. How old are you?  
       
3. How would you describe your ethnicity? 
 White 
 Black 
 South Asian (e.g. Indian, Bangladeshi, Pakistani) 
 East Asian (e.g. Chinese, Japanese, Korean) 
 Mixed 
 Other:   
 
4. What’s your home postcode? Please write the first part of your postcode (e.g. E14) or 
your full postcode (e.g. E14 2DR):  
 
5. Do you have any long-term health conditions other than your asthma? 
If the answer is yes please tick 'other' and describe your condition(s) in the text box 
No   
Other:    
Section 2: Asthma Control Test 
6. In the past 4 weeks, how much of the time did your asthma keep you from getting 
as much done at work, school or home? 
 All of the time 
 Most of the time 
 Some of the time 
 A little of the time 
 None of the time 
 
7. In the past 4 weeks, how often have you had shortness of breath? 
 More than once a day 
 Once a day 
 3 to 6 times a day 
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 Once or twice a week 
 Not at all 
 
8. In the past 4 weeks, how often did your asthma symptoms (wheezing, coughing, 
chest tightness, shortness of breath) wake you up at night or earlier than usual in 
the morning? 
 4 or more nights a week 
 2 to 3 nights a week 
 Once a week 
 Once or twice 
 Not at all 
 
9. In the past 4 weeks, how often have you used your reliever inhaler (usually blue)? 
 3 or more times per day 
 1 to 2 times per day 
 2 to 3 times per week 
 Once a week or less 
  Not at all 
How would you rate your asthma control during the past 4 weeks? 
 Not controlled at all 
 Poorly controlled 
 Somewhat controlled 
 Well controlled 
 Completely controlled 
 
If you had completely controlled asthma in the last 4 weeks 
1. Would you say your asthma has gone away 
 Yes 
 No 
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Section 3: Adherence 
 
1. What type of inhaler(s) or other medications do you use on a regular basis? 
Only mention medication you use on a daily or weekly basis 
Inhaler  
Please 
cross: 
Blue inhaler (salbutamol or Ventolin) 
 
 
Red inhaler (ciclesonide or Alvesco) 
 
 
Purple inhaler (fluticasone/salmeterol or Seretide) 
 
 
Red/white inhaler (budesonide/formoterol or Symbicort) 
 
 
Brown/white inhaler (budesonide or Pulmicort) 
 
 
Brown inhaler (beclometasone or Becotide) 
 
 
Orange inhaler (fluticasone or Flixotide) 
 
 
Green inhaler (salmeterol or Serevent) 
 
 
Steroid tablets: Prednisolone (usually pink)  
 
Theophylline tablets or Nuelin SA (usually white)  
 
LTRA tablet (montelukast or Singulair)  
 
I don't take any medication  
 
I have other inhalers or medications but I don't know their names 
 
Other:  
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10. Do you use a spacer with any of your inhalers? 
 Yes, I use a spacer with all of my inhalers 
 Yes, I use a spacer with some of my inhalers 
 No, I do not use a spacer with any of my inhalers 
 
If you are using a spacer: 
11. How often do you use your spacer? 
 All of the time 
 Most of the time 
 Some of the time 
 A little of the time 
 None of the time 
If you are using a spacer 
12. Know_02: What do you think your spacer is for 
 So I can see the spray from my inhaler: 0 
 To make sure I don’t breeze in too much medication: 0 
 To help asthma medication go into my lungs: 1 
 To improve the taste: 0 
 Other: ___________: 2 
 
13. 14-Adh2a: Do you feel comfortable when you use your inhaler at school? 
 Not at all comfortable: 1 
 Hardly comfortable: 2 
 Somewhat comfortable: 3 
 Very comfortable: 4 
 Completely comfortable: 5 
 
14. 14-Adh2b: Do you feel comfortable when you use your inhaler outside of school 
(e.g. at home)? 
 Not at all comfortable  
 Hardly comfortable 
 Somewhat comfortable 
 Very comfortable 
 Completely comfortable 
 I do not need to use it in school 
If you are taking a regular inhaler (e.g. brown inhaler) 
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11. 16-Adh4: Do you sometimes forget to take your regular preventer inhaler (e.g. 
brown inhaler)? 
 All of the time: 1 
 Most of the time: 2 
 Some of the time: 3 
 A little of the time: 4 
 None of the time: 5 
I do not have a regular inhaler: 6 
 
If you are taking regular preventer medication, e.g. brown inhaler 
12. 17-Adh5: Do you sometimes miss your regular preventer inhaler (e.g. brown 
inhaler) on purpose? 
 All of the time 
 Most of the time 
 Some of the time 
 A little of the time 
 None of the time 
18-Adh6: Would you like to tell us why?  
 
If you are taking a regular preventer inhaler, e.g. brown inhaler  
13. Know_01: What is your regular preventer inhaler for (e.g. brown inhaler): 
 To make my asthma go away for good: 0 
 To reduce symptoms during an asthma attack: 0 
 To stop me getting an infection: 0 
 To reduce the chances of me having an asthma attack: 1 
 Other: 2 
 
If you are taking tables (e.g. steroid tablets or montelukast): 
14. 9_ADH_tabC: Do you sometimes forget to take your tables when you should? 
 All of the time: 1 
 Most of the time: 2 
 Some of the time: 3 
 A little of the time: 4 
 None of the time: 5 
I do not have tablets: 6 
 
ADH_tabC2: Would you like to tell us why you might not take them?  
 
If you are taking tables (e.g. steroid tablets or montelucast): 
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15. 15-Adh3b: How comfortable do you feel with taking your tablets? 
 Not at all comfortable 
 Hardly comfortable 
 Somewhat comfortable 
 Very comfortable 
 Completely comfortable  
 
16. ADH_5b: Do you sometimes not use your blue reliever inhaler when you would 
need it? 
 All of the time 
 Most of the time 
 Some of the time 
 A little of the time 
 None of the time 
 
ADH_7: Would you like to tell us why?  
 
17. Know_03: When should you use a blue inhaler? Tick all that apply 
 When I wake up in the morning: a 
 Before PE: b 
 When I am wheezing: c 
 If I feel dizzy: d 
 When I am sneezing: e 
 When I have difficulty breathing: f 
Section 4 Medical attention 
 
11. How many times have you had an unplanned visit to your GP/doctor due to your asthma 
in the last month? 
 4 or more times 
 2-3 times 
 1-2 times 
 Not at all 
 
12. How many times have you had an unplanned visit to the hospital due to your asthma in 
the last month? 
 4 or more times 
 2-3 times 
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 1-2 times 
 Not at all 
 
13. How many times have you had an unplanned visit to the school nurse/first-aider due to 
your asthma in the last month? 
 4 or more times 
 2-3 times 
 1-2 times 
 Not at all 
Section 5: School activity 
 
11. How many times have you missed a whole day of school due to your asthma in the last 
month? 
 4 or more times 
 2-3 times 
 
12. How many times have you missed part of a day at school due to your asthma in the 
last month? 
 4 or more times 
 2-3 times 
 1-2 times 
 Not at all 
 
13. How many times have you missed all or part of a regular class lesson due to your 
asthma in the last month? 
 4 or more times 
 2-3 times 
 1-2 times 
 Not at all 
   
14. How many times have you missed all or part of a P.E. lesson due to your asthma in the 
last month? 
 4 or more times 
 2-3 times 
 1-2 times 
 Not at all 
 
15. Do you feel that your asthma has a negative impact on how well you do in any of 
your classes or exams? 
 1-2 times 
 Not at all 
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 My asthma doesn’t have an impact at all 
 My asthma hardly has an impact  
 My asthma has a little bit of an impact 
 My asthma has some impact 
 My asthma has a big impact 
Would you like to tell us more about any negative impacts your asthma has on your 
classes or exams?  
Section 6: Lifestyle and smoking 
 
11. Do you smoke? (This includes cigarettes/cigars, shisha/hookah, marijuana/weed etc.) 
 Yes, everyday 
 Yes, 5-6 days a week 
 Yes, 3-4 days a week 
 Yes, 1-2 days a week 
 Yes, less than once a week 
 No, not at all 
 
12. Do your parents/carers or other people you live with smoke at the moment? 
 Yes 
 No 
 
If your parents/carers or other people you live with don’t smoke now,  
13. Did any of them use to smoke at any time? 
 Yes 
 No 
Section 7: Emotion and behavior 
11. Are you happy to answer some questions about how you feel at school?  
(It would be helpful to our research if you answered a few questions about your 
emotions and behavior and bullying at school. Answering these questions will allow us 
to work out whether or not it would be useful to offer young people with asthma 
support with their emotions and behavior) 
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If you are happy to continue, below is a questionnaire which is going to ask you 
how you feel.  There are no right or wrong answers. You should just pick the 
answer which is best for you. 
 Always Sometimes Never 
I feel lonely    
I cry a lot    
I am unhappy    
Nobody likes me    
I worry a lot    
I have problems sleeping    
I wake up in the night    
I am shy    
I feel scared    
I worry when I am at 
school    
I get very angry    
I lose my temper    
I hit out when I am angry    
I do things to hurt people    
I am calm    
I break things on purpose    
 
12. Have you ever been teased, made fun of or bullied because of your asthma? 
 I’ve been bullied all the time because of my asthma 
 I’ve been bullied a lot because of my asthma 
 I’ve been bullied a little bit because of my asthma 
 I’ve hardly been bullied because of my asthma 
 I’ve never been bullied because of my asthma 
 Rather not say 
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Appendix 4: Table of Responses and Missing Data for 
Questionnaire 
Question Answer Total 
Responses 
Missing Data 
N (%) 
Asthma Control Test 
In the past 4 weeks, how much time did 
your asthma keep you from getting as 
much done at work, school, or home? 
 766 0 
 All the time   
 Most of the time   
 Some of the time   
 A little of the time   
 None of the time   
In the past 4 weeks, how often have you 
had shortness of breath? 
 766 0 
 More than once a day   
 Once a day   
 3-6 times a day   
 Once or twice a week   
 Not at all   
    
In the past 4 weeks, how often did your 
asthma symptoms wake you up at night 
or earlier than usual in the morning? 
 766 0 
 4+ nights a week   
 2-3 nights a week   
 Once a week   
 Once or twice    
 Not at all   
In the past 4 weeks, how often have you 
used your reliever inhaler (usually blue)? 
 766 0 
 3+ times a day   
 1-2 times a day   
 2-3 times a week   
 Once a week or less   
 Not at all   
How would you rate your asthma control 
during the past 4 weeks? 
 766 0 
 Not controlled at all   
 Poorly controlled   
 Somewhat controlled   
 Well controlled   
 Completely controlled   
If you had completely controlled 
asthma in the last 4 weeks: Would you 
say your asthma has gone away? 
   
 Yes   
 No   
Medication Adherence 
What type of inhaler(s) do you use on a 
regular basis? Only mention medication 
you use on a daily or weekly basis 
 766 0 
    
Do you use a spacer with any of your 
inhalers? 
 762 4 (0.5) 
 Yes, I use a spacer with all 
of my inhalers 
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 Yes, I use a spacer with 
some of my inhalers 
  
 No, I do not use a spacer 
with any of my inhalers 
  
If you are using a spacer: How often do 
you use your spacer? 
 310 1 (0.3) 
 All of the time   
 Most of the time   
 Some of the time   
 A little of the time   
 None of the time   
If you are using a spacer: What do you 
think your spacer is for? 
 311 0 
    
Do you feel comfortable when you use 
your inhaler at school? 
 762 4 (0.5) 
 Not at all comfortable   
 Hardly comfortable   
 Somewhat comfortable   
 Very comfortable   
 Completely comfortable   
 I do not need to use it in 
school 
  
Do you feel comfortable when you use 
your inhaler outside school (e.g. at 
home)? 
 762 4 (0.5) 
 Not at all comfortable   
 Hardly comfortable   
 Somewhat comfortable   
 Very comfortable   
 Completely comfortable   
If you are taking a preventer inhaler: 
Do you sometimes forget to take your 
preventer inhaler? 
 414  9 (2.1) 
 All of the time   
 Most of the time   
 Some of the time   
 A little of the time   
 None of the time   
 I do not have a regular 
inhaler 
  
If you are taking a preventer inhaler: 
Do you sometimes miss your preventer 
inhaler on purpose? 
 391 32 (7.6) 
 All of the time   
 Most of the time   
 Some of the time   
 A little of the time   
 None of the time   
 I do not have one   
If you are taking a preventer inhaler: 
What is your inhaler for? 
 
 0 0 
If you are taking tablets: Do you 
sometimes forget to take your tablets? 
 36 1 (2.7) 
 All of the time   
 Most of the time   
 Some of the time   
 A little of the time   
 None of the time   
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If you are taking tablets: How 
comfortable do you feel with taking your 
tablets? 
 34 3 (8.1) 
 Not at all comfortable   
 Hardly comfortable   
 Somewhat comfortable   
 Very comfortable   
 Completely comfortable   
Do you sometimes not use your blue 
inhaler when you would need it? 
 606 42 (6.5) 
 All of the time   
 Most of the time   
 Some of the time   
 A little of the time   
 None of the time   
Medical Attention 
How many times have you had an 
unplanned visit to your GP/doctor due to 
your asthma in the last month? 
 743 23 (3) 
 4 or more times   
 2-3 times   
 1-2 times   
 Not at all   
How many times have you had an 
unplanned visit to the hospital due to 
your asthma in the last month? 
 743 23 (3) 
 4 or more times   
 2-3 times   
 1-2 times   
 Not at all   
How many times have you had an 
unplanned visit to the school nurse/first-
aider due to your asthma in the last 
month? 
 743 0 
 4 or more times   
 2-3 times   
 1-2 times   
 Not at all   
School Activity 
How many times have you missed a 
whole day of school due to your asthma 
in the last month? 
 738 28 (3.7) 
 4 or more times   
 2-3 times   
 1-2 times   
 Not at all   
How many times have you missed part 
of a school day due to your asthma in the 
last month? 
 738 28 (3.7) 
 4 or more times   
 2-3 times   
 1-2 times   
 Not at all   
How many times have you missed all or 
part of a regular lesson due to your 
asthma in the last month? 
 738 28 (3.7) 
 4 or more times   
 2-3 times   
 1-2 times   
 Not at all   
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How many times have you missed all or 
part of a PE lesson due to your asthma in 
the last month? 
 738 28 (3.7) 
 4 or more times   
 2-3 times   
 1-2 times   
 Not at all 
 
 
  
Do you feel that your asthma has a 
negative impact on how well you do in 
any of your classes or exams? 
 740 26 (3.4) 
 My asthma doesn’t have an 
impact at all 
  
 My asthma hardly has an 
impact 
  
 My asthma has a little bit of 
an impact 
  
 My asthma has some impact   
 My asthma has a big impact   
Lifestyle and Smoking 
Do you smoke?  766 0 
 Yes, everyday   
 Yes, 5-6 days a week   
 Yes, 3-4 days a week   
 Yes, 1-2 days a week   
 Yes, less than once a week   
 No, not at all   
Do your parents/carers/other people you 
live with smoke at the moment? 
 734 32 (4.2) 
 Yes   
 No   
If your parents/carers other people 
you live with don’t smoke now: Did 
any of them used to smoke at any time? 
 543 6 (1.1) 
 Yes   
 No   
Emotion and Behaviour 
Are you happy to answer some questions 
about how you feel at school? 
 732 34 (4.4) 
 Yes   
 No   
I feel lonely  596 16 (2.6) 
 Always   
 Sometimes   
 Never   
I cry a lot  596 16 (2.6) 
 Always   
 Sometimes   
 Never   
I am unhappy  596 16 (2.6) 
 Always   
 Sometimes   
 Never   
Nobody likes me  596 16 (2.6) 
 Always   
 Sometimes   
 Never   
I worry a lot  596 16 (2.6) 
 Always   
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 Sometimes   
 Never   
I have problems sleeping  596 16 (2.6) 
 Always   
 Sometimes   
 Never   
I wake up at night  596 16 (2.6) 
 Always   
 Sometimes   
 Never   
I am shy  596 16 (2.6) 
 Always   
 Sometimes   
 Never   
I feel scared  596 16 (2.6) 
 Always   
 Sometimes   
 Never   
I worry when I am at school  596 16 (2.6) 
 Always   
 Sometimes   
 Never   
I get very angry  592 20 (3.3) 
 Always   
 Sometimes   
 Never   
I lose my temper  592 20 (3.3) 
 Always   
 Sometimes   
 Never   
I hit out when I am angry  592 20 (3.3) 
 Always   
 Sometimes   
 Never   
I do things to hurt people  592 20 (3.3) 
 Always   
 Sometimes   
 Never   
I am calm  577 35 (5.7) 
 Always   
 Sometimes   
 Never   
I break things on purpose  592 20 (3.3) 
 Always   
 Sometimes   
 Never   
Have you ever been teased, made fun of, 
or bullied because of your asthma? 
 594 18 (2.9) 
 I’ve been bullied all the time 
because of my asthma 
  
 I’ve been bullied a lot 
because of my asthma 
  
 I’ve been bullied a little bit 
because of my asthma 
  
 I’ve hardly been bullied 
because of my asthma 
  
 I’ve never been bullied 
because of my asthma 
  
 Rather not say   
Appendix 5: Parental Information Sheet: Focus Groups 
Information for Parents/ Carers 
 
Dear parent/carer,  
 
Your child has been invited to take part in a focus group about asthma at their school by 
researchers from Queen Mary University of London, in collaboration with Centre of the Cell.  
 
We are scientists from Queen Mary University of London and work on a science project which 
tries to improve understanding of asthma in young people: the School-based Asthma Project.  
 
We have previously visited your child’s school and we collected information about their asthma, 
using an online questionnaire. The focus group is a discussion group in which we try to give 
young people with asthma a voice to determine the next steps for our research.  
 
The focus group will take place in your child’s school and will be led by researchers of the School-
based Asthma Project (SAP). The focus group plans to meet a few times over the next 6 months. 
We will work with the school to make sure the focus groups will not have any impact on your 
child’s other school activities (e.g. by organising lunchtime meetings).  
 
What will we ask your child to do:  
what they think the outcomes might mean.  
asthma in young people and ask your child for their 
thoughts and opinions about future research we could do.  
 
Benefits:  
 
d interesting.  
time, and free snacks if your child missed any other break time.  
group.  
 
It is important for you to know:  
Participation: Your child does not have to take part in the focus group. You or your child can 
decide to stop participating in the group at any time.  
Are there risks in taking part: We do not anticipate any risks from taking part in the study. 
If you have a concern about any aspect of this study, you should contact the researchers. If you 
remain unhappy and wish to complain formally, you can do this through the NHS complaints 
procedure (see below for contact details).  
Recording what was said: In order to have a record of what was said, we would like to tape 
record some activities. Only the research team and the person who transcribes the tape will hear 
the recordings, which will be destroyed afterwards. No names will be written down when the 
recording is transcribed. In exceptional circumstances, for example in case of a medical 
emergency, information about what was said during the meeting related to this event may be 
disclosed to other professionals.  
 
What will the information be used for: What was said in the focus group will be summarised 
and written into a report. The report we write will be used to guide the next steps of our research. 
We might also publish some information we collected in the focus group, for example quotes of 
what was said. Publications could include a research journal or our funder’s website. Everything 
we write will be anonymous and your child’s name will not be used.  
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Contact Details of our Research Team:  
Chief Investigator:  
Professor Jonathan Grigg, 07787 550775, j.grigg@qmul.ac.uk  
Outreach and Learning Officer:  
Dr Gioia Mosler, 020 7882 2361, g.mosler@qmul.ac.uk  
PhD Student:  
Katherine Harris, 020 7882 2361, k.harris@qmul.ac.uk  
Research Team Address:  
Centre for Paediatrics, the Blizard Institute, 4 Newark Street,  
London E1 2AT  
 
For advice about taking part in research in the NHS:  
INVOLVE Wessex House Upper Market Street Eastleigh Hampshire SO50 9FD  
Telephone: 023 8065 1088 Textphone: 023 8062 6239 Fax: 023 8065 2885  
Email: admin@invo.org.uk 
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Appendix 6: Participant Information Sheet: Focus Groups 
Tell us what you think! 
 
Thank you again for taking part in our school-based Asthma Project questionnaire! From 
all the questionnaires we collected we know a lot more about asthma in young people like 
you. We would now like to invite you to take part in a FOCUS GROUP about our asthma 
research at your school.  
 
The focus group is a discussion group where you meet us, the researchers, and others with 
asthma from your school.  
 
1. We will show you some of summarised results of the questionnaire and want to hear from 
you what you think the outcomes mean.  
2. We also want to hear your opinion about ideas for future asthma research we might want 
to do.  
 
We will of course make the meetings fun as well, and we will bring some snacks to keep you 
going.  
 
Before you decide whether you would like to take part or not it is important to understand why 
the focus group is organised and what it will involve. If you do not understand anything just ask 
us.  
Who are we?  
Our names are Dr Gioia Mosler and Ms Kate Harris and we work at Queen Mary University of 
London. We also work together with the Centre of the Cell, who develop school workshops and 
shows about health and medicine.  
 
What are we doing?  
The information we collected in the questionnaire gave us a lot of information about young people 
and their asthma. We now have some ideas about the next steps we can take to improve life with 
asthma for young people. Our future research will need to work for young people like you. It is 
therefore very important for us to hear what you think about the questionnaire results and to get 
your opinion on our ideas.  
 
What will you be doing in the focus group?  
During the meetings we would like to hear your opinion about our questionnaire results and what 
the next steps for our research could be. SAP focus group participant information v1.0, 20/05/15  
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When would the meetings take place?  
We would like to meet with you a few times over the next 6 months. The meetings will take place 
during or after school and each meeting would be up to 1 hour long. We will work together with 
your teachers to find times when the meetings can take place.  
 
Will you get anything for helping?  
We will provide snacks during the meetings. You will also get a certificate for your participation 
to show that you’ve helped with some real science research.  
 
How will we record what you say?  
We would like to record some activities but we will ask you if this is OK first. We will only record 
your voice, you will not be filmed. This is so we don’t forget what you have said. Only we and 
the person who types up the recording will hear it and the recording will be destroyed afterwards.  
We will not use your name in anything we write.  
 
What will happen to the information we collect from you?  
All your views and experiences will be put together with other information we have collected 
from other young people. The report we write will be used to determine the next steps of our 
research. We might also publish some information we have from focus groups for example in a 
research magazine.  
 
What if I want to stop taking part?  
You don’t have to take part and you can stop taking part at any time.  
If you want to ask any questions you can get in touch with me:  
Dr Gioia Mosler, Outreach and Learning Officer  
g.mosler@qmul.ac.uk  
Tel: 020 7882 2361  
 
Many thanks for your time! 
 
Please contact your teacher [contact teacher’s name] if you would like to take part 
in our focus group! 
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Appendix 7: Focus Group Structure 
Item Activity Format 
1 Icebreaker ‘asthma is’ Game 
2 Explanation of ACT Discussion 
3 Scenario: Perception of 
asthma control 
Discussion 
4 Perception of optimal 
asthma control 
Discussion 
5 Quick fire: Percentage of 
teenagers who miss 
preventer 
Discussion 
6 Explanations for non-
adherence 
Discussion 
7 Attitudes about asthma 
management and peer 
awareness 
Discussion 
8 Knowledge Discussion 
9 Intervention ideas Discussion 
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Appendix 8: Confidentiality Agreement 
The following agreement applies to all persons carrying out transcription, translation, voiceovers, 
or any other type of service for The Transcription Agency (TTA).  
1. Confidential Information - in the performance of my duties with TTA, I will be exposed to Confidential 
Information of both TTA and its clients. I understand that "Confidential Information" means information or 
material that is non-public and could therefore be damaging to TTA or its clients if it became public. This 
includes, but is not limited to:  
 
(a) Classified information i.e. Official, Restricted, Confidential, Secret and Top Secret which is sensitive, 
government information that required protection from the public domain.  
(b) technical information concerning TTA and its clients’ products and services, including product/service 
know-how, formulas, designs, devices, diagrams, software code, test results, processes, inventions, 
research projects and product development, technical memoranda and correspondence;  
(c) information concerning TTA and its clients’ business, including cost information, profits, sales information, 
accounting and unpublished financial information, business plans, markets and marketing methods, market 
research, customer lists and customer/contact information, purchasing techniques, supplier lists and supplier 
information and advertising strategies;  
(d) Information concerning TTA and its clients’ employees/contacts, including salaries, strengths, 
weaknesses and skills;  
(e) information submitted by TTA and its clients’ customers, suppliers, employees, consultants or co-venture 
partners for study, market research, evaluation or use; and  
(f) Any other information not generally known to the public which, if misused or disclosed, could reasonably 
be expected to adversely affect TTA and its clients’ business.  
 
2. Non-disclosure of Confidential Information - I shall keep TTA and its clients’ Confidential Information, 
whether or not prepared or developed by myself, in the strictest confidence. I will not disclose such 
information to anyone outside of TTA without TTA’s prior written consent. Nor will I make use of any 
Confidential Information for my own purposes or in any way other than that originally requested by TTA.  
 
However, I shall have no obligation to treat as confidential any information which:  
(a) Was in my possession or known to me, without an obligation to keep it confidential, before such 
information was disclosed to me by TTA;  
(b) Is or becomes public knowledge through a source other than myself and through no fault of myself; or  
(c) Is or becomes lawfully available to myself from a source other than TTA.  
I will not, without the prior written consent of TTA, permit any of the Confidential Information:  
(a) To be disclosed, except to TTA Management who may need to have such information; or  
(b) To be discussed between myself and any family, friends and/or third parties; or  
(c) To be copied or reproduced, or to be commercially exploited in any way; or  
(d) To pass outside of my control  
 
3. Return of materials - when I no longer provide services to TTA, for whatever reason, I will promptly 
deliver to TTA all originals and copies of all documents, records, software programs, media and other 
materials containing any Confidential Information which was required to be kept for the duration of my 
provision of services. I will also return to TTA all equipment, files, software programs and other personal 
property belonging to TTA’s clients which was required to be kept for the duration of my provision of services. 
Any electronic materials will be securely and permanently removed from all applicable computer systems 
and transfer methods.  
 
4. Confidentiality obligation services provision of services - my obligation to maintain the confidentiality 
and security of Confidential Information remains even after my provision of services with TTA ends and 
continues for so long as such Confidential Information remains a trade secret and/or solely the property of 
TTA and/or its client.  
 
I understand that approval should first be obtained before any disclosure of other Confidential Information 
not addressed in this document, TTA’s guidelines and/or policies and procedures, is made.  
I also understand that the unauthorized disclosure of TTA and its clients’ Confidential or Proprietary 
Information is grounds for disciplinary action, up to and including immediate dismissal and court action for 
breach of this confidentiality contract.  
I hereby acknowledge, by my signature below, that I understand and will comply with all terms and 
requirements outlined in this Confidentiality Agreement document and the Data Protection Act as noted on 
http://www.legislation.gov.uk/  
[Signature] [Date]  
[Print Name]  
[Full address, including country]  
[Landline phone number] [Mobile/cell number] 
[Email address] 
Appendix 9: Code Log for Focus Group Analysis 
Code Sub-theme 1 Sub-theme 2 Sub-theme 3 Description 
Asthma    This code refers 
to all 
discussions 
about general 
opinions of 
asthma 
 Asthma control   Students 
discuss their 
perception of 
asthma control, 
and what it 
means for daily 
life 
  Activity 
restrictions 
 Students talk 
about how 
asthma control 
influences 
ability to 
participate in 
activities 
  Asthma 
management 
 Students 
discuss how 
their asthma 
management is 
affected by 
asthma control 
  Experience of 
symptoms 
 Students 
mention the 
symptoms that 
might be 
associated with 
good and poor 
control 
   Misperceptions Some students 
demonstrated 
misperceptions 
about the 
symptoms that 
might be 
experienced 
with good and 
poor control 
   Night-time 
symptoms 
The students 
talked about 
how night-time 
symptoms vary 
according to 
how well 
controlled 
asthma is 
  Medication use  The students 
discussed the 
differences in 
medication use, 
depending on 
how well 
controlled 
asthma is 
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   Misperceptions Some students 
demonstrated 
incorrect 
knowledge 
about how 
asthma 
medication 
should be used 
in relation to 
asthma control 
 
 
 
 
 Consequences  
 
 
 Students talked 
about the 
general 
consequences 
of living with 
asthma 
 
  Activity 
limitations 
 Students talked 
about how 
having asthma 
can impact on 
their ability to 
participate in 
activities, not 
specific to 
asthma control 
  Sleep 
disturbances 
 The students 
talked about 
how asthma can 
affect sleeping 
habits 
 Embarrassment   The students 
discuss feeling 
embarrassed 
about having 
asthma 
 Medication use   The students 
talked about the 
different 
medications 
that are 
associated with 
asthma 
 Personal 
opinion 
  Students give 
some of their 
opinions on 
what asthma is 
 Symptoms   Students 
mention some 
of the 
symptoms of 
asthma 
Communication    This code refers 
to 
communicating 
with people 
regarding 
asthma 
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 Healthcare 
Professionals 
  Students talk 
about 
communicating 
with healthcare 
professionals 
  ACT scores  Students 
discuss the 
benefits of GP’s 
knowing their 
ACT scores 
  Language 
barriers 
 Students 
discuss some of 
the difficulties 
with the 
medical 
terminology 
  Trust in the 
level of care 
 Students 
discuss 
continuity of 
care, and seeing 
different 
doctors 
 Non-asthmatics   The students 
talked about 
discussing 
asthma with 
people that 
don’t have 
asthma 
  Not being 
listened to 
 Students 
discuss not 
being listened 
to when they try 
to explain about 
their symptoms 
  Not taking 
asthma 
seriously 
 Students 
mentioned that 
many people, 
including 
teachers and 
peers, do not 
take asthma 
seriously 
  Reluctance to 
talk about 
asthma 
 The students 
talked about 
how 
uncomfortable 
some teenagers 
feel talking 
about their 
asthma 
 Undiagnosed 
cases 
  Students 
discuss some 
people with 
asthma 
symptoms  who 
haven’t had a 
diagnosis of 
asthma 
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  Barriers to 
diagnosis 
 The students 
talked about 
why some 
people do not 
see their GP 
even when they 
have symptoms 
of asthma 
Knowledge    This code refers 
to knowledge 
and how it 
impacts on 
asthma 
management 
 Causes   Students would 
like to know 
more about the 
causes of 
asthma 
 General 
knowledge 
  The students 
wanted to learn 
more asthma 
general 
knowledge 
 Medication   The students 
mentioned that 
they would like 
to know more 
about asthma 
medication and 
how it helps 
 Preventing 
exacerbations 
  The students 
discussed 
knowing more 
about how to 
avoid asthma 
attacks 
 Side-effects   The students 
wanted to learn 
more about the 
side-effects of 
asthma 
 Triggers   The students 
wanted to learn 
more about 
asthma triggers 
Medication    This code refers 
to asthma 
medication, 
specifically 
adherence 
 Adherence   Students talk 
about barriers to 
adherence 
among 
teenagers 
 
 
 
  Absence of 
symptoms 
 The students 
talked about 
how not having 
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asthma 
symptoms is a 
barrier to 
adherence 
  Apathy  The students 
talk about not 
being bothered 
about their 
asthma 
medication 
  Embarrassment  The students 
discuss feeling 
embarrassed 
about using 
inhalers in front 
of people 
  Excuse to miss 
lessons 
 The students 
talk about how 
some people 
use their asthma 
as an excuse to 
get out of class 
  Forgetfulness  Students 
discuss how it 
is easy to forget 
medication 
  Inconvenience  The students 
talk about the 
difficulties of 
using their 
inhalers when 
they have other 
things to do 
  Inhaler efficacy  The students 
discuss their 
beliefs on the 
effectiveness of 
the medication 
  Reliance  The students 
discuss 
concerns over 
becoming 
reliant on their 
medication 
  Reluctance to 
use in public 
 Students 
discuss using 
inhalers in 
public 
  Side-effects  The students 
talk about some 
of the side-
effects of 
asthma 
medication 
 
 
 
  Use of different 
medication 
 The students 
discuss the 
different 
inhalers, and 
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how they are 
used 
Psychological 
Impact 
   This code refers 
to the 
psychological 
impact of 
asthma 
 
 Social   Students talk 
about the social 
concerns 
associated with 
having asthma 
as a teenager 
  Bullying  Students 
discuss fears of 
bullying 
because of 
asthma 
  Peer awareness  The students 
talk about the 
awareness of 
their peers 
  Stigma  Students 
discuss some of 
the stigma faced  
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Appendix 10: Systematic Review Quantitative Search Strategy 
#1 AST:MISC1 
#2 MeSH DESCRIPTOR Asthma Explode All 
#3 asthma*:ti,ab 
#4 #1 or #2 or #3 
#5 MeSH DESCRIPTOR Schools Explode All 
#6 MeSH DESCRIPTOR School Health Services 
#7 MeSH DESCRIPTOR School Nursing 
#8 school*:ti,ab,kw 
#9 academ*:ti,ab,kw 
#10 colleg*:ti,ab,kw 
#11 lesson*:ti,ab,kw 
#12 pupil*:ti,ab,kw 
#13 #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 
#14 MeSH DESCRIPTOR Self Care Explode All 
#15 MeSH DESCRIPTOR Health Education Explode All 
#16 MeSH DESCRIPTOR Case Management 
#17 MeSH DESCRIPTOR Patient Education as Topic 
#18 educat*:ti,ab,kw 
#19 manag*:ti,ab,kw 
#20 self-car*:ti,ab,kw 
#21 self NEXT car*:ti,ab,kw 
#22 train*:ti,ab,kw 
#23 instruct*:ti,ab,kw 
#24 teach*:ti,ab,kw 
#25 patient-cent*:ti,ab,kw 
#26 patient NEXT cent*:ti,ab,kw 
#27 MeSH DESCRIPTOR Patient-Centered Care 
#28 patient-focus*:ti,ab,kw 
#29 patient NEXT focus*:ti,ab,kw 
#30 coach*:ti,ab,kw 
#31 skill*:ti,ab,kw 
#32 knowledge NEXT develop*:ti,ab,kw 
#33 tutor*:ti,ab,kw 
#34 #14 or #17 or #18 or #19  or #20 or #21 or #22 or #23 
or #24 or #25 or #26 or #27 or #28 or #29 or #30 or #31 or 
#32 or #33 
#35 #4 AND #13 AND #34 
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Appendix 11: Systematic Review Process Evaluation Search 
Strategy 
Cochrane Database of Systematic Reviews 
#1 MeSH Descriptor Asthma explode all 
#2 Asthma* 
#3 #1 or #2 
#4 MeSH descriptor Schools explode all 
#5 MeSH descriptor School Health Services 
#6 MeSH descriptor School Nursing (nothing available in mesh term, school nursing searched 
in KW, TI and AB) 
#7 school* 
#8 academ* 
#9 colleg* 
#10 lesson* 
#11 pupil* 
#12 #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 
#13 MeSH descriptor Self Care explode all 
#14 MeSH descriptor Health Education explode all 
#15 MeSH descriptor Case Management 
#16 MeSH descriptor Patient Education as topic 
#17 educat* 
#18 manag* 
#19 self-car* 
#20 self NEXT car* 
#21 train* 
#22 instruct* 
#23 teach* 
#24 patient-cent* 
#25 patient NEXT cent* 
#26 MeSH descriptor Patient-Centred Care 
#27 patient-focus* 
#28 patient NEXT focus* 
#29 coach* 
#30 skill* 
#31 knowledge NEXT develop 
#32 tutor* 
#33 #13 or #16 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or 
#29 or #30 or #31 or #32 
#34 #3 AND #12 AND #33 
 
EMBASE 
 
#1 “Asthma” 
#2 “Schools” 
#3 “School health services” 
#4 “School nursing” 
#5 “School” 
#6 “Academy” 
#7 “Academic” 
#8 “Academies” 
#9 “College” 
#10 “Colleges” 
#11 “Lesson” 
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#12 “Lessons” 
#13 “Pupil” 
#14 “Pupils” 
#15 #2 or #3 or #4 or #5 or #6 or ‘7 or #8 or #9 or #10 or #11 or #12 or #13 or ‘14 
#16 “Self care” 
#17 “Health Education” 
#18 “Case management” 
#19 “Patient education” 
#20 “Educate” 
#21 “Education” 
#22 “Educator” 
#23 “Manage” 
#24 “Management” 
#25 “Self-care” 
#26 “Train” 
#27 “Training” 
#28 “Trainer” 
#29 “Instruct” 
#30 “Instructor” 
#31 “Instruction” 
#32 “Teach” 
#33 “Teacher” 
#34 “Patient-center” 
#35 “Patient-centre” 
#36 “Patient-centred care” 
#37 “Patient-focus” 
#38 “Patient focus” 
#39 “Coach” 
#40 “Skill” 
#41 “Skills” 
#42 “Knowledge develop* 
#43 “Tutor” 
#44 #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or 
#29 or #30 or #31 or #32 or #33 or #34 or #35 or #36 or #37 or #38 or #39 or #40 or #41 or #42 
or #43 
#45 #1 and #15 and #44 
 
Web of Knowledge 
 
#1 (Asthma) 
#2 (Asthma*) 
#3 #1 or #2 
#4 (Schools) 
#5 (Schools health services) 
#6 (School nursing) 
#7 (School*) 
#8 (Academ*) 
#9 (Colleg*) 
#10 (Lesson*) 
#11 (Pupil*) 
#12 #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 
#13 (Self care) 
#14 (Health education) 
#15 (Case management) 
#16 (Patient education) 
#17 (Educat*) 
#18 (Manag*) 
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#19 (Self-car*) 
#20 (Self car*) 
#21 (Train*) 
#22 (Instruct*) 
#23 (Teach*) 
#24 (Patient-cent*) 
#25 (Patient cent*) 
#26 (Patient-centred care) 
#27 (Patient-focus*) 
#28 (Patient focus* 
#29 (Coach*) 
#30 (Skill*) 
#31 (Knowledge develop*) 
#32 (Tutor*) 
#33 #13 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or 
#28 or #29 or #30 or #31 or #31 
#34 #3 and #12 and #33 
 
DOPHER 
 
Same strategy as Web of Knowledge 
 
NIHR HTA 
 
#1 “Asthma” 
#2 “Asthma*” 
#3 #1 or #2 
#4 “Schools” 
#5 “Schools health services” 
#6 “School nursing” 
#7 “School” 
#8 “Academy” 
#9 “Academies” 
#10 “College” 
#11 “Colleges” 
#12 “Lesson*” 
#13 “Pupil*” 
#14 ‘4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 
#15 “Self care” 
#16 “Health education” 
#17 “Case management” 
#18 “Patient education” 
#19 “Educate” 
#20 “Education” 
#21 “Manage” 
#22 “Management” 
#23 “Self-care” 
#24 “Self care” 
#25 “Train” 
#26 “Training” 
#27 “Instruct” 
#28 “Instructor” 
#29 “Instruction” 
#30 “Instructing” 
#31 “Teach” 
#32 “Teacher” 
#33 “Teaching” 
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#34 “Patient-centered” 
#35 “Patient centered” 
#36 “Patient-centered care” 
#37 “Patient-focus” 
#38 “Patient focus” 
#39 “Coach” 
#40 “Coaching” 
#41 “Skill” 
#42 “Skills” 
#43”Knowledge development” 
#44 “Tutor” 
#45 #13 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or 
#28 or #29 or #30 or #31 or #32 or #33 or #34 or #35 or #36 or #37 or #38 or #39 or #40 or #41 
or #42 or #43 
#46 #3 and #14 and #45 
 
ASSIA 
 
((SU.Exact.Explode 
(“Boarding schools” 
Or “Charter schools” 
Or “City technology colleges” 
Or “Classroom management” 
Or “Classrooms” 
Or “Comprehensive schools” 
Or “Continuation high schools” 
Or “Denominational schools” 
Or “Elementary schools” 
Or “Girls’ schools” 
Or “Grant maintained schools” 
Or “High schools” 
Or “Hospital schools” 
Or “Independent schools” 
Or “Infant schools” 
Or “International schools” 
Or “Islamic schools” 
Or “Jewish schools” 
Or “Junior high schools” 
Or “junior schools” 
Or “Junior secondary schools” 
Or “Kindergartens” 
Or “Language schools” 
Or “Middle schools” 
Or “Missionary schools” 
Or “Neighbourhood schools” 
Or “Nursery schools” 
Or “Preparatory schools” 
Or “Preschools” 
Or “Primary schools” 
Or “Private schools” 
Or “Protestant missionary schools” 
Or “Public schools” 
Or “Religious residential schools 
Or “Religious schools” 
Or “Residential schools” 
Or “Roman catholic schools” 
Or “Schools” 
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Or “Secondary schools” 
Or “Special schools” 
Or “Steiner schools” 
Or “Summer schools” 
Or “Sunday schools” 
Or “Supplementary schools” 
Or “Truancy”) 
Or (school* or academ*) 
Or (colleg* or lesson* 
Or (SU.Exact.Explode(“School psychologists”) 
Or SU.Exact.Explode(“School nurses”) 
Or SU.Exact.Explode(“School psychology”) 
Or SU.Exact.Explode(“School nursing”) 
And SU.Exact.Explode(“Asthma” 
Or “Chronic asthma” 
Or “Occupational asthma”) 
Or asthma* 
And ((self-car* or (Self near/0 car* 
Or educat*) 
Or SU.Exact.Explode(“Selfcare”) 
Or SU.Exact.Explode(“Alcohol education” or “behavioural health education” or “drug 
education” or “health education” or sexual health education”) 
Or SU.Exact.Explode(“Patient education”) 
Or SU.Exact.Explode(“Patient centredness”) 
Or SU.Exact.Explode(“Patient care”)) 
Or SU.Exact.Explode(“Case management”) 
Or (manag* or train*) 
Or (instruct* or teach*) 
Or (patient near/0 focus* or patient-focus*) 
Or (coach* or skill*)) 
Or ((knowledge near/0 develop*) 
Or tutor*)) 
 
CENTRAL 
 
TI = title; AB = abstract’ KY = keywords 
#1 MeSH descriptor Asthma explode all trees 
#2 Asthma*: TI, AB, KY 
#3 #1 or #2 
#4 MeSH descriptor Schools explode all trees 
#5 MeSH descriptor School Health Services explode all trees 
#6 MeSH descriptor School nursing explode all trees 
#7 School*: TI, AB, KY or Academ*: TI, AB, KY or Colleg*: TI, AB, KY or Lesson*: TI, AB, 
KY or Pupil*: TI, AB, KY 
#8 #4 or #5 or #6 or #7 
#9 Educat*: TI, AB, KY or Manag*: TI, AB, KY or Self-car*: TI, AB, KY or self NEXT car*: 
TI, AB, KY or Train*: TI, AB, KY or Instruct*: TI, AB, KY or Teach*: TI, AB, KY or Patient-
cent*: TI, AB, KY or patient NEXT cent*: TI, AB, KY or Patient-focus: TI, AB, KY or Patient 
NEXT focus: TI, AB, KY or Coach*: TI, AB, KY or Skill*: TI, AB, KY or Knowledge NEXT 
develop*: TI, AB, KY or Tutor*: TI, AB, KY 
#10 MeSH descriptor Self care explode all trees 
#11 MeSH descriptor Health education explode all trees 
#12 MeSH descriptor Case management explode all trees 
#13 MeSH descriptor Patient education explode all trees 
#14 MeSH descriptor Patient-centered care explode all trees 
#15 #9 or #10 or #11 or #12 or #13 or #14 
#16 #3 and #8 and #15 
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AMED 
 
#1 exp Asthma/ 
#2 exp Schools/ 
#3 asthma*.mp. [mp = title, other title, abstract, heading words] 
#4 #1 or #3 
#5 exp School health services/ 
#6 exp School nursing/ 
#7 (School* or academ* or colleg* or lesson* or pupil*).mp. 
#8 #2 or #5 or #6 or #7 
#9 (educat* or manag* or self-car* or train* or instruct* or teach* or patient-cent* or coach* or 
skill* or tutor*).mp. 
#10 ((self adj1 car*) or (patient adj1 cent*) or (patient adj1 focus*) or (knowledge adj1 
develop*)).mp. 
#11 exp Self care/ 
#12 exp Health education/ 
#13 exp Case management/ 
#14 exp Patient education/ 
#15 exp Patient centred care/ 
#16 #9 or #10 or #11 or #12 or #13 or #14 or #15 
#17 #4 and #8 and #16 
#18 from 17 keep 1-100 
#19 Limit 18 to yr = 1995-current 
 
PSYCINFO 
 
Full search conducted 
 
CINAHL 
 
#1 asthma* 
#2 (MH “Asthma+”) 
#3 (MH “Schools+”) or (MH “School health services+”) or (MH “School nursing+”) or School* 
or Academ* or Colleg* or Lesson* or Pupil* 
#4 (MH “Self Care+”) or (MH “Health Education+”) or (MH “Case Management+”) or (MH 
“Patient education+”) or Educat* or Manag* or Self-car* or Self n1 car* or Train* or Instruct* 
or Teach* or Patient-cent* 
#5 Patient n1 cent* or (MH “Patient-centered care+”) or Patient-focus* or Patient N1 focus* or 
Coach* or Skill* or Knowledge n1 develop* or Tutor* 
#6 #4 or #5 
#7 #1 or #2 
#8 #3 and #6 and #7 
 
PubMed 
 
Search everywhere 
(((“Asthma” [Mesh] or asthma*)) 
And (((“Schools” [Mesh]) 
Or “School health services” [Mesh]) 
Or “School nursing” [Mesh] 
Or school* 
Or academ* 
Or colleg* 
Or lesson* 
Or pupil*)) 
And (((((“Self care” [Mesh]) 
Or “Health education” [Mesh] 
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Or “Case management” [Mesh]) 
Or “Patient education as topic” [Mesh]) 
Or “Patient-centered care” [Mesh] 
Or Educat* 
Or Manag* 
Or Self-car* 
Or Self n1 car*) 
Or Train* 
Or Instruct* 
Or Teach* 
Or Patient-cent* 
Or (Patient n1 cent*) 
Or Patient-focus*) 
Or Patient n1 focus* 
Or Coach* 
Or Skill* 
Or (Knowledge n1 develop*) 
Or Tutor*) 
And 1995 
Search run as protocol (MESH terms consistent etc) 
After 1/1/1995 filter applied 
 
HMIC 
 
Same strategy as AMED 
 
IBSS 
 
((SU.Exact.Explode 
(“Boarding schools” 
Or “Charter schools” 
Or “City technology colleges” 
Or “Classroom management” 
Or “Classrooms” 
Or “Comprehensive schools” 
Or “Continuation high schools” 
Or “Denominational schools” 
Or “Elementary schools” 
Or “Girls’ schools” 
Or “Grant maintained schools” 
Or “High schools” 
Or “Hospital schools” 
Or “Independent schools” 
Or “Infant schools” 
Or “International schools” 
Or “Islamic schools” 
Or “Jewish schools” 
Or “Junior high schools” 
Or “junior schools” 
Or “Junior secondary schools” 
Or “Kindergartens” 
Or “Language schools” 
Or “Middle schools” 
Or “Missionary schools” 
Or “Neighbourhood schools” 
Or “Nursery schools” 
Or “Preparatory schools” 
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Or “Preschools” 
Or “Primary schools” 
Or “Private schools” 
Or “Protestant missionary schools” 
Or “Public schools” 
Or “Religious residential schools 
Or “Religious schools” 
Or “Residential schools” 
Or “Roman catholic schools” 
Or “Schools” 
Or “Secondary schools” 
Or “Special schools” 
Or “Steiner schools” 
Or “Summer schools” 
Or “Sunday schools” 
Or “Supplementary schools” 
Or “Truancy”) 
Or (school* or academ*) 
Or (colleg* or lesson* 
Or (SU.Exact.Explode(“School psychologists”) 
Or SU.Exact.Explode(“School nurses”) 
Or SU.Exact.Explode(“School psychology”) 
Or SU.Exact.Explode(“School nursing”) 
And SU.Exact.Explode(“Asthma” 
Or “Chronic asthma” 
Or “Occupational asthma”) 
Or asthma* 
And ((self-car* or (Self near/0 car* 
Or educat*) 
Or SU.Exact.Explode(“Selfcare”) 
Or SU.Exact.Explode(“Alcohol education” or “behavioural health education” or “drug 
education” or “health education” or sexual health education”) 
Or SU.Exact.Explode(“Patient education”) 
Or SU.Exact.Explode(“Patient centredness”) 
Or SU.Exact.Explode(“Patient care”)) 
Or SU.Exact.Explode(“Case management”) 
Or (manag* or train*) 
Or (instruct* or teach*) 
Or (patient near/0 focus* or patient-focus*) 
Or (Coach* or skill*)) 
Or ((Knowledge near/0 develop*) 
Or tutor*)) 
 
SOCABS 
 
Same strategy as IBSS 
 
SPP 
 
Same strategy as HMIC 
 
NHS EED; DARE 
 
#1 MeSH descriptor “asthma” explode all trees 
#2 (Asthma*) 
#3 #1 or #2 
#4 MeSH descriptor “school nursing” explode all trees 
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#5 MeSH descriptor “school health services” explode all trees 
#6 MeSH descriptor “schools” explode all trees 
#7 (School*) or (Academ*) or (Colleg*)  
#8 (Lesson*) or (Pupil*) 
#9 MeSH descriptor “self care” explode all trees 
#10 MeSH descriptor “health education” explode all trees 
#11 MeSH descriptor “case management” explode all trees 
#12 MeSH descriptor “patient education” as topic; explode all trees 
#13 (Educat*) or (Manag*) or (Self-Car*)  
#14 (Self near Car*) or (Train*) or (Instruct*)  
#15 (Teach*) or (Patient-cent*) or (Patient near Cent*) 
#16 (Patient-focus*) or (Coach*) or (Skill*)  
#17 (Knowledge near Develop*) or (Tutor*)  
#18 (School*) or (Academ*) or (Colleg*) 
#19 (Lesson*) or (Pupil*)  
#20 (Educat*) or (Manag*) or (Self-Car*) 
#21 (Self near Car*) or (Train*) or (Instruct*)  
#22 (Teach*) or (Patient-Cent*) or (Patient near cent*)  
#23 (Patient-focus*) or (Patient near focus*) or (Coach*) 
#24 (Skill*) or (Knowledge near develop*) or (Tutor*) 
#25 #9 or #10 or #11 or #12 or #20 or #21 or #22 or #23 or #24 
#26 #4 or #5 or #6 or #18 or #19 
#27 #3 and #25 and #26  
 
BIBLIOMAP 
 
#1 Free text: “asthma*” 
#2 Free text: “school*” or “academ*” or “colleg*” or “lesson*” or “pupil*” 
#3 Free text: “educ*” or “manag*” or “self-car*” or “train*” or “instruct*” or “teach*” or 
“patient-cent*” or “patient-focus*” or “coach*” or “skill*” or “tutor*” 
#4 Free text: “self car*” or “patient cent*” or “patient focus*” or “knowledge develop*” 
#5 #3 or #4 
#6 #1 and #3 and #5 
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Appendix 12a: Data Tables for Process Evaluation Models 
Model One: Setting and Participant Characteristics 
 Successful 
Intervention 
School-
based 
Health 
Centre 
High 
School 
Parents 
Involved 
Teacher 
Training 
Stakeholder 
Training 
Joseph 
2010 
0.52 0.55 1 0 0 0 
Kouba 
2012 
0.33 0.33 1 1 0 0 
Dore-Stites 
2007 
0.67 0.66 0 1 0 0 
Joseph 
2013 
1.00 0.55 1 0 0 0 
Mujuru 
2011 
0.67 0.66 0 0 1 0 
Henry 
2004 
0.83 0.33 1 0 1 0 
Pike 2011 0.67 0.33 0 0 1 0 
Spencer 
2000 
0.33 0.66 0 1 0 0 
Engelke 
2013 
0.50 0.66 0.5 1 1 1 
Splett 2006 0.50 1.00 0.5 0 1 1 
Kintner 
2012 
0.83 0.66 1 1 0 1 
Berg 2004 0.83 0.66 1 0 0 0 
Howell 
2005 
0.33 0.75 0 1 0 0 
Gerald 
2006 
0.33 0.55 0 0 0 0 
Langenfeld 
2010 
0.33 0.66 0 0 1 0 
Al-Sheyab 
2012 
0.83 0.33 1 0 0 0 
Levy 2006 0.52 0.33 0 0 1 0 
Terpstra 
2012 
1.00 0.66 0.66 1 0 0 
Horner 
2015 
0.67 0.66 0 0 0 0 
Bruzzese 
2008 
0.94 0.66 0.66 1 0 0 
Lee 2011 0.50 0.66 0 0 0 0 
Bruzzese 
2004 
0.33 0.55 1 0 0 1 
Cicutto 
2013 
0.67 0.33 0 0 0 1 
Brasler 
2006 
0.00 0.66 0.66 1 0 0 
Crane 2014 0.50 0.33 0 0 0 0 
Bruzzese 
2011 
0.88 0.55 1 0 0 1 
Magzamen 
2008 
0.19 0.55 0.75 0 1 0 
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Model Two: Recruitment and Retention Processes 
 Successful 
intervention 
Provision of 
additional 
marketing 
materials 
Provision of 
incentives 
Make-up 
sessions 
provided 
Reminders 
for activity 
attendance 
Joseph 2010 0.52 1 1 0 0 
Kouba 2012 0.33 1 0 1 0 
Dore-Stites 2007 0.67 1 1 0 0 
Joseph 2013 1.00 1 1 0 0 
Mujuru 2011 0.67 0 0 0 1 
Henry 2004 0.83 0 0 0 0 
Pike 2011 0.67 0 0.5 0 0 
Spencer 2000 0.33 1 0 0 0 
Engelke 2013 0.50 0 0 0 0 
Splett 2006 0.50 0 0 0 0 
Kintner 2012 0.85 1 1 1 0 
Berg 2004 0.83 0 1 0 0 
Howell 2006 0.33 0 1 1 1 
Gerald 2006 0.33 0 0 0 0 
Langenfeld 2010 0.33 0 1 0 0 
Al-Sheyab 2012 0.83 0 0 0 0 
Levy 2006 0.52 0 0 0 0 
Terpstra 2012 1.00 1 1 1 1 
Horner 2015 0.67 0 0 0 0 
Bruzzese 2008 0.94 0 0 1 0 
Lee 2011 0.50 0 0.75 0 0 
Bruzzese 2004 0.33 0 1 0 1 
Cicutto 2013 0.67 0 0 1 0 
Brasler 2006 0.00 1 1 1 1 
Crane 2014 0.50 0 0 0 0 
Bruzzese 2011 0.88 0 0 1 0 
Magzamen 2008 0.19 1 1 0 1 
 
 
 
 
 
 
 
 
 
 
Model Three: Curriculum, Pedagogy and Intervention Emphasis 
 Successfu
l 
Interventi
on 
Curriculu
m: 
Forming 
Alliances 
and 
Monitori
ng 
Symptom
s 
Curricul
um 
Reflected 
Learning 
about 
Asthma 
Triggers 
and 
Monitori
ng 
Symptom
s 
Emphasis 
on 
Interventi
on as 
Tailored 
or 
Personali
sed 
Emphasis 
on 
Developing 
Personal 
Responsibi
lity 
Pedagogi
cal Style 
Focussed 
on 
Interacti
ve 
Methods 
Diverse 
Pedagogi
cal Style 
Joseph 
et al 
(2010) 
0.52 0 1 1 0 0 0 
Kouba 
et al 
(2012) 
0.33 0 0 0 1 0 0 
Dore-
Stites 
(2007) 
0.67 1 0 0 1 0 0 
Joseph 
et al 
(2013) 
1.00 0 1 1 0 0 1 
Mujuru 
et al 
(2011) 
0.67 0 1 0 0 0 0 
Henry et 
al 
(2004) 
0.83 0 0 0 0 0 0 
Pike et 
al 
(2011) 
0.67 0 1 0 0 0 0 
Spencer 
et al 
(2000) 
0.33 0 0 0 0 1 0 
Engelke 
et al 
(2013) 
0.50 0 0 0 0 0 1 
Splett et 
al 
(2006) 
0.50 0 0 0 0 1 0 
Kintner 
et al 
(2012) 
0.83 0 1 0 0 0 0 
Berg et 
al 
(2004) 
0.83 0 1 1 0 0 0 
Howell 
(2005) 
0.33 0 1 0 0 0 0 
Gerald 
et al 
(2006) 
0.33 1 0 0 0 0 0 
Cheung 
et al 
(2015) 
0.33 0 0 0 1 0 0 
Al-
Sheyab 
0.83 0 1 0 1 0 1 
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et al 
(2012) 
Levy et 
al 
(2006) 
0.52 0 0 0 0 0 1 
Terpstra 
et al 
(2012) 
1.00 1 0 0 1 0 0 
Horner 
et al 
(2015) 
0.67 1 0 0 1 0 0 
Bruzzes
e et al 
(2008) 
0.94 0 1 0 1 0 0 
Lee 
(2011) 
0.50 0 0 0 0 0 1 
Bruzzes
e et al 
(2004) 
0.33 0 0 1 0 0 0 
Cicutto 
et al 
(2013) 
0.67 1 0 0 0 0 0 
Brasler 
and 
Lewis 
(2006) 
0.00 0 1 0 0 0 0 
Crane et 
al 
(2015) 
0.50 0 0 0 1 0 0 
Bruzzes
e et al 
(2011) 
0.88 0 0 1 0 0 0 
Magzam
en et al 
(2008) 
0.19 0 1 0 0 0 0 
Model Four: Modifiable Design Features 
 Intervention 
success 
Theory 
driven 
Personalised 
or 
individualised 
sessions 
Implemented 
during 
lesson time 
Implemented 
during free 
time 
School 
nurse 
involved 
in 
delivery 
Joseph 2010 0.52 1 1 1 0.33 0 
Kouba 2012 0.33 1 1 0 1 0 
Dore-Stites 
2007 
0.67 1 0 0.33 0.33 0.66 
Joseph 2013 1.00 1 1 0.75 0.75 0 
Mujuru 
2011 
0.67 0 0 1 0 0 
Henry 2004 0.83 0 0 1 0 0 
Pike 2011 0.67 0 0 1 0 0 
Spencer 
2000 
0.33 0 1 0.33 0.33 0.66 
Engelke 
2013 
0.50 0 0.66 0.33 0.33 1 
Splett 2006 0.50 0 1 0.33 0.33 1 
Kintner 
2012 
0.83 1 0 1 1 0.66 
Berg 2004 0.83 1 0.66 0.33 0.33 0.66 
Howell 
2005 
0.33 1 1 0.33 0.33 0.66 
Gerald 2006 0.33 0 0 1 0.33 0 
Langenfeld 
2010 
0.33 0 1 0.33 0.33 1 
Al-Sheyab 
2012 
0.83 1 0 0.33 0.33 1 
Levy 2006 0.52 0 0.66 0.33 0.33 1 
Terpstra 
2012 
1.00 1 0 0 1 0.66 
Horner 
2015 
0.67 1 0 0 1 0 
Bruzzese 
2008 
0.94 1 0 0.33 0.33 0.66 
Lee 2011 0.50 1 0 1 0 0.66 
Bruzzese 
2004 
0.33 1 1 0.75 0.75 0 
Cicutto 
2013 
0.67 1 0 0 1 0 
Brasler 
2006 
0.00 0 0 0.75 0.75 0.66 
Crane 2014 0.50 1 0 0 1 0.66 
Bruzzese 
2011 
0.88 1 1 0.33 0.33 0 
Magzamen 
2008 
0.19 0 0 0 1 1 
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Model Five: Stakeholder Involvement and Engagement 
 Successful 
intervention 
School 
asthma 
policy 
Good 
relationships/engagement 
with students 
Good 
relationships/engagement 
with school nurses 
Child 
satisfaction 
Joseph 2010 0.52 0 0 0 0 
Kouba 2012 0.33 0 0 0 0 
Dore-Stites 
2007 
0.67 0 0.75 1 1 
Joseph 2013 1.00 0 1 0 0 
Mujuru 2011 0.67 0 0.25 0 0 
Henry 2004 0.83 1 0 0 0 
Pike 2011 0.67 0 0 0 0 
Spencer 2000 0.33 0 1 1 0 
Engelke 2013 0.50 1 1 0 0 
Splett 2006 0.50 1 0 1 0 
Kintner 2012 0.83 0 0.25 0 1 
Berg 2004 0.83 0 0 0 1 
Howell 2005 0.33 0 0.75 0.75 0.63333 
Gerald 2006 0.33 0 0 0 0 
Langenfeld 
2010 
0.33 1 0 1 0 
Al-Sheyab 
2012 
0.83 0 0 0 0.63333 
Levy 2006 0.52 1 0 0 0 
Terpstra 2012 1.00 0 0.25 0 0 
Horner 2015 0.67 0 0 0 0 
Bruzzese 2008 0.94 0 1 0 1 
Lee 2011 0.50 0 0 0 0 
Bruzzese 2004 0.33 0 0 0 0.63333 
Cicutto 2013 0.67 1 0  0 
Brasler 2006 0.00 1 0 1 0.63333 
Crane 2014 0.50 0 0 1 0 
Bruzzese 2011 0.88 0 0 0 0 
Magzamen 
2008 
0.19 0 0 0 0 
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Appendix 12b: Truth Tables for Process Evaluation Models 
Model One: Setting and Participant Characteristics 
 School 
health 
centre 
High 
school 
Parents 
involved 
Teacher 
training 
Stakeholder 
training 
Outcome 
Code 
(based on 
consistency 
score) 
Studies with 
membership 
in causal 
combination 
> 0.5 
Consistency 
score with 
sub-set 
relationship 
Proportional 
reduction in 
inconsistency 
Studies 
1 1 1 0 1 0 1 2 1 1 Bruzzese 
2008; 
Terpstra 
2012 
2 1 0 1 0 0 1 1 1 1 Henry 
2004 
3 1 1 1 1 1 1 1 1 1 Kintner 
2012 
4 0 0 1 0 1 1 1 0.995 0.99 Cicutto 
2013 
5 0 0 0 0 0 1 2 0.918 0.588 Crane 
2014; Pike 
2011 
6 1 0 0 0 0 1 1 0.889 0.811 Al-Sheyab 
2012 
7 1 1 0 0 1 0 2 0.865 0.662 Bruzzese 
2004; 
Bruzzese 
2011 
8 1 1 0 0 0 0 4 0.852 0.761 Berg 2004; 
Joseph 
2010; 
Joseph 
2013; 
Magzamen 
2008 
9 0 1 0 0 0 0 4 0.845 0.543 Horner 
2015; 
Langenfeld 
2010; Lee 
2011; 
Mujuru 
2011 
10 0 0 1 0 0 0 1 0.763 0.136 Levy 2006 
11 0 1 1 0 0 0 1 0.754 0 Gerald 
2006 
12 1 0 0 1 0 0 1 0.751 0.647 Kouba 
2012 
13 0 1 0 1 0 0 3 0.73 0.56 Dore-Stites 
2007; 
Howell 
2005; 
Spencer 
2000 
14 1 1 1 1 0 0 1 0 0 Brasler 
2006 
 
Model Three: Curriculum, Pedagogy and Intervention Emphasis 
 Curriculum: 
forming 
alliances/monitor
ing symptoms 
Curriculum: asthma 
triggers/monitoring 
symptoms 
Tailored/personalised 
intervention 
Aim: 
developing 
personal 
responsibility 
Pedagogical 
style focused 
on 
interactive 
methods 
Diverse 
pedagogical 
style used 
Outcome 
code 
Studies with 
membership 
in causal 
combination 
>0.5 
Consistency 
score with 
sub-set 
relationship 
Proportional 
reduction in 
inconsistency 
Studies 
1 0 1 1 0 0 1 1 1 1 1 Joseph 
2013 
2 0 1 0 1 0 0 1 1 0.938 0.933 Bruzzese 
2008 
3 0 0 0 0 0 0 0 1 0.833 0.8 Henry 
2004 
4 0 1 0 1 0 1 0 1 0.833 0.8 Al-Sheyab 
2012 
5 1 0 0 1 0 0 0 3 0.778 0.714 Dore-Stites 
2007; 
Horner 
2015; 
Terpstra 
2012 
6 0 1 1 0 0 0 0 2 0.677 0.523 Berg 2004; 
Joseph 
2010 
7 0 0 1 0 0 0 0 2 0.604 0.486 Bruzzese 
2004; 
Bruzzese 
2011 
8 0 0 0 0 0 1 0 3 0.507 0.027 Engelke 
2013; Lee 
2011; 
Levy 2006 
9 1 0 0 0 0 0 0 2 0.5 0.25 Cicutto 
2013; 
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Gerald 
2006 
 
 
 
 
10 0 1 0 0 0 0 0 6 0.448 0.287 Brasler 
2006; 
Howell 
2005; 
Kintner 
2012; 
Magzamen 
2008; 
Mujuru 
2011; Pike 
2011 
11 0 0 0 0 1 0 0 2 0.717 0 Spencer 
2000; 
Splett 
2006 
12 0 0 0 1 0 0 0 3 0.389 0 Crane 
2014; 
Kouba 
2012; 
Langenfeld 
2010 
Model Four: Modifiable Design Features 
The
ory 
driv
en 
Persona
lised or 
individu
al 
sessions 
Impleme
nted 
during 
lesson 
time 
Impleme
nted 
during 
free 
time 
Scho
ol 
nurse 
invol
ved 
in 
deliv
ery 
Outc
ome 
code 
Studies 
with 
member
ship in 
causal 
combin
ation 
>0.5 
Consist
ency 
score 
with 
sub-set 
relation
ship 
Proporti
onal 
reductio
n in 
inconsist
ency 
1 0 0 0 1 1 2 1 1 
1 0 0 0 0 1 1 1 1 
1 0 1 1 1 1 1 1 1 
1 1 0 0 0 1 1 0.996 0.993 
1 0 0 1 1 1 1 0.931 0.816 
1 1 1 0 0 1 2 0.931 0.872 
1 0 1 0 1 1 1 0.903 0.729 
1 1 1 1 0 0 2 0.852 0.729 
1 0 0 1 0 0 2 0.833 0.706 
1 1 0 0 1 0 2 0.753 0.602 
1 1 0 1 0 0 1 0.732 0.481 
0 0 1 0 0 0 5 0.659 0.035 
0 1 0 0 1 0 0 4 0.683 
0 0 1 1 1 0 0 1 0.05 
0 0 0 1 1 0 0 1 0.444 
 
 
 
 
Model Five: Stakeholder Involvement and Engagement 
 
 School 
policy 
Good parent 
relationship/engagement 
Good school nurse 
relationship/engage
ment 
Child 
satisfaction 
Outcome 
code 
Number of studies 
with membership in 
causal combination 
>0.5 
Consistency 
score with 
sub-set 
relationship 
Proportional 
reduction in 
inconsistency 
Studies 
1 0 1 0 0 1 1 1 1 Joseph 2013 
2 0 1 0 1 1 1 0.958 0.939 Bruzzese 2008 
3 0 0 0 1 1 4 0.857 0.786 Al-Sheyab 2012; Berg 2004; 
Bruzzese 2004; Kintner 2012 
4 0 1 1 1 0 2 0.723 0.465 Dore-Stites 2007; Howell 
2005 
5 1 0 0 0 0 3 0.674 0.515 Cicutto 2013; Henry 2004; 
Levy 2006 
6 0 0 0 0 0 10 0.615 0.405 Bruzzese 2011; Gerald 2006; 
Horner 2015; Joseph 2010; 
Kouba 2012; Lee 2011; 
Magzamen 2008; Mujuru 
2011; Pike 2011; Terpstra 
2012 
7 0 0 1 0 0 1 0.6 0 Crane 2014 
8 1 1 0 0 0 1 0.5 0 Engelke 2013 
9 0 1 1 0 0 1 0.488 0 Spencer 2000 
10 1 0 1 0 0 2 0.352 0 Langenfeld 2010; Splett 2006 
11 1 0 1 1 0 1 0 0 Brasler 2006 
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Appendix 13: Intervention Protocol 
Title: Multifaceted theory-based self-management intervention to improve adolescents’ asthma 
control: A cluster randomised controlled trial (RCT) 
Protocol version: 1.0 
Date of Protocol: 7th December 2017 
Grant Reference: MGU0400 
REC Reference: QMERC2017/77 
Date of Ethical Approval: 12th April 2018 
Principal Investigator (PI): Professor Jonathan Grigg 
Co-Investigator 1: Professor Chris Bonell2 
Co-Investigator 2: Professor Chris Griffiths3 
Co-Investigator 3: Dr Liz Steed3 
Co-Investigator 4: Kate Harris1 
Co-Investigator 5: Dr Gioia Mosler1 
Organisations: (1) Genomics and Child Health, Blizard Institute, Barts and the London School 
of Medicine and Dentistry; (2) London School of Hygiene and Tropical Medicine; (3) Centre for 
Primary Care and Public Health, Barts and the London School of Medicine and Dentistry 
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1. Study Summary 
Full Title Multifaceted theory-based self-
management intervention to improve 
adolescents’ asthma control: A cluster 
randomised controlled trial 
Short Title My Asthma in School 
Protocol Version 1.0 
Protocol Date 7th December 2017 
Methodology Pilot cluster RCT 
Study Duration 2 years 
Study Centres Barts and the London School of Medicine 
and Dentistry, Queen Mary, University of 
London; Centre for Primary Care and 
Public Health, Queen Mary, University of 
London 
Primary Objectives To test the effectiveness of an intervention 
to improve asthma control in adolescents 
with asthma, through a targeted school-
based self-management intervention 
Secondary Objectives (1) Raise awareness of asthma in 
schools among peers; (2) Facilitate the 
capacity of young people to communicate 
about their asthma to heath care 
professionals  
Number of Participants At least 360 children with doctor-
diagnosed asthma across all three groups 
(approximately 20 asthmatic children 
from 18 schools), accounting for a 15% 
attrition rate 
Main Inclusion Criteria Year 7 & 8 Secondary school children in 
Greater London 
Statistical Methodology and Analysis Descriptive statistics, Mann-Whitney U 
tests, chi-squared analysis 
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3. Glossary of Terms and Abbreviations 
Term Acronym Page Number 
Principal Investigator PI 1 
United Kingdom UK 6 
Inhaled Corticosteroids ICS 6 
Long-Acting Beta-Agonists LABA 6 
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Asthma Control Test ACT 6 
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Medical Research Council MRC 7 
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324 
 
4. Rationale and Background 
Approximately 1.1 million children and young people in the United Kingdom (UK) are living 
with asthma, making it the most common chronic disease in children in the UK. According to the 
Global Initiative for Asthma [2], people with good asthma control should not experience 
troublesome symptoms. Despite this, asthma-related morbidity and mortality in the UK is 
disproportionally higher than in most other western countries; however the reasons for this remain 
unclear. In the UK and Ireland, approximately 15% of the respective populations are living with 
asthma [17]. This is in comparison with the rest of Western Europe, where asthma prevalence is 
approximately 6% [59]. In England, asthma mortality among 5-34 year olds is approximately 3.2 
per 100,000 asthmatics, compared with European nations such as Finland and Sweden, where 
mortality rates are 1.6 and 2.0 per 100,000 asthmatics, respectively [1]. According to the National 
Review of Asthma Deaths [14], asthma-related deaths in the UK are preventable in up to 65% of 
cases. Factors identified in the review, that have been found to be associated with asthma-related 
deaths, include poor medication adherence, as well as a poor understanding of the risks related to 
the condition, especially in children and young people.  
Our recent observational study [258] evaluated current levels of asthma control and self-
management in adolescents. The study, in combination with our earlier focus groups, informs 
about current levels of asthma control among adolescents in London, and existing barriers to 
successful self-management. Poor asthma control, poor medication adherence, and poor 
understanding of asthma were identified as unmet needs of secondary school children. We found 
that 45.7% of the secondary school children in our sample had suboptimal asthma control, as 
indicated by a score of 19 or less out of 25 on the Asthma Control Test (ACT), and 60.4% of 
students did not take their Inhaled Corticosteroids (ICS) + Long-Acting Beta-Agonists (LABA) 
inhaler as prescribed; 30% of students did not take their Short-Acting Beta-Agonist (SABA) 
inhaler when they needed it [258]. The subsequent focus groups highlighted barriers to medication 
adherence among teenagers. The reported barriers included forgetfulness, incorrect or unhelpful 
medication beliefs, and social factors such as discomfort about taking medication at school due 
to embarrassment and bullying concerns. The focus groups also highlighted low levels of peer 
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awareness and perceived social stigma as a concern among teenagers. Concerns about 
communication with General Practitioner’s (GP) were also highlighted. For example, some 
students expressed concern that they see a different GP each time they have an appointment, and 
each GP says something different. Moreover, some students felt that it was difficult to understand 
the medical terminology often used in consultations, which made it difficult to follow doctor 
recommendations.  
A recent systematic review of school-based interventions, conducted by KH and JG with 
colleagues at the Institute of Education and Cochrane [200], conducted a process evaluation [175] 
and meta-analyses on included studies looking at school-based self-management interventions for 
children with asthma. The outcomes from this review identified that school-based self-
management interventions are successful at improving children’s outcomes across several areas, 
including reduced rates of unscheduled care, improved health-related Quality of life and improved 
medication use. The process evaluation component of the systematic review furthermore 
identified that a theoretical framework is an important component in intervention implementation 
success.  
Improving asthma understanding, self-efficacy, and unhelpful beliefs towards asthma and it’s 
treatment are key to improving adherence and self-management [9]. Better understanding and 
appropriate beliefs can empower teenagers to take control of their asthma, particularly when 
preparing for the transition to adult care. The effects of poor self-management and non-adherence 
can also last into adulthood, if a lack of self-management skills and awareness remains.  
Following the findings above, and the Medical Research Council (MRC) framework for complex 
interventions [247], a preliminary theory-based multifaceted intervention has been developed. 
This draws on our earlier work [258] and theory. This aims to improve asthma self-management 
and control in young people. The development of the intervention is theory driven, and addresses 
barriers to successful self-management. The PRECEDE-PROCEED model was used conduct the 
initial diagnosis of social, epidemiological, educational and administrative diagnosis.  We then 
used the behaviour change wheel [248] as a framework to translate identified behaviours into 
326 
 
specific interventions with specific translation into behaviour change techniques to maximise 
transparency of the intervention and understanding of the processes of action.  
The intervention will engage asthmatic teenagers and their peers. This will be delivered in three 
components:  
1. A theatre workshop for all year 7 and 8 students. The aim of this component is to raise 
awareness of asthma in schools among peers;  
2. A series of four self-management workshops for asthmatic students. The aim of this 
component is to teach children with asthma about the condition, using interactive 
elements, including role plays and games. The students will complete a questionnaire, at 
the beginning and end of the session, and every few months for 12 months post-
intervention, to test the effect of these workshops on their self-management behaviours. 
The questionnaire will include questions about asthma attitudes and beliefs, medication 
adherence, healthcare use, and school attendance. The students will also receive a 
resource pack to take home and go through with their parents, including a certificate of 
involvement and an ‘asthma passport’, which will include an asthma action plan and 
information about medication adherence; 
3. We will contact the parents of the children and send them the healthcare use component 
of the questionnaire, to validate the responses provided by the children, as the data being 
collected is all self-report.  
We will also continue testing different elements of the workshops in schools until the intervention 
is implemented.  
 
5. Study Objectives 
This study includes one primary objective, and two secondary objectives.  
5.1 Primary Objective 
The primary objective is to test the effectiveness of an intervention to improve asthma control in 
adolescents with asthma, through a targeted school-based self-management intervention.  
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5.2 Secondary Objectives 
The secondary objective of this study is to raise awareness of asthma in schools among peers. 
This will be addressed through the delivery of a theatre workshop, in collaboration with 
Greenwich and Lewisham Young People’s Theatre (GLYPT) Company.  
 
6. Study Design 
The study design is a cluster-randomised trial, with schools acting as the unit of allocation. There 
will be three intervention arms:  
(1) Asthma workshop and theatre group 
The asthma workshop and theatre group will receive the self-management workshops for 
asthmatic children and the theatre performance for the whole year group. 
(2) Theatre only group 
The “theatre only group” will receive the theatre performance only. The theatre only group was 
included as a treatment arm to identify whether raising awareness among peers was sufficient to 
change self-management behaviours among asthmatics, without the added self-management 
workshops.   
 (3) Control group  
The control groups will receive usual care for the duration of the intervention. 
The self-management workshops will take place in the interventions schools, over the course of 
one school day. The theatre performance will be delivered to students before the self-management 
workshops. Baseline data will be collected, followed by 3, 6 and 12 month follow-up post-
intervention. This method of follow-up data collection will be tested with teenagers during the 
pilot study.  
7. Recruitment 
The target population for this study is children with asthma in years 7 and 8, who are attending 
secondary school in London. In our earlier study, school recruitment was initially local, through 
partner organisations (such as the Centre of the Cell). After initially limited uptake, most London 
secondary schools (in excess of 700) were contacted via email and invited to take part. The sample 
size was calculated, based on a power calculation, using Asthma Control Test (ACT) score as the 
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primary outcome measure. Adjusting for a 15% attrition rate, a minimum of 360 children are 
required for this study, from 18 schools (6 schools in each arm of the intervention; 20 students 
with asthma from each school). Maintaining allocation concealment, the schools will be 
randomised to one of the three intervention arms. Participation will be offered to all of our existing 
partner schools (n = 24), as well as all other schools in London who have not previously 
participated in our research. All schools will be randomised to one of the three arms of the study. 
Control schools will be offered the full intervention at the end of the trial.  
The schools will be recruited via established recruitment strategies. This includes targeted emails 
and phone calls to teachers at each school to inform them of the research. The schools will be 
responsible for identifying eligible children (both asthmatic and non-asthmatic) and disseminating 
the information sheets and withdrawal forms to parents.  
7.1 Inclusion Criteria 
The inclusion criteria states that children with asthma will be eligible to participate if they have 
doctor-diagnosed asthma, are in years 7 or 8 at secondary school (aged 11 to 14 years), and are 
attending the secondary school in which the study is implemented.  
For the theatre component of the study, which will be delivered to the whole year group (asthmatic 
and non-asthmatic children), students will be eligible if they are in years 7 or 8, and are attending 
the school at the time that the theatre workshop is delivered.  
No inclusion criteria will be placed on schools, instead, state schools and private schools will be 
invited to participate. Children with special educational needs at participating schools will also 
be invited to participate, if they have capacity to provide assent. The research team will follow 
the school guidance for supporting these children (e.g. inviting their one-to-one support workers, 
if appropriate, to support the child through the study). 
7.2 Exclusion Criteria 
Students will not be eligible for participation in the workshops if they do not have asthma, as 
diagnosed by their doctor, they are not in years 7 or 8 at school, or they are not attending the 
school at the time that the intervention is delivered. Specialist units will be excluded from the 
study.  
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8. Summary of Investigational Plan 
Already established partner schools, from the earlier school-based asthma project, will be invited 
to participate. A minimum of 360 children from at least ten schools are required. A minimum of 
360 children with asthma will directly benefit from the intervention. Given a prevalence of 9%, 
approximately 1000 peers without asthma will also benefit from an increased understanding of 
life with asthma. If further schools are required, established recruitment strategies will be 
followed, including emails and telephone schools to designated teachers (e.g. head of science) in 
schools.  
The intervention comprises two components. In the first component, a theatre workshop will be 
delivered to the whole of year groups 7 & 8, by collaborators at GLYPT, and aims to raise 
awareness of asthma in schools. The second component will be a series of educational workshops 
delivered to children in years 7 & 8 with asthma only, to improve asthma control through self-
management.  
Opt-out consent for the intervention will be obtained from all parents of children with asthma, 
followed by student assent, which will be collected from participating students on the morning of 
the intervention. For the children without asthma, consent to participate in the theatre workshop 
will be provided by the school as part of a learning tool. This consent procedure was considered 
the most appropriate as it was used in our earlier schools-based research. Feedback from teachers 
suggested that opt-in consent was too time consuming, and opt-out consent was their preferred 
method.  
The results of this study will inform the development of a larger trial, to be delivered to UK 
secondary schools nationwide. The results of this trial will also influence national clinical 
guidance through the updating of the British Asthma Guidelines. The study will form a central 
element of the Asthma UK Centre for Applied Research’s (AUKCAR) programme to reduce risk 
of asthma death.  
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9. Methodology 
9.1 Outcome Measures 
The primary outcome in this study is asthma control, which will be measured using the validated 
Asthma Control Test [68]. The secondary outcomes are medication adherence, which will be 
measured using the Medication Adherence Rating Scale [249]; unscheduled care, which will be 
measured using the scale used in our earlier study [258]; asthma attitudes, which will be measured 
using the Brief Illness Perception Questionnaire [250]; school absences, which will be measured 
using the scale used in our earlier study [258]; asthma knowledge, which will be measured using 
a scale adapted from an earlier study about asthma [251]; and beliefs about asthma medication, 
which will be measured using the Beliefs about Medicine questionnaire [252].  
 9.2 GLYPT Theatre Workshops 
A drama workshop will be delivered to all students in years 7 and 8 in secondary schools, to 
facilitate awareness and understanding of asthma among the direct peer group. At the end of the 
theatre workshop, the main character will stay in role, and will encourage audience participation 
and discussion on the play. Earlier focus groups identified barriers to medication adherence 
among teenagers in schools, including a belief that their peers do not understand asthma. Through 
changing attitudes and awareness among peers at school, students with asthma should feel less 
concerned about the social barriers that currently prevent positive self-management behaviours.  
 9.3 Self-Management Workshops 
A total of four self-management workshops will be delivered to children with asthma, following 
delivery of the theatre workshop. Each workshop will last approximately one hour, and will 
include a series of games, role play, media (films) and discussion. The main topics will include 
asthma general knowledge and understanding; GP communication; asthma triggers and 
symptoms; medication and emergency response; and self-management techniques and goal 
setting. Schools will also receive a toolkit, which will include emergency response posters, and 
advice on asthma friendly schools.  
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 9.4 Statistical Analysis Plan 
All of the outcomes in this study will be evaluated using the outcome measures outlined in section 
10.1 of this protocol, and the findings from this study will be analysed quantitatively. Spearman’s 
rank order correlation co-efficient will be used to assess the relationship between asthma control 
scores and other continuous variables (e.g. age). Chi-squared analyses and Mann-Whitney U tests 
will be used to look at whether differences in attitudes and knowledge exist between the asthmatic 
and non-asthmatic children, and the differences in outcomes between the asthmatic children in 
the three arms of the study. Chi-square analyses will also assess differences in outcomes across 
subgroups, including gender and ethnicity. All statistical analyses will be discussed with a 
statistician.  
 
10. Safety Considerations and Ethics 
10.1 Risks 
Our previous work within schools did not highlight any risks or negative impact of taking part in 
our research. All parts of the intervention will be conducted in schools, therefore participating 
schools must enforce relevant health and safety practices. All members of the team will have up-
to-date enhanced DBS checks prior to entering the schools. Participants will be reminded during 
the workshops that they can leave at any time. All young people who have any concerns or further 
questions beyond the scope of the intervention will be signposted to online asthma information 
(for example the Asthma UK website), and will be encouraged to contact their GP.  
10.2 Data protection and confidentiality 
All data that is collected will be stored securely behind two locked doors, and will be accessible 
only by members of the research team as on ‘as needs’ basis. Questionnaire data will be stored 
electronically on QMUL computers, with the relevant electronic security certificates and 
protocols installed. All student identifiable data will be substituted with an anonymous identifier 
for the purposes of analysis. All participant data will remain confidential, and our procedures for 
handling, processing, storing and destroying data will be compliant with the Data Protection Act 
1998.  
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10.3 Data monitoring 
Random audits of the data quality will be performed by members of the investigating team (KH 
and GM), under the supervision of the PI. 
10.4 Premature termination of the study 
This study is scheduled to run for two years. It is not expected that there will be any cause for 
premature termination of the study.  
10.5 Ethical review 
The protocol will be reviewed by the Queen Mary University of London ethics committee.   
 
11. Study Timetable 
Months: 1 2 3 4 5   6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 
School 
recruitment & 
registration of 
asthmatics 
          
X 
 
X         X   X 
Intervention 
delivery 
         
X 
  
X         X   X 
Follow-up 1           X  X         X   X 
Follow-up 2          X  X         X   X 
Follow-up 3          X  X         X   X 
Analysis            X  X         X   X 
Writing up and 
dissemination 
         
X 
 
X         X   X 
X Key milestones 
The first key milestone is at the end of month 10: end of interventions in trial schools 
The second milestone is at the end of month 21: end of data collection 
X Deliverable 
Deliverable end of month 12: intermediate report to the funder 
Deliverable month 24: final report to the funder 
 
12. Statistical Analysis and Study Power 
The primary outcome measure used for the power calculation for this study is ACT score, as this 
is a continuous outcome and is therefore more sensitive to differences in asthma control. A power 
calculation will be used based on 80% power and a significance level of 5% to test a 3 point 
difference in ACT scores. This 3 point difference is chosen as this is the minimal important 
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difference. The standard deviation (SD) that is used in the power calculation (SD = 4.3) comes 
from our earlier school-based asthma study.  
The power calculation is adjusted to allow for Intracluster correlation (ICC), as is required for 
cluster randomised trials. An ICC of 0.07 was chosen, taken from a study of asthmatics where a 
questionnaire was the outcome measure, but the clusters to be randomised were GP surgeries 
rather than schools. This means that the ICC is likely to be a conservative estimate for our study, 
as children in different schools are likely to be less heterogeneous than patients in different GP 
surgeries.  
The findings from the intervention will be analysed quantitatively, using SPSS. Statistical 
analyses will include descriptive statistics, Mann-Whitney U tests, and chi-squared analysis. 
 
13. Sponsorship and Indemnity 
This trial will be sponsored by Queen Mary University of London. The contact details for the 
sponsor can be found at the beginning of the protocol. The Joint Research and Management Office 
(JRMO) will arrange suitable indemnity for negligent harm arising as a result of participation in 
this study to be in place.  
 
14. Dissemination 
Regular meetings will be held with key Patient and Public Involvement (PPI) stakeholder groups 
to plan key messages from our research. This will include the lay research advisory panel at the 
NIHR CLAHRC North Thames, as well as teachers, teenagers and parents.  
Established channels of social media will be used to disseminate the findings of the intervention. 
This will include the established twitter account for the project (@SchoolsAsthma) to reach key 
organisations, and tweet important messages related to this work.  
We will also work closely with our established partners, such as Healthy London Partnership, 
AUKCAR, and the Asthma UK knowledge exchange team to disseminate the findings to the 
media and relevant stakeholders, and to continue developing this research.  
The findings of the intervention will be submitted at national and international conferences, 
attended by clinicians within the field. We will also look to present our findings at local authority 
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health and well-being boards. The findings will also be submitted to a peer-reviewed journal. If 
successful, a grant application will be submitted to the NIHR to support the implementation of 
the intervention across the UK.  
Elements of this work is also presented at events organised by companies associated with our 
research. This has previously included the QMUL Festival of Communities, Barts Health NHS 
Trust Paediatric Asthma Study Day, and Barts and QMUL Science Festival. Attendees at these 
events have previously included school children and teachers, healthcare professionals, and the 
general public.  
Finally, the project’s research approach will be documented through a short documentary film, 
which will be available on the research team’s website.  
